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Introduction
Coronary artery disease (CAD) remains one of the leading causes of morbidity and mortality worldwide. 
Moreover, the disease is reaching endemic proportions and will put an enormous strain on health care eco-
nomics in the near future. Non-invasive testing is important to exclude CAD with a high certainty on the one 
hand, and to detect CAD with its functional consequences at an early stage, to guide optimal patient man-
agement, on the other hand. For these purposes, non-invasive imaging techniques have been developed 
and used extensively over the last years. Currently, the main focus of non-invasive imaging for diagnosis of 
CAD is twofold: 1. functional	imaging, assessing the hemodynamic consequences of obstructive CAD, and 
2. anatomical	imaging, visualizing non-invasively, the coronary artery tree. For functional imaging, nuclear 
cardiology, stress echocardiography and magnetic resonance imaging (MRI) are used, whereas for anatomi-
cal imaging or non-invasive angiography, MRI, multi-slice CT (MSCT) and electron beam CT (EBCT) are used.
The aim of this chapter is to update the reader on the current status of non-invasive imaging, with a special 
focus on functional imaging versus anatomical imaging for the detection of CAD. The accuracies of the 
different imaging modalities are illustrated using pooled analyses of the available literature data when 
available. 
Functional Imaging
What information does functional imaging provide?
The hallmark of functional imaging is the detection of CAD by assessing the hemodynamical consequences 
of CAD rather than by direct visualization of the coronary arteries. For this purpose, regional perfusion 
or wall motion abnormalities are induced (or worsened) during stress, reflecting the presence of stress-
induced ischemia. Ischemia induction is based on the principle that although resting myocardial blood 
flow in regions supplied by stenotic coronary arteries is preserved, the increased flow demand during stress 
cannot be met, resulting in a sequence of events referred to as “the ischemic cascade” 1. Initially perfusion 
abnormalities are induced, followed by diastolic and (at a later stage) systolic dysfunction; only at the very 
end of the cascade, ECG changes and angina occur (Figure 1).  
Accordingly, the occurrence of perfusion abnormalities during stress may be more sensitive for the 
detection of CAD than the induction of systolic dysfunction (wall motion abnormalities). 
Currently, functional imaging can be performed using (gated) SPECT or PET, (contrast) stress 
echocardiography and MRI; all techniques allow integrated assessment of perfusion and function, at rest 
and after stress and are used clinically according to local availability and expertise.
Types of stress
An increased demand can be achieved through physical (bicycle or treadmill) exercise, or (in 
patients unable to exercise), pharmacological stress can be applied including adrenergic stimulation 
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and vasodilation. Dobutamine (a beta-1-specific agonist) increases heart-rate, contractility and 
arterial blood pressure, resulting in increased myocardial oxygen demand. The vasodilators include 
dipyridamole and adenosine. Adenosine is a direct vasodilator, while dipyridamole inhibits cellular 
uptake and breakdown of adenosine. Dipyridamole therefore has a slower onset, while its effect lasts 
longer. Aminophylline can be used as antidote.
Safety of all pharmacological stressors has been investigated extensively and although continuous 
patient monitoring is required, severe complications are rare 2;3.
Which modalities are available for functional imaging?
SPECT,	assessment	of	perfusion
Most experience for assessment of perfusion in daily clinical practice has been obtained with SPECT. 
Three radiopharmaceuticals are used: thallium-201, technetium-99m sestamibi and technetium-99m 
Figure 2. Example of a reversible defect on technetium-99m tetrofosmin SPECT. Panels A and B show short-axis 
slices following stress and at rest, respectively. A reversible defect is present in the anterior and antero-lateral 
regions (white arrows), illustrating stress-inducible ischemia. A fixed perfusion defect, most likely representing 
scar tissue is present in the postero-lateral and inferior region. 
Figure 1. The ischemic cascade represents the sequence of pathophysiological events following ischemia. 
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tetrofosmin. Currently, the technetium-99m labeled tracers are preferred for their higher photon energy 
resulting in less attenuation artefacts. Two sets of images are obtained: after stress and at rest. In general, 
reversible and irreversible defects are considered indicative of CAD. While reversible (stress-induced) 
defects reflect ischemia, irreversible (fixed) defects mainly represent infarcted myocardium (Figure 2). 
Images are interpreted visually or using automated quantification. For segmentation of the left 
ventricle (LV), a 17-segment model is developed, that can be applied to all functional imaging 
modalities4. To assess the diagnostic accuracy of SPECT for detection of CAD, Underwood et al 
pooled 79 studies (n=8964 patients) showing a weighted mean sensitivity and specificity of 86% 
and 74% (Figure 3) 5. The lower specificity of SPECT may be (partially) attributable to referral bias, i.e. 
among patients with normal SPECT studies, only those with a high suspicion for CAD are referred for 
coronary angiography. To overcome this problem, the normalcy rate has been introduced, which is 
the percentage of normal SPECT studies in a population with a low likelihood of CAD. Pooled analysis 
of 10 studies (n=543 patients) showed a normalcy rate of 89%.5 
Figure 3. Sensitivities and specificities of SPECT imaging for the detection of CAD, using different stressors (Based 
on reference 5).
SPECT,	assessment	of	systolic	function	
The introduction of ECG-gated SPECT imaging, has allowed assessment of global and regional 
LV function in addition to perfusion. Direct comparisons between gated SPECT and MRI (or 
echocardiography) showed excellent correlations for assessment of LV ejection fraction, volumes 
and regional wall motion6;7. Addition of these systolic function parameters has improved diagnostic 
accuracy. In particular, artefacts caused by soft tissue attenuation, could be unmasked by the 
demonstration of normal wall motion. This resulted in a substantial reduction of false-positive test 
results 8. Integration of perfusion and systolic function by SPECT resulted in a significant reduction 
(from 31% to 10%) of inconclusive tests, with in an increase in normalcy rate from 74% to 93% 9. 
87
73
90
8585
79
89
66
86
74
0
20
40
60
80
100
Sensitivity Specificity
%
Exercise
Adenosine
Dobutamine
Dipyridamole
Combined
16 Chapter 1
Echocardiography,	assessment	of	systolic	function
Stress echocardiography is readily available for the routine evaluation of (stress-inducible) wall 
motion abnormalities (Figure 4); both resting and stress-induced (or worsened) wall motion 
abnormalities are indicative of CAD. While stress-induced (or worsened) wall motion abnormalities 
reflect ischemia, resting wall motion abnormalities mainly represent infarcted myocardium. 
Figure 4. Example of a stress-induced wall motion abnormality on dobutamine echocardiography. Panels A, B, C 
and D are obtained during rest, low- (10 μg/kg/min) and high-dose dobutamine (40 μg/kg/min) and recovery. In 
the septal region (white arrow), normal wall motion is present at rest and during low-dose dobutamine infusion, 
whereas dyskinesia is induced at high-dose dobutamine. 
A total of 15 studies (n=1849 patients) used exercise echocardiography to detect CAD, with a 
weighted mean sensitivity and specificity of 84% and 82%.10 Pooled data from 28 dobutamine 
echocardiography studies (n=2246 patients), showed a weighted mean sensitivity and specificity 
of 80% and 84% to detect CAD.10 The accuracies for the different forms of stress echocardiography 
are summarized in Figure 5. It has been demonstrated that continuation of beta-blockers reduced 
sensitivity, which could be improved by addition of atropine. Also, sensitivity increased in parallel 
to the number of diseased vessels, from 74% for 1-vessel disease to 92% for 3-vessel disease. 
Disadvantages of stress echocardiography in general include a suboptimal acoustic window in up 
to 25% of patients and drop-out of the anterior and lateral walls. Improved endocardial border 
delineation can be obtained by using second harmonic imaging and administration of intravenous 
contrast agents. 
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Figure 5. Diagnostic accuracy of stress (exercise and dobutamine) echocardiography (data based on reference 10).
Echocardiography,	assessment	of	perfusion	
At the same time the use of contrast agents has allowed the assessment of myocardial perfusion. 
After contrast injection, the micro-bubbles remain in the vascular space until they dissolve, and thus 
reflect the microvascular circulation. Accordingly, their relative concentrations in different regions 
of the myocardium (as measured by signal intensity) reflect the relative myocardial blood volume in 
those regions. Similar to SPECT, resting perfusion defects suggest infarcted myocardium, whereas 
stress-induced perfusion defects indicate ischemia. Currently, many modifications of the technology 
have been introduced and real-time assessment of perfusion by contrast echocardiography is now 
possible 11.
Recent studies from experienced centers showed an excellent agreement between SPECT and 
myocardial contrast echocardiography for detection of perfusion abnormalities, with a comparable 
sensitivity/specificity for the detection of CAD 12;13. In a head-to-head comparison, Jucquois et al 14 
demonstrated an agreement of 62% between SPECT and contrast echocardiography for detection of 
perfusion defects; the disagreement between the 2 techniques was related to attenuation artefacts 
and when these segments were excluded, the concordance improved to 82%.
The integration of assessment of perfusion and function by contrast echocardiography performed at 
rest and after stress should provide optimal information on the detection of CAD. Moir et al recently 
performed myocardial contrast echocardiography in addition to combined dipyridamole-exercise 
echocardiography in 85 patients 15. In 70 of these patients, data could be compared to conventional 
coronary angiography. Sensitivity for the detection of CAD was significantly improved by the addition 
of contrast from 74% to 91%; specificity on the other had showed a (non-significant) decrease from 
81% to 70%. Pooled analysis of the 7 currently available studies (n=245 patients) on the additive 
value of perfusion imaging with contrast to standard wall motion imaging showed similar results: 
the weighted mean sensitivity for detection of CAD was 89% with a specificity of 63% 15-21. 
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MRI,	assessment	of	perfusion	
A relatively new technique to evaluate myocardial perfusion is MRI. For this purpose, 5-8 slices in 
the short-axis orientation are imaged during the first pass of a bolus of a contrast agent. Imaging 
is repeated during pharmacological stress. The applied contrast agent, gadolinium, temporarily 
changes the T1-relaxation time and thereby increases the signal intensity of the perfused 
myocardium. In contrast, ischemic regions are identified as areas with little or reduced signal 
intensity (Figure 6). 
Figure 6. MR perfusion images in respectively rest (Panel A) and stress (Panel B) showing a fixed perfusion defect 
in the inferior wall (white arrows). Images were acquired using a breath hold sensitivity encoding imaging 
technique during the first pass of an intravenously administered bolus of Gadolinium contrast agent. 
Pooling of 17 MRI perfusion studies (n=502 patients, using either dipyridamole or adenosine stress) 
revealed a weighted mean sensitivity and specificity of 84% and 85% (Figure 7) 10;22-24. The high spatial 
resolution (approximately 2 mm), enables distinction between subendocardial and transmural 
perfusion defects. This is an important advantage over SPECT imaging, since the occurrence of 
subendocardial perfusion defects may indicate compromised blood flow at an early stage. 
For clinical routine, images are evaluated visually, although semi-quantitative assessment is possible 
by calculation of the myocardial perfusion reserve index 25;26. In the future, absolute quantification 
of myocardial perfusion may be allowed by the use of new intravascular contrast agents. At present 
however, quantitative analysis is still time-consuming and in order to fully exploit this modality in 
standard clinical routine, automated quantification algorithms are needed. 
MRI,	assessment	of	systolic	function	
In addition to myocardial perfusion, global and regional systolic LV function can also be obtained 
with MRI. The most widely used steady-state free precession technique allows clear identification of 
endocardial borders due to a high blood pool signal. In addition, the tomographic approach allows 
measurement of volumes without geometric assumptions, resulting in accurate measurements 
in severely distorted ventricles as well. Global and regional LV function can be obtained at rest 
and during stress (mainly using dobutamine). Pooled data of 10 dobutamine MRI studies (n=654 
patients) revealed a weighted mean sensitivity and specificity of 89% and 84% (Figure 7) 10;22.
The excellent endocardial-blood pool contrast is in particular beneficial for patients with poor 
echocardiographic windows. Unfortunately, MRI is still limited to highly specialized centers and 
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acquisition protocols are still time consuming, making the technique currently unsuitable for 
evaluation of larger populations. No MRI studies with integration of systolic wall motion and 
perfusion to detect CAD are currently available.  
Figure 7. Diagnostic accuracy of perfusion and wall motion imaging MRI (data are based on references 10;22-24). For 
the perfusion studies, adenosine or dipyridamole was used, while dobutamine was administered during the wall 
motion studies.
Anatomical Imaging
Why is anatomical imaging needed? 
Although a safe and accurate evaluation of patients with known or suspected CAD is offered by 
functional imaging, in a substantial number of patients anatomical imaging is needed.  First, in 
patients with abnormal stress tests, direct visualization of the coronary tree is still required for the 
definite diagnosis of CAD. Moreover, decisions on treatment strategy, e.g. whether the observed 
coronary lesions will be treated conservatively (medically) or more aggressively by means of PCI 
or CABG are based to a large extent on the findings of conventional coronary angiography. Also, 
in certain subpopulations, e.g. diabetes, functional imaging may be less reliable. In these patients, 
diffuse atherosclerosis in all major epicardial vessels is frequently present, resulting in the absence 
of detectable perfusion abnormalities. Considering the fact that if CAD is present, prognosis is 
substantially worse compared to non-diabetic individuals, knowledge of coronary anatomy is 
needed. Thus, besides detection of hemodynamical consequences, direct visualization of the 
coronary anatomy is frequently needed.  
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What is the current gold standard for anatomical imaging?
At present, conventional X-ray angiography with selective contrast injection through cardiac 
catheterization remains the reference standard for the evaluation of the coronary arteries. Both 
spatial (0.2 mm) and temporal resolution (5 ms) of the technique are extremely high. In addition, the 
degree of luminal narrowing can be precisely measured using quantitative coronary angiography. 
Also, when during the diagnostic procedure the presence of one or more significant lesions is 
confirmed, direct intervention is possible. 
Currently, approximately 3000 invasive diagnostic procedures per million inhabitants have been 
performed in Europe in 2001, which resulted in PTCA in only one out of three 27. The development of 
non-invasive imaging of the coronary arteries would potentially facilitate the access to anatomical 
imaging and expand the indications for revascularization. 
What are the available modalities for non-invasive anatomical imaging?
Currently, 3 techniques are being developed for non-invasive angiography, MRI, MSCT and EBCT. 
Although results are promising, all techniques still have shortcomings and limitations, hampering 
implementation in routine clinical practice. Since the coronary arteries are small, tortuous and show 
rapid movement during cardiac cycle, demands on spatial and temporal resolution of the techniques 
are tremendous. However, all techniques are developing at a rapid pace and as a result, image quality 
and diagnostic accuracy are continuously improving. 
Non-invasive	angiography	with	MRI	
More than 10 years ago, the first results of non-invasive angiography were reported by Manning 
and colleagues 28. The authors performed a comparison between 2D MRI and conventional 
angiography in 39 patients and observed a sensitivity and specificity of 90% and 92%, respectively. 
With these first generation techniques, data were acquired during consecutive breath holds, 
requiring substantial patient cooperation. To enable free breathing, navigator techniques, that 
allow real-time monitoring of diaphragm motion, have been developed. In combination with the 
development of 3-dimensional acquisition techniques, superior visualization of coronary anatomy 
was achieved. In Figure 8, examples of non-invasive coronary angiography with 3D MR acquisition 
techniques are provided. 
Pooled data from 28 studies (n=903 patients) directly comparing MRI with invasive angiography 
showed a weighted mean sensitivity of 72% with a specificity of 87%  (Figure 9). 29 However, the 
percentage of interpretable segments is still insufficient and exclusion of up to 30% of all segments 
has been reported, even with newer acquisition techniques. Thus, full coverage of the coronary 
arteries within a reasonable amount of time still cannot be achieved. Future developments in the 
area of coronary MRA, including higher field strengths (3T) and improved contrast techniques, 
such as balanced steady-state-free-precession techniques and the development of blood pool 
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contrast agents, will improve diagnostic accuracy. Moreover, extensive research is directed towards 
assessment of plaque composition as well as assessment of coronary flow, which may potentially 
enable the technique to provide a comprehensive evaluation of both the presence and extent, as 
well as the functional significance of CAD. 
Figure 9. Diagnostic accuracy of non-invasive coronary angiography with MRI in the detection of significant 
stenoses (data based on reference 29). 
Figure 8. Non-invasive coronary angiography with MRI. In Panel A, a native right coronary artery (black arrow) 
and a venous coronary bypass (white arrow) on the left anterior descending coronary artery can be observed. In 
contrast, Panel B depicts the right coronary artery (white arrows) of a healthy volunteer. Images were acquired 
with a 1.5 T system, using T2-preparation for background suppression during respiratory gating.  
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Non-invasive	angiography	with	MSCT	
More recently, MSCT has emerged as a potential modality for non-invasive angiography. Initial 
studies with 4-slice technology showed promising results, with sensitivities and specificities ranging 
from 66% to 90% and from 71% to 99%, respectively 29. However, the technique was still hampered by 
the high percentage of segments (approximately 25%) with non-diagnostic quality. Modern systems 
have an X-ray gantry rotation time of 400 ms or less while data are acquired using 16 or more parallel 
detectors with sub-millimeter collimation. At present, 11 studies with 16-slice technology have been 
reported 29. As expected, considerably more segments were available for evaluation, approximately 
96% of segments. Furthermore, an increase in sensitivity from (on average) 80% to 88% could also 
be observed with no loss in specificity  (Figure 10). With 64-slice systems that have recently become 
available, both the percentage evaluable segments and sensitivity are expected to improve further.
 
Figure 10. Diagnostic accuracy of non-invasive coronary angiography with 4- and 16-slice MSCT in the detection 
of significant stenoses (data based on reference 29). 
Since data are acquired during consecutive heartbeats, a stable heart rate is important in order to 
obtain good image quality. Similar to MRI, the technique has therefore limited value in patients 
with atrial fibrillation or frequent extra-systolic contractions, although for the latter raw data can 
sometimes be manually corrected. Other contra-indications to MSCT include renal failure or 
pregnancy due to the administration of contrast agent and the use of ionizing radiation, respectively. 
Moreover, the radiation dose associated with a MSCT examination is still considerably high and 
remains an important limitation of the technique. To reduce radiation dose, prospective X-ray tube 
modulation or more dedicated filtering may be applied while other dose reduction strategies are 
currently investigated. 
78 80
9496
88
96
0
20
40
60
80
100
120
% Assessable Sensitivity Specificity
%
4-slice
16-slice
23Cardiac Imaging in Coronary Artery Disease: Differing Modalities
Non-invasive	angiography	with	EBCT	
The first experiences with coronary angiography with EBCT were described in 1995 30. Instead of a 
mechanically rotating tube, X-rays are created through an electron beam that is guided along a 210° 
tungsten target ring in the gantry. As a result, a high-resolution image is acquired in 50 -100 ms. The 
acquisition of serial overlapping cross-sectional images with a 1.5 or 3.0 mm slice thickness is performed 
during the administration of an iodinated contrast agent, using prospective ECG triggering. To cover the 
whole heart, 40 to 50 slices are necessary, typically requiring a breath hold of 30 to 40 seconds, depending 
on the heart rate. Pooled analysis of the 10 available studies (n=583 patients) comparing contrast-
enhanced EBCT angiography with conventional angiography demonstrated a weighted mean sensitivity 
and specificity of 87% and 91% respectively 31; 16% of the coronary arteries were non-interpretable (Figure 
11). Similar to other non-invasive coronary angiography techniques, distal coronary segments are relatively 
more difficult to image, while coronary artery motion and breathing artifacts also frequently occur. 
Figure 11. Image quality and diagnostic accuracy of EBCT (Data based on reference 31). 
Coronary	artery	calcium	scoring	
Another, more frequently performed application of EBCT is the quantification of calcium in the 
coronary arteries. The presence of calcium serves as a marker of atherosclerosis. The absence 
of calcium virtually excludes atherosclerosis, and no further analysis is needed. This is also 
supported by the very low rate of cardiac events in patients without calcium on EBCT; Raggi et al 32 
demonstrated in 4800 patients without diabetes and no coronary calcium that the 5-year survival 
was 99.4%. By multivariate analysis, the presence of coronary calcium contributed to the prediction 
of all cause mortality in 9474 asymptomatic and non-diabetic subjects to the same extent as age, 
hyperlipidemia, hypertension and active smoking. Moreover, Berman et al 33 showed that <1% of 
patients with minimal coronary calcium had ischemia on SPECT imaging.
However, the presence of coronary calcium only indicates atherosclerosis in general and requires 
additional evaluation. In particular, no relation between the extent of coronary calcium and stenosis 
severity has been shown. 31
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Keypoints
1. In the presence of a significant coronary artery stenosis, a sequence of events called the “ischemic 
cascade” occurs during stress: first perfusion abnormalities occur, followed by wall motion 
abnormalities, while ECG changes and angina occur at a later stage.
2. Non-invasive imaging to assess CAD can be divided into functional imaging and anatomical 
imaging.
3. Functional imaging aims at assessment of the hemodynamic consequences of obstructive CAD; 
the available techniques are nuclear imaging (mainly SPECT), stress echocardiography (with the 
optional use of intravenous contrast agents) and MRI. 
4.  Currently, all three functional imaging modalities allow comprehensive evaluation including 
assessment of both perfusion and wall motion. 
5.  For non-invasive anatomical imaging, or non-invasive coronary angiography, MRI, MSCT and 
EBCT are used. These modalities do not yet assess the hemodynamic consequences of CAD.
Conclusion and outline of the thesis
As discussed in this chapter, the emphasis of non-invasive imaging has traditionally been on 
functional imaging (assessing the hemodynamic consequences of obstructive CAD, i.e. ischemia). 
Over the past decades, non-invasive imaging for the detection of CAD has mainly relied on SPECT 
and stress echocardiography, functional imaging techniques to assess perfusion or wall motion 
abnormalities (as markers of CAD) respectively. Over time, these techniques were considered 
complementary, rather than competitive, since they provided different information. At present 
however, both SPECT and echocardiography have developed into comprehensive imaging 
techniques, and each can assess both perfusion and wall motion. Similarly, MRI can also assess both 
perfusion and wall motion. Still, for proper patient management, knowledge on coronary anatomy 
is frequently needed and patients are subsequently referred for invasive angiography. 
 
With the more recent introduction of non-invasive coronary angiography, emphasis has shifted to 
anatomic imaging. In particular, initial results with MSCT have been promising. However, prior to optimal 
integration of this novel technique within daily clinical practice, several issues need to be considered. 
The aim of this thesis was to describe the value and potential role of MSCT within the multiple 
modalities that are available for evaluation of patients with suspected CAD.  
Initially, this new technique, allowing non-invasive coronary angiography, has been validated against 
conventional coronary angiography, as described in Chapters 2-4 in Part I. In Chapter 2, data acquisition, 
post-processing and potential applications of MSCT are outlined. The diagnostic accuracy of 16- and 
64-slice MSCT in detecting significant coronary stenoses is evaluated in Chapters 3 and 4, respectively. 
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In Chapter 5 the diagnostic accuracy of MSCT was compared to MRI based on a meta-analysis of the 
available literature. Subsequently, in Part II, the potential value of non-invasive imaging with MSCT 
and MRI was investigated in certain subset of patients, in order to define potential candidates for MSCT 
in more detail. Populations that were studied included patients with risk factors (Chapters 6-8) and 
patients with previous revascularization (Chapters 9-12). 
While MSCT coronary angiography has been suggested as an alternative first-line imaging modality to 
rule out CAD prior to more invasive procedures, comparisons to the traditionally used non-invasive first-
line techniques were not available. The purpose of Part III therefore, was to evaluate the relationship 
between anatomical observations on MSCT, namely atherosclerosis, and functional consequences 
on MPI, namely ischemia. In Chapter 13, an update of the various non-invasive modalities, including 
both anatomical as well as functional modalities, is provided. In addition, a potential algorithm for 
integration of these modalities is proposed, which is further discussed in Chapter 15. The relation 
between MSCT and functional imaging is investigated in Chapters 14,16, and 17. 
In Part IV, the potential of atherosclerosis imaging with MSCT was further explored. First, differences 
in plaque patterns between various clinical presentations were evaluated in Chapters 18 and 19. The 
potential prognostic value of MSCT plaque observations was tested in Chapter 20.
Finally, in Part V, non-coronary applications are evaluated, including quantification of infarct 
transmurality (Chapter 21), analysis of resting LV function and perfusion (Chapters 22 and 23) and 
imaging of the cardiac venous system (Chapter 24). 
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Abstract
The introduction of multi-slice computed tomography (MSCT) has allowed non-invasive coro-
nary angiography. Although widely applied, extensive information on technical details of the 
technique is lacking. In this manuscript, detailed information is provided on patient prepara-
tion, data acquisition, reconstruction and interpretation is provided. In addition, a summary on 
the available studies using MSCT for non-invasive angiography is provided. Based on pooled 
analysis of direct comparisons between MSCT and invasive angiography, the weighted mean 
sensitivity and specificity of current 16-slice MSCT to detect coronary artery disease are 88% 
and 96% respectively. At present, the technique is particularly well-suited to reliably exclude 
coronary artery disease. It is important to emphasize that MSCT only provides anatomical im-
ages, visualizing the presence of atherosclerosis, but information on the hemodynamic signifi-
cance of these lesions (i.e. ischemia) can not be derived.
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Introduction
Multi-slice computed tomography (MSCT) has attracted a lot of attention recently. This technique al-
lows non-invasive visualization of the coronary arteries and comparison with invasive coronary angi-
ography has yielded good results 1-3. In particular, many studies have recently been published on the 
accuracy of MSCT to detect (or exclude) coronary artery disease. Currently, comprehensive information 
on the technique and its clinical value is lacking. In this manuscript, a summary is provided on the data 
acquisition, reconstruction and analysis with MSCT; also, a summary on the accuracy of the technique 
to assess coronary artery disease, based on the available studies, is provided.
How to perform MSCT, data acquisition
Various issues are of importance in data acquisition with MSCT. High heart rates influence image 
quality and patients with heart rates ≥65 bpm should receive beta-blockers orally before the scan, 
unless contra-indicated. Patients with (supra-)ventricular arrhythmias should not undergo MSCT un-
less  software that allows the editing of the ECG is available (see below) 4.
The contrast agent should be administered through an antecubital vein to allow high flow rates 5. 
High intravascular attenuation and low beam-hardening artefacts in the right heart are recommend-
ed for an optimal MSCT coronary angiogram (CA). On average a bolus of 100 ml of iodine contrast 
material (350-400 mgl/ml) administered at 3-5 ml/s, immediately followed by 40 ml saline, provides 
optimal arterial enhancement 6;7. To synchronize the arrival of contrast material in the coronary arter-
ies and the scan, a test bolus or bolus tracking can be used 5;8. 
The optimal scan protocol results in high spatial resolution (thinner collimation), a high temporal 
resolution (faster gantry rotation) with low radiation exposure (prospectively ECG-triggered tube 
current modulation 9) compatible with a good signal to noise ratio (Figure 1). 
Figure 1. Three-dimensional volume rendering using 64-slice MSCT. Small diagonal branches of the LAD (Panel 
A, arrowhead), the obtuse marginal branches of the LCX (Panels A, arrow and B, arrowhead), the acute marginal 
branches of the RCA (Panel B, arrow), and the PDA are clearly visible.
Abbreviations: Ao= ascending 
aorta; LA= left atrium; LV= left ven-
tricle; LAD= left anterior descend-
ing; LCX= left circumflex;  
RA= right atrium; RV= right ven-
tricle; RCA= right coronary artery; 
PDA= posterior descending artery.
34 Chapter 2
How to perform MSCT, data reconstruction
Since the ECG is simultaneously registered during the examination, the acquired raw data can be 
reconstructed at any time point during the cardiac cycle. When performing these reconstructions, 
several approaches can be used, which are depicted in Figure 2 10;11. During the most widely used ap-
proach, data are reconstructed at a fixed percentage delay based on the R wave. However, data can 
also be reconstructed using an absolute prospective delay based on the previous R wave, although 
this technique is more sensitive to minimal variations in heart rate and therefore may result in data 
inconsistencies. The third approach, which is also frequently applied, utilizes an absolute reverse 
delay based on the upcoming R wave. As a result, data are reconstructed during end-diastole regard-
less of the absolute heart rate or potential variations in heart rate. Finally, the temporal window can 
theoretically also be positioned on the top of the P wave. Although this approach allows accurate re-
construction of data in end-diastole, it is not commonly performed due to the current unavailability 
of software that recognizes P waves.
Figure 2. Retrospective reconstruction of MSCT image data sets. Several different methods are available to de-
fine the temporal window in which the image data set is reconstructed. In Panel A, data are reconstructed using 
a fixed percentage delay, in this case at every 60% of the cardiac interval. In Panel B, an absolute prospective 
delay is used, resulting in the reconstruction of images at 650 ms after every R-peak. The same temporal window 
is achieved in Panel C however, by reconstructing at an absolute reverse delay, which is in this case 350 ms be-
fore every R-peak. In Panel D, the temporal window for data reconstruction is set with its end on the top of the 
P wave in order to allow reconstruction of images during the very last moment of limited cardiac motion before 
systolic contraction. 
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At present, no consensus has been established concerning which protocol provides the most opti-
mal results, and frequently a mixture of the available approaches is used. The phase of the cardiac 
cycle providing most of the information is the mid-to-end diastole, when the heart is in the iso-volu-
metric filling phase and motion is minimal. In some cases, including patients with higher heart rates 
during data acquisition, the tele-systolic phase can also provide relevant information since at the 
end of myocardial contraction, the motion of the coronary arteries is also reduced (Figure 3). 
Figure 3. The position of the temporal reconstruction window. Three main areas in the cardiac cycle are relevant 
for MSCT image reconstruction. The tele-diastolic phase (a), which typically occurs at 55% to 70% of the R-R inter-
val, represents the cardiac phase without contraction and thus minimal motion. During the tele-systolic phase (c, 
typically 25% to 40% of the R-R interval) isovolumetric contraction occurs, resulting in reduced coronary motion 
as well. In between lies the early-to-mid diastolic phase (b) during which some residual motion is present. 
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An important feature of some ECG-gating software is the possibility to edit the position of the tem-
poral windows within the cardiac cycle, and to exclude ECG irregularities such as pre-mature ventric-
ular beats (or extra-systoles) (Figure 4) 4. Another relevant reconstruction parameter is the effective 
slice width that is usually slightly thicker than the minimal collimation in order to improve the signal 
to noise ratio. The reconstruction increment should be around 50% of the effective slice thickness to 
improve the spatial resolution and the oversampling along the z-axis. The field of view should be as 
small as possible including the entire heart in order to fully exploit the constant image matrix (512 x 
512 pixels). The filtering should be a trade-off between the noise and the quality of the image. Usu-
ally medium convolution filters are applied for coronary imaging. Higher filters improve visualization 
of calcified vessel walls or stent struts and the lumen within the stents (Figure 5).
Figure 4. Editing of the ECG in the presence of premature ventricular beats.
The presence of a premature beat can result in motion artifacts on MSCT. The explanation for this is related to the 
mis-alignment of the temporal window in the diastolic pause before the premature beat (Panel A, arrow in ECG 
tracing). This results in motion artifacts that worsen the image quality (Panel A, arrowhead). The operator should 
delete the temporal window during the premature beat and fill the following long diastolic pause with addi-
tional temporal windows (Panel B, arrow in the ECG tracing) until the minimum heart rate interval is achieved. 
Accordingly, recovery of data is possible and diagnostic image quality can be obtained (Panel B, arrowhead).
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Figure 5. Effect of convolution filters on stent visualization. In Panel A, the 3D volume rendered image shows 
a left coronary artery with two stents in the LAD and in the first diagonal branch (D1). The stent in the LAD is 
displayed in curved multiplanar reconstructions in panels B, C, and D using progressively sharper convolution 
filters. The visualization of the stents and the differentiation between the struts and the lumen is improved by 
sharp convolution filters.
Abbreviations: Ao= ascending aorta; LAD= left anterior descending; LCX= left circumflex.
How to perform MSCT, data interpretation
To date, the studies reported have used semi-quantitative detection of significant stenosis (defined as 
≥50% lumen reduction) 12-14, no studies with quantitative MSCT-CA have been reported yet. The coro-
nary arteries are evaluated according to scoring systems used for invasive CA and include a 15- or 16-
segment model suggested by the American Heart Association 15 (Figure 6). Axial images should always 
be reviewed first, in order to detect possible morphological abnormalities or non-coronary findings 
e.g. pulmonary nodules. 
Figure 6. Classification of coronary segments can be performed by dividing the coronary tree into 15 segments 
(modified from the American Heart Association 15). This classification includes most of the segments with a di-
ameter larger than 1.5 mm. 
Abbreviations: LCA= left coronary artery; CX= left circumflex; LAD= left anterior descending; LM= left main; MO= 
marginal branch; RCA= right coronary artery; D1= first diagonal branch; D2= second diagonal branch; PL= postero-
lateral branch; PDA= posterior descending artery.
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Figure 7. Planes adopted on MSCT 
for the visualization of coronary ar-
teries. Using the 3D volume rendered 
image as a reference (Panel A) the 
three main planes for visualization of 
the coronary arteries are displayed. 
The atrio-ventricular plane with vol-
ume rendering (Panel B) and the cor-
responding cross-section with maxi-
mum intensity projection (Panel C) 
allow visualization of the RCA and 
CX. The inter-ventricular plane (Pan-
els D and E) allows the visualization 
of the LAD along the anterior wall 
of the left ventricle. The para-axial 
plane parallel to the LAD (Panels F 
and G) allows the visualization of the 
LAD and the diagonal branches. 
Abbreviations: CX= left circumflex; 
D1= first diagonal branch; LAD= left 
anterior descending coronary artery; 
LV= left ventricle; RCA= right coronary 
artery; RV= right ventricle; RVOT= 
right ventricle outflow tract.
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The multiplanar reconstructions (MPR) are employed for the evaluation of coronary arteries. The 
main planes useful are: 1) plane parallel to the atrio-ventricular groove (allows the longitudinal vi-
sualization of the right coronary artery and of the left circumflex coronary artery) 2) plane parallel 
to the inter-ventricular groove (allows visualization of the left anterior descending coronary artery) 
(see Figures 7 and 8).
On these planes a maximum intensity projection algorithm can be useful (from 5-8 mm to 3 mm of 
thickness, depending on extent and severity of calcifications). When the vessel is displayed within 
one plane, dedicated software permits to perform a central-lumen line reconstruction and the re-
sulting image can be rotated 360° around its axis (Figure 8).
In parallel, an orthogonal view of the same vessel is displayed, allowing a better evaluation of ste-
nosis. In general, 3D volume rendering is performed to provide an overview (and variations) of the 
coronary anatomy (total occlusions, aberrant coronary arteries) and should not be used for assess-
ment of stenotic lesions (Figure 7).
Figure 8. Curved central-lumen-line re-
constructions on MSCT. The conventional 
coronary angiogram and the curved re-
constructions are displayed for the RCA 
(Panels A-C), the LAD (Panels D-F), and 
for the CX (Panels G-I). For each vessel an 
orthogonal cross section performed in a 
region close to the ostium is displayed.
Abbreviations: CX= left circumflex; LAD= 
left anterior descending coronary artery; 
RCA= right coronary artery.
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Artifacts
Artifacts are mainly related to 8 issues (Table 1). Motion is commonly observed in MSCT-CA, and is 
mainly caused by (supra-)ventricular arrhythmias or breathing. Image noise can be related to obesity 
or to insufficient vascular contrast enhancement. Beam hardening is usually associated with high-
attenuation objects such as surgical clips, stents and severe calcifications. Volume averaging is due 
to contamination by attenuation of high-attenuation objects surrounded by tissue with lower at-
tenuation. Incorrect positioning of the temporal window can generate artifacts because there are 
only a few moments during the cardiac cycle when the heart stands still for a reasonable amount of 
milliseconds. Data can be missing because of irregularities in heart rate. Poor vascular enhancement 
is a result of low injection rate, low contrast volume, or iodine concentration. Images can be blurred 
because of several of the aforementioned issues.
Table 1. Classification and cause of artifacts.
Artifact Description Cause
Motion High or irregular heart rate Insufficient temporal resolution
(Supra-)ventricular arrhythmias
Patient breathing  
Image contrast/noise Insufficient vascular 
enhancement
Inadequate contrast administration
Obesity High tissue absorption throughout the dataset
Beam hardening Streak artifacts Extensive calcifications, coronary artery stents, 
arterial clips
Volume averaging “Blooming” Extensive calcifications, coronary artery stents, 
arterial clips
Temporal window Motion artifacts (HR 
independent)
Sub-optimal selection of temporal window
Premature heart beats
Irregular ECG-wave
Missing data Lack of information Irregular ECG baseline
Mis-triggering
Vessel enhancement Poor enhancement Low injection rate, low volume, low iodine content
Image quality Blurred images See Motion
Blurred vessels See Vessel enhancement
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Accuracy to assess coronary artery disease
Figure 9. Bar graph showing the diagnostic accuracy of 4- and 16-slice MSCT for the evaluation of significant 
coronary artery stenoses (data based on reference 16). 
Assessable = the average percentage of coronary segments that were of sufficient image quality to include in the 
analyses concerning diagnostic accuracy. 
During the past few years, extensive research has been invested in the development of non-invasive 
CA with MSCT, resulting in a considerable number of publications on the diagnostic accuracy of this 
technique. In 1998, the first generation of multi-slice scanners was introduced, allowing the simulta-
neous acquisition of 4 slices, thereby enabling MSCT systems to visualize the coronary arteries. Re-
ported sensitivities and specificities ranged from 66% to 99%, with weighted means of respectively 
80% and 94% 16. To obtain these results however, more than 20% of the available segments were on 
average excluded, representing an important limitation of the technique at that stage. 
More recently, results of the newer generation of 16-slice systems have become available. With these 
systems, sections as thin as 0.5 mm and a temporal resolution of 105-250 ms can be obtained. As a 
result, a considerable improvement in assessability (approximately 96%) as well as sensitivity (ap-
proximately 88%) could be observed, with no loss in specificity, as shown in Figure 9 16. Further re-
finement is anticipated by the introduction of 64-slice scanners that have been recently introduced, 
although currently no studies are available regarding the diagnostic accuracy of these systems. Ex-
amples of 64-slice MSCT-CA in patients with respectively normal and abnormal coronary arteries are 
provided in Figures 10 and 11.
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Figure 10. An example of normal coronary arteries obtained with 64-slice MSCT. An intra-myocardial course of 
the LAD can be observed (Panels B and H-arrows).
Abbreviations: LAD= left anterior descending coronary artery; D1= first diagonal branch; LCx= left circumflex coro-
nary artery; MO= marginal branch.
Figure 11. An example of a patient with a total occlusion of the LAD, obtained with 64-slice MSCT. The LAD is 
occluded (Panels A, B, D, E, arrows), whereas the first diagonal branch and the LCx are diffusely diseased. Conven-
tional coronary angiography showed comparable findings (Panels C and F).
Abbreviations: LAD= left anterior descending coronary artery; D1= first diagonal branch; LCx= left circumflex coro-
nary artery.
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In patients presenting with recurrent angina after surgical or percutaneous revascularization, MSCT 
may be applied to assess patency of either coronary bypass grafts or stents. The axial course, large 
diameter and relative immobility of coronary bypass grafts during the cardiac cycle facilitate evalu-
ation with MSCT. In Figure 12, an example is provided of 64-slice MSCT imaging of a patient with 
previous coronary bypass grafting. Several studies have explored the accuracy of MSCT to evalu-
ate graft patency in comparison to conventional CA. In these 7 studies, with a total of 257 patients 
included, virtually all grafts were of sufficient image quality to assess patency 17-22. Pooled analysis of 
these studies showed a weighted mean sensitivity of MSCT to detect graft occlusion of 88%, while 
the weighted mean specificity was 98%. In 5 studies, assessment of graft stenosis was undertaken 
18-20;23;24. In these studies, with 267 patients included, 80% of grafts were eligible for evaluation, with a 
weighted mean sensitivity and specificity of 84% and 95%, respectively. Data are summarized in Fig-
ure 13. Despite these encouraging results, still several important limitations remain. Metal artefacts 
resulting from surgical clips frequently obscure assessment, while difficulties are also encountered 
frequently in the evaluation of distal anastomoses and distal parts of sequential grafts. 
Figure 12. An example of a patient with previous coronary bypass surgery, obtained with 64-slice MSCT. As shown 
in Panels A and B, the LIMA is patent, while one of the 2 saphenous vein grafts is occluded (Panel A, left arrow). 
Conventional coronary angiography confirmed patency of the left internal mammary artery graft (Panel C). 
Abbreviations: LAD= left anterior descending coronary artery; SVG= saphenous vein graft; LIMA= left internal mam-
mary artery; RCA= right coronary artery. 
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Figure 13. Bar graph showing the diagnostic accuracy of MSCT in the evaluation of patients after coronary by-
pass surgery (data based on references 17-24). 
Assessable = the average percentage of bypass grafts that were of sufficient image quality to include in the analyses 
concerning diagnostic accuracy.
Another application of MSCT that is currently under investigation is the assessment of coronary 
stents, which are difficult to image with MSCT. Their metal content leads to high-density artifacts, 
and subsequent obscuring of a considerable part of the stent lumen. In many studies regarding the 
diagnostic accuracy of MSCT therefore, stented segments are still excluded from analysis. However, 
substantial progress has been obtained with the increased image quality of the newer generation of 
MSCT scanners. With 4-slice systems, the stent lumen was virtually invisible, whereas with 16-slice 
systems improved visualization has been reported, in particular in stents with either a large diameter 
or thinner struts 25. With the recently introduced 64-slice systems (Figure 14) as well as the previously 
discussed dedicated filters (Figure 5), an even higher percentage of stents will be eligible for assess-
ment of patency. Still, artificial narrowing of the stent lumen will currently remain to some extent, 
thereby hampering detection of subtle neo-intima hyperplasia. 
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Figure 14. Coronary stent imaging with 64-slice MSCT. In Panels A and B, the patency of the stented LAD is 
demonstrated. In Panels D and E, absence of in-stent restenosis in the stented RCA is demonstrated. The MSCT 
findings were confirmed by conventional coronary angiography (Panels C and F). 
Abbreviations: LAD= left anterior descending coronary artery; D1= first diagonal branch; D2= second diagonal 
branch; RCA= right coronary artery; LM= left main. 
Additional applications of MSCT
Besides the assessment of coronary artery disease, MSCT can also be used for evaluation of left 
ventricular (LV) function; LV function (and LV volumes) are important prognostic parameters. Since 
MSCT data are acquired throughout the entire cardiac cycle, during continuous registration of the 
ECG, images can be reconstructed at any cardiac phase. As a result, information on LV function can 
be derived from the same data set as used for the evaluation of the coronary arteries. 
In the assessment of LV ejection fraction, initial studies have shown good correlations between 
MSCT and either MRI or echocardiography 26-30. In addition to global function, regional contractile 
function can be assessed (Figure 15). A recent comparison between MSCT and 2D echocardiogra-
phy revealed an overall agreement of 91% in 493 segments evaluated for the presence of regional 
wall motion abnormalities 31. Preferably, systolic wall thickening should be assessed during stress as 
well as resting conditions. However, with regard to the radiation dose associated with MSCT, such a 
protocol remains at present unattractive.
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Figure 15. Regional wall motion analysis with 64-slice MSCT. In Panels A and B, short-axis left ventricular recon-
structions in respectively end-diastole and end-systole are shown of a patient with normal wall motion; the left 
ventricular ejection fraction was 55%. In Panels C and D, similar reconstructions are shown of a patient with a 
previous anterior myocardial infarction. In the corresponding region (arrows), abnormal wall motion can be ap-
preciated; the ventricular ejection fraction was 38%.
In addition to LV function, MSCT has been used for the evaluation of pulmonary vein anatomy in 
patients with atrial fibrillation considered for pulmonary vein ablation. Ectopic foci located within 
the pulmonary veins have been linked to the induction of atrial fibrillation and/or tachycardia 32. 
As a result, different percutaneous ablation strategies have been developed to either eliminate the 
pulmonary venous foci or encircle and electrically isolate the pulmonary veins from the left atrium. 
Despite a good success rate of these strategies, the procedure and fluoroscopy times are still consid-
erable due to several reasons. The veno-atrial junctions and the pulmonary veins or their ostia are 
not easily visualized using fluoroscopy, while the pulmonary venous anatomy itself is highly variable 
33. Knowledge of pulmonary venous anatomy, including potential anomalies in number and inser-
tion of pulmonary veins as well as ostial shape, prior to the ablation procedure, therefore, would be 
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of great benefit and potentially facilitate procedures. Preliminary studies have demonstrated that 
this information can be provided by MSCT 34. In Figure 16, an example of visualization of different 
variants of pulmonary vein anatomy by MSCT is provided. Jongbloed et al recently performed a 
head-to-head comparison between MSCT and intracardiac echocardiography in 42 patients prior 
to pulmonary vein ablation 35. The authors observed a higher sensitivity for MSCT in the detection of 
additional branches and right-sided early branching. In addition, an underestimation of ostial size 
by intracardiac echocardiography was demonstrated. These findings underline the superiority of 3D 
imaging techniques to demonstrate asymmetrical shape of pulmonary vein ostia. Further investiga-
tions however are needed to evaluate how MSCT data can be used or integrated with other data for 
optimization of pulmonary vein ablation strategies. 
Figure 16. Different variants of pulmonary vein anatomy, as visualized by 3D volume rendered 64-slice MSCT 
reconstructions. In Panel A, early branching (arrow) of the right inferior pulmonary vein can be observed. An ad-
ditional right pulmonary vein can be observed in Panel B (arrow).
Abbreviations: LA= left atrium; LIPV= left inferior pulmonary vein; LSPV= left superior pulmonary vein; RIPV= right 
inferior pulmonary vein; RSPV= right superior pulmonary vein.
Conclusion
MSCT has been demonstrated to allow non-invasive coronary angiography. To improve this imag-
ing modality technique, optimization of patient preparation, data acquisition and reconstruction is 
required. Standardized data analysis and reporting is also needed. Several issues that are important 
related to these issues are summarized in this article. 
When the currently available data are pooled, a high sensitivity with an excellent specificity is ob-
tained. In particular, the specificity of 96% is an indicator that MSCT can adequately rule out coro-
nary artery disease. It is important to keep in mind that this technique visualizes atherosclerosis and 
not ischemia. Therefore, the technique can not be compared directly with the currently available 
imaging modalities to non-invasively assess coronary artery disease, such as nuclear myocardial per-
fusion imaging and stress echocardiography. Rather, these techniques visualize the consequences 
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of atherosclerosis and indicate whether ischemia is present or not. The precise role of these imaging 
modalities (MSCT to assess atherosclerosis and myocardial perfusion imaging or stress echocardiog-
raphy to assess ischemia) is to be established. A potential scenario could be to use these techniques 
mainly in patients with an intermediate likelihood of coronary artery disease in a sequential manner. 
MSCT could first be applied to rule out coronary artery disease; if present, myocardial perfusion im-
aging could be used to refine the consequences of the atherosclerosis: ischemia or not.
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Abstract
Background 
In recent years, multi-slice computed tomography (MSCT) has been demonstrated as a feasible 
imaging modality for non-invasive coronary angiography and left ventricular (LV) function 
analysis. The present study evaluates the overall performance of 16-slice MSCT in the detection 
of significant coronary artery disease (CAD), stent or bypass graft stenosis in combination with 
global LV function analysis. 
Methods
In 45 patients, 16-slice MSCT was performed. From the MSCT images, the presence of signifi-
cant coronary artery stenoses (≥50% luminal diameter reduction) in native coronary segments, 
bypass grafts and coronary stents were evaluated and compared with conventional coronary 
angiography. In addition, LV ejection fraction was calculated and compared to 2-dimensional 
echocardiography. 
Results
MSCT was performed successfully in all patients. A close correlation between MSCT and 2-
dimensional echocardiography was demonstrated for the assessment of LV ejection fraction 
(y = 0.93x + 3.33, r=0.96, p<0.001). A total of 298 (94%) of native coronary artery segments 
could be evaluated on the MSCT images, whereas 81 of 94 (85%) grafts and 41 of 52 (79%) 
coronary stents were evaluable. Including all segments, overall sensitivity, specificity, positive 
and negative predictive values were 85%, 89%, 71% and 95%, respectively. 
Conclusion
16-slice MSCT is a feasible modality for the non-invasive evaluation and exclusion of CAD in 
patients presenting with chest pain. 
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Introduction
The introduction of 16-slice scanners has led to improved image quality in combination with shorter 
acquisition times and preliminary results show indeed a substantial improvement in terms of inter-
pretability and accuracy in the evaluation of coronary arteries 1-3. However, data are still scarce and 
have been obtained predominantly in carefully selected patient groups 1-3. In these initial studies, 
simultaneous LV function analysis has not been performed, thus not taking full benefit of the ac-
quired data. The present study evaluates the overall performance of 16-slice MSCT in the detection 
of significant coronary artery, stent or bypass graft stenosis in combination with global LV function 
analysis. Conventional coronary angiography and 2D-echocardiography served as the standards of 
reference.
Methods
Patients and study protocol
A total of 45 patients presenting with known or suspected CAD and scheduled for invasive coronary 
angiography due to chest pain complaints were included as part of ongoing protocols at our institu-
tion. Only patients in sinus rhythm and without contraindications to the administration of iodinated 
contrast media were included.  All patients gave written informed consent to the study protocol, 
which was approved by the local ethics committee.
MSCT; Data acquisition 
All MSCT examinations were performed with a 16-slice Toshiba Multi-slice Aquilion 16 system (Toshi-
ba Medical Systems, Otawara, Japan). Collimation was 16 x 0.5 mm. If arterial grafts were present 
however, a collimation of 16 x 1.0 mm was used to reduce scan time. Rotation time was 400, 500 or 
600 ms, depending on the heart rate, while the tube current and tube voltage were 250 mA and 120 
kV, respectively. The total contrast dose for the scan ranged from 120 to 150 ml depending on the 
total scan time, with an injection rate of 4 ml/s through the antecubital vein (Xenetix 300®, Guerbet, 
Aulnay S. Bois, France). Automated detection of peak enhancement in the aortic root was used for 
timing of the scan. All images were acquired during an inspiratory breath hold with simultaneous 
registration of the patient’s electrocardiogram. With the aid of a segmental reconstruction algo-
rithm, data of two or three consecutive heartbeats were used to generate a single image. 
For the assessment of LV ejection fraction, 2.0 mm slices were reconstructed in the short-axis ori-
entation at 20 time points, starting at early systole (0% of the cardiac cycle) to the end of diastole 
(95% of the cardiac cycle) in steps of 5%. Images were transferred to a remote workstation with dedi-
cated cardiac function analysis software (MR Analytical Software System [MASS], Medis, Leiden, the 
Netherlands).
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To evaluate the presence of coronary artery stenoses, separate reconstructions in diastole (typically 
75% or 80% of the cardiac cycle) were generated with a reconstructed section thickness of either 0.4 
mm or 0.8 mm. If motion artifacts were present, additional reconstructions were made at 40, 45, and 
50% of the R-R range. Axial data sets were transferred to a remote workstation (Vitrea2, Vital Images, 
Plymouth, Minn. USA) for post-processing and subsequent evaluation. 
MSCT; Data analysis
Endocardial borders were outlined manually by an independent observer on the short-axis cine images. 
Papillary muscles were regarded as being part of the ventricular cavity. After calculation of LV end-sys-
tolic and LV end-diastolic volumes, the related LV ejection fraction was derived by subtracting the end-
systolic volume from the volume at end-diastole and dividing the result by the end-diastolic volume.
MSCT angiograms were evaluated by 2 experienced observers, who were blinded to the results of 
coronary angiography. The following protocol was applied in the evaluation of the MSCT coronary 
angiograms: Of each patient, the 3-dimensional volume rendered reconstruction was inspected first 
to obtain general information of the status and course of the coronary arteries, and if present, coro-
nary bypass grafts and stents. In patients without coronary bypass grafts, native coronary arteries 
were divided in segments according to the American Heart Association-American College of Cardi-
ology guidelines and classified as evaluable or not by visual estimation. Subsequently, the interpre-
table segments were evaluated for the presence of significant narrowing (≥50% reduction of lumen 
diameter) using both the original axial slices and curved multiplanar reconstructions. In stented seg-
ments, the presence of restenosis was defined reduced run-off of contrast distally, whereas stent 
occlusion was defined as the absence of contrast within the stent in combination with the absence 
of run-off of contrast distally.
In patients with previous coronary bypass grafting, grafts and the distal course of the recipient ves-
sels were evaluated first. Sequential grafts were considered as separate graft segments. Although 
patency was assessed in all grafts, the presence of luminal narrowing of 50% or more was deter-
mined only in grafts with sufficient image quality. If a graft demonstrated significant narrowing or 
total occlusion, native segments prior to the graft anastomosis were also evaluated. Remaining na-
tive vessels, e.g. vessels not supplied by coronary bypass grafts, were evaluated afterwards. 
2D-echocardiography
For the comparison of LV ejection fraction, 2D-echocardiography was performed prior or after the 
MSCT examination within 3 days. Patients were imaged in the left lateral decubitus position using 
a commercially available system (Vingmed System FiVe/Vivid-7, GE-Vingmed, Milwaukee, WI, USA). 
Images were acquired using a 3.5 MHz transducer at a depth of 16 cm in the parasternal and apical 2-, 
4- and 5-chamber views. LV ejection fractions were calculated by an independent observer without 
knowledge of the angiographic or MSCT data from the 2- and 4 chamber images using the biplane 
Simpson’s rule 4-6. 
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Conventional coronary angiography 
Conventional coronary angiography was performed according to standard techniques. The femo-
ral approach with the Seldinger technique was applied to obtain vascular access. Average interval 
between conventional coronary angiography and MSCT was 18 ± 26 days. Angiograms were visu-
ally evaluated by consensus reading of two experienced observers without knowledge of the MSCT 
data.
Statistical analysis 
Sensitivity, specificity, positive and negative predictive values for the detection of ≥50% luminal 
narrowing in respectively native coronary artery segments, bypass graft segments and stented seg-
ments were calculated. Coronary segments supplied by coronary bypass grafts were included in the 
native vessel analysis. For linear regression analysis of LV ejection fractions, the Pearson correlation 
coefficient r was computed. Bland-Altman analysis was performed for each pair of values of LV ejec-
tion fraction to calculate limits of agreement and systematic error between the two modalities 7. A 
p-value <0.05 was considered to indicate statistical significance.
Results
MSCT was performed successfully in all 45 patients. Main clinical characteristics of the study popula-
tion are listed in Table 1. 
Table 1. Characteristics of the study population (n= 45).
n (%)
Male/Female  42/3
Age (years)  63 ± 10
Heart rate during data acquisition 65 ± 10
Beta blocker medication 35 (78%)
Previous myocardial infarction 29 (64%)
Previous percutaneous coronary intervention 30 (67%)
Previous coronary bypass grafting 22 (49%)
Number of coronary vessels narrowed
         1                         4 (9%)
         2                                     10  (22%)
         3                                          30  (67%)
Angina Pectoris                                
       Canadian Cardiovascular Society class 1/2 10 (22%)
       Canadian Cardiovascular Society class 3/4 35 (78%)
Heart Failure
        New York Heart Association class 1/2 34 (75%)
        New York Heart Association class 3/4 11 (24%) 
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LV ejection fraction 
Average LV ejection fraction as determined by MSCT was 47 ± 13% (range 15% to 72%) and 47 ± 14% 
(range 16% to 75%) with 2D-echocardiography.  Linear regression analysis (Figure 1A) demonstrated 
an excellent correlation (r=0.96, p<0.001) between both modalities. A mean difference of -0.02 ± 
3.9% was demonstrated by Bland-Altman analysis (Figure 1B), not statistically different from zero.
Figure 1. Comparison of MSCT and echocardiography in the assessment of LV function. Panel A represents a 
linear regression plot showing the correlation between the LV ejection fraction as determined by 2D-echocar-
diography and MSCT. In panel B, a Bland-Altman plot of LV ejection fraction is shown. The difference between 
each pair is plotted against the average value of the same pair (solid line= mean value of differences and dotted 
lines = mean value of differences ± 2SDs). 
Abbreviation: LVEF: left ventricular ejection fraction.
Coronary angiography 
Conventional coronary angiography, which was performed in 317 native segments, revealed nar-
rowing of ≥50% of luminal diameter in 64 segments. A total of 298 (94%) of these segments could 
be evaluated on the MSCT images. Causes of uninterpretability were small size of the vessel (n=9), 
ectopic heartbeats (n=1), motion artifacts (n=4), vascular clips (n=1) and insufficient contrast (n=4). 
Significant stenoses were correctly identified in 59 segments, while the presence of significant ste-
nosis was correctly ruled out in 231 of 253 segments, resulting in a sensitivity and specificity of 93% 
and 91%. Considering only the interpretable segments, sensitivity and specificity were 98% and 
97%, respectively. 
A total of 62 grafts (arterial grafts: 13, venous grafts: 49) of which 31 sequential grafts, were present, 
resulting in 94 graft segments. Total occlusion was correctly identified in 23 of 24 occluded grafts, 
whereas patency was correctly determined in all 70 patent grafts. Thirteen graft segments (all arte-
rial grafts) were of insufficient quality to assess the presence of ≥50% stenosis. In the remaining 81 
grafts, the presence of significant stenosis was correctly identified in all 27 grafts with 50% or more 
y = 0.93x + 3.33
r= 0.96, p<0.001
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narrowing. In 2 of 54 graft segments without significant stenosis however, the presence of stenosis 
was incorrectly observed on the MSCT images, resulting in a specificity of 96%. 
Of the 52 stented segments that were present in the study population, a total of 41 (79%) was judged 
interpretable by MSCT. In the interpretable stents, 7 of 8 stented segments with significant in-stent 
restenosis and all patent stented segments (n=33, 100%) were correctly identified on the MSCT im-
ages. However, when uninterpretable stents were included in the analysis, sensitivity and specificity 
were 54% and 85%, respectively. 
Details of all analyses including positive and negative predictive values are summarized in Table 2. 
Examples of MSCT images and corresponding conventional angiograms are depicted in Figure 2.
Figure 2. Non-invasive coronary angiography with MSCT
A: A curved multiplanar reconstruction of a right coronary artery with small calcifications (arrowheads) but no 
significant stenosis is shown. C: An example of a coronary stent (arrowhead) with no significant in-stent resteno-
sis, placed in the proximal left anterior descending coronary artery. However, distal to the stent, both soft and 
calcified plaque can be observed (arrows). E: An example of an intermediate stenosis in the left anterior descend-
ing coronary artery is shown in panel E, while panels E1-3 represent cross-sectional images. G,H: An example of a 
venous bypass graft supplying an obtuse marginal branch is provided. On both MSCT images, a curved multipla-
nar reconstruction (panel G) and a 3D volume rendered reconstruction (panel H), narrowing of more than 50% 
lumen diameter is demonstrated. B,D,F,I: Corresponding coronary angiograms confrimed findings.
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Table 2. D
iagnostic accuracy of M
SC
T.
N
ative segm
ents 
(≥50%
 stenosis)
G
raft segm
ents 
(occlusion)
G
raft segm
ents (≥50%
 
stenosis)
Stented segm
ents (≥50%
 
in-stent stenosis)
A
ll segm
ents
(≥50%
 stenosis)
Evaluation possible
298/317 (94%
)
94/94 (99%
)
81/94 (85%
)
41/52 (79%
)
420/463 (91%
)
Sensitivity 
59/60 (98%
)
23/24 (96%
)
27/27 (100%
)
7/8 (88%
)
93/95 (98%
)
Specificity
231/238 (97%
)
70/70 (100%
)
52/54 (96%
)
33/33 (100%
)
316/325 (97%
)
Positive predictive value
59/66 (89%
)
22/22 (100%
)
27/29 (93%
)
7/7 (100%
)
93/102 (91%
)
N
egative predictive value
231/232 (100%
)
70/71 (99%
)
52/52 (100%
)
33/34 (97%
)
316/318 (99%
)
D
iagnostic Accuracy
290/298 (97%
)
93/94 (99%
)
79/81 (98%
)
40/41 (98%
)
409/420 (97%
)
Including uninterpretable segm
ents
Sensitivity 
59/64 (93%
)
23/24 (96%
)
27/32 (84%
)
7/13 (54%
)
93/109 (85%
)
Specificity
231/253 (91%
)
70/70 (100%
)
52/62 (84%
)
33/39 (85%
)
316/354 (89%
)
Positive predictive value
59/81 (73%
)
22/22 (100%
)
27/36 (75%
)
7/13 (54%
)
93/131 (71%
)
N
egative predictive value
231/236 (98%
)
70/71 (99%
)
52/57 (91%
)
33/39 (85%
)
316/332 (95%
)
D
iagnostic Accuracy
290/317 (91%
)
93/94 (99%
)
79/94 (84%
)
40/52 (77%
)
409/463 (88%
)
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Discussion
The results of the present study demonstrate that non-invasive assessment of the presence of CAD in 
patients presenting with chest pain is feasible with 16-slice MSCT. In 317 native coronary artery seg-
ments, a sensitivity and specificity of 93% and 91%, respectively, were demonstrated without exclu-
sion of the 6% segments that were uninterpretable. These findings are in line with results of previous 
16-slice MSCT studies 1-3;8. Although in the individual studies observed sensitivities and specificities 
ranged from 89% to 95% and 86% to 98%, negative predictive values were consistently above 97%, 
similar to our results (98%). Thus, the current findings emphasize the potential of MSCT to serve as 
a first-line diagnostic modality to rule out the presence of CAD. This is an important finding since 
approximately 20% of invasive catheterizations are performed for purely diagnostic purposes and 
are not followed by any interventions. Therefore, MSCT may be particularly valuable to avoid the 
discomfort, risks and costs of invasive angiography in a considerable number of patients. 
In all coronary bypass grafts, patency could be assessed with a high accuracy (99%). More subtle de-
tection of graft stenosis, however, could be performed in only 85% of grafts, resulting in a sensitivity 
and specificity of 84%.  Considering only interpretable bypass grafts, sensitivity and specificity were 
100% and 96%, respectively.
Slightly lower results were observed in the evaluation of stented segments. Only 41 of 52 available 
stented segments could be evaluated for the presence of significant in-stent stenosis. In the inter-
pretable stented segments, resulting sensitivity and specificity were 88% and 100%, respectively.
Thus, although patients with suspected in-stent stenosis may still benefit more from direct referral 
to invasive coronary angiography, MSCT may be particularly useful to evaluate patients with known 
or suspected CAD or with recurrent chest pain after coronary artery bypass grafting. In addition, 
information on LV function can be derived. 
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Abstract
Background
The purpose of the present study was to determine the diagnostic accuracy of current 64-slice 
multi-slice computed tomography (MSCT) in the detection of significant coronary artery dis-
ease (CAD) using conventional coronary angiography as the gold standard. 
Methods
In 61 patients scheduled for conventional coronary angiography, 64-slice MSCT was per-
formed and evaluated for the presence of significant (≥50% luminal narrowing) stenoses. 
Results
One patient had to be excluded due to a heart rate above 90 beats per minute during data 
acquisition. In the remaining 60 patients (46 men/14 women, average age 60 ± 11 years) 854 
segments were available for evaluation. Of these segments 842 (99%) were of sufficient image 
quality. Conventional coronary angiography identified 73 lesions, of which 62 were detected 
by MSCT. Corresponding sensitivity and specificity were 85% and 97%, respectively. On a pa-
tient-per-patient analysis, sensitivity, specificity, and positive and negative predictive values 
were 94%, 97%, 97%, and 93%, respectively. 
Conclusion
The present study confirms that 64-slice MSCT enables accurate and non-invasive evaluation 
of significant coronary artery stenoses. 
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Introduction
In a short period of time, spiral multi-slice computed tomography (MSCT) has rapidly matured into 
a technique that is on the verge of being used as an alternative modality in the clinical evaluation of 
patients suspected of having coronary artery stenoses. While thorough assessment of the entire cor-
onary tree was still problematic with the original 4-slice systems, substantial improvement was ob-
tained with the introduction of 16-slice scanners 1. In addition, results of numerous studies compar-
ing MSCT to conventional coronary angiography suggested enhanced sensitivity of the technique 
as well, with no loss in specificity 2. Currently, 64-slice MSCT systems are rapidly installed, offering 
further improved image quality while acquiring data in even shorter periods of time 3;4. Accordingly, 
the purpose of the present study was to determine the diagnostic accuracy of current 64-slice MSCT 
in the detection of significant coronary artery disease (CAD) using conventional coronary angiogra-
phy as the gold standard. 
Methods
Patients and study protocol 
The study group consisted of 61 patients who were scheduled for conventional coronary angiog-
raphy. In addition, MSCT coronary angiography was performed. Patients with contraindications to 
MSCT were excluded 5. Conventional catheter-based coronary angiography was performed prior 
or after MSCT and served as reference standard. All patients gave written informed consent to the 
study protocol, which was approved by the local ethics committee.
Data acquisition 
MSCT was performed using a Toshiba Multi-slice Aquilion 64 system (Toshiba Medical Systems, To-
kyo, Japan) with a collimation of 64 x 0.5 mm and a rotation time of 0.4 s. The tube current was 300 
mA, at 120 kV. In obese patients (BMI ≥ 30 kg/m2), parameters were adjusted to 350 mA at 135 kV 
in order to improve image quality. Non-ionic contrast material was administered in the antecubital 
vein with an amount of 80-110 ml, depending on the total scan time, and a flow rate of 5.0 ml/sec 
(Iomeron 400 ®). Automated peak enhancement detection in the descending aorta was used for tim-
ing of the bolus using a threshold of +100 Hounsfield Units. Data acquisition was performed during 
an inspiratory breath hold of approximately 8 to 10s. 
During the MSCT examination, ECG was recorded simultaneously for retrospective gating of the 
data. An initial data set was reconstructed at 75% of the R-R interval with a slice thickness of 0.5 mm 
and a reconstruction interval of 0.3 mm. In 17 patients, additional reconstructions were explored 
to obtain more optimal reconstruction phases. Similarly, in case of high-density artefacts, sharper 
reconstruction kernels were explored to improve image quality. Finally, images were transferred to a 
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remote workstation (Vitrea2, Vital Images, Plymouth, Minn. USA) for post-processing and evaluation.  
Conventional diagnostic coronary angiography was performed according to standard techniques. 
Data analysis 
MSCT angiograms were evaluated by an invasive cardiologist with several years of experience of scor-
ing MSCT coronary angiograms. Image analysis was performed blinded to the results of coronary 
angiography. 3D volume rendered reconstructions were used to obtain general information of the 
status and course of the coronary arteries. Then, the original transaxial slices were inspected for the 
presence of significant (≥50% reduction of lumen diameter) narrowing, assisted by curved multiplanar 
reconstructions. Segmentation of the coronary arteries was performed based on the American Heart 
Association-American College of Cardiology guidelines 6. Segments containing coronary stents were 
included in the analysis; the presence of restenosis in a stented segment was identified by reduced or 
complete absence of contrast within the stent as well as reduced or absent run-off of contrast distally. 
Conventional angiograms were evaluated by an experienced observer without knowledge of the 
MSCT data who identified the available coronary segments based the American Heart Association-
American College of Cardiology guidelines 6. Each segment was then evaluated for the presence of 
≥50% diameter stenosis, based on evaluation of 2 orthogonal views. 
Statistical analysis 
Obstructive CAD was defined as luminal narrowing of 50% or more. Accordingly, sensitivity, specific-
ity, positive and negative predictive values (including 95% confidence intervals) for the detection 
of stenosis ≥50% on conventional angiography, were calculated on a patient, vessel and segmental 
basis. A patient or vessel was classified as correct positive if the presence of any stenosis was identi-
fied correctly. In the per vessel analysis, the intermediate branch was considered as part of the left 
circumflex. All statistical analyses were performed using SPSS software (version 12.0, SPSS Inc, Chi-
cago, Il, USA). A value of P<0.05 was considered statistically significant.
Results
Patient characteristics 
In total, 61 consecutive patients (46 men/15 women, age 60 ± 11 years) were included. The average 
interval between MSCT and conventional angiography was 49 ± 61 days. In one patient, the heart 
rate rose above 90 bpm during MSCT, rendering the complete data set uninterpretable. The patient 
characteristics of the remaining 60 patients are summarized in Table 1. In total, CAD was suspected 
in 25 (42%) patients, whereas it was known in 35 (58%) patients. A total of 44 stented segments was 
included in the analysis. 
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Table 1. Clinical characteristics of the study population (n=60).
n (%)
Male/Female     46/14
Age (years) 60 ± 11 
   (range)                                                 38-80
Heart Rate (beats per minute) 60 ± 11
   (range) 44 - 83
Average calcium score  (Agatston) 423 ± 868
   (range)                               0 - 6264
Beta-Blocking medication 43 (72%)
Diabetes Mellitus         6 (10%)
Hypertension a           26 (43%)
Hypercholesterolemia b    27 (45%)
Positive family history        22 (37%)
Current smoking            33 (55%)
Body Mass Index ≥ 30 kg/m2   15 (25%)
History of CAD
   No history                         25 (42%)
   Previous coronary angioplasty   33 (55%) 
   Previous coronary bypass grafting    0 
   Previous myocardial infarction     33 (55%)
           Anterior wall                26 (79%) 
           Inferior wall                     7 (21%)
Number of coronary arteries narrowed as determined on angiography
       None                                    14 (23%)
       1                                      26 (43%)
       >1                                  20 (33%)
a defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg, and/or use of anti-
hypertensive medication. 
b defined as total serum cholesterol ≥230 mg/dl and/or serum triglycerides ≥200 mg/dl or use of a lipid-lowering 
agent.
MSCT coronary angiography
In 854 segments evaluated on conventional coronary angiography, a total of 74 significant stenoses 
was identified. MSCT image quality was insufficient in 12 (1.4%) segments to allow further evalua-
tion. Reasons for uninterpretability were low contrast-to-noise due to a high BMI (n=2), extensive 
calcifications (n=5) and small vessel size (n=5). A total of 6 uninterpretable segments were located 
in the left circumflex coronary artery (segment 10, n=3, segment 12, n=1, and segment 17, n=2), 
whereas 4 uninterpretable segments were located in the distal RCA (segment 4, n=2 and segment 
16, n=2) and 1 in the first diagonal branch. In the remaining 842 segments, the presence of stenosis 
was correctly ruled out by MSCT in 755 of 769 segments, while 62 of 73 segments were correctly 
identified as having a significant lesion on MSCT. A total of 14 lesions that were non-significant 
on conventional coronary angiograpy were overestimated on MSCT, while 11 lesions were falsely 
66 Chapter 4
deemed to be insignificant. Accordingly, resulting sensitivity and specificity for the detection of sig-
nificant lesions were 85% and 98% on a segmental level. In the 44 stented segments, 3 of 3 segments 
with significant in-stent restenosis were correctly detected, whereas the absence of significant le-
sions was correctly identified in 41 patent stented segments. 
Figure 1. Example of a patient with significant coronary artery disease. 
In Panel A, a 3D volume rendered reconstruction is shown, providing an overview of the left anterior descending 
(LAD) and left circumflex (LCx). An enlargement of the section indicated by the black arrowhead (Panel B) dem-
onstrates a significant narrowing in the LAD (black arrowhead) and, more distally, a small coronary calcification 
(white arrowhead) that can also be observed on the curved multiplanar reconstruction (Panel D). Cross-sectional 
images (Panel E) confirm the presence of a significant non-calcified lesion. In Panel F, a curved multiplanar recon-
struction of the LCx without significant lesions is provided. In the right coronary artery (Panel G, 3D volume ren-
dered reconstruction and Panel H, curved multiplanar reconstruction), no significant narrowings were observed 
as well. Findings were confirmed by conventional coronary angiography (Panels C and I).
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Vessel analysis
Due to extensive calcifications, 1 left circumflex was deemed uninterpretable. In the remaining 239 
coronary arteries, 46 of 53 coronary arteries were correctly identified as having one or more signifi-
cant lesions whereas the absence of any stenosis was correctly identified in 179 of 186 vessels, result-
ing in a sensitivity and specificity of 87% and 96%, respectively.
Patient analysis 
Conventional coronary angiography identified 31 patients with one or more significant lesions. On 
MSCT, 29 (94%) of these patients were correctly identified. In one of these patients however, a lesion 
in the left anterior descending coronary artery was misjudged to be significant on MSCT, whereas 
in fact a lesion in the right coronary artery proved to be significant during conventional coronary 
angiography. In the remaining patients, the correct lesion was identified on MSCT. An example of a 
patient with a significant stenosis is provided in Figure 1. MSCT correctly ruled out the presence of 
any significant lesion in 28 of 29 (97%) patients. Only 3 patients were incorrectly diagnosed by MSCT. 
In one patient, a significant lesion in origin of the second diagonal was missed due to the small size 
of the coronary side-branch. In the other patient with false negative MSCT results, a significantly dis-
eased left anterior descending and left circumflex were incorrectly classified as having non-obstruc-
tive disease. Finally, in one patient who was incorrectly classified positive, a lesion of approximately 
40% located in the left anterior descending was overestimated by MSCT.
Results of all analyses including positive and negative predictive values with 95% confidence inter-
vals are summarized in Table 2. 
Table 2. Diagnostic accuracy of Multi-Slice Computed Tomography (n=60).
Segmental analysis Vessel analysis Patient analysis
Excluded 12/854, 1.4% 1/240, 0.4% 0%
Sensitivity 62/73 (85%, 77% - 93%) 46/53 (87%, 78% - 96%) 29/31 (94%, 86% - 100%)
Specificity 755/769 (98%, 97% - 99%) 179/186 (96%, 93% - 99%) 28/29 (97%, 91% - 100%)
Positive  
Predictive Value
62/76 (82%, 73% - 91%) 46/53 (87%, 78% - 96%) 29/30 (97%, 91% - 100%)
Negative 
Predictive Value
755/766 (99%, 98% - 100%) 179/186 (96%, 93% - 99%) 28/30 (93%, 84% - 100%)
Diagnostic 
accuracy
817/842 (97%, 96 % - 98%) 225/239 (94%, 91% - 97%) 57/60 (95%, 89% - 100%)
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Discussion
On a segmental level, a diagnostic accuracy of 97% was observed. Importantly, only 12 (1%) seg-
ments could not be evaluated for the presence or absence of significant lesions due to insufficient 
image quality. In addition, an excellent specificity of 98% was observed with a somewhat lower 
sensitivity of 85% on a segmental basis. Nonetheless, from a clinical point of view, data regarding 
the performance on a patient rather than segmental basis are preferred, since selection of patients 
needing further invasive evaluation or intervention will be based on these findings. In the present 
study, a sensitivity of 94% was noted with a corresponding specificity of 97% in the detection of 
patients with obstructive CAD. Thus, in contrast to several previous studies 4;7, no loss in specificity 
was observed when shifting from a segmental to a patient analysis. The current observations are in 
line with the few initial investigations with 64-slice MSCT that have been published thus far 3;4;8. Simi-
lar sensitivity and specificity of 86% and 95% on segmental basis were reported by Raff et al, who 
performed 64-slice MSCT in 70 patients 7. More recently, results in 52 patients presenting with a wide 
range of clinical conditions were reported by Mollet and colleagues 4. As a result of the highly symp-
tomatic population included, a higher sensitivity (100%) with somewhat lower specificity (92%) was 
obtained.
Since the purpose of the present study was to compare the diagnostic accuracy of MSCT to invasive 
coronary angiography, only patients with a relatively high likelihood of having significant stenoses 
were included. As a result, only 42% of included patients presented without known CAD. Although 
this percentage still compares favourably to most of the other available data on MSCT coronary an-
giography, it stipulates the current lack of data in lower CAD prevalence populations. Considering 
that non-invasive coronary angiography is most likely to be used in these particular populations to 
allow definite exclusion of significant CAD, data on the performance of MSCT in these populations 
are needed. 
Despite rapid technological advancements, several limitations inherent to MSCT remain. First, a sta-
ble and preferably low heart rate remains essential for high-quality MSCT images and administration 
of beta-blockers prior to the examination is often needed. Secondly, the current lack of validated 
quantification algorithms for MSCT represents another important issue. Although visual evaluation 
will be sufficient in most segments, more precise assessment of the degree of luminal narrowing will 
be needed in a considerable number of examinations. However, as shown by Leber and colleagues, 
the ability to visually quantify the grade of luminal obstruction on MSCT remains limited, even with 
64-slice technology 3. Indeed, also in the present study, the degree of stenosis was incorrectly esti-
mated as either more or less than 50% diameter narrowing in 2 patients, resulting in false diagnosis 
although in fact the presence of lesions was correctly identified. Accordingly, quantification of MSCT 
coronary angiography is likely to provide enhanced diagnostic accuracy while also improving re-
producibility of the technique and further investments in the development of such algorithms are 
needed. Finally, the radiation burden of MSCT remains of concern. 
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Abstract
Background  
Magnetic Resonance Imaging (MRI) and Multi-Slice Computed Tomography (MSCT) have 
emerged as potential non-invasive coronary imaging techniques. The objective of the present 
study was to clarify the current accuracy of both modalities in the detection of significant cor-
onary artery lesions (compared to conventional angiography as the gold standard) by means 
of a comprehensive meta-analysis of the presently available literature.
Methods 
A total of 51 studies on the detection of significant coronary artery stenoses (50% diameter 
stenosis or more) and comparing results to conventional angiography were identified by 
means of a MEDLINE search. Weighted sensitivities, specificities, predictive values, all with 95% 
confidence intervals (CIs), as well as summary odds ratios were calculated for both techniques. 
In addition, the relationship between diagnostic specificity and disease prevalence was deter-
mined using meta-regression analysis. 
Results 
A comparison of sensitivities and specificities revealed significantly higher values for MSCT 
(weighted average: 85%, 95% CI: 86%-88% and 95%, 95% CI: 95%) as compared with MRI 
(weighted average: 72%, 95% CI: 69%-75% and 87%, 95% CI: 86-88%). A significantly higher 
odds ratio (16.9-fold) for the presence of significant stenosis was observed for MSCT as com-
pared to MRI (6.4-fold) (p<0.0001). Linear-regression analysis revealed a better specificity for 
MSCT versus MRI in lower disease prevalence populations (p=0.056). 
Conclusion 
Meta-analysis of the available studies with MRI and MSCT for non-invasive coronary angiog-
raphy indicates that MSCT has currently a significantly higher accuracy to detect or exclude 
significant CAD.
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Introduction
In the western world, coronary artery disease (CAD) remains the leading cause of death and its 
prevalence is still increasing. The current gold standard for the detection of CAD, invasive coronary 
angiography (CAG), allows direct visualization of the coronary lumen with high spatial and tempo-
ral resolution. However, it is an invasive procedure with several important drawbacks, including the 
significant costs and a small risk of serious complications 1;2. Furthermore, in a substantial number 
of procedures, no evidence of clinically important CAD is demonstrated. In patients with a low to 
intermediate pre-test likelihood of CAD, therefore, non-invasive evaluation of the coronary arteries 
would be highly desirable, whereas direct referral for invasive CAG may still be preferred in patients 
with a high pre-test likelihood. 
Over the past decade, Magnetic Resonance Imaging (MRI) and, more recently, Multi-Slice Computed 
Tomography (MSCT) have emerged as non-invasive cardiac imaging techniques. Their rapid devel-
opment has lead to the expectation that both techniques can be applied in the detection of CAD by 
direct visualization of coronary artery stenoses (instead of the detection of their functional conse-
quences). However, which technique is more likely to be implemented in the diagnostic workup of 
patients with suspected CAD eventually, still remains a heated issue of debate. 
To evaluate the accuracies of MRI and MSCT in the detection of CAD, we performed a comprehensive 
meta-analysis of the presently available literature on MRI and MSCT in the detection of significant 
coronary artery stenoses. 
Methods
Review of published reports
The objective of the current analysis was to evaluate the available reports on the diagnostic accuracy 
of MSCT and MRI in the detection of CAD. The studies were identified by means of several search 
strategies:
1. A search of the MEDLINE database (January 1990 –January 2005) was performed using the fol-
lowing keywords: computed tomography, magnetic resonance imaging, coronary artery disease, 
stenosis, occlusion, detection, and angiography.
2. A manual search of cardiology and radiology journals (American Heart Journal, American Journal of 
Cardiology, Circulation, European Heart Journal, European Journal of Radiology, Heart, Journal of the 
American College of Cardiology, Journal of Magnetic Resonance Imaging, Magnetic Resonance Imag-
ing, Magnetic Resonance in Medicine, Radiology) from 1990 to 2005.
3. Reference lists from the cited manuscripts were screened for additional studies that may have 
been missed.
Only articles performing a head-to-head comparison between non-invasive angiography with 
 either MRI or MSCT and invasive CAG in patients with known or suspected CAD were considered for 
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> 50, V
SE
N
A
83 (45/54)
94 (115/122)
1997
Kessler et al. 9
73
60
75
N
A
> 50, V
G
E
52 (236/455)
65 (28/43)
88 (169/193)
1998
W
oodard et al. 22 
10
60
50
N
A
> 30, V*
G
E
N
A
70 (7/10)
N
A
1999
Sandstede et al. 16
30
63
77
100
> 50, V*
SE
77 (92/120)
81 (30/37)
89 (49/55)
1999
Van G
euns et al. 18
32
N
A
62
N
A
> 50, V
G
E
74 (151/203)
50 (13/26)
91 (114/125)
1999
Kessler et al.  10†
6
N
A
N
A
N
A
> 50, V
G
E
N
A
60 (3/5)
N
A
2000
Sardanelli et al. 17
42
65
79
87 
> 50, V
G
E
86 (234/273)
82 (55/67)
89 (149/167)
2001
Kim
 et al. 11
109
59
69
59 
> 50, Q
V*
G
E
86 (374/434)
83 (78/94)
73 (204/280)
2002
Plein et al. 13
10
61
80
100 
> 50, V*
G
E
93 (37/40)
88 (15/17)
85 (17/20)
2002
W
eber et al. 20
11
61
N
A
N
A
> 50, V
TFE
70 (62/88)
88 (14/16)
93 (43/46)
2002
W
ittlinger et al. 21 
25
62
80
N
A
#, V
SE
85 (102/120)
75 (18/24)
100 (78/78)
2002
Regenfus et al.  15†
32
58
72
69 
> 50, V
G
E
69 (155/224)
60 (15/25)
88 (115/130)
2002
W
atanabe et al. 19
12
71
75
100 
> 50, V
TFE
70 (49/70)
80 (12/15)
85 (29/34)
2002
Van G
euns et al. 23
27
59
N
A
70
>50, V
G
E
69 (139/201)
46 (12/26)
90 (102/113)
2003
Bogaert et al. 3
21
62
71
68 
> 50, Q
TFE
72 (134/186)
56 (15/27)
83 (89/107)
2003
Ikonen et al. 8
69
58
63
 68
> 50, Q
*
G
E
84 (233/276)
75 (64/85)
62 (92/148)
2004
Jahnke et al. 7†
40
62
60
63
> 50, V
SSFP
79 (254/320)
72 (26/36)
92 (200/218)
2005
G
erber et al. 6
27
65
89
81
>50, Q
TFFE
100 (294/294)
62 (36/58)
84 (198/236)
2004
M
üller et al. 5
30
60
83
100
>50, N
A
G
E
100 (221/221)
85 (35/41)
84 (151/180)
2005
Som
m
er et al.  4 
18
63
61
61
>50, Q
TFE
87 (109/126)
82 (14/17)
88 (80/91)
W
eighted m
ean
82 (2953/3731)
73 (543/744)
85 (2047/2399)
3T2005 
Som
m
er et al. 4
18
63
61
61
>50, Q
TFE
86 (108/126)
82 (14/17)
89 (80/90)
W
eighted m
ean 1.5 T
83 (3441/4147)
72 (749/1043)
 87 (2600/2997)
* O
nly vessels available, no segm
ental analysis
, † Sam
e study group. In case of study com
paring 2 techniques, results of technique w
ith best results w
ere included in the overall w
eighted m
ean. 
Abbreviations: CAG
: conventional angiography, G
E: gradient echo; N
A: not available, Q
: quantitative analysis, SE: spin-echo, SSFP: steady-state free precession, TFE: turbo flash echo, TFFE: turbo flash field echo, V: visual 
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evaluation, while abstracts, reviews and articles written in another language than English were dis-
regarded. Finally, reports indicating that the patients included were subsets of previously published 
studies (n=1) or reports with insufficient data to calculate sensitivity and specificity on a segmental 
basis (n=9) were also excluded. When papers reported results of multiple observers, data from the 
observer with the highest accuracy were used for further analysis.
Statistical Methods
From each publication, a 2 x 2 frequency table was constructed based upon true negative and posi-
tives and false negative and positives. Diagnostic sensitivity (= true positives / [true positive + false 
negatives]) and specificity (= true negatives / [true negatives + false positives]) were calculated. 
Pooled calculations for diagnostic accuracy of MRI and MSCT techniques were performed based 
upon the proportional sample size of each report. The 95% confidence intervals (CIs) of the weighted 
sensitivities and specificities were calculated using the following formula: p ± 1.96*√{(p*(100-p))/n}, 
where p = weighted sensitivity or specificity (%) and n = the total number of segments. 
Summary odds ratios were calculated using the Comprehensive Meta AnalysisTM program (www.
meta-analysis.com, access date: February 2004). The odds ratio and summary odds ratio, with 95% 
CIs, for angiographic CAD was defined for positive MSCT and MRI studies. For this analysis, only data 
with negative and positive study findings were included. Pooled summary data for CAD incident 
cases/denominators of negative and positive studies were also calculated. A chi-square test for het-
erogeneity was calculated. The summary odds ratio was calculated using a random effects inverse 
variance approach. Analysis of variance techniques were also applied to compare the effect size for 
MSCT versus MRI. 
To compare the relationship between accuracy and disease prevalence, a meta-regression analysis 
was performed. For MSCT, a univariable meta-regression was performed estimating the influence of 
diagnostic specificity on CAD prevalence. Use of multivariable regression analyses did not alter the 
univariable relationship but were performed and included the prevalence of males and average age 
of the population. From this model, a linear regression model was employed to calculate the correla-
tion and beta coefficients. 
Diagnostic sensitivity and specificity was compared for intermediate and high-risk groups by em-
ploying analysis of variance techniques. Using a general linear model, the average diagnostic sensi-
tivity and specificity for intermediate and high-risk groups was compared for MSCT and MRI; weight-
ed by average sample size. A p-value <0.05 was considered statistically significant.
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Table 2. D
iagnostic accuracy of M
SC
T to detect coronary artery stenoses in 24 studies w
ith 1300 patients. 
Year
A
uthor
Pts (n)
M
ean age 
(yrs)
M
ale (%
)
Prevalence 
of CA
D
 (%
)
CA
G
  
criterium
BB-use
A
ssessable (%
) 
(nr segm
ents)
Sensitivity (%
)
(nr segm
ents)
Specificity (%
)
(nr segm
ents)
4-slice
2001
Achenbach et al. 31
64
63
75
N
A
> 50, Q
*
N
A
68 (174)
85 (40/47)
76 (96/127)
2001
Knez et al.  33
44
N
A
86
 70   
> 50, V
N
o
93 (358)
78 (39/50)
98 (301/308)
2002
N
iem
an et al. 38
53
56
75
 62 
> 50, Q
N
o
70 (358)
82 (42/51)
93 (285/307)
2002
Becker et al. 32
28
64
96
 64 
> 50, V
N
o
†
95 (187)
81 (21/26)
90 (145/161)
2002
Vogl et al. 40
64
56
56
N
A
> 50, V
Yes
100 (1039)
75 (59/79)
99 (955/960)
2002
N
iem
an et al. 37
78
57
73
75 
> 50, Q
N
o
68 (505)
84 (48/57)
95 (424/448)
2003
N
iem
an et al. 39
24
64
83
100 
> 50, Q
N
A
69 (146)
90 (71/79)
75 (50/67)
2003
M
organ-H
ughes et al. 36
30
56
80
N
A
> 70, Q
N
o
†
68 (140)
72 (18/25)
86 (99/115)
2003
Leber et al. 35 
91
62
79
 67 
> 50, V
Yes
80 (653)
81 (72/88)
95 (539/565)
2004
Kuettner et al. 34
66
61
74
100 
> 70, Q
N
o
57 (487/858)
66 (39/59)
98 (420/428)
2004
G
erber et al. 6
27
65
89
81
> 50, Q
Yes
100 (294/294)
79 (46/58)
71 (168/236)
W
eighted m
ean
78 (4877/6243)
80 (495/619)
94 (3482/3722)
8-slice
2004
M
aruyam
a et al. 41
25
63
68
64
> 50, Q
N
o
74 (258/348)
90 (27/30)
99 (226/228)
2004
M
atsuo et al. 42
25
65
76
76
> 50, Q
Yes
94 (94/100) *
75 (45/60)
96 (177/185)
W
eighted m
ean
79 (352/448)
80  (72/90)
98 (403/413)
16-slice
2003
Ropers et al. 53
77
58
65
53  
> 50, Q
*
Yes 
88 (270/308)
91 (51/56)
93 (200/214)
2002
N
iem
an et al. 43
59
58
90
86    
> 50, Q
*
Yes
100 (231/231)
95 (82/86)
86 (125/145)
2004
Kuettner et al. 45
60
‡
58
73
60
> 50, Q
Yes
100 (728/728) 
70 (39/56)
97 (655/672)
True 16-slice 
2004
D
ew
ey et al. 44
34
64
79 
N
A
> 50, Q
*
N
o
98 (133/136) 
88 (37/42)
94 (86/94)
2004
M
ollet et al.  47
128
59
88
83
> 50, Q
Yes
100 (1384/1384)
92 (216/234)
95 (1092/1150)
2004
M
artuscelli et al. 49
64
58
92
67
> 50, Q
Yes
84 (613/729)
89 (83/93)
98 (511/520)
2004
H
offm
ann et al. 50
33
57
82
67
> 50, Q
Yes
83 (438/530)
70 (30/43)
94 (371/393)
2005
Kuettner et al. 46
72
64
58
50
> 50, Q
Yes
100 (936/936)
82 (96/117)
98 (805/819)
2005
M
ollet et al. 52
51
59
73
63
> 50, Q
Yes
100 (610/610)
95 (61/64)
98 (537/546)
2005
Schuijf et al.  48
45
63
93
98
> 50, V
N
o
94 (298/317)
98 (59/60)
97 (231/238)
2005
M
organ-H
ughes et al. 51
58
61
81
56
> 50,V
N
o
100 (675/675)
83 (75/90)
97 (566/585)
W
eighted m
ean 
96 (6316/6584)
88 (829/941)
96  (5179/ /5376)
W
eighted m
ean overall 
87 (11545/13275)
85 (1396/1650)
95 (9064/9511)
BB-use: additional adm
inistration of BB m
edication prior to data acquisition to reduce heart rates.
* O
nly vessels available, no segm
ental analysis.
† Exclusion of patients w
ith heart rates higher than 75 bpm
‡  O
f these 60 patients, 4 had previous bypass grafting, sensitivity and specificity data are w
ithout these 4 patients.
Abbreviations: BB: beta-blocking m
edication, CAG
: conventional angiography, N
A: not available, Q
; quantitative analysis, V: visual analysis. 
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Results
Accuracy of MRI
A total of 28 studies comparing MRI to invasive CAG were analyzed and are summarized in Table 1. 
In 21 studies, the 3D navigator technique was used 3-23, whereas data were acquired during breath-
holds in 10 studies 10;15;24-30.  Analysis of the original data resulted in weighted means for sensitivity 
and specificity of respectively 72% (95% CI: 69% to 75%) and 87% (86% to 88%) for 1.5 T MRI. Average 
percentage assessable coronary segments was 83% with a 95% CI of 82% to 84%.
Accuracy of MSCT
The results of the studies that compared either 4-slice MSCT 6;31-40, 8-slice 41;42 or 16-slice MSCT 43-53 to 
invasive CAG are summarized in Table 2. For all MSCT studies combined, weighted sensitivities and 
specificities were 85% (95% CI: 83-87 and 95% (95% CI: 95%). Average percentage segments with di-
agnostic image quality was 87% (95% CI: 86% to 88%), while a significant increase could be observed 
from 78% with 4-slice systems to 96% with the more recent 16-slice systems.
Figure 1. Comparison of sensitivities and specificities of MRI and MSCT in the detection of significant CAD.
Comparison between the 2 techniques 
The results of the pooled analysis with the corresponding 95% CIs are summarized in Table 3. In 
the detection of significant CAD, weighted means for sensitivity, specificity, positive and negative 
predictive values were higher for MSCT as compared to MRI, without overlap of 95% CIs. Also, the 
percentage evaluable segments was significantly higher with MSCT as compared to MRI. In Figure 1, 
sensitivities and specificities of both MRI and MSCT in the detection of coronary artery stenosis are 
shown. 
In a subset analysis of MSCT and MRI, the summary odds ratios and the 95% CIs for the different 
techniques are plotted in Figure 2. Based upon a combined analysis, the summary odds ratio was 
elevated 16.9-fold (95% CI: 11.0-26.1) for an abnormal MSCT (p<0.0001), indicating that an abnormal 
0
20
40
60
80
100
Sensitivity Specificity
P
e
rc
e
n
ta
g
e
MRI MSCT
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segment had 16.9-fold increased odds of significant CAD at cardiac catheterization. In contrast, the 
summary odds ratio was increased 6.4-fold (95% CI: 5.0-8.3) for MRI (p<0.0001). The analysis of vari-
ance analysis noted a significantly higher odds of CAD with MSCT (p<0.0001).
Figure 2.  Forest plot of summary odds ratio (OR) comparing MSCT with MRI for the diagnosis of CAD stenosis >50%. 
(n) = number of included studies. Positive = number with CAD/number of positives; Negative = number without 
CAD/number of normals. 
The relationships between the diagnostic specificities of MRI and MSCT and the prevalence of CAD 
were plotted between 50-100% and predicted for 10-50% prevalence of CAD in the study population 
(Figure 3).  Using meta-regression techniques, an inverse relationship between diagnostic specificity 
and CAD prevalence for MSCT was observed (p=0.056). The amount of explanatory variance was 
–0.37 for MSCT. When examining these results for MRI, no relationship for MRI and CAD prevalence 
was observed (r2=0.25, p=0.55).  For MSCT, this relationship remained consistent even when control-
ling for the average age and the frequency of men enrolled in each study. 
MSCT (n of studies)
Positive
segments
w/ CAD
Negative
segments 
w/ CAD
Decreased OR Increased OR
Total N
of Segments
p<0.0001 for each comparison.
16 Slice* (2) 998 90 / 112 31 / 886
8 Slice (2) 503 72 / 90 10 / 413
4 Slice (11) 4,341 495 / 619 240 / 3,722
Summary (22) 10,794 419 / 9,272 1,201 / 1,522
16 Slice Collimation (7) 4,952 545 / 701 138 / 4,251
0.01
0.01
0.1
0.1
1
1
10
10
100
100
MRI (n of studies)
Positive
Segments
w/ CAD
Negative
Segments 
w/ CAD
Decreased OR Increased OR
Total N
of Segments
p<0.0001 for each comparison.
3D Navigator (18) 2,754 455 / 635 276 / 2,119
3D Breathhold (4) 769 107 / 136 58 / 633
2D Breathhold (3) 312 74 / 96 21 / 216
Summary MRI (26) 3,942 650 / 884 365 / 3,058
3T (1) 107 14 / 17 10 / 90
0.01
0.01
0.1
0.1
1
1
10
10
100
100
* 12 inner rings applied
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Table 3. Diagnostic accuracy for the different imaging techniques.
Technique
Sens  
(%)
95% 
CI (%)
Spec 
(%)
95% 
CI (%)
PPV 
(%)
95% 
CI (%)
NPV 
(%)
95% 
CI (%)
MRI 2D BH (n = 5) 80 74-86 89 85-93 84 78-90 86 82-91
MRI 3D BH (n = 5) 78 71-85 91 89-93 65 58-72 95 93-97
MRI 3D Navigator  
(n = 21)
73 70-76 85 84-86 61 58-64 91 90-92
MRI Overall (n = 28) 72 69-75 87 86-88 65 62-68 90 89-91
MSCT  4-slice (n = 11) 80 77-83 94 93-95 67 64-70 97 96-98
MSCT  8-slice (n = 2) 80 72-88 98 97-99 88 81-95 96 94-98
MSCT 16-slice (n = 11) 88 86-90 96 95-97 81 79-83 98 98
MSCT Overall (n = 24) 85 83-87 95 95 76 74-78 97 97
Diagnostic accuracy including uninterpretable segments
MRI 3D Navigator (n = 8) 59 54-63 71 68-74 40 36-44 84 82-86
MRI Overall (n = 9) 58 53-63 70 68-72 37 33-41 85 83-87
MSCT 4-slice (n = 8) 66 62-70 76 75-77 32 29-35 93 92-94
MSCT 16-slice (n = 10) 85 83-87 94 93-95 71 68-74 97 97
MSCT Overall (n = 18) 77 75-79 94 93-95 51 49-53 96 96
BH: breath hold; CI: confidence interval; PPV: positive predictive value; NPV: negative predictive value
Number in parentheses represents number of studies. 
 
Discussion
Analysis of the available literature on MRI and MSCT revealed a considerable advantage for MSCT 
compared to MRI in the detection of CAD. A significant higher overall accuracy in the detection of 
coronary artery stenoses was demonstrated for MSCT as compared to MRI. In addition, an almost 
17-fold elevated odds ratio was observed for an abnormal test result with MSCT, significantly higher 
than MRI (P<0.0001). Linear-regression analysis revealed a better specificity for MSCT versus MRI in 
lower disease prevalence populations (p=0.056). This is an important observation, since non-invasive 
imaging of the coronary arteries is most likely to be implemented as diagnostic tool to exclude CAD 
in patients with a low to intermediate likelihood of CAD, and thus to avoid the risks and expenses of 
invasive CAG in this particular patient group.
Although MRI has become an established modality in the non-invasive evaluation of many cardiac 
parameters, including ventricular function, myocardial perfusion and mass, our analysis suggests 
that concerning coronary imaging the technique is currently outperformed by MSCT. Despite initial 
promising results, diagnostic accuracy was significantly less compared to MSCT studies. However, 
it should be taken into account that both technologies are in a constant evolutionary state. For in-
stance, the introduction of 3 Tesla systems may increase the resolution of MRI sufficiently to allow 
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improved detection of CAD 54. With MSCT on the other hand, the number of detector rows has 
increased from 4 to 64 and further expansion to 128 will soon be realized. This will result in faster 
acquisition times, enabling the coverage of the whole heart in less than 10 seconds. With these sys-
tems, breathing artefacts or breath-hold associated increases in heart rate during acquisition are less 
likely to occur. Indeed, studies performed with 16-slice technology show an increase in the number 
of evaluable segments as well as diagnostic accuracy as compared to results obtained with 4-slice 
systems (Table 3). Still, several important limitations exist, including the relatively high radiation ex-
posure (which will increase slightly with more detector rows) and the limited value in patients with 
heart rates above 65 37 or with tachy-arrhythmias (for which reasons beta-blockers are frequently ad-
ministered). The use of multi-segmented reconstruction algorithms, which are available on certain 
MSCT systems, may allow the inclusion of patients with higher heart rates without loss in temporal 
resolution or need for beta-blockade 44;55. 
Another limitation of MSCT is that currently the technique does not allow quantification of stenosis 
severity. Eventually reliable absolute measurements of vessel diameter and lesion severity, similar 
to quantitative coronary angiography, will be needed. Nevertheless, a reliable estimate of overall 
coronary plaque burden can already be derived from MSCT. Indeed, the technique shows a clear po-
tential for plaque characterization 56;57. Several studies comparing MSCT to intravascular ultrasound 
imaging, have shown a relation between the average Hounsfield Unit of the coronary plaque and its 
echogenicity, suggesting that MSCT can distinguish between soft, intermediate and calcified plaque 
56;57.
Figure 3. Relationship between CAD prevalence and diagnostic specificity for MSCT and MRI. Diagnostic speci-
ficity is plotted with a line of best fit within a range from >50% to 100% and predicted across a range of CAD 
prevalence rates from 10% to 50%.
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Clinical implications
Because of its invasive nature and cost, indications for catheter-based diagnostic CAG have been 
restricted to a small fraction of high-risk patients with high pre-test likelihood of CAD. These 
patients are usually selected by risk-stratification and prior non-invasive imaging. Therefore, in 
current practice, coronary anatomy remains unknown in the majority of patients with CAD as well 
as in all asymptomatic subjects with a high-risk profile, frequently resulting in suboptimal therapy. 
The emergence of non-invasive diagnostic angiography by MSCT will grant the opportunity to 
obtain anatomic information about the coronary atherosclerotic process at a pre-clinical stage on 
a large scale. This is likely to have a profound impact on the practice of cardiology, in particular in 
the fields of revascularization on the one end, and prevention on the other end of the spectrum. 
Limited information is currently available on the accuracy of MSCT in low- and intermediate-
prevalence populations, although extrapolation of the available data (Figure 3) suggests no loss 
in specificity of MSCT with decreasing disease prevalence. This observation suggests that the 
presence of CAD can be excluded with high accuracy such that the use of MSCT as a first-line 
evaluation tool could now be tested prospectively in selected subgroups.
Conclusion 
Meta-analysis of available studies with MRI and MSCT for non-invasive coronary angiography in-
dicates that MSCT has currently a significantly higher accuracy to detect or exclude significant 
CAD. MSCT may be considered the technique of choice to non-invasively evaluate coronary artery 
anatomy. 
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Abstract
Background 
Early identification of coronary artery disease (CAD) in patients with diabetes is important, 
since these patients are at elevated risk for developing CAD and have worse outcome as com-
pared to non-diabetic patients, once diagnosed with CAD. Recently, non-invasive coronary 
angiography and assessment of left ventricular (LV) function has been demonstrated with 
multi-slice computed tomography (MSCT). The purpose of the present study was to validate 
this approach in patients with type 2 diabetes.
Methods 
MSCT was performed in 30 patients with confirmed type 2 diabetes. From the MSCT images, 
coronary artery stenoses (≥ 50% luminal narrowing) and LV function (LV ejection fraction, 
regional wall motion) were evaluated and compared with conventional angiography and 
2D-echocardiography.
Results 
A total of 220 (86%) of 256 coronary artery segments were interpretable with MSCT. In these 
segments, sensitivity and specificity for the detection of coronary artery stenoses were 95%. 
Including the uninterpretable segments, sensitivity and specificity were 81% and 82%, respec-
tively. Bland-Altman analysis in the comparison of LV ejection fractions demonstrated a mean 
difference of –0.48% ± 3.8% for MSCT and echocardiography, not significantly different from 
zero. Agreement between the 2 modalities for assessment of regional contractile function was 
excellent (91%, kappa statistic 0.81).
Conclusion 
Accurate non-invasive evaluation of both the coronary arteries and LV function with MSCT is 
feasible in patients with type 2 diabetes. This non-invasive approach may allow optimal iden-
tification of high-risk patients.
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Introduction
Type 2 diabetes is a major risk factor for coronary artery disease (CAD) and is associated with a 2- to 
4- fold increase in the risk of developing CAD 1. Furthermore, prognosis of patients with type 2 diabe-
tes and confirmed CAD has been demonstrated to be worse than in non-diabetic patients with CAD. 
For example, the likelihood of developing myocardial infarction is significantly higher in diabetic 
patients with unstable angina compared to non-diabetic individuals. Moreover, mortality rate after 
myocardial infarction has also been shown to be doubled 2. Early identification of CAD is therefore of 
paramount importance in patients with diabetes. 
Non-invasive testing including myocardial perfusion scintigraphy and dobutamine stress echocar-
diography have been used to detect CAD 3;4. However, direct visualization of the coronary arteries 
may be preferred since patients with diabetes frequently have diffuse, multi-vessel CAD. Currently, 
conventional angiography is performed to evaluate the presence and extent of CAD. However, this 
is an invasive approach associated with a minimal but definitive risk of complications, and a non-
invasive technique that is capable of direct visualization of the coronary arteries would be preferred. 
A promising new imaging technique for the non-invasive detection of CAD is multi-slice computed 
tomography (MSCT), which allows the acquisition of high quality images of the entire heart within 
a single breath-hold. Several studies have demonstrated the technique to be useful in the detection 
of coronary artery stenoses with sensitivities and specificities ranging from 72% to 95% and 75% to 
99%, respectively 5-11. 
In addition, MSCT allows simultaneous assessment of left ventricular (LV) function, which also is an 
important prognostic parameter 4. Although the studies on assessment of LV function with MSCT 
are scarce, the initial results demonstrated a good relation between LV ejection fraction assessed by 
MSCT and 2D-echocardiography or Magnetic Resonance Imaging (MRI) 12-14.
Combined assessment of LV function and the coronary artery status with MSCT may allow optimal 
non-invasive evaluation of patients with diabetes with suspected CAD. Thus far, the value of MSCT 
has not been evaluated in patients with diabetes. Accordingly, the purpose of the present study was 
to perform a combined assessment of coronary arteries and LV function in patients with type 2 dia-
betes using MSCT; the results were compared to conventional angiography and 2D-echocardiogra-
phy, respectively.  
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Methods
Patients and study protocol
The study group consisted of 30 patients with known type 2 diabetes who were scheduled for con-
ventional angiography because of anginal complaints. Criteria for the diagnosis of diabetes were, as 
recommended by the American Diabetes Association 15: 
1.  symptoms of diabetes plus casual plasma glucose concentration ≥ 200 mg/dl (11.1 mmmol/l) or
2.  fasting plasma glucose level ≥ 126 mg/dl (7.0 mmol/l). 
 Exclusion criteria were: atrial fibrillation, renal insufficiency (serum creatinine >120 mmol/L), 
known allergy to iodine contrast media, severe claustrophobia and pregnancy.
The average interval between conventional angiography and MSCT was 17 ± 27 days, whereas 
2D-echocardiography was performed prior or after the CT examination within two weeks. All pa-
tients gave written informed consent to the study protocol, which was approved by the local ethics 
committee.
MSCT; Data acquisition
In the initial 12 patients, MSCT was performed using a Toshiba Multi-Slice Aquilion 0.5 (collimation 
4 x 2.0 mm) system and in the remaining 18 patients using a Toshiba Multi-slice Aquilion 16 system 
(collimation 16 x 0.5 mm) (Toshiba Medical Systems, Otawara, Japan). Rotation time was 0.4s or 0.5s, 
depending on the heart rate, while the tube current was 250 mA, at 120 kV. A bolus of 140 ml con-
trast (Xenetix 300®, Guerbet, Aulnay S. Bois, France) was administered with an injection rate of 4 ml/s 
in the antecubital vein. To time the scan, automated peak enhancement detection in the aortic root 
was used. The heart was imaged from the aortic root to the cardiac apex during inspiratory breath 
hold, while the ECG was recorded simultaneously for retrospective gating of the data. To assess LV 
function, 20 cardiac phases were reconstructed in the short-axis orientation with a slice thickness of 
2.00 mm and subsequently transferred to a remote workstation with dedicated cardiac software (MR 
Analytical Software System [MASS], Medis, Leiden, the Netherlands).
To evaluate the coronary arteries, 5 reconstructions covering diastole (65% - 85% of the R-R range) 
were generated with a slice thickness of either 1.0 mm (4-slice system) or 0.5 mm (16-slice system). 
If motion artifacts were present, additional reconstructions were made at 40%, 45% and 50% of the 
cardiac cycle. Images were transferred to a remote workstation (Vitrea2, Vital Images, Plymouth, 
Minn. USA) for post-processing. 
MSCT; Data analysis
Stenosis assessment was performed using a modified AHA-ACC segmentation model: the left main 
coronary artery (segment 5), the right coronary artery (segments 1, 2, 3, and if present 4 and 16), 
the left anterior descending coronary artery (segments 6,7, 8, and 9), and the left circumflex artery 
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(segment 11, 13, and if present 12, 14, 15, and 17). Only side-branches of ≥1.5 mm as determined by 
quantitative coronary angiography or supplied by coronary bypass grafts were evaluated. Images 
were evaluated by an experienced observer blinded to the catheterization results, using both the 
original axial MSCT images and curved multiplanar reconstructions. Each segment was first evalu-
ated as interpretable or not. Subsequently, the presence of significant narrowing (≥50% reduction of 
lumen diameter) was determined in the assessable segments. In addition, coronary bypass grafts, if 
present, were evaluated for the presence of ≥50% luminal narrowing or not. In those patients, native 
coronary segments prior to the anastomosis of a patent graft, were not evaluated.
Regional wall motion was assessed visually using the short-axis slices (displayed in cine-loop format) 
by one observer blinded to all other data using a previously described 17-segment model 16. Each 
segment was assigned a wall motion score using a 4-point scale (1=normokinesia, 2=hypokinesia, 
3=akinesia, and 4=dyskinesia).  LV ejection fraction was calculated using semi-automated endocar-
dial contour detection, with manual correction when necessary. Papillary muscles were regarded as 
being part of the LV cavity.
Conventional angiography
Conventional angiography was performed according to standard techniques. Vascular access was 
obtained by using the femoral approach with the Seldinger technique.
Coronary angiograms were visually evaluated by an experienced observer blinded to the MSCT 
data. 
2D-echocardiography
Patients were imaged in the left lateral decubitus position using a commercially available system 
(Vingmed System FiVe/Vivid-7, GE-Vingmed, Milwaukee, WI, USA). Images were acquired using a 3.5 
MHz transducer at a depth of 16 cm in the parasternal and apical views.
Regional wall motion was analyzed using the same 17- segment model and 4-point scale as de-
scribed above. LV ejection fractions were calculated from the 2- and 4-chamber images using the 
biplane Simpson’s rule 17. 
Statistical analysis
Sensitivity, specificity, positive and negative predictive values for the detection of significant coro-
nary artery stenoses were calculated. In addition, a patient based analysis was performed. MSCT was 
considered correct in the individual patient analysis if at least one significant stenosis was detected 
on the MSCT images or if MSCT ruled out the presence of any significant stenosis. Pre-test likeli-
hood of CAD in patients without previous myocardial infarction or coronary bypass grafting was es-
timated using the Diamond-Forrester method 18. Bland-Altman analysis was performed for each pair 
of values of LV ejection fraction to calculate limits of agreement and systematic error between the 
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two modalities 19. Agreement for regional wall motion was expressed in a 4x4 table using weighted 
kappa statistics. A kappa value of <0.4 represents poor agreement, a kappa value between 0.4 and 
0.75 fair to good agreement, and a kappa value of >0.75 is considered an excellent agreement, based 
on the Fleiss’ classification 20. A p-value <0.05 was considered to indicate statistical significance.
Results
Patient characteristics
The patient characteristics are summarized in Table 1. The study group consisted of 30 patients (26 
men, mean age 62 ± 10 years) with type 2 diabetes. The average duration of diabetes mellitus was 
2.9 ± 4.4 years at the time of MSCT. A total of 11 patients received oral hypoglycaemic medication or 
insulin (n=5). Cardiac medication was continued during the study period. A total of 16 (53%) patients 
used beta-blocking agents, and no additional beta-blocking agents were administered in prepara-
tion of the scan.
Table 1. Clinical characteristics of the study population (n=30).
n (%)
Gender (M/F) 26/4
Age (years) 62 ± 10
Beta-blocking medication 16 (53)
Heart rate during acquisition 69 ± 13
Diabetes type 2       30 (100)
Average HbA1c                   6.9% ± 1.4%
Other risk factors for CAD
        Hypertension 16 (73)
        Smoking 12 (56)
        Hypercholesterolemia 21 (95)
        Family with CAD 12 (56)
History
         Previous MI 20 (67)
         Previous PCI/CABG 21 (70)/11 (37) 
Vessel disease
         1-vessel 6 (20)  
         2-vessel 6 (20)  
         3-vessel 16 (53)
Angina Pectoris                              
        CCS class 1/2 7 (23)
        CCS class 3/4 23 (77)
Heart Failure
        NYHA class 1/2 25 (83)
        NYHA class 3/4 5 (17) 
CABG: coronary artery bypass grafting; CCS: Canadian Cardiovascular Society; MI: myocardial infarction; NYHA: New 
York Heart Association; PCI: percutaneous coronary intervention.
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Coronary artery stenoses
A total of 256 coronary segments were present for evaluation by both MSCT and conventional an-
giography. Of the 99 segments studied with 4-slice MSCT, 18 (18%) were uninterpretable, whereas 
also 18 (11%) of 157 segments acquired with 16-slice MSCT were of non-diagnostic quality. Thus, 
36 (14%) segments were classified uninterpretable. In the remaining 220 segments, conventional 
angiography revealed 59 significant (≥50% diameter reduction) lesions. Evaluation of the MSCT im-
ages resulted in the correct identification of 56 (95%) stenoses. In 153 of 161 (95%) segments, the 
presence of significant stenosis was correctly ruled out. Thus, resulting sensitivity and specificity 
were 95%. When the uninterpretable segments were included in the analysis, resulting sensitivity 
and specificity were 81% and 82%, respectively. 
Figure 1. In panel A, a curved multiplanar reconstruction of a left circumflex coronary artery (LCx) with severe 
narrowing of the lumen is depicted. No abnormalities however were observed in the left anterior descending 
coronary artery (LAD) of this patient (panel B). Also, in the 3D volume rendered reconstruction (panel C), steno-
ses in the LCx as well as patency of the LAD are clearly visible. Findings were confirmed by conventional X-ray 
angiography (panel D). 
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A total of 21 grafts were present (arterial=5, venous=16). Conventional angiography revealed the 
presence of ≥ 50% luminal narrowing in 9 grafts. MSCT correctly identified all 9 grafts with signifi-
cant stenosis, whereas 9 of 12 grafts without significant stenosis were correctly identified on the 
MSCT images. In the 3 remaining grafts however the presence of significant narrowing could not be 
evaluated, although patency of the graft could be assessed correctly.
On a per patient basis, MSCT was accurate in 26 (87%) of 30 patients. In 7 patients, no significant ab-
normalities were observed during conventional angiography, and 5 (71%) of these patients were cor-
rectly identified as having no significant lesions using the MSCT images. Of the remaining 23 patients 
with significant lesions on conventional angiography, 21 (91%) were correctly identified using MSCT. 
In 23 patients CAD was known. In the remaining 7 patients with suspected CAD, the pre-test likeli-
hood according to Diamond-Forrester was intermediate in 2 and high in 5 patients. Conventional 
angiography demonstrated the presence of significant lesions in 5 patients, of which 4 (80%) were 
correctly identified with MSCT. Of the 2 patients without significant CAD, 1 (50%) was correctly as-
sessed with MSCT. 
Examples of MSCT images of both a stenotic and non-stenotic coronary artery with the correspond-
ing angiographic images are shown in Figure 1. 
LV function
From one patient, MSCT data were lost (due to technical errors) after successful acquisition, and 
therefore data from 29 patients were available for LV function analysis. 
Figure 2. Bland-Altman plot in the comparison of MSCT and echocardiography in the assessment of LV ejection 
fraction. 
The difference between each pair is plotted against the average value of the same pair (solid line= mean value 
of differences and dotted lines = mean value of differences ± 2SDs).
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Global	function
Mean LV ejection fraction, as determined by echocardiography and MSCT, was 43% ± 14% (range: 
19% - 75%) and 43% ± 14% (range: 15% - 72%, ns), respectively. Bland-Altman analysis in the com-
parison of CT and echo LV ejection fraction demonstrated a mean difference of  -0.48% ± 3.8%, not 
significantly different from zero (Figure 2). 
Regional	function	
Echocardiography revealed contractile dysfunction in 157 (32%) of 493 segments, with 71 (45%) 
showing hypokinesia, 74 (47%) akinesia and 12 (8%) dyskinesia. In 149 (95%) of the dysfunctional 
segments, decreased systolic wall thickening was also observed on the MSCT images. An excellent 
agreement was shown between the two techniques, with 91% of segments scored identically on 
both modalities (kappa statistic 0.81 ± 0.03). Agreements for the individual gradings (1-4) were 97%, 
82%, 73%, and 92%, respectively. In Figure 3, examples of short-axis reconstructions are shown, il-
lustrating patients with and without wall motion abnormalities.
Figure 3. MSCT short-axis reconstructions in end-diastole (ED, left panels) and end-systole (ES, right panels). In 
the upper two panels (A), normal systolic wall thickening is clearly present in all segments. In the lower two pan-
els, short-axis reconstructions of a patient with a previous inferolateral infarction are shown. Although preserved 
wall motion is still present in the anterior region (arrowheads), akinesia of the severely thinned wall is clearly 
visible in the infarcted region (arrows) (B). 
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Discussion
Our study demonstrates that non-invasive coronary angiography is feasible in patients with diabe-
tes. An excellent sensitivity and specificity of both 95% were shown for the detection of coronary 
artery stenoses. Corresponding positive and negative predictive values were 88% and 98%, respec-
tively. With inclusion of the uninterpretable segments, sensitivity and specificity were still 81% and 
82%, respectively. Moreover, although inclusion of uninterpretable segments resulted in a positive 
predictive value of 62%, the negative predictive value remained high (92%), which is in line with pre-
vious studies 11;21. This is an important finding, since clinical management is often difficult in patients 
presenting with diabetes and suspected CAD. In a substantial number of patients, non-invasive tests 
are inconclusive and knowledge of coronary anatomy (by means of invasive angiography) is often 
needed in order to determine the most optimal treatment strategy. The high accuracy of MSCT in 
the exclusion of CAD as demonstrated by the high specificity and negative predictive value in the 
current study underscores the potential of this technique to function as a first-line diagnostic modal-
ity in the workup of patients with suspected CAD. By ruling out the presence of significant stenoses, 
risks and costs of invasive angiography can thus be avoided in a substantial number of patients. 
Moreover, accurate information of coronary anatomy and extent of atherosclerosis as well as car-
diac function is obtained, which may optimize treatment strategy and prognostification and may 
eventually even serve as a guide for interventional procedures.  However, further prognostic studies 
are needed in larger cohorts before MSCT can become an established diagnostic tool and replace 
conventional coronary angiography in certain patient groups. 
In addition, LV function analysis was performed after retrospective reconstruction of the acquired 
data. In the assessment of LV ejection fraction, a close correlation was observed between MSCT and 
2D-echocardiography. Mean LV ejection fraction as determined by MSCT was slightly less as com-
pared to the echocardiographic results, but no statistical difference was reached. A slight underesti-
mation of LV ejection fraction with MSCT has been reported previously 12-14 which may be attributed 
to an overestimation of LV end-systolic volume. Since minimal ventricular volume is maintained for 
only 80-200 ms, temporal resolution of MSCT may not have been sufficient in all patients. 
Overall agreement of regional wall motion score was excellent with 91% of segments scored identi-
cally. The agreement for the individual wall motion scores was highest in the extremes, i.e. in seg-
ments with either normal contractility (97%) or dyskinesia (92%), whereas it was slightly lower in 
segments showing intermediate contractile dysfunction. Since MSCT is most likely to be applied as 
a first line screening tool, baseline LV function may be used to further refine risk stratification in the 
individual patient. However, it does currently not offer an alternative to echocardiographic examina-
tion since evaluation of valvular or diastolic function is not possible with MSCT. 
Some limitations of the current study need to be acknowledged. First, in the present study only 30 
patients were included. Studies in larger patients cohorts are needed to precisely determine the ac-
curacy of MSCT in patients with type 2 diabetes. 
Second, LV function analysis was compared to 2D-echocardiography instead of MRI, which is consid-
ered the current gold standard for evaluation of LV function. In contrast to MRI, 2D-echocardiogra-
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phy relies on geometrical assumptions and may thus be somewhat less accurate. Still, our results are 
very similar to those obtained in the few available comparisons between MSCT and MRI 13;14. Third, 
in the present study 14% of coronary segments were uninterpretable, which is in line with previous 
studies 6;11;22. However, with the introduction of 32- and 64-slice systems the percentage of uninter-
pretable segments is likely to decline further.
Fourth, although some authors have recommended the use of beta-blocking agents 7, no additional 
beta-blocking agents were administered prior to the examination in the present study. The use of 
a multi-segmented reconstruction algorithm, which is available on our MSCT equipment, allowed 
the inclusion of patients with heart rates higher than 65 beats per minutes without loss in temporal 
resolution 23. Furthermore, additional administration of beta-blocking agents may have interfered 
with cardiac function analysis, rendering it less reliable.
Finally, a major drawback of MSCT remains the radiation dose, which is approximately 6-9 mSv 24-26. 
The development of new filters and optimized acquisition protocols will lead to a substantial reduc-
tion of radiation dose.
In conclusion, accurate non-invasive evaluation of both the coronary arteries and LV function with 
MSCT is feasible in patients with type 2 diabetes. This combined strategy may improve the non-inva-
sive evaluation of CAD in this particular patient group. 
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Abstract 
Background 
Because patients with hypertension are at increased risk for developing coronary artery 
disease, early and non-invasive identification of the disease in patients with hypertension is 
important. Recently, multi-slice computed tomography  (MSCT) has been demonstrated to 
allow both non-invasive coronary angiography and assessment of left ventricular function. 
The purpose of the present study therefore was to demonstrate the feasibility of this approach 
in patients with hypertension with known or suspected coronary artery disease and compare 
the results to invasive coronary angiography and 2D-echocardiography respectively.
Methods 
MSCT was performed in 31 patients with confirmed hypertension. From the MSCT images, the 
presence of significant coronary stenoses (≥50% luminal narrowing) and regional wall mo-
tion abnormalities were evaluated and compared with invasive coronary angiography and 
2D-echocardiography. In addition, left ventricular ejection fraction was calculated from the 
MSCT images.
Results 
A total of 243 (88%) coronary artery segments could be evaluated with MSCT. Sensitivity and 
specificity for the detection of significant coronary artery stenoses were 93% and 96%. On a 
per patient basis, multi-slice computed tomography was accurate in 28 (90%) patients.  Mean 
left ventricular ejection fraction was 46 ± 14% (range: 16% to 64%. The agreement for assess-
ing regional wall motion was 91% (kappa statistic 0.81). 
Conclusion 
Simultaneous, non-invasive evaluation of coronary artery stenoses and left ventricular func-
tion with MSCT is accurate in patients with hypertension. This non-invasive approach may al-
low triage of patient treatment in terms of conservative versus invasive management. 
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Introduction
Coronary artery disease (CAD) is the major cause of morbidity and mortality in hypertensive pa-
tients, especially since patients with hypertension are at increased risk for developing CAD as com-
pared to normotensive individuals 1;2. Moreover, since hypertension is present in 1 of every 5 adults, 
non-invasive detection of CAD in this particular patient group has become a clinically important 
issue 3. However, of several non-invasive tests, including exercise ECG and myocardial perfusion 
imaging, a limited specificity in hypertensive patients has been reported due to an increased oc-
currence of false positive results in this particular patient group 4-7. These positive test results may 
represent impaired vasodilator reserve and increased myocardial oxygen demand as a consequence 
of microvascular disease, and thus myocardial ischemia in the absence of significant coronary artery 
abnormalities 4-9. A non-invasive test therefore should ideally allow direct visualization of the coro-
nary arteries to detect or exclude obstructive CAD to triage patients for optimal medical therapy or 
invasive evaluation.  
Over the recent years, Multi-Slice Computed Tomography (MSCT) has emerged as a potential non-in-
vasive imaging method that allows the acquisition of high-quality images of the entire heart within 
a single breath-hold. High sensitivities and specificities in the detection of coronary artery stenoses 
have been reported, ranging from 72% to 95% and 75% to 99%, respectively 10-19. Furthermore, the 
simultaneous recording of ECG data permits the reconstruction of images at any moment of the 
cardiac cycle, thus allowing cardiac function analysis in addition to the evaluation of the coronary 
arteries, although data are scarce 20-23. 
Since no specific data are available on the performance of MSCT in patients with hypertension, the 
purpose of the present study was to demonstrate the feasibility of evaluation of the coronary arter-
ies and left ventricular (LV) function using MSCT in patients with hypertension. Conventional coro-
nary angiography and 2D-echocardiography served as reference standards. 
 
Methods
Patients and study protocol
The study group comprised 31 patients with 1). chest pain and/or dyspnea, 2). confirmed hyper-
tension (defined by sequential (on separate occasions) blood pressure measurements using an arm 
cuff and a mercury manometer). All patients were scheduled for conventional coronary angiography 
for the evaluation of chest pain/dyspnea complaints. Hypertension was defined as systolic blood 
pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg, and/or use of antihypertensive 
medication. 
Patients with atrial fibrillation were excluded, and additional exclusion criteria were renal insufficien-
cy (serum creatinine >120 mmol/L), known allergy to iodine contrast media, severe claustrophobia, 
and pregnancy.
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All patients gave informed consent to the study protocol, which was approved by the local ethics 
committee.
Multi-slice computed tomography
Data	acquisition 
In the initial 17 patients, MSCT angiography was performed with a Toshiba Multi-Slice Aquilion 0.5 
system and in the remaining patients with a Toshiba Multi-slice Aquilion 16 system (Toshiba Medical 
Systems, Otawara, Japan). Thus, detector collimation was either 4 x 2.0 mm or 16 x 0.5 mm. Other pa-
rameters were: rotation time 400, 500 or 600 ms (depending on the heart rate), tube current 250 mA, 
and tube voltage 120 kV. A bolus non-ionic contrast (Xenetix 300®, Guerbet, Aulnay S. Bois, France) 
was injected in the antecubital vein at a flow rate of 4.0 ml/s, resulting in a total administered dose of 
120-150 ml, depending on the scan time. Automated detection of peak enhancement in the aortic 
root was used for timing of the scan. During a breath hold of approximately 25s, cardiac images, from 
the aortic root to the apex, were acquired. Data were reconstructed using retrospective ECG gating. 
A multi-segment reconstruction algorithm was applied, meaning that data from up to 4 consecutive 
heartbeats were used to generate a single image, thereby resulting in a temporal resolution of 105 
– 200 ms. Spatial resolution was 0.5 x 0.5 x 2.0 mm and 0.5 x 0.5 x 0.5 mm for the 4-slice and 16-slice 
system, respectively. No beta-blocking medication to reduce the heart rate was administered prior 
to the examination and patients were included regardless of heart rate. 
To evaluate the presence of coronary artery stenoses, reconstructions in diastole (65% - 85% of the 
cardiac cycle) were generated with a reconstructed section thickness of either 1.0 mm (4-slice sys-
tem) or 0.4 mm (16-slice system). Images were transferred to a remote workstation (Vitrea2, Vital 
Images, Plymouth, Minn. USA) for post-processing and evaluation. Images containing the fewest 
motion artifacts were used for evaluation.
For the evaluation of LV function, the same original raw data set (acquired for the evaluation of the 
coronary arteries) was used. Images were reconstructed retrospectively at 20 time points, starting 
at early systole (0% of the cardiac cycle) to the end of diastole (95% of the cardiac cycle). Subse-
quently, short-axis images with a slice thickness of 2.00 mm were generated and transferred to a re-
mote workstation with dedicated cardiac function analysis software (MR Analytical Software System 
[MASS], Medis, Leiden, the Netherlands).
Data	analysis
The images were evaluated by an experienced observer, blinded to the catheterization results. A 
modified AHA-ACC segmentation model was used for stenosis assessment: the left main coronary 
artery (segment 5), the right coronary artery (segments 1, 2, 3), the left anterior descending coronary 
artery (segments 6,7, and 8), and the left circumflex artery (segment 11, 13) 24. If present and of suf-
ficient size (diameter larger than 2.0 mm), distal segments and side-branches (segments 4, 9, 10, 12, 
14, 15, 16 and 17) were also evaluated. 
In addition to the original axial slices, curved multiplanar reconstructions and 3D volume rendered 
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reconstructions were used to assess the presence of luminal narrowing. First, assessability was deter-
mined for each segment. Interpretable segments were subsequently classified as having significant 
stenosis (≥50% reduction of lumen diameter) or not.
An experienced observer blinded to all other data evaluated the presence of regional wall motion 
abnormalities visually on the short-axis slices (displayed in cine-loop format) using a previously de-
scribed 17-segment model 25. Each segment was graded on a 4-point scale (1= normokinesia, 2= 
hypokinesia, 3= akinesia and 4= dyskinesia). 
In order to calculate LV ejection fractions, endocardial contours were manually drawn on both the 
end-systolic and end-diastolic short-axis images. Papillary muscles were regarded as being part of 
the LV cavity. LV end-systolic and end-diastolic volumes were calculated using commercially avail-
able software (MASS) developed at our institution by summation of the product (area × slice dis-
tance) of all slices. Finally, the related LV ejection fraction was derived by subtracting the end-systolic 
volume from the volume at end-diastole and dividing the result by the end-diastolic volume.
Invasive coronary angiography
Invasive coronary angiography was performed according to standard techniques. Vascular access 
was obtained through the femoral approach with Seldinger’s technique and a 6 Fr or 7 Fr catheter. 
Coronary angiograms were visually evaluated by an experienced observer without knowledge of 
the MSCT data. The same segmentation as described above for MSCT was applied to determine the 
presence of significant luminal reduction in each coronary segment. 
2D-echocardiography
2D-echocardiography was performed in the left lateral decubitus position using a commercially 
available system (Vingmed System FiVe/Vivid-7, GE-Vingmed, Milwaukee, WI, USA). Images 
were acquired using 3.5 MHz transducer at a depth of 16 cm in standard parasternal and apical 
views.
Regional wall motion was scored using the 17-segment model and 4-point scale as described above 
for MSCT. 
Statistical analysis
Sensitivity, specificity, positive and negative predictive values with their corresponding 95% Con-
fidence Intervals (CIs) for the detection of significant coronary artery stenoses were calculated. The 
95% CIs were calculated using the following formula: p ± 1.96*√ {(p*(100-p))/n}, where p = sensitivity 
or specificity (%) and n = the total number of segments. Additionally, data were analyzed on a per 
patient basis. MSCT was considered correct in the individual patient analysis if at least one signifi-
cant stenosis was detected on the MSCT images or if MSCT ruled out the presence of any significant 
stenosis. Agreement for regional wall motion was expressed in a 4x4 table using weighted kappa 
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statistics. A kappa value of <0.4 represents poor agreement, a kappa value between 0.4 and 0.75 fair 
to good agreement, and a kappa value of >0.75 is considered an excellent agreement based on the 
Fleiss’ classification 26. A p-value <0.05 was considered to indicate statistical significance. 
Results
Patient characteristics
The patient characteristics are listed in Table 1. The study group consisted of 31 patients with con-
firmed hypertension; mean systolic blood pressure was 138 ± 21 mmHg (range: 110-167 mmHg), 
whereas mean diastolic blood pressure was 81 ± 10 mmHg (range: 67-105 mmHg). Average dura-
tion of hypertension at the time of MSCT was 3.1 ± 5.8 years (range: 0 - 9 years). Mean LV mass, as 
determined by echocardiography was 197 ± 68 g. Mean body mass index was 25 ± 3 kg/m2. Cardiac 
medication was continued during the study period. A total of 23 patients (74%) used beta-block-
ing agents. Other medications included angiotensin converting enzyme inhibitors (n=25), calcium-
 antagonists (n=16), nitrates (n=13), diuretics (n=10), oral anticoagulants (n=30) and statins (n=30). 
The average interval between conventional coronary angiography and MSCT was 1.9 ± 2.7 days. The 
interval between 2D-echocardiography and MSCT was 2.2 ± 1.8 days.
Table 1. Clinical characteristics of the study population (n=31).
Characteristic Value
Gender (M/F)  28/3
Age (yrs) 63 ± 11 
Hypertension 31 (100)
Heart rate during data acquisition (bpm) 68 ± 14
Beta blocker medication 23 (74)
Angina Pectoris                                
     CCS class 1/2 7 (23)
     CCS class 3/4 24 (77)
Heart Failure
     NYHA class 1/2 23 (74)
     NYHA class 3/4 8 (26)
History
    Previous MI 15 (48)
    Previous PCI/CABG 25 (81)/ 10 (34)
 Other risk factors for CAD 
    Diabetes type 2 16 (52)
    Smoking 15 (48)
    Hypercholesterolemia 29 (94)
    Family with CAD  17 (55)
Data between parentheses are %.
Bpm: beats per minute; CABG: coronary artery bypass grafting; CAD: coronary artery disease; CCS: Canadian Cardiovas-
cular Society; MI: myocardial infarction; NYHA: New York Heart Association; PCI: percutaneous coronary intervention.
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Coronary artery stenoses
A total of 277 coronary segments was available for comparison between conventional angiogra-
phy and MSCT. Of these segments, 243 (88%) were of sufficient quality to evaluate the presence 
of significant (≥50%) narrowing. Reasons of uninterpretability were predominantly the presence of 
coronary stents and motion artifacts. Furthermore, the majority of uninterpretable segments was 
located in distal segments (segments 3, 8 and 13).  Conventional angiography revealed 57 significant 
stenoses in the interpretable segments. Of these lesions, 53 were correctly detected by MSCT. The 
presence of significant stenosis was correctly ruled out in 179 out of 186 non-diseased segments. 
Accordingly, the sensitivity and specificity for the detection of coronary artery stenoses were 93% 
and 96%, respectively. Details per coronary artery, including positive and negative predictive values, 
are summarized in Table 7.2; among the different coronary arteries, no significant differences were 
noted. On a per patient basis, MSCT was accurate in 28 (90%) patients. Of 21 patients with significant 
lesions on conventional angiography, 20 (95%) patients were correctly identified. In the remaining 
10 patients with no significant abnormalities, MSCT was accurate in 8 (80%) patients. In Figures 1 and 
2, MSCT images of both stenotic and normal coronary arteries are shown. Of note, to obtain a multi-
planar reconstruction, each vessel needs to be reconstructed separately. Thus, no side-branches are 
visible, since only multiplanar reconstructions of the three major vessels are provided. 
Figure 1. Severe lesion in the left anterior descending coronary artery (LAD). In Panel A, a curved multiplanar 
MSCT reconstruction of the LAD is shown, demonstrating a severe stenosis (white arrowhead) in the proximal 
part of the vessel. A 3D volume rendered reconstruction is provided in Panel B. The severe lesion is also clearly 
visible in Panel C (black arrowhead), an enlargement of Panel B.  
Findings were confirmed by conventional angiography (panel D). 
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Table 2. Diagnostic accuracy (with 95% Confidence Intervals) of MSCT in the detection of stenoses.
Parameter All segments LM LAD LCx RCA
Interpretable 243/277 
(88, 84-92)
30/31
(97, 91-100)
84/97
(87, 80-94)
59/66
(89, 81-97)
70/83
(84, 76-92)
Sensitivity 53/57
(93, 86-100)
1/1
(100, NA)
22/23
(96, 88-100)
11/14
(79, 58-100)
19/19
(100, NA)
Specificity 179/186
(96, 93-99)
27/29
(93, 84-100)
58/61
(95, 90-100)
45/45
(100, NA)
49/51
(96, 91-100)
PPV 53/60
(88, 80-96)
1/3
(33, 0-86)
22/25
(88, 75-100)
11/11
(100, NA)
19/21
(90, 77-100)
NPV 179/183
(98, 96-100)
27/27
(100, NA)
58/59
(98, 94-100)
45/48
(94, 87-100)
49/49
(100, NA)
Values are the absolute values used to calculate the percentages. Numbers in parentheses are the percentages 
with the corresponding 95% CIs.
LAD: left anterior descending coronary artery; LCx: left circumflex coronary artery; LM: left main coronary artery; 
MSCT: multi-slice computed tomography; NPV: negative predictive value; PPV: positive predictive value; RCA: right 
coronary artery.
LV function
LV ejection fraction, as determined by MSCT, ranged from 16% to 64% (mean 46 ± 14%), respectively. 
Abnormal wall motion was observed in 158 (30%) of 527 segments, with 86 (54%) of these segments 
showing hypokinesia, 55 (35%) akinesia and 17 (11%) dyskinesia. In 148 (94%) of these segments, 
MSCT also demonstrated abnormal wall motion. Overall, 91% of segments were scored identically 
on both modalities (kappa statistic 0.81, Table 3), indicating an excellent agreement between 2D-
echocardiography and MSCT. For the individual wall motion scores (1-4), agreements were 97%, 
78%, 71% and 94%, respectively. Examples of short-axis reconstructions are shown in Figure 3 and 4, 
showing patients with normal and abnormal LV function.
Figure 2. Patent coronary arteries. Curved multiplanar MSCT reconstructions of the left anterior descending 
artery, left circumflex artery and right coronary artery, respectively, showing the absence of significant luminal 
narrowing in all vessels.
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Table 3. Relation between regional wall motion as determined by echocardiography and MSCT (agreement 
91%, kappa statistic 0.81).
Echocardiography
MSCT 1 2 3 4 Total
1 357 10 0 0 367
2 12 67 13 0 92
3 0 9 39 1 49
4 0 0 3 16 19
Total 369 86 55 17 527
1= normokinesia, 2=hypokinesia, 3= akinesia, and 4= dyskinesia
Discussion
The results of the current study demonstrate that accurate evaluation of the coronary arteries and 
LV function in patients with hypertension using contrast-enhanced MSCT is feasible. In the detec-
tion of significant coronary artery stenoses, an excellent sensitivity and specificity of 93% and 96% 
were demonstrated. These results are in line with previous studies obtained in the general patient 
population. In a study by Ropers et al 19, coronary artery stenoses were detected with a sensitivity 
and specificity of 91% and 93%, respectively. A somewhat higher sensitivity (95%) and slightly lower 
specificity (89%) were reported by Nieman et al 16. In both studies a negative predictive value of 97% 
was reported, similar to our results (98%). These findings demonstrate the potential of MSCT to func-
tion as a diagnostic tool to rule out the presence of CAD. This may improve the non-invasive work 
up of patients with hypertension in particular, since in these patients false positive test results in the 
absence of coronary artery stenoses are frequently encountered with other non-invasive imaging 
modalities, including nuclear perfusion imaging and stress echocardiography 5. These imaging mo-
dalities visualize the consequences of ischemia (induction of perfusion abnormalities or systolic wall 
motion abnormalities). In contrast, direct visualization of the coronary arteries is allowed by MSCT. 
Figure 3. MSCT short-axis reconstructions in end-diastole and end-systole. Normal systolic wall motion is clearly 
present in all segments. 
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Thus, by ruling out the presence of CAD, non-invasive angiography with MSCT may substantially 
reduce the number of patients that will need diagnostic invasive coronary angiography. However, 
when significant abnormalities are observed on the MSCT images, this information could be used for 
a more efficiently targeted (interventional) treatment strategy. Still, further prognostic studies are 
needed in larger cohorts before MSCT can become an established diagnostic modality and replace 
conventional coronary angiography in certain patient groups. 
In addition to non-invasive coronary angiography, LV function analysis was performed. Agreement of 
regional wall motion scores was excellent with 91% of segments scored identically, resulting in a kap-
pa statistic of 0.81. For the individual wall motion scores, agreement was highest for segments with 
either normal contractility (97%) or dyskinesia (94%), whereas it was slightly lower in segments with 
intermediate motion abnormalities (75%). This phenomenon may be attributed to the temporal reso-
lution of the technique (105 –200 ms), which may be insufficient to allow detection of subtler wall mo-
tion abnormalities in some cases. For echo, wall motion was derived from parasternal and apical views 
whereas only short-axis views were used with MSCT and this may also account for discrepancies.
In contrast to several other studies 16;19, no beta-blocking agents were administered prior to the 
MSCT data acquisition in order to lower heart rates higher than 65 beats per minute. The use of a 
multi-segmented reconstruction algorithm, available on our MSCT equipment, allowed the inclu-
sion of patients with higher heart rates without compromise to temporal resolution. 
Figure 4. Example of MSCT short-axis reconstructions of a patient with reduced wall motion in the anteroseptal 
region (black arrow). 
Several limitations of the present study need to be addressed. 
First, both a 4-slice system and 16-slice system were used for data acquisition. Since 16-slice systems 
have been demonstrated to result in both better assessability and accuracy as compared to 4-slice 
systems, the use of 2 different systems is likely to have influenced our results. Moreover, of the 34 
coronary artery segments with insufficient quality to assess the presence or absence of significant 
coronary artery stenoses, 68% was acquired with the 4-slice system. As expected, assessability was 
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lowest in the right coronary artery, since this vessel displays the fastest movement during the cardiac 
cycle. In addition, the presence of coronary stents also frequently resulted in degraded image qual-
ity. Similar percentages have been reported previously 13;19;27. In the near future however, this limita-
tion may be overcome by the introduction of 32- and 64-detector row scanners in combination with 
faster rotation times, which are likely to reduce the percentage of non-assessable segments. 
Second, an important drawback of MSCT is the radiation dose that is still considerably high; approxi-
mately 8 mSv. However, with the use of new filters the radiation dose will decrease substantially. 
Third, precise quantification of luminal stenosis (as can be performed with angiography) is currently 
not possible with MSCT, since the spatial resolution is still suboptimal and validated software is cur-
rently not available. Finally, the prevalence of CAD in the present population was high and valida-
tion of the technique in patients with lower prevalence of CAD is warranted. Similarly, patients with 
late-stage as well as early stage hypertension were included, since the purpose of the present study 
was to demonstrate the feasibility of the technique in this population. Thus, further testing of the 
technique in patients with early-stage hypertension is needed. 
In conclusion, accurate, simultaneous evaluation of both the coronary arteries and LV function in 
patients with hypertension is feasible. 
Perspectives
This combined strategy may offer a new approach for a non-invasive, conclusive workup in patients 
with hypertension and known or suspected CAD. Direct visualization of the coronary arteries may 
result in improved identification of patients at risk for cardiovascular events. However, whether this 
translates into improved clinical management still needs to be tested, particularly in patient groups 
with early-stage hypertension and lower prevalence of CAD.
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Abstract
Background 
Multi-Slice Computed Tomography (MSCT) is a relatively new non-invasive imaging modal-
ity in the evaluation of patients with suspected coronary artery disease (CAD). Whether diag-
nostic accuracy is influenced by gender or risk factors for CAD is currently unknown and was 
evaluated in the present study.
Methods 
In 197 patients (171 men, mean age 60 ± 11 years) 16-slice MSCT was performed and com-
pared to invasive coronary angiography at 2 different centers (Leiden and Rotterdam, the 
Netherlands). Diagnostic accuracy for the detection of ≥50% luminal narrowing was calcu-
lated for all patients combined as well as for patients with known versus suspected CAD. In ad-
dition, diagnostic accuracy was determined in men versus women and in different subsets of 
patients, based on the presence of risk factors for CAD including hypertension, type 2 diabetes 
mellitus, hypercholesterolemia, and obesity. Only segments with a diameter ≥2.0 mm were 
evaluated, whereas smaller segments as well as stents were excluded from the analysis.
Results 
Overall, a sensitivity and specificity of 99% and 86% on a patient level were demonstrated, 
with corresponding positive and negative predictive values of respectively 95% and 96%. Sim-
ilar values were observed in the different subsets of patients, with no statistical differences.
Discussion
These findings confirm the high diagnostic accuracy of MSCT, regardless of gender or risk 
factors. 
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Introduction
Over the past few years, Multi-Slice Computed Tomography (MSCT) has emerged as a promising modal-
ity for non-invasive evaluation of coronary anatomy 1;2. Moreover, with the introduction of 16- and 64-slice 
scanners, the non-invasive diagnosis of significant CAD has improved substantially. Reported sensitivi-
ties and specificities are in the range of 70% to 98% and 86% to 98% respectively, with an average sen-
sitivity and specificity of 88% and 96% respectively 3. In addition, more complete coverage of the coro-
nary tree has been achieved, with a substantial reduction in the number of non-diagnostic segments 3. 
Accordingly, routine evaluation for CAD has become realistic and the expectation is that (in the near 
future) MSCT may replace invasive angiography to rule out CAD. For this purpose, the technique should 
primarily be implemented in the clinical work-up of patients with suspected CAD rather than known CAD. 
Considering the fact that the majority of these patients will present with atypical or even no complaints 
but with an elevated risk of CAD due to the presence of multiple risk factors, information on the accuracy 
of MSCT in these various clinical conditions is highly needed. However, despite the overwhelming num-
ber of reported studies thus far, it is unknown whether diagnostic accuracy is influenced by gender or 
risk factors. The purpose of the present study therefore, was to evaluate the influence of gender and risk 
factors for CAD on the diagnostic accuracy of 16-slice MSCT in a large cohort of patients.
Methods
Study population
A total of 201 patients, presenting with known or suspected CAD (based on symptoms and/or mul-
tiple risk factors for CAD) and scheduled for invasive coronary angiography for diagnostic purposes 
were included at 2 different centers (Rotterdam and Leiden, the Netherlands). The following exclu-
sion criteria were applied: renal insufficiency (serum creatinine >120 μmol/L [1.35 mg/dL]) or other 
contraindications to the administration of iodinated contrast, pregnancy, acute coronary syndromes 
and (supra-)ventricular arrhythmias. For all patients, the presence of coronary risk factors was docu-
mented according to the following criteria:
1. Type 2 Diabetes was defined as 1. Symptoms of diabetes plus casual plasma glucose concentra-
tion ≥200 mg/dl (11.1 mmol/l) or 2. Fasting plasma glucose level ≥126 mg/dl (7.0 mmol/l)4.
2. Hypertension was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pres-
sure ≥90 mm Hg, and/or use of anti-hypertensive medication 5.
3. Obesity was defined as a body mass index (BMI) ≥30 kg/m 2 5;6.
4. Hypercholesterolemia was defined as total serum cholesterol ≥230 mg/dl and/or serum triglyc-
erides ≥200 mg/dl or use of a lipid-lowering agent 5;7. 
5. Smoking.
6. A positive family history was defined as having relatives of first or second degree with premature 
(younger than 55 years of age) cardiovascular disease.
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The study protocol was approved by the local ethics committees, and informed consent was ob-
tained from all patients.
MSCT; Data acquisition
All studies were performed with a 16-detector row system. In Rotterdam, a Sensation 16 (Siemens, 
Germany) was used, whereas in Leiden, data were acquired with an Aquilion 16 system (Toshiba, 
Japan). If the heart rate was 65 beats/min or higher, additional beta-blockers (metoprolol, 100 mg, 
single dose, 1 hour prior to scan) were provided if tolerated. Scan parameters of the Sensation 16 
system were the following: collimation 16 x 0.75 mm, tube rotation 420 ms, table feed 3 mm/rota-
tion, and tube voltage 120 kV, while the tube current was 400 to 450 mAs 8. A bolus of 100 ml contrast 
(Visipaque 320, Amersham Health, Forchheim, United Kingdom) was injected intravenously at a flow 
rate of 4 ml/s. Scan parameters of the Aquilion 16 were: collimation 16 x 0.5 mm, tube rotation, 400 
or 500 ms, table feed 3-4 mm/rotation, and tube voltage 120 kV at 250mA. The total contrast dose 
for the scan ranged from 120 to 150 ml depending on the total scan time, with an injection rate of 4 
ml/s through the antecubital vein (Xenetix 300®, Guerbet, Aulnay S. Bois, France), followed by a saline 
flush of 40 ml 9. Both systems used an automated bolus tracking system for timing of the helical scan. 
Images were obtained during a single breath hold of approximately 20-25 seconds, while the ECG 
was recorded simultaneously to allow retrospective gating of the data.
Images were reconstructed in cardiac phase containing the fewest motion artifacts, typically during 
the mid-to-end diastolic phase. However, other reconstruction windows were obtained when nec-
essary. Reconstructed images were then transferred to a remote workstation for evaluation. 
MSCT; Data evaluation
MSCT angiograms were independently evaluated for the presence of significant (≥50% narrowing 
of luminal diameter) by 2 observers (blinded to all other data). In addition to the original axial slices, 
thin-slab maximum intensity projections and multiplanar reconstructions were used to estimate 
the degree of luminal narrowing. Segments with coronary stents or side-branches with a diameter 
smaller than 2.0 mm were excluded from the analysis. In case of previous bypass grafting, only native 
segments distal to the anastomosis of a patent bypass graft were evaluated. 
Conventional coronary angiography
Conventional coronary angiography was performed according to standard clinical protocols within 
1 month of the MSCT examination. To obtain vascular access, the femoral approach with the Seld-
inger technique was applied. Angiograms were evaluated by consensus reading of 2 experienced 
observers without knowledge of the MSCT data.
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Stress electrocardiography
In a subset of patients, stress-testing, by means of a 12-lead ECG at rest and during stress, was per-
formed within 3 months of MSCT and conventional coronary angiography. Patients with revascular-
ization in the period between the stress-ECG and MSCT/conventional coronary angiography were 
excluded, resulting in 44 eligible patients. Electrocardiographic findings during peak stress were 
graded as normal or abnormal based on the presence of ≥1.0-mm ST-segment changes (horizontal 
or downslope) measured at 80 ms after the J point in 2 contiguous leads during peak stress or im-
mediately after recovery.
Data evaluation and statistical analysis
Sensitivity, specificity, positive and negative predictive values with corresponding 95% confidence 
intervals (CI) for the detection of ≥50% luminal narrowing were calculated. Data were analyzed on 
a patient, vessel and segmental level. In addition, diagnostic accuracy was compared between men 
and women and the data were analyzed according to the presence of risk factors for CAD. A p-value 
<0.05 was considered to indicate statistical significance.
Table 1. Characteristics of the study population (n=197).
Characteristic value (%)
Gender (M/F)   171/26
Age (yrs) 60 ± 11
Heart rate during acquisition 61 ± 10
Beta blocker medication  181 (92%)
Previous PCI/ CABG 59(30%)/23 (12%)
Risk factors for CAD
    Diabetes type 2     54 (27%)
    Hypertension 106 (54%)
    Smoking 83 (42%)
    Hypercholesterolemia 143 (73%)
    Family with CAD  90 (46%)
    Obesity 44 (22%)
Vessel disease 
    0-vessel 34 (17%)
    1-vessel 57 (29%)
    2-vessel 56 (28%)
    3-vessel 50 (25%)
Data are presented as absolute values (%).
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Results
Clinical features	
In total, 201 patients were evaluated with MSCT, of which 128 in Rotterdam 8 and 73 in Leiden 9. A 
subset of patients has been included in previous studies 8;9. MSCT was performed successfully in all 
but 2 patients. In those 2 patients, the examination could not be evaluated due to technical issues. 
In 2 other patients, all 3 vessels were stented and these patients were excluded from the analysis as 
well. Main clinical features of the remaining 197 patients are presented in Table 1. 
Coronary angiography in all patients
Based on invasive coronary angiography, significant CAD (defined by the presence of significant 
stenoses or previous revascularization) was present in 163 patients (1-vessel disease in 57 patients, 
2-vessel disease in 56, and 3-vessel disease in 50).
A total of 2015 segments were available for analysis. Of these segments, 92 (5%) were of low image 
quality but were included in the analysis. A total of 21 (1%) segments were excluded from the analy-
sis. Causes of poor image quality or uninterpretability were predominantly calcifications, motion 
artifacts, and low contrast-to-noise ratio.
Table 2. Diagnostic accuracy of MSCT in the entire study population (n=197).
Segmental basis Vessel basis Patient basis
Excluded 1% 1% 0%
Evaluation possible with low 
confidence
5% 2% 8% 
Sens (%, 95% CI) 90, 87-93 92, 89-95 99, 97-100
Spec (%, 95% CI) 96, 95-97 93, 91-95 86, 76-96
PPV (%, 95% CI) 82, 78-86 87, 83-91 95, 92-98
NPV (%, 95% CI) 98, 97-99 96, 94-98 96, 90-100
NPV: negative predictive value; PPV: positive predictive value; sens: sensitivity; spec: specificity.
Significant stenoses were correctly identified in 303 segments, while the presence of significant ste-
nosis was correctly ruled out in 1591 of 1658 segments, resulting in a sensitivity and specificity of 
90% (95% CI 87-93%) and 96% (95% CI 95-97%). In only 2 of 147 (1%) patients, the presence of one 
or more significant stenoses was missed on MSCT (resulting in a sensitivity of 99% on a patient level, 
95% CI 97-100%), while the absence was correctly identified in 43 of 50 (86%, 95% CI 76-96%) pa-
tients without significant stenoses. On a vessel basis, a sensitivity and specificity of respectively 92% 
(95% CI 89-95%) and 93% (95% CI 91-95%) were obtained. 
Data are summarized in Table 2. 
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Influence of gender
In total, 26 (13%) of included patients were female. Similar diagnostic accuracy was observed in men 
and women (Table 3). Sensitivity and specificity (on a segmental basis) were respectively 90% (95% 
CI 79-100%) and 97% (95% CI 95-99%) in women and 90% (95% CI 87-93%) and 96% (95% CI 95-97%) 
in men (sensitivity and specificity not significant versus women). 
Table 3. Influence of gender on the diagnostic accuracy of MSCT.
Females
(n=26)
Males 
(n=171)
Patient basis
Sens (%, 95% CI) 100 98, 96-100
Spec (%, 95% CI) 90, 71-100 85, 74-96
PPV(%, 95% CI) 94, 83-100 96, 93-99
NPV (95% CI) 100 94, 86-100
Segmental basis
Sens (%, 95% CI) 90, 79-100 90, 87-93
Spec (%, 95% CI) 97, 95-99 96, 95-97
PPV (%, 95% CI) 79, 65-94 82, 78-86
NPV (95% CI) 99, 98-100 98, 97-99
NPV: negative predictive value; PPV: positive predictive value; 
sens: sensitivity; spec: specificity.
Diagnostic accuracy in the presence of different risk factors for CAD
Next, the diagnostic accuracy of MSCT was explored in the presence of different risk factors (type 
2 diabetes n=54, hypertension n=106, hypercholesterolemia n=143, obesity n=44, positive family 
history n=90, and smoking n=83). Results are summarized in Table 4. No statistical differences were 
observed between the different groups. 
Comparison of patients with suspected and known CAD
Based on clinical evaluation (ECG, history etc) the presence of significant CAD was already known in 
75 (38%) patients, whereas it was suspected (based on the presence of symptoms and/or multiple 
risk factors for CAD) in the remaining 122 (62%). In the former, sensitivity and specificity on a seg-
mental basis were respectively 97% (95% CI 93-100%) and 99% (95% CI 98-100%). In the latter, these 
values were respectively 89% (95% CI 85-93%, p<0.05 versus known CAD) and 95% (95% CI 94-96%, 
p<0.05 versus known CAD). Thus, a slightly higher sensitivity/specificity on a segmental basis was 
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observed in patients with known CAD as compared to patients with suspected CAD. However, no 
differences were observed when analysis was performed on a patient level (see Table 5). 
Comparison of coronary angiography with stress-electrocardiography
In 44 patients (36 male, 8 female, average age 61 ± 11 years), stress-ECGs were available to evaluate 
the presence of inducible ischemia. In one patient, the presence of left bundle branch block preclud-
ed ECG interpretation. In the remaining 43 patients, stress ECG was abnormal in 10 patients. In all but 
1 patient (90%), MSCT confirmed the presence of one or more significant lesions. In 33 patients, no 
ischemia was detected during stress-ECG testing. Nevertheless, in 18 (55%) of these patients at least 
1 or more significant lesion was demonstrated during MSCT. In 4 of these patients with a normal 
stress-ECG, left main or 3 vessel disease was observed. 
Table 4. Influence of coronary risk factors on the diagnostic accuracy of MSCT.
Risk factor
DM type 2
(n=54)
Obesity
(n=44)
Hypercholes-
terolemia
(n=143)
Hypertension
(n=106)
Family
(n=90)
Smoking
(n=83)
Segmental basis
Excluded 2.7% 1.3% 1.4% 0.6% 0.9% 1.8%
Evaluation 
possible with low 
confidence
3.2% 5.7% 5.3% 4.6% 4.6% 3.2%
Sens (%, 95% CI) 89, 82-96 92, 85-99 94, 91-97 91, 87-95 90, 85-95 91, 86-96
Spec (%, 95% CI) 95, 93-97 98, 97-99 96, 95-97 96, 95-97 98, 97-99 97, 96-98
PPV (%, 95% CI) 80, 72-88 85, 77-93 82, 77-88 82, 76-88 89, 84-94 82, 75-89
NPV (%, 95% CI) 98, 97-99 99, 98-100 99, 98-100 98, 97-99 98, 97-99 99, 98-100
Patient basis
Sens (%, 95% CI) 100 97, 91-100 98, 95-100 98,95-100 98, 95-100 100
Spec (%, 95% CI) 100 90, 71-100 86, 76-96 92, 81-100 92, 82-100 81,66-96
PPV (%, 95% CI) 100 97, 91-100 95,91-99 98,95-100 97, 93-100 92, 85-99
NPV (%, 95% CI) 100 90, 71-100 95,88-100 92, 81-100 96, 88-100 100
NPV: negative predictive value; PPV: positive predictive value; sens: sensitivity; spec: specificity.
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Discussion
The results of the present study demonstrate the clinical value of MSCT in the assessment of patients 
presenting with chest pain. In line with previous reported results, a sensitivity and specificity of re-
spectively 90% and 96% on a segmental level was observed in the entire study population. Similar to 
other studies, the diagnostic accuracy of MSCT for the detection of significant CAD differed between 
analyses on a patient and segmental level 10. Whereas specificity and negative predictive values were 
high on a segmental based analysis (respectively 96% and 98%), these values tended to slightly de-
crease (86% and 96%) when analyzed on a patient basis. In contrast, sensitivity and positive predic-
tive value increased from 90% and 82% to 99% and 95%, respectively. To a large extent, this observa-
tion may be attributed to the high prevalence of CAD in the present population, which was 83% with 
one in 4 patients having 3-vessel disease. 
Table 5. Diagnostic accuracy of MSCT in patients with known versus suspected CAD. 
Suspected CAD
(n=122)
Known CAD 
(n=75)
Patient basis
Sens (%, 95% CI) 100 95, 88-100
Spec (%, 95% CI) 88, 73-100 85, 73-97
PPV (%, 95% CI) 98, 95-100 89, 80-98
NPV (%, 95% CI) 100 93, 84-100
Segmental basis
Sens (%, 95% CI) 89, 85-93 97, 93-100
Spec (%, 95% CI) 95, 94-96 99, 98-100
PPV (%, 95% CI) 79, 74-84 93, 88-98
NPV (%, 95% CI) 98, 97-99 100
NPV: negative predictive value; PPV: positive predictive value; 
sens: sensitivity; spec: specificity.
Gender
In the current study, no gender differences in diagnostic accuracy were observed. Particularly in 
women, a non-invasive modality to visualize the coronary arteries may be of benefit, since obstruc-
tive CAD is less likely to be demonstrated than in age-matched men, despite the presence of symp-
toms 11. Indeed, no abnormalities are observed in almost half of all women referred for invasive coro-
nary angiography as compared to 17% in men 12. However, similar to previous studies using MSCT, 
women contributed only to a small portion (13%) of the present study population. Clearly, larger 
cohorts of women need to be studied in order to provide consistent evidence that the technique is 
not limited in women.
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Known CAD, suspected CAD and risk factors
In addition, diagnostic accuracy was compared between patients with suspected and known CAD 
(according to clinical presentation). Although the majority of studies involving the diagnostic ac-
curacy of MSCT have thus far been confined to predominantly populations with known CAD, the 
use of the technique will eventually shift towards early evaluation of patients with an intermediate 
likelihood of CAD. Thus, it is important to establish whether diagnostic accuracy is not affected by 
knowledge of previous CAD. In the present study, a comparable diagnostic accuracy was observed 
between patients with suspected and known CAD, suggesting that the MSCT can indeed be of value 
for early diagnosis of CAD in patients presenting with first complaints or elevated risk profiles. In-
deed, these are precisely the patient populations in which MSCT will play an increasingly important 
role in clinical management. Since in these patients, certain risk factors such as hypertension or type 
2 diabetes mellitus are highly prevalent, it has become increasingly important to establish the influ-
ence of these clinical conditions on diagnostic performance. At present however only limited data 
on the performance of MSCT in the presence of these risk factors for CAD are available. Thus far, two 
studies have previously reported on the feasibility of MSCT in either patients with type 2 diabetes 
mellitus 13 and hypertension 14. No effect of either risk factor on the diagnostic accuracy of MSCT 
was demonstrated and reported sensitivity/specificity were 95%/95% and 93%/96% in respectively 
patients with type 2 diabetes and patients with hypertension. However, only a limited number of 
patients were included in both studies. Still, results were very similar to the present findings, which 
further underline that the diagnostic accuracy of MSCT is not affected by the presence of risk factors. 
A slightly higher percentage uninterpretable segments however, was in the present study observed 
in patients with type 2 diabetes (2.7%) as compared to the entire study population (1%). To some 
extent this phenomenon may be attributed to the more generalized diffuse atherosclerosis that is 
known to be present in patients with type 2 diabetes, resulting in an increased incidence of (exten-
sive) calcifications, which in turn may affect image quality 15. Nevertheless, diagnostic accuracy was 
not different in patients with type 2 diabetes. 
Obesity is another risk factor that may influence image quality due to a decreased signal to noise 
ratio in these patients. Indeed, the largest number of segments with low image quality was observed 
in patients with a BMI over 30. The percentage of uninterpretable segments however, was similar to 
the general study group, with no differences in diagnostic accuracy either. As expected, other risk 
factors such as a positive family history for CAD, smoking and hypercholesterolemia, were found to 
influence neither image quality nor diagnostic accuracy. 
Stress-testing
Finally, results of MSCT were compared in a subset of patients to first-line stress-testing by means 
of stress-electrocardiography. Although the observation of ischemia on stress-electrocardiography 
and the presence of significant lesions on MSCT correlated well (90%), correlation between the ab-
sence of ischemia versus no significant lesions visible during anatomical testing was considerably 
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lower (46%). Obstructive CAD was identified in approximately half of patients with a normal stress-
ECG, with 4 patients having even left main or 3-vessel disease. Nonetheless, the majority of observed 
lesions with normal stress-ECG may have represented stenoses without hemodynamic relevance. 
Comparable findings were reported by Hacker et al, who compared MSCT to myocardial perfusion 
scintigraphy (MPS) in 25 patients. Similarly, only 47% of lesions on MSCT were associated with isch-
emia during MPS 16. Thus, the presence of ischemia, as it appears to concern only a moderate portion 
of significant lesions, cannot be predicted based on the findings obtained with MSCT. Accordingly, 
functional testing remains essential in case of an abnormal MSCT examination to determine further 
management (medical therapy versus revascularization). 
Limitations
First, patients were evaluated with two different MSCT systems, while presently no data are avail-
able on the relative performance of systems of different manufacturers. Also, to what extent subtle 
differences in image acquisition or evaluation protocols between both centers may have influenced 
the results is unknown. Only patients with a high suspicion for CAD and thus referred for invasive 
coronary angiography were included in the present study, and as a result the prevalence of CAD was 
high (83%). Accordingly, validation of MSCT in the presence of coronary risk factors is still needed 
in populations with a lower CAD prevalence, as these populations represent the target population 
for non-invasive anatomical imaging. Finally, an important limitation is the fact that only segments 
with a diameter of ≥ 2.0 mm were included, while also stented segments were excluded. With 4- and 
16-slice MSCT, evaluation of segments with a small diameter still pose significant problems, which 
is even worse in the presence of calcifications. Inclusion of segments <2.0 mm would likely have 
resulted in reduced overall percentage interpretable segments as well as a lower diagnostic perfor-
mance. However, segments less than 2.0 mm can frequently not be surgically revascularized, and 
were therefore not included in the present study.
In addition, MSCT has several disadvantages in general. First the radiation dose of a single MSCT ex-
amination still ranges between 8 to 12 mSv, which compares unfavorably to conventional coronary 
angiography. Regarding clinical management, another important limitation exists, which is the fact 
that no information on the hemodynamical importance of the observed lesions can be derived from 
MSCT, as also observed in the present study. As a result, the implementation of MSCT may potential-
ly lead to an increased number of patients that are referred to conventional coronary angiography, 
rather than the desired decrease in referral for angiography. Accordingly, the anatomical MSCT data 
of patients with a positive examination should ideally be integrated with functional information in 
order to determine clinical management more precisely. 
Conclusion
These findings confirm the high diagnostic accuracy of MSCT, regardless of gender or risk factors. 
Also, accuracy was comparable between patients with known and suspected CAD, suggesting that 
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the technique may be of value in the early diagnosis of CAD. As both image quality and diagnostic 
performance of the technique will continue to improve with the latest generation of 64-slice scan-
ners, cardiologists will become increasingly confident to use the technique as a first-line imaging 
modality. Nevertheless, comparison between stress-testing and MSCT showed a considerable dis-
crepancy between functional and anatomical findings. Future research therefore should not merely 
focus on the diagnostic accuracy of MSCT but rather on how to relate this new modality to other 
available, first-line techniques in order to allow most optimal integration of MSCT in daily clinical 
cardiology. 
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Abstract
Background 
Intracoronary stent implantation is a frequently performed procedure in the treatment of ste-
noses in coronary arteries, although in-stent restenosis still occurs in approximately 20%. A 
non-invasive diagnostic procedure to evaluate in-stent restenosis would therefore be of great 
benefit. The purpose of this study was to demonstrate the feasibility of assessing stent patency 
using 16-slice Computed Tomography. 
Methods 
In 22 patients with previously implanted stents, Multi-Slice Computed Tomography (MSCT) 
was performed. For each stent, assessability was determined and related to stent type and 
diameter. Subsequently, the presence of significant restenosis was determined in the evalu-
able stents. In addition, peri-stent lumina (5.00mm proximal and distal to the stent) were also 
evaluated. Conventional angiography in combination with quantitative coronary angiogra-
phy (QCA) served as the standard of reference. 
Results 
MSCT was performed successfully in all but one patient. Of 65 stents, 50 (77%) were deter-
mined assessable. Uninterpretable stents tended to have a thicker strut thickness and/or a 
smaller diameter. In the evaluable stents, 7 of 9 stenoses were detected and the absence of 
restenosis was correctly identified in all 41 patent stents, resulting in a sensitivity and specific-
ity of 78% and 100%, respectively. Sensitivity and specificity for the detection of peri-stent 
stenosis were 75% and 96%, respectively. 
Conclusion 
MSCT may be useful in the assessment of stent patency and may function as a gatekeeper 
prior to invasive diagnostic procedures. 
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Introduction
Although promising results have been obtained using Multi-Slice Computed Tomography (MSCT) 
for the detection of coronary artery stenoses 1;2, imaging of metallic stents is technically difficult, and 
not much data are available. Stent-related high-density artifacts lead to artificial narrowing of the 
lumen, leaving only a small portion of the lumen visible 3;4. However, the recently introduced 16-slice 
CT systems allow simultaneous acquisition of 16 submillimeter slices, which has lead to improved 
spatial resolution. In combination with the increased temporal resolution due to faster rotation 
times, stent assessability is thus likely to improve, which has already been demonstrated in vitro 5. 
Recent advances in stent design are also likely to result in improved stent assessability. The purpose 
of this study was to demonstrate the feasibility of assessing coronary stent patency using 16-slice 
MSCT. 
Methods
Patients and study protocol
 The study group consisted of 22 consecutive patients who had previously undergone percutaneous 
transluminal coronary angioplasty (PTCA) treatment in combination with stent placement. Exclusion 
criteria were: 1). atrial fibrillation, 2). renal insufficiency (serum creatinine >120 mmol/L), 3). known 
allergy to iodine contrast media, 4). severe claustrophobia, and 5). pregnancy. All patients under-
went a cardiac MSCT examination for the evaluation of stent patency. Conventional catheter-based 
coronary angiography with QCA analysis was performed prior or after MSCT and served as reference 
standard. All patients gave written informed consent to the study protocol, which was approved by 
the local ethics committee.
Data acquisition 
Cardiac MSCT was performed on a Toshiba Multi-slice Aquilion 16 system (Toshiba Medical Systems, 
Tokyo, Japan) with a collimation of 16 x 0.5 mm and a rotation time of 0.4 or 0.5 s, depending on the 
heart rate. The tube current was 250 mA, at 120 kV. Non-ionic contrast material was administered in 
the antecubital vein with an amount of 120-150 ml, depending on the total scan time, and a flow rate 
of 4.0 ml/sec (Xenetix 300®, Guerbet, Aulnay S. Bois, France). Automated peak enhancement detec-
tion in the aortic root was used for timing of the bolus. Images were acquired during inspiratory 
breath hold preceded by mild hyperventilation. During the CT examination, the electrocardiogram 
was recorded simultaneously for retrospective gating of the data. With the aid of a segmental recon-
struction algorithm, data of 2 or 3 consecutive heartbeats were used to generate a single image. 
To evaluate the coronary arteries, 5 separate reconstructions covering diastole (65% - 85%) were ob-
tained with an effective slice thickness of 0.5 mm and a reconstruction interval of 0.4 mm. If motion 
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artifacts were present in one of the coronary arteries, additional reconstructions were made at 40%, 
45% and 50% of the cardiac cycle. Images were transferred to a remote workstation (Vitrea2, Vital 
Images, Plymouth, Minn. USA) for post-processing. For each individual coronary artery, the data set 
containing no or minimal motion artifacts were used for further evaluation. 
Conventional X-ray coronary angiography was performed according to standard techniques. Vas-
cular access was obtained using the femoral approach with the Seldinger technique and a 6- or 7-
French catheter.
Data analysis 
For the assessment of coronary stents, both the original axial CT images and curved multiplanar 
reconstructions were evaluated by an experienced observer blinded to the catheterization results. 
First, each stent was assigned an image quality score of: 1 (poor image quality or uninterpretable), 
2 (adequate image quality) or 3 (good image quality). Subsequently, the presence of significant 
restenosis (≥50% reduction of lumen diameter) was assessed in the evaluable stents. A stent was 
considered patent if both distal run-off was present and contrast medium could be detected within 
the stent. In case of doubt, cross-sections were also taken into account. In addition, the presence of 
peri-stent stenosis, ≥50% or ≥70% narrowing of luminal diameter 5.00 mm proximal and distal to the 
stent, or, in case of overlapping stents, the stented segment, was evaluated.
Conventional angiograms were evaluated by an experienced observer without knowledge of the 
MSCT data. Subsequently QCA was performed of both the stent or stented vessel and their proximal 
and distal lumina according to a standard algorithm (QCA-CMS version 5.2, Medis, Leiden, The Neth-
erlands) 6. 
Statistical analysis 
To relate stent assessability to stent type, stents were divided in either large (>3.00 mm) or small 
(≤3.00 mm) diameter stents and stents with either thick (≥140 μm) struts or thin (<140 μm) struts. 
Subsequently, percentage assessable stents and average image quality were calculated for each 
category. Sensitivity and specificity for the detection of restenosis ≥50%, as determined by visual in-
spection of conventional angiograms, were determined for each stent and stented coronary artery. 
A separate analysis was performed per vessel, since in several patients (partially) overlapping stents 
or even completely stented vessels were present, thus hampering individual assessment. A stented 
vessel was considered assessable, when at least one stented segment was interpretable. Stented 
side-branches were also included in the analysis. In addition, sensitivity and specificity were also 
determined for the detection of significant (≥50%) or high-grade (≥70%) narrowing of the peri-stent 
lumina (5.00 mm proximal and distal to the stent). For this analysis, QCA served as the standard of 
reference.
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Results
Clinical characteristics of the study group 
Twenty-two patients (20 men, aged 63 ± 7 years), with a total of 68 stents (1 to 9 stents per patient, 
average 3 ± 2.8), scheduled for invasive coronary angiography, were investigated. The average in-
terval between MSCT and conventional angiography was 3 ± 2 days. All patients had previously un-
dergone PTCA with stent implantation. Seventeen patients (77%) were on continuous beta-blocker 
medication, and no additional beta-blockers were administered. The patient characteristics are sum-
marized in Table 1. 
Table 1. Clinical characteristics of the study population (n=22).
n (%)
Male/Female                  20/2 
Age (years) 62 ± 7  
Heart Rate (bpm)            65 ± 11
Single vessel coronary disease 4 (18%)
Multi-vessel coronary disease 18 (82%)
Previous myocardial infarction 14 (64%)
Previous coronary angioplasty 22 (100%) 
Previous Coronary Bypass Grafting 3 (14%)
Beta-Blocker                    17 (77%)
Angina Pectoris
           CCS  class 1/2 4 (18%)
           CCS class  3/4 18 (82%)
Heart Failure 
           NYHA class  1/2 18 (82%)
           NYHA class  3/4 4 (18%)
Stent location
           Left Main 1 (1%)
           Left Anterior Descending 28 (41%)
           Left Circumflex 5 (7%)
           Right Coronary Artery 28 (41%)
         Saphenous Vein Graft 6 (9%)
Values are n (%).
CCS: Canadian Cardiovascular Society; NYHA: New York Heart Association; 
138 Chapter 9
Stent characteristics
A total of 68 stents was studied, of which 23 implanted more than one month before and 6 placed in 
coronary bypass grafts. On average, MSCT was performed 14 ± 26 months (range 0 – 2469 days) after 
stent implantation. Diameter of implanted stents ranged from 2.25 to 5.0 mm. Fourteen different 
stent types were present: Ave (S660 and S670, Medtronic) 11, Driver (Medtronic) 4, Wiktor Hepa-
med (Medtronic) 2, Ultra (Guidant) 3, Zeta (Guidant) 9, Penta (Guidant) 1, Tristar (Guidant) 4, Achieve 
(Guidant) 2, Orbus (Orbus technologies) 3, R-stent (Orbus technologies) 2, Cypher (Cordis) 23, Bx 
Velocity (Cordis) 2, Bx Sonic (Cordis) 1, and Express (Boston Scientific) 1.
MSCT
MSCT was performed successfully in all but one patient. In this patient, the electrocardiographical 
signal was lost during data acquisition and this patient was therefore excluded from analysis.
Of the remaining 65 stents, 50 (77%) were of sufficient quality to assess patency. Reasons of unin-
terpretability were motion artifacts, metal artifacts, small size of the stent, severe calcifications or 
a combination of the above. Average image quality score was 2.7 ± 0.7 for stents with a diameter 
Figure 1. Example of a curved multiplanar reconstruction of an uninterpretable stent placed in the distal left 
circumflex. Due to high-density artifacts of the thick struts of the stent, the lumen is obscured in a large part of 
the stent, rendering it uninterpretable.
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>3.0 mm, in contrast to an average of 2.2 ± 0.9 for stents with a diameter ≤3.0 mm. Of the stents with 
a thick strut thickness (≥140 μm), 11 (41%) were uninterpretable, whereas 34 (89%) of stents with 
thin struts were assessable. Figure 1 shows an example of an uninterpretable stent with a thick strut 
thickness.
Restenosis (≥50% of lumen diameter reduction) was correctly ruled out in 41 stents (Figure 2). MSCT 
identified 7 stents with restenosis correctly. However, in 2 stents, distal to occluded stents, the pres-
ence of restenosis was not observed on MSCT. Accordingly, the sensitivity and specificity for the 
assessment of patent/stenotic stents were 78% and 100%, respectively. When the uninterpretable 
stents were included in the analysis, the overall sensitivity remained 78%, whereas the specificity 
decreased to 73%. Details are summarized in Table 2.
Table 2. Individual stent analysis.
n (%)
Total stents 65
Assessable 50 (77%)
Sensitivity 7/9 (78%)
Specificity 41/41 (100%)
Uninterpretable stents 15
   diameter ≤ 3.0 mm 13
   diameter > 3.0 mm 2
   strut thickness < 140 μm 4 
   strut thickness ≥ 140 μm 11
Interpretable stents 50 
   diameter ≤ 3.0 mm 33
   diameter > 3.0 mm 17
   strut thickness <140 μm 34 
   strut thickness ≥ 140 μm 16
In 8 patients, overlapping stents or even completely stented vessels were present, thus hampering 
individual stent assessment. Therefore, analysis was also performed per coronary artery or side-
branch individually (Table 3). In 4 patients, one or more coronary arteries were uninterpretable. Thus, 
29 stented vessels (81%) were available for evaluation. Significant in-stent restenosis (≥50%) was 
correctly detected in 3 vessels (1 left anterior descending and 2 right coronary arteries). Absence of 
restenosis was correctly identified in the remaining 26 patent coronary arteries. Therefore, on a per 
patient basis, the presence or absence of significant in-stent restenosis was correctly identified in all 
patients. 
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Figure 2. Example of a patent stent in the left anterior descending.  In panel A, a curved multiplanar recontruc-
tion is shown, which reveals a patent stent, as also evidenced by the distal run-off. Also in panel B, a three-di-
mensional volume rendered reconstruction, distal run-off is clearly present. Findings were confirmed by conven-
tional angiography (panel C).
In 2 patients, both the left anterior descending and the diagonal branch were stented, resulting in 
only one proximal stent lumen and two distal stent lumina. In 6 other stented arteries, both the prox-
imal and distal lumina were uninterpretable and in one patient, only the proximal part of a stent, 
placed in the distal left circumflex, could be evaluated. Therefore, 57 of 70 peri-stent lumina were 
available for evaluation. Narrowing of ≥50% (as determined by QCA) of the peri-stent lumen was 
correctly ruled out in 51 of 53 peri-stent lumina and 3 of 4 significant narrowings were also found on 
the MSCT images. One of these significant narrowings, however, was underestimated by MSCT, and 
when the threshold was increased to high-grade stenosis (≥70%), sensitivity decreased therefore to 
50%. Specificity, however, increased from 96% to 100%.
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Table 3. Diagnostic accuracy to detect significant in-stent or peri-stent restenosis (per vessel analysis).
All branches Left Main Left Anterior 
Descending
Left 
Circumflex
Right 
Coronary 
Artery
Saphenous 
Vein Graft
Stents 
(≥50%)
 
Peristent 
(≥50%)
(≥70%)
 Total
Assessable
Sensitivity
Specificity
Total
Assessable
Sensitivity
Specificity
Sensitivity
Specificity
36
29 (81%)
3/3 (100%)
26/26 (100%)
70
57 (81%)
3/4 (75%)
51/53 (96%)
2/4 (50%)
53/53 (100%)
1
1 (100%)
-
1/1 (100%)
2
2 (100%)
-
2/2 (100%)
-
2/2 (100%)
15
12 (80%)
 1/1 (100%)
11/11 (100%)
28
22 (79%)
0/1 (0%)
20/21 (95%)
0/1 (0%)
21/21 (100%)
5
3 (60%)
-
3/3 (100%)
10
7 (70%)
-
7/7 (100%)
-
7/7 (100%)
13
11 (85%)
2/2 (100%)
9/9 (100%)
26
22 (85%)
2/2 (100%)
19/20 (95%)
2/2 (100%)
20/20 (100%)
2
2 (100%)
-
2/2 (100%)
4
4 (100%)
1/1 (100%)
3/3 (100%)
0/1 (0%)
3/3 (100%)
Values are n (%) and include side-branches.
Discussion
The purpose of this study was to demonstrate the feasibility of stent patency assessment using 16-
slice MSCT. A total of 65 stents was evaluated, of which 50 (77%) were of sufficient image quality to 
assess patency. As expected, stents with thicker struts were found to be more prone to high-density 
artifacts (and thus decreased assessability) than stents with a thin strut thickness. The effect of di-
ameter on assessability was even more pronounced: 13 out of 15 (87%) uninterpretable stents had 
a diameter ≤ 3.0 mm. Stents with a large diameter are more likely to be evaluable since a sufficient 
portion of the stent lumen will remain visible despite artificial narrowing.
In the evaluable stents, we demonstrated a good sensitivity and specificity for the detection of sig-
nificant in-stent stenosis. Furthermore, the presence or absence of significant in-stent stenosis was 
correctly identified in all patients. Therefore, our results indicate that, although detection of subtle 
in-stent hyperplasia remains impossible, qualitative assessment of coronary stents is feasible using 
16-slice MSCT. In particular, the presence of contrast enhancement of the vessel distal to the stent 
is a potent sign of patency, while the near absence of distal run-off almost certainly indicates severe 
stenosis or total stent occlusion.
An important limitation of the present study is that similar to previous studies concerning the as-
sessment of stent patency, only a small number of patients (14%) with significant in-stent restenosis 
was present. Therefore, our data concerning the sensitivity for detecting in-stent restenosis have to 
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be interpreted with care and more data are needed to precisely determine the sensitivity of MSCT in 
the detection of in-stent restenosis. Still, as evidenced by the high specificity, the current data sug-
gest that 16-slice MSCT may be useful in the assessment of stent patency, especially in patients with 
large diameter stents. Since a substantial amount of all coronary angiograms are not followed by an 
intervention, MSCT could play an important role in excluding in-stent restenosis and thus function 
as a gatekeeper prior to invasive diagnostic procedures. 
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Abstract 
Background
Recent investigations have shown increased image quality and diagnostic accuracy for non-in-
vasive coronary angiography with 64-slice multi-slice computed tomography (64-slice MSCT) 
as compared to previous generations MSCT scanners, but data on the evaluation of coronary 
stents are scarce. The purpose of the present study was to evaluate the diagnostic accuracy of 
64-slice MSCT coronary angiography in the follow-up of patients with previous coronary stent 
implantation.
Methods 
In 182 patients (152 (84%) males, aged 58 ± 11 years) with previous stent (≥2.5mm diameter) 
implantation (n=192), 64-slice MSCT angiography using either a Sensation 64 (Siemens, Ger-
many) or Aquilion 64 (Toshiba, Japan) was performed. At each center, coronary stents were 
evaluated by two experienced observers and evaluated for the presence of significant (≥50%) 
in-stent restenosis. Quantitative coronary angiography served as the standard of reference. 
Results
A total of 14 (7.3%) stented segments were excluded because of poor image quality. In the in-
terpretable stents, 20 of the 178 (11.2%) evaluated stents were significantly diseased, of which 
19 were correctly detected by 64-slice MSCT. Accordingly, sensitivity, specificity and positive 
and negative predictive value to identify in-stent restenosis in interpretable stents were 95.0% 
(CI: 85% to 100%), 93.0% (CI: 90% to 97%), 63.3% (CI: 46% to 81%), and 99.3% (CI: 98% to 100%), 
respectively. 
Conclusion 
In-stent restenosis can be evaluated with 64-slice MSCT with good diagnostic accuracy. In par-
ticular a high negative predictive value of 99% was observed, indicating that 64-slice MSCT 
may be most valuable as a non-invasive method to exclude in-stent restenosis. 
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Introduction
Stent-implantation is increasingly performed in the treatment of significant coronary artery disease 
(CAD) and has significantly reduced the occurrence of restenosis as compared to balloon angioplas-
ty 1;2. Moreover, with the recent introduction of drug-eluting stents (DES), the occurrence of in-stent 
restenosis has further decreased 3-5. Nonetheless, a subset of patients still presents with recurrent 
chest pain with possible in-stent restenosis and frequently evaluation with invasive coronary angi-
ography is required. 
A non-invasive alternative approach to evaluate these patients may be offered by 64-slice Multi-
Slice Computed Tomography (MSCT). In native coronary arteries, sensitivities and specificities of 
approximately 90% and 96% 6-9 for detection of CAD have been reported, with a substantial gain in 
diagnostic accuracy over 4- and 16-slice MSCT. Also the evaluation of coronary stents, which posed 
still considerable problems with 4- and 16-slice MSCT 10, may have improved with 64-slice MSCT. 
However, few data are currently available and the routine use of MSCT in patients with a history 
of stent implantation is at present not recommended 11;12. The purpose of the present study was to 
evaluate the diagnostic performance of 64-slice MSCT to identify in-stent restenosis (and occlusion) 
in comparison to the gold standard, invasive coronary angiography.
Methods
Study population
The study population consisted of 182 patients who were referred for invasive coronary angiogra-
phy after previous coronary stent (≥2.5 mm diameter) implantation. Referral of patients for invasive 
coronary angiography was partially part of an ongoing protocol and partially routine (based on the 
presence of symptoms, abnormal exercise ECG and/or ischemia on myocardial perfusion imaging). 
In addition to invasive coronary angiography, 64-slice MSCT was performed. Exclusion criteria were 
the following: 1) atrial fibrillation, 2) renal insufficiency (serum creatinine >120 mmol/L), 3) known 
allergy to iodine contrast media, 4) pregnancy and 5) coronary stent diameter <2.5 mm. The study 
was approved by the ethical committee of the different centers, and all participating patients gave 
informed consent.
Scan protocol and image reconstruction
MSCT angiography was performed with 2 different 64-slice MSCT scanners (Sensation 64®, Siemens, 
Germany, n=150, and Aquilion 64, Toshiba Medical Systems, Japan, n=32). Thirty-four patients 
(19%) had a pre-scan heart rate ≥65 beats per minute, and were given a single oral dose of 100 mg 
metoprolol one hour before the examination in the absence of contraindications. A bolus of 100 ml 
iomeprol (400 mgI/ml; Iomeron®, Bracco) was intravenously injected (4-5 ml/s) followed by 50 ml of 
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saline at the same rate using a double-head injector (Stellant, MedRAD, Pittsburgh, USA). To trigger 
the start of the scan a real-time bolus tracking technique was used 13. During the scan which was per-
formed during an inspiratory breath hold of 8 s to 12 s the MSCT data and ECG trace were acquired. 
Scan parameters were (for Siemens and Toshiba, respectively): individual detector collimation 32 x 2 
x 0.6 mm and 64 x 0.5 mm, tube voltage 120 kV for both, mAs 900 and 712, gantry rotation time 330 
ms and 400 ms. No ECG-pulsing was used.
Reconstruction parameters (for Siemens and Toshiba, respectively): effective slice width 0.75 mm and 
0.5 mm, increment 0.4 mm and 0.3 mm, standard and sharp heart view convolution filters for both. 
For Siemens, B30f and B46f were used, whereas for Toshiba, Q04 was used in addition to Q05-Q07. 
Synchronized to the recorded ECG, axial slices were reconstructed from the acquired MSCT data with 
the use of segmented or half reconstruction algorithms. 
Image data sets were reconstructed during the mid-to-end diastolic phase, during which coronary 
artery displacement is relatively small, with reconstruction window positions starting at 400 ms 
before the next R wave and/or at 75% of the R-to-R interval. If indicated, additional temporal win-
dow positions were explored including the end-systolic phase to obtain images with least motion 
artefacts. 
MSCT image interpretation
At each center two observers, both blinded to angiographic and clinical findings but aware of pre-
vious cardiac history, evaluated the MSCT examinations using axial slices, multiplanar and curved 
reconstructions. Of note, different window settings, including 1500/300 HU were used for optimal 
stent assessment. 
A stent was judged to be occluded when the lumen inside the stent was darker than the contrast-
enhanced vessel before the stent and/or when no run-off could be visualised at the distal end of the 
stent 14;15.  
Non-occlusive in-stent re-stenosis was considered when the lumen inside the stent showed a darker 
rim (eccentric or concentric) between the stent and the enhanced vessel lumen with a lumen re-
duction ≥50% (as compared to other portions of the stent). In addition, the presence of reduced 
run-off distal to the stent was taken into consideration; if reduced distal run-off was observed, this 
was found to be suggestive of in-stent restenosis. Importantly, the presence of distal run-off was not 
used as a criterium for the absence of significant in-stent restenosis, since collateral filling may occur 
(which cannot be detected adequately by MSCT). In Figures 1, 2 and 3, examples are provided of 
patent and diseased stents.
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Figure 1. Example of a patent stent.
Conventional coronary angiography (Panel A) demonstrated patency of a stent (Cypher, 3.0 x 18 mm) placed 
in the left circumflex coronary artery. In Panels B and C two orthogonal curved multiplanar reconstructions 
obtained with 64-slice MSCT (Siemens Sensation, kernel B46f ) are provided, also demonstrating patency of the 
stent. 
Invasive coronary angiography
Conventional selective coronary angiography was performed with standard techniques and evaluated 
by a reviewer blinded to the MSCT results with the use of quantitative coronary angiography systems 
(CAAS II, Pie Medical, Maastricht, The Netherlands or QCA-CMS version 6.0, Medis, Leiden, The Neth-
erlands). The diameter stenosis, as a percentage of the reference diameter, was determined in two or-
thogonal directions and the average between these two values determined the stenosis severity.
Statistical analysis
Sensitivity, specificity, positive and negative predictive values (including 95% confidence intervals (CI)) 
for the detection of in-stent restenosis ≥50% using conventional angiography in combination with 
QCA as the gold standard, were calculated. All statistical analyses were performed using SPSS software 
(version 12.0, SPSS Inc, Chicago, Il, USA). A value of P<0.05 was considered statistically significant.
Results  
Patient characteristics
In total, 182 patients (152 males, aged 57.8 ± 10.6 years) with a total of 192 coronary stents were 
enrolled in the study. A total of 4 patients were not enrolled due to the presence of stents with a 
diameter <2.5 mm. Also, 5 patients were not studied due to a high heart rate in combination with 
beta-blocker intolerance. Baseline characteristics of the study population are provided in Table 1. 
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The average time interval between stent implantation and 64-slice MSCT coronary angiography was 
6.2 ± 1.6 months; 64-slice MSCT and conventional angiography were performed within 1 month of 
each other (average 9 ± 8 days); MSCT was always performed first. The site of stent implantation was: 
right coronary artery (RCA) in 55 (28.6%), left main coronary (LM) in 11 (5.7%), left anterior descend-
ing (LAD) in 113 (58.9%), and left circumflex (LCx) in 13 (6.8%). Average stent diameter was 3.1 ± 0.4 
mm (range 2.5 mm to 4.5 mm), whereas stent length ranged from 8.0 mm to 33 mm (average 18 ± 
7 mm). Eight different stent types were evaluated, the non-DES stents being Vision (Guidant), Driver 
(Medtronic), Ave S7 (Medtronic), Orbus (Orbus technologies), Bx Velocity (Cordis), and Liberté (Bos-
ton Scientific). Included DES-stents were Cypher (Cordis) and Taxus (Boston Scientific). Average heart 
rate during MSCT data acquisition was 60 ± 7.9 beats per minute.
Table 1. Demographic and angiographic characteristics of patients (n=182).
n (%)
Age (yrs) 57.8±10.6
Males 152, 84%
Previous myocardial infarction 94, 52%
Previous PCI 182, 100%
Body mass index (kg/m2) 28.8 ± 3.8
Diabetes mellitus type II 23, 13%
Hypercholesterolemia 64, 35%
Hypertension 57, 31%
Family history of CAD 88, 48%
Current smoking 110, 60%
Angiography
  1-vessel disease 134, 72.5%
  2-vessel disease 34, 18.7%
  3-vessel disease 16, 8.8%
Stent location
     RCA 55, 28.6%
LM 11, 5.7%
LAD 113, 58.9%
LCx 13, 6.8%
Abbreviations: CAD: coronary artery disease; LAD: left anterior descending coronary artery, LCx: left circumflex coro-
nary artery; LM: left main coronary artery; PCI: percutaneous coronary intervention.
Coronary stent analysis
In total, 178 stents were available for evaluation while 14 stents (7.3%) were considered uninterpre-
table due to residual motion and high-density artefacts (Table 2). No significant differences were 
observed in interpretability between the different stent diameters; 3 (5.8%) of 52 stents with a diam-
eter <3.0 mm were uninterpretable, whereas 7 (10%) of 70 and 4 (5.7%) of 70 stents with diameter of 
respectively 3.0 mm or >3.0 mm were uninterpretable (Table 3). 
151Usefulness of 64-slice Multi-Slice Computed Tomography Coronary Angiography to assess In-stent Restenosis
The incidence of significant in-stent restenosis (non-occlusive in-stent restenosis and total stent oc-
clusions) was 11.2% (20/178), as determined by conventional angiography. Examples of patent as 
well as stents with significant in-stent restenosis are provided in Figures 1, 2, and 3, respectively. 
Figure 2. Example of in-stent restenosis.
Conventional coronary angiography (Panel A) revealed in-stent restenosis in a stent (Taxus, 2.5 x 20 mm) placed 
in the second marginal branch of the left circumflex coronary artery (arrowhead). In Panel B, a curved multipla-
nar reconstruction obtained with 64-slice MSCT (Siemens Sensation, kernel B46f ) is provided. In the proximal 
part of the stent (arrowhead), a hypodense area can be observed, indicating the presence of in-stent restenosis. 
All 7 stent occlusions were correctly identified by 64-slice MSCT, whereas 1 stent (located in the sec-
ond diagonal) of 13 stents with significant but non-occlusive in-stent restenosis remained undetect-
ed by MSCT. Of the 158 stents without significant in-stent restenosis, 147 were correctly evaluated 
by 64-slice MSCT, whereas 11 stents were incorrectly considered positive. Accordingly, the overall 
sensitivity, specificity, positive and negative predictive value to detect significant in-stent restenosis 
were 95.0% (19/20, CI: 85% to 100%), 93.0% (147/158, CI: 90% to 97%), 63.3% (19/30, CI: 46% to 81%), 
and 99.3% (147/148, CI: 98% to 100%), respectively. More detailed information is depicted in Table 
2. In stents without significant stenosis on conventional angiography, average percentage stenosis 
as determined by QCA was significantly higher in stents falsely classified positive on MSCT as com-
pared to stents correctly classified negative (36% versus 25%, P<0.05). Similarly, average percentage 
stenosis was lower in stents false negative on MSCT as compared to correct positive stents (65% 
versus 73%, P=NS). 
In a subanalysis, the rate of false diagnosis was evaluated according to stent diameter. In stents with a 
diameter <3.0 mm, 3 (6.1%) of 49 stents were incorrectly diagnosed. For stents with a diameter of 3.0 
mm, this percentage was 1.6% (1 of 63), while in stents with a diameter >3.0 mm incorrect diagnosis 
was obtained with MSCT in 8 of 66 (12.0%). More details on the rate of false positives and negatives 
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are provided in Table 3. In Table 4, the results from the 2 scanners from the 2 centers are reported 
separately. At the Leiden center, relatively more stents were deemed uninterpretable as compared 
to the Rotterdam center (14.3% versus 5.3%, P=NS). Diagnostic accuracy was slightly lower in the 
Rotterdam center (91.5% versus 100%, P<0.05). However, when all stents (including the uninterpre-
table stents) were included in the analysis, no significant differences were observed. 
Table 2.  Diagnostic accuracy of 64-slice MSCT to detect significant in-stent restenosis. 
≥ 50% in-stent restenosis
Assessable 178/192 (92.7%, 89% to 97% )
With uninterpretable stents excluded
Sensitivity
Specificity
Positive predictive value
Negative predictive value
19/20 (95.0%, 85% to 100%)
147/158 (93.0%, 90% to 97%)
19/30 (63.3%, 46% to 81% )
 147/148 (99.3%, 98% to 100%)
With uninterpretable stents included
Sensitivity
Specificity
Positive predictive value
Negative predictive value
19/21 (90.5%, 78% to 100%)
147/171 (86.0%, 81% to 92%)
19/43 (44.2%, 29% to 59%)
147/149 (98.7%, 97% to 100%)
Values are segments (%, 95% CI). 
Discussion
In the present study, a sensitivity and specificity of respectively 95% and 93% were observed for the 
non-invasive detection of coronary in-stent restenosis. In addition, a negative predictive value of 
99% was observed, suggesting that 64-slice MSCT may allow reliable exclusion of in-stent restenosis 
prior to more invasive procedures such as conventional coronary angiography. 
During MSCT imaging, visualization of stents is particularly challenging because of the metallic 
struts resulting in “blooming artefacts” 16. Accordingly, the stent wall appears enlarged on the MSCT 
images, which in turn affects the capability to visualize the in-stent lumen. The extent of this artefact 
depends on the material and design of the stent with more severe artefacts in stents with high metal 
content. While this effect is of minor or no importance in large vessels, such as the aorta and its ab-
dominal branches, it can considerably impair the visualization of the lumen in smaller vessels such as 
the coronary arteries 16. 
Not surprisingly therefore, visualization of stent lumen could not be achieved in preliminary investi-
gations using 4-slice MSCT scanners 10. In a more recent report 16-slice MSCT was applied, resulting 
in a sensitivity and specificity of 78% and 100% 15. Nonetheless, 15 (23%) of the 65 included stents 
were uninterpretable, indicating still a limited value for MSCT coronary angiography in populations 
with previous stent implantation 15. More detailed analysis of these 15 uninterpretable stents re-
vealed that stent assessability appears to be highly dependent on stent type and size in particular. 
These observations were further underlined by Gilard and colleagues 17 who showed in 143 patients 
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undergoing 16-slice MSCT, an increase of stent interpretability from 51% for stents ≤ 3.0 mm to 
81% when only stents >3.0 mm were included. More recently, data on stent evaluation using more 
advanced MSCT technology were reported by Gaspar et al 18, who evaluated 65 patients with 111 
implanted coronary stents using 40-slice MSCT. A considerable improvement in image quality was 
witnessed in this study, since only a small number of stents (n=5, 5%) were of non-diagnostic image 
quality. Considering these 5 stents as having restenosis, the authors reported a sensitivity and speci-
ficity for detection of in-stent restenosis of 89% and 81% respectively. 
Figure 3. Example of high-grade in-stent restenosis.
In Panel A, a conventional coronary angiogram is provided demonstrating the presence of high-grade in-stent 
restenosis in the proximal part of a stent (Taxus, 3.0 x 24 mm) placed in the left anterior descending coronary 
artery (arrowhead). Also Panel B, a curved multiplanar reconstruction obtained with 64-slice MSCT (Siemens 
Sensation, kernel B46f ), shows the presence of a large obstructing hypodense lesion in the proximal part of the 
stent (arrowhead), indicating the presence of high-grade in-stent restenosis.
These observations are further underlined by the first ex vivo reports on stent evaluation with 64-
slice MSCT, suggesting further improvement in stent visibility as well a reduction of artificial lumen 
narrowing as compared to 16-slice MSCT 19;20. Also in vivo promising results were reported using 64-
slice MSCT by Rist et al, who could evaluate 45 (98%) of 46 stents with a sensitivity and specificity of 
75% and 92%, respectively 21. Nonetheless, somewhat discouraging results were recently reported 
by Rixe et al 22, who performed 64-slice MSCT in 64 patients with 102 previously implanted stents. 
Similar to our study, 64-slice MSCT was shown to be highly accurate with reported sensitivity and 
specificity of 86% and 98%, respectively. However, evaluation could be performed in only 58% of 
stents, indicating a major limitation of the current technique. In contrast, only 7% of stents were 
deemed uninterpretable in our present study. To a large extent this discordance may be due to dif-
ferences in image interpretation. In our present study evaluation was performed with the intention 
to diagnose in order to allow generalization of results as much as possible to daily clinical routine. 
Thus, only stents with severely degraded image quality were excluded. In contrast, a more stringent 
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approach was performed by Rixe et al, and in their study, stents were deemed uninterpretable in the 
presence of any artifact, albeit small. Importantly, both in their study as well as ours, a high negative 
predictive value was obtained (98% and 99%, respectively), implying a potential role for MSCT to 
exclude in-stent restenosis in patients presenting with chest pain after stent implantation.
Table 3. Relationship between stent size and accuracy.
Stent diameter
<3.0 mm 3.0 mm >3.0 mm
Assessable
False positive
False negative
49/52 (94.2%, 88% to 100%)
2/49 (4.1%, 0% to 9.7%)
1/49 (2.0%, 0% to 5.9%)
63/70 (90.0%, 83% to 97%)
1/63 (1.6%, 0% to 4.7%)
0/63 (0%, NA)
66/70 (94.3%, 89% to 100%)
8/66 (12%, 4.2% to 19.8%)
0/66 (0%, NA)
Values are segments (%, 95% CI).
NA: not applicable.
Limitations
Several limitations should be addressed. First, only patients having stents with a diameter ≥2.5 mm 
were included, whereas stents <2.5 mm, which may be encountered in 3% to 5% of patients with 
previous stent placement, were excluded, as at present, they cannot be accurately evaluated with 
MSCT. Accordingly, the results obtained in the present study may not be generalizable to other pop-
ulation with different stent characteristics.
Second, as previously reported with MSCT coronary angiography, only patients with stable and low 
heart rates were included in this study and a high percentage received additional β-blockers to fur-
ther reduce heart rate. Accordingly, the results of the present study may not apply to the general 
population, as in addition to patients with smaller stents, also patients with atrial fibrillation and 
contra-indications to β-blocking medication were not studied. Third, in-stent restenosis was only 
present in a small number of stents (11%). However, the findings reflect the current clinical situation, 
with low in-stent restenosis rates 3-5. In addition, data acquisition was performed in 2 different cen-
ters using 2 different 64-slice MSCT systems which may have influenced the results. Also, no data on 
interobserver variability were available. Finally, several disadvantages are inherent to the technique 
itself, including the high radiation exposure (15 to 20 mSv) 23;24 and use of iodinated contrast which 
remain a matter of concern for routine use of this technique. Also, an important limitation of MSCT 
remains the fact that only anatomical information is obtained, whereas the presence or absence of 
ischemia cannot be established from the MSCT images. Accordingly, in patients with significant re-
stenosis, functional testing remains mandatory to determine further management. 
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Table 4.  Results from the 2 scanners from the 2 centers separately. 
Rotterdam
Siemens Sensation 64-slice
Leiden
Toshiba Aquilion 64-slice
Assessable
Sensitivity
Specificity*
Positive predictive value*
Negative predictive value
142/150 (94.7%, 91% to 99%)
15/16 (93.8%, 82% to 100%)
115/126 (91.3%, 86% to 96%)
15/26 (57.7%, 39% to 77%)
115/116 (99.1%, 97% to 100%)
36/42 (85.7%, 76% to 96%)
4/4 (100%)
32/32 (100%)
4/4 (100%)
 32/32 (100%)
With uninterpretable stents included
Sensitivity
Specificity
Positive predictive value
Negative predictive value
15/17 (88.2%, 82% to 100%)
115/133 (86.5%, 80% to 92%)
15/33 (45.5%, 28% to 62%)
115/117 (98.3%, 95% to 100%)
4/4 (100%)
32/38 (84.2%, 72% to 96%)
4/10 (40.0%, 10% to 70%)
32/32 (100%)
Values are segments (%, 95% CI). 
* P<0.05 between 2 centers
Conclusion
In-stent restenosis can be evaluated with 64-slice MSCT with good diagnostic accuracy. In particular, 
a high negative predictive value of 99% was observed, indicating that 64-slice MSCT may be most 
valuable to exclude in-stent restenosis. 
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Abstract
Background
To prospectively evaluate the diagnostic accuracy of 64-slice Multi-Slice Computed Tomogra-
phy (MSCT) for the assessment of in-stent or peri-stent restenosis, using conventional coro-
nary angiography as the reference standard.
Methods
The study was approved by the medical ethics committee and informed consent was ob-
tained in all 50 (40 men, mean age 60 ± 11 years) enrolled patients. In addition to conventional 
coronary angiography with quantitative coronary angiography (QCA), 64-slice MSCT was per-
formed. For each stent, assessability was determined and related to stent characteristics and 
heart rate using Chi-Square. In the interpretable stents and peri-stent lumina (5.00mm proxi-
mal and distal to the stent), the presence of significant (≥50%) restenosis was determined. For 
this analysis, partially overlapping stents were considered as a single stented segment. 
Results 
Of 76 stents, 65 (86%) were determined assessable. Increased heart rate and overlapping posi-
tioning were found to be associated with increased stent uninterpretability (P<0.05), whereas 
stent location or strut thickness were not. In 7 patients stents were placed overlapping result-
ing in 58 stented segments available for the evaluation of significant (≥50%) in-stent resteno-
sis. All 6 significant (≥50%) in-stent restenoses were detected and the absence of significant 
(≥50%) restenosis was correctly identified in the 52 remaining stented segments, resulting in 
a sensitivity and specificity of 100%. Sensitivity and specificity for the detection of significant 
(≥50%) peri-stent stenosis were 100% and 98%, respectively. 
Conclusion 
In selected patients with previous stent implantation, sensitivity and specificity of 100% to 
detect significant (≥50%) in-stent restenosis and 100% and 98%, respectively, to detect signifi-
cant (≥50%) peri-stent stenosis were observed for 64-slice MSCT.
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Introduction
Currently, follow-up imaging in patients presenting with recurrent symptoms after previous intra-
coronary stent placement is performed by means of conventional coronary angiography. However, 
this is an invasive procedure associated with a small but definite risk of serious complications 1;2. 
Considering the fact that a substantial number of procedures are not followed by an intervention, a 
non-invasive diagnostic procedure capable of evaluating not only native coronary arteries but also 
coronary stents would therefore be of great benefit. 
Although promising results have been obtained using Multi-Slice Computed Tomography (MSCT) 
for the detection of coronary artery stenoses in native coronary arteries 3-5, evaluation of metallic 
stents has not been as promising 6-10. While substantial improvement in image quality and diagnostic 
accuracy was observed with 16-slice as compared to 4-slice MSCT systems, still relatively high num-
bers of stents with inadequate image quality were reported. In particular, stents with thicker struts or 
smaller diameters tended to suffer from degraded image quality 6;7;9.
Recently, 64-slice MSCT systems have become available and studies evaluating coronary stent assess-
ment in vitro using 64-slice MSCT suggest further improvement in image quality 11;12. However, only 
limited data with 64-slice MSCT are available in patients thus far with conflicting results, as a percent-
age interpretable stents of 58% was recently reported by Rixe et al. 13. Thus, the purpose of this study 
was to prospectively evaluate the diagnostic accuracy of 64-slice MSCT for the assessment of in-stent 
or peri-stent restenosis, using conventional coronary angiography as the reference standard.
Methods
Patients 
The study group consisted of 50 consecutive patients (40 men, mean age 60 ± 11 years, range 41 to 79 
years) who met our criteria and who had previously undergone percutaneous transluminal coronary 
angioplasty (PTCA) treatment in combination with stent placement. Patients were scheduled for diag-
nostic conventional coronary angiography from June 2005 to May 2006. In addition, MSCT coronary 
angiography was performed to allow non-invasive evaluation of the presence of in-stent restenosis or 
occlusion. Exclusion criteria were the following: 1) atrial fibrillation, 2) renal insufficiency (serum cre-
atinine >120 mmol/L), 3) known allergy to iodine contrast media, and 4) pregnancy. All patients were 
on continuous beta-blocker medication, and no additional beta-blockers were administered prior to 
MSCT (Table 1). On average, MSCT was performed 13.4 ± 13.3 months (range 1 – 66 months) after stent 
implantation.
Conventional coronary angiography in combination with quantitative coronary angiography (QCA) 
analysis was performed on average 14 ± 9 days after MSCT and served as reference standard. All pa-
tients gave informed consent to the study protocol, which was approved by the ethics committee of the 
Leiden University Medical Center, after the study details, including radiation exposure, were explained. 
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Table 1. Clinical characteristics of the study population (n=50).
n (%)
Gender (M/F) 40/10
Age (years) 60 ± 11
Heart Rate (bpm)  58 ± 10
Single vessel disease 22 (44%)
Multi-vessel disease   28 (56%)
Previous myocardial infarction 46 (92%)
    Anterior 31 (67%)
    Inferior  14 (30%)    
    Both 1 (2%)
Previous PTCA 50 (100%)      
Previous CABG    0 (0%)
Stent location
    LM 0 (0%)
    LAD  36 (47%)
    LCx     11 (14%)  
    RCA   29 (38%)
Values are n (%).
Bpm: beats per minute; CABG: coronary artery bypass grafting; LM: Left main coronary artery; LAD: Left anterior 
descending coronary artery; LCx: Left circumflex coronary artery; RCA: Right coronary artery. 
Stent characteristics
Diameter of implanted stents ranged from 2.25 to 4.0 mm with an average of 3.4 ± 0.3 mm, while 
stent length ranged from 8.0 mm to 33.0 mm with an average of 19.4 ± 5.0 mm. In total, 21 stents were 
positioned with partial overlap. Ten different stent types were evaluated, of which the majority were 
non-drug-eluting stents (DES): Vision (Guidant, n=33), Driver (Medtronic, n=3), Ave S7 (Medtronic, 
n=2), Ave S670 (Medtronic, n=1), Orbus (Orbus technologies, n=2), Tristar (Guidant, n=2), Bx Velocity 
(Cordis, n=1), and Liberté (Boston Scientific, n=1). In addition, 31 DES-stents (Cypher, Cordis, n=30 
and Achieve, Guidant, n=1) were included.
Of these stents, Cypher, Bx Velocity and Tristar were considered to have thick struts (≥140 μm).
Data acquisition
Multi-Slice	Computed	Tomography
MSCT was performed using a Toshiba Multi-slice Aquilion 64 system (Toshiba Medical Systems, To-
kyo, Japan) with a collimation of 64 x 0.5 mm and a rotation time of 0.4, 0.45 or 0.5 s, depending on 
the heart rate. The tube current was 350 mA, at 120 kV. Non-ionic contrast material was administered 
in the antecubital vein with an amount of 90-105 ml, depending on the total scan time, and a flow 
rate of 5.0 ml/sec (Iomeron 400 ®). Repetitive low-dose monitoring examinations (120 kV, 10 mA) 
were performed 5 seconds after the start of contrast medium injection. After the preset contrast en-
hancement threshold level of baseline HU + 100 HU in the descending aorta was reached, the MSCT 
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examination was automatically initiated. After a 2 second delay, data acquisition was performed 
during an inspiratory breath hold of approximately 10 seconds, while the ECG was recorded simulta-
neously to allow retrospective gating of the data. 
For evaluation of the coronary arteries and intracoronary stents, data were reconstructed using a 
segmented reconstruction algorithm at 75% of the R-R interval with a slice thickness of 0.5 mm and 
a reconstruction interval of 0.3 mm. If motion artefacts were still present in this phase, additional 
reconstructions were explored to obtain the reconstruction phase with least motion artefacts (23 
patients). For this purpose, images were reconstructed at a single level throughout the R-R interval 
in steps of 20ms to obtain information on the individual patient’s pattern of cardiac motion. Based 
on these images, the time point to reconstruct the entire data set was chosen. Also, in all patients, an 
additional data set was reconstructed in the most optimal phase(s) using a sharper reconstruction 
kernel (Q04 instead of Q05-07) to improve stent image quality 14. MSCT was performed successfully 
in all patients. Average heart rate during the acquisition was 58 ± 10 (range 38 to 86).
Conventional	coronary	angiography
Conventional coronary angiography was performed according to standard techniques by 2 experi-
enced operators with respectively 10 and 15 years experience. Vascular access was obtained using 
the femoral approach with the Seldinger technique and a 6- French catheter. 
Data analysis
Multi-Slice	Computed	Tomography
For each individual coronary artery, the data set containing no or the least motion artifacts was trans-
ferred to a dedicated workstation (Vitrea2, Vital Images, Plymouth, Minn. USA) for post-processing. 
Coronary stents were evaluated on both the standard kernel and sharper kernel reconstructions 
using predominantly the original axial MSCT images, while manually obtained curved multiplanar 
reconstructions were used for verification of findings. 3D volume rendered reconstructions were not 
used. In addition, the axial images and curved multiplanar reconstructions were viewed in 3 differ-
ent window and level settings; 1000/200 HU as a standard window level while also window levels 
of 1600/300 HU and 2500/900 HU were used to improve stent appearance. Assessment was per-
formed blinded to the conventional coronary angiography results in consensus reading by 2 experi-
enced observers, both having 3.5 years experience in the evaluation of MSCT coronary angiography, 
with one also having extensive (15 years) experience in conventional coronary angiography and 
intervention. 
First, each individual stent was assigned an image quality score of: 1 (good image quality, no arti-
facts), 2 (moderate image quality, minor or moderate artifacts present but diagnosis possible) or 3 
(uninterpretable, no diagnosis possible) as previously described 9;15. Also, it was documented wheth-
er stents were positioned partially overlapping or not. If so, the stents were consequently considered 
as a single stented segment for the evaluation of in-stent or peri-stent stenosis. 
Subsequently, the presence of significant restenosis (≥50% reduction of lumen diameter) was as-
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sessed for each stented segment, while also the observation of non-significant (<50% reduction of 
lumen diameter) neo-intima hyperplasia within the stented segment was documented. Finally, since 
restenosis of the stent borders may also regularly occur, the presence of peri-stent stenosis, ≥50% 
narrowing of luminal diameter 5.00 mm proximal and distal to the stented segment was also evalu-
ated as previously described 9. 
Conventional	and	quantitative	coronary	angiography	
Conventional angiograms were evaluated in consensus by two experienced observers without 
knowledge of the MSCT data. First, the location of the intracoronary stents was identified on the 
images before contrast injection. Subsequently, QCA with automated vessel contour detection after 
catheter-based image calibration was performed in end-diastolic frames by 2 qualified observers 
with respectively 2 and 10 years experience in QCA using a standard algorithm dedicated for stent 
analysis (Brachy-DES analysis, QCA-CMS version 6.0, Medis, Leiden, The Netherlands) 16. QCA was 
performed of the stented segment as well as its proximal and distal (5.00 mm) lumina and percent-
age diameter reduction was determined. An in-stent lumen diameter narrowing ≥50% in diameter 
(up to in-stent occlusion) was defined as a significant restenosis.
Statistical	analysis
Continuous variables are presented as means ± one standard deviation (SD), whereas categorical 
data are summarized as frequencies and percentages. In order to relate stent assessability to stent 
characteristics, stents were divided according to location in the coronary tree and according to strut 
thickness (with  stents with ≥140 μm struts regarded as having thick struts and stents with <140 μm 
struts regarded as having thin struts), as previously described 9. Distinction was also being made 
between stents positioned partially overlapping or not. Percentage assessable stents was calculated 
for each category and compared using Chi-Square analysis with Yates’ correction. In addition, aver-
age heart rate was compared between interpretable stents and stents uninterpretable due to at-
tenuation artefacts or motion artefacts using the Student’s t test for independent samples.  Logistic 
regression analyses were applied to correlate segment and patient characteristics to image qual-
ity, using the generalized estimating equation (GEE) method developed by Liang and Zeger 17. Two 
(dichotomous) outcome variables were considered: good versus moderate-or-uninterpretable im-
age quality, and good-or-moderate quality versus uninterpretable image quality. The GEE analyses 
were performed with proc GENMOD with a binominal distribution for the outcome variable, the link 
function specified as logit, and patients as separate subjects. Odds ratios and 95% confidence inter-
vals (CI) are reported. Sensitivity, specificity, positive and negative predictive values (including 95% 
confidence intervals) for the detection of in-stent restenosis ≥50%, as determined by conventional 
angiography in combination with QCA, were determined for each stented segment. In addition, di-
agnostic accuracy was also determined for the detection of significant (≥50%) narrowing of the peri-
stent lumina (5.00 mm proximal and distal to the stented segment). 
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Table 2. Results from GEE analysis
Odds Ratio (95% CI)
Good versus moderate-or-uninterpretable image quality
Heart rate* 0.98 (0.93-1.05) 
Overlapping (Y/N) 0.70 (0.17-2.96)
Strut Thickness (≥140µm or <140µm) 0.44 (0.15-1.29) 
Good-or-moderate versus uninterpretable image quality
Heart rate* 0.94 (0.86-1.03)
Overlapping (Y/N) 0.16 (0.03-0.87)
Strut Thickness (≥140µm or <140µm) 0.38 (0.08-1.77)
* Odds ratio per beat per minute
Abbreviations: CI: confidence interval
Statistical analyses were performed using SPSS software (version 12.0, SPSS Inc, Chicago, Il, USA) 
and SAS software (The SAS system, release 6.12, Cary, NC, USA: SAS Institute Inc.). A value of P<0.05 
was considered statistically significant. 
Results
Stent analysis; image quality
The 50 patients had a total of 76 stents (1 to 5 stents per patient, average 1.5 ± 0.87) that were studied. 
A total 41 (54%) and 24 (32%) stents were of respectively good or moderate image quality, whereas 
stent lumen could not be visualized in the remaining 11 (14%) stents. Reasons of uninterpretability 
were motion artifacts in 5 (45%) stents and attenuation artefacts in 6 (55%) stents. 
Of the uninterpretable stents, 6 were placed in the right coronary artery (RCA), whereas 3 and 2 were 
positioned in the left anterior descending (LAD) and left circumflex coronary arteries (LCx), respec-
tively. No significant differences were observed in interpretability between the different coronary 
arteries (P=0.35).
Average heart rate during data acquisition was significantly higher in stents deemed uninterpretable 
due to motion artifacts (72 ± 9) as compared to stents deemed uninterpretable due to attenuation 
artefacts (55 ± 2, P=0.002). No significant difference was observed between stents uninterpretable 
due to attenuation artefacts and interpretable stents (57 ± 9, P=0.62). 
In stents positioned without any overlap (n=55), image quality was good in 31 (56%), moderate in 
20 (36%) and non-diagnostic in 4 (7%). In contrast, image quality in stents positioned with partial 
overlap (n=21) was significantly lower as image quality in these stents was good in 10 (48%) and 
moderate in 4 (19%), whereas 7 (33%) were uninterpretable (P=0.01). 
A trend towards improved image quality in stents with thin struts (<140 μm; n=43) could be ob-
served as compared to stents with thick struts (≥140 μm; n=33). In the latter 14 (42%) and 12 (36%) 
were of respectively good or moderate image quality with 7 (21%) stents being uninterpretable. 
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In contrast, respectively 27 (63%) and 12 (28%) of stents with thinner struts were of either good or 
moderate image quality, while 4 (9%) stents were uninterpretable. Still, no statistical significance 
was observed (P=0.15). 
Results from GEE analyses are provided in Table 2.
Figure 1. Example of a patent thick-strut drug-eluting stent (diameter 3.5 mm) placed in the left anterior de-
scending coronary artery of a 53-year old male patient. In Panels A and B, a curved multiplanar and 3D volume 
rendered reconstruction are provided, showing a patent thick-strut drug-eluting stent with only limited neo-
intima hyperplasia (white arrowhead). Also on the cross-sectional image (insert Panel A), no significant in-stent 
restenosis can be observed. The corresponding conventional coronary angiogram is provided in Panel C.
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Stent analysis; diagnosis of (significant) in-stent restenosis (Table 3)
In 7 patients, a total of 21 stents were placed partially overlapping, thereby hampering individual 
evaluation of the presence of in-stent restenosis. Consequently, overlapping stents were considered 
as a single stented segment, resulting in the availability of 58 stented segments for the diagnosis of 
significant (≥50% of lumen diameter reduction) in-stent restenosis. Significant restenosis was cor-
rectly ruled out in all 52 stented segments without significant in-stent restenosis as determined by 
conventional coronary angiography in combination with QCA (Figures 1 and 2). The remaining 6 
stented segments with significant in-stent restenosis were correctly identified on MSCT (Figure 3). 
Accordingly, the sensitivity and specificity for the assessment of significant in-stent restenosis were 
100%. In the 52 stented segments without significant in-stent restenosis, average luminal narrow-
ing as determined by QCA was 23.4 ± 8.6% (range: 4.3% to 42.4%). Non-significant restenosis could 
be observed on MSCT in 37 (71%) stented segments, whereas no neo-intima hyperplasia could be 
observed on MSCT in 15 stented segments. In stented segments without neo-intima hyperplasia 
visible on MSCT, average luminal narrowing as determined by QCA was slightly but not significantly 
lower as compared to that of stented segments with visible neo-intima hyperplasia (20.6% ± 11.7% 
vs. 24.0% ± 7.6%). 
Figure 2. Example of a patent thin-strut, non-drug-eluting stent placed in the left anterior descending coronary 
artery of a 46-year old male patient. In Panel A, a curved multiplanar reconstruction is provided of a patent thin-
strut stent (diameter 3.5 mm). Cross-sectional image perpendicular of the stent (insert) confirms the presence 
of only minimal in-stent hyperplasia (appearing as a small rim of hypoattenuating tissue, white arrow). Observa-
tions were confirmed by invasive coronary angiography (Panel B).
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Peri-stent lumina (Table 3)
Of the 76 implanted stents, 21 were positioned (partially) overlapping. As a result, 55 single stented 
segments and 10 stented segments resulting from overlapping stents were available, including both 
interpretable as uninterpretable stented segments. Also, 1 stent (located in the RCA) originated di-
rectly from the aorta. Accordingly, 64 proximal stent lumina and 65 distal stent lumina were available 
for analysis. All but 1 (1%) of the 129 peri-stent lumina were of sufficient image quality to evalu-
ate the presence of significant narrowing. Conventional coronary angiography in combination with 
QCA demonstrated the presence of significant stenosis of 5 peri-stent lumina, which were all cor-
rectly identified on MSCT. However, 2 lesions (1 proximal and 1 distal) were overestimated by MSCT, 
resulting in a specificity of 98%. 
Table 3. Diagnostic accuracy to detect (significant) in-stent or peri-stent restenosis. 
≥ 50% in-stent restenosis Peri-stent restenosis
Assessable* 65/76 (86%, 78% - 94%) 128/129 (99%, 97% - 100%)
Sensitivity 6/6 (100%) 5/5 (100%)
Specificity 52/52 (100%) 121/123 (98%, 96% - 100%)
Positive predictive value 6/6 (100%) 5/7 (71%, 37% - 100)
Negative predictive value 52/52 (100%) 121/121 (100%)
Values are segments (%, 95% confidence intervals). 
* Includes all available stents, for the diagnostic accuracy calculations, (partially) overlapping positioned stents 
were considered as a single stented segment.
Discussion
In our present study, 76 coronary stents were evaluated using 64-slice MSCT, of which 65 (86%) were 
interpretable. Both elevated heart rate and overlapping positioning appeared to be associated with 
decreased interpretability, while no effect of stent type or location was observed. In the interpre-
table stented segments, a sensitivity and specificity to detect significant (≥ 50%) in-stent restenosis 
of 100% was obtained, whereas the presence of non-obstructing in-stent restenosis was accurately 
identified in 71% of stented segments. Also the presence of peri-stent stenosis could be accurately 
detected with a sensitivity and specificity of 100% and 98%, respectively. 
Our current observations compare favourably to previous studies reporting on coronary stent imag-
ing with 16-slice MSCT. In an earlier study by Schuijf et al, 21 patients with 65 previously implanted 
stents were evaluated 9. A moderate sensitivity 78% and an excellent specificity of 100%, respec-
tively, to detect in-stent restenosis were observed. However, only 50 (77%) of stents proved to be 
of sufficient image quality for evaluation. Exploration of the characteristics of 23% uninterpretable 
stents showed that predominantly stents with thicker struts (≥140 μm) as well as stents with smaller 
diameter (e.g. ≤3.0 mm) tented to suffer from degraded image quality. The effect of thick struts 
was particularly pronounced, 41% of thick strut stents were uninterpretable, as compared to 11% 
of stents with thinner struts. Diameter showed less prominent effect, although still a substantially 
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higher percentage of stents with a diameter ≤3.0 mm was uninterpretable as compared to stents 
with a larger diameter (28% versus 11%). These observations were recently confirmed in a larger 
population (143 patients included with a total of 232 stents) 6. In this study by Gilard et al, also using 
16-slice MSCT, a substantial increase in interpretability from 51% to 81% was observed in stents with 
diameters >3.0 mm as compared to those with diameters ≤3.0 mm. In addition, sensitivity to detect 
in-stent restenosis increased similarly from 54% to 86%. For all stents, regardless of diameter, a speci-
ficity of 100% was observed. In this particular study the effect of strut thickness was not explored.  
In our present study, improved interpretability of stents with 64-slice MSCT was observed with suf-
ficient image quality in 86% of stents. Exploration of the characteristics of uninterpretable stents 
showed that similar to previous studies in native coronary arteries, elevated heart rate was a signifi-
cant cause of non-diagnostic image quality 18. Indeed, uninterpretability was due to motion artefacts 
in 45% of uninterpretable stents. Accordingly, these observations underline the need for adequate 
heart rate control during MSCT coronary angiography. 
Further evaluation of the uninterpretable stents demonstrated that also partially overlapping posi-
tioned stents are associated with deteriorated image quality. The increased metal content is likely to 
amplify high-density artefacts, thereby increasing the artificial narrowing of the stent lumen. Indeed, 
whereas 93% of single stents were interpretable, 33% of partially overlapping stents were of non-
diagnostic quality. Accordingly, in patients with partially overlapping stents, evaluation by means 
of another modality than MSCT may be preferred. In contrast to previous studies, no pronounced 
effect of strut thickness was observed. Nonetheless, the presence of thick struts still tended to result 
in non-diagnostic image quality more often as compared to stents with thin struts (21% versus 9%, 
P=0.15). Accordingly, the influence of strut thickness on image quality with 64-slice MSCT should be 
evaluated in larger cohort as our study may have been underpowered to demonstrate any effect.  
In the interpretable stented segments, the presence or absence of significant (≥50%) in-stent reste-
nosis was correctly identified in all stented segments. Also, the presence or absence of peri-stent 
restenosis could be detected with diagnostic accuracy of 98%. In particular, observed negative 
 predictive value to exclude the presence of in-stent or peri-stent restenosis was extremely high. Ac-
cordingly, the technique may be well suited for non-invasive rule out of significant (≥50%) in-stent 
or peri-stent restenosis. Somewhat lower sensitivity and specificity were reported by a recent study 
employing 40-slice MSCT technology 19. In this study by Gaspar and colleagues, evaluating 65 pa-
tients with 111 implanted coronary stents, a sensitivity and specificity to detect ≥50% in-stent re-
stenosis of 89% and 81% were observed 19. In part, this discrepancy may be explained by the fact 
that in this study only a very small number of stents (5%) were excluded from the analysis, whereas 
the number of excluded stents was higher in our own study. Still, also in the study by Gaspar, a high 
negative predictive value (97%) was observed, underlining the potential of MSCT as a non-invasive 
technique to rule out the presence of in-stent restenosis. 
Another finding of our study was that in contrast to 16-slice MSCT 9;14 the superior image quality 
of 64-slice MSCT has improved visualization of non-significant in-stent hyperplasia in addition to 
significant in-stent restenosis. The presence of in-stent hyperplasia albeit limited was demonstrated 
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by QCA in all stents and correctly recognized in 71% of stents on MSCT as well. Our observations are 
in line with a recent study by Mahnken et al using 64-slice MSCT in a phantom model 20. Comparison 
of16-slice MSCT to 64-slice MSCT in 8 stents with a diameter of 3.0 mm positioned in a static chest 
phantom showed superior visualization of stent lumina with 64-slice MSCT due to significantly less 
artificial lumen reduction and image noise. Still, a considerable portion of stent lumina remained 
obscured even with 64-slice MSCT and in our own study, the presence of neo-intima hyperplasia 
could not be observed on MSCT in 30% of stents. Accordingly, the value of MSCT to identify moder-
ate in-stent hyperplasia appears to remain limited at present. 
Limitations
A relatively small number of patients were evaluated in the present study. As a result, the total num-
ber of stents and importantly, the number of patients with significant in-stent restenosis (12%), were 
relatively low as well. Nonetheless, a much higher prevalence of in-stent restenosis is not likely to be 
encountered in daily practice and extrapolation of the current results to clinical practice may there-
fore be justifiable 21;22. Also, the number of evaluated stents was low and the influence of stent and 
patient characteristics on stent interpretability should be explored in larger patient cohorts in order 
Figure 3. Diagnosis of in-stent restenosis in 2 adjacent stents placed in the left anterior descending coronary 
artery of a 61-year old male patient. Curved multiplanar reconstruction (Panel A) demonstrates the presence of 
in-stent restenosis (slightly exceeding 50% luminal diameter narrowing at the mid level [white arrowhead] and 
more severe at the distal part of the stent [white arrow]) in 2 adjacent non-drug-eluting stents (diameter 3.5 and 
3.0 mm). Panel B: Also on the cross-sectional images obtained at the mid level, the presence of in-stent restenosis 
(appearing as hypoattenuating tissue) can be observed. Panel C: Findings were confirmed by invasive coronary 
angiography.
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to fully establish which characteristics should potentially be avoided when performing stent evalu-
ation with MSCT. In particular, the range of stent diameters was limited in the present study with an 
average of 3.4 ± 0.3 mm and as a result a potential effect of stent diameter could not be evaluated 
in the present study. Thus, our study could possibly best be regarded as a basis for further larger 
studies concerning image quality and diagnostic accuracy of 64-slice MSCT in coronary stents. In ad-
dition, despite the technological advancements of 64-slice MSCT, several limitations inherent to the 
technique remain. First, as also observed in our present study, a stable and low heart rate remains 
crucial for high-quality MSCT images and administration of beta-blockers prior to the examination 
therefore is often required 18. Finally, an important consideration is the relatively high effective radia-
tion dose (10-15 mSv) to which a patient undergoing MSCT coronary angiography is exposed. For 
this purpose, dose-modulation protocols are currently under development.  
Conclusion
In selected patients with previous stent implantation, sensitivity and specificity of 100% to detect 
significant (≥50%) in-stent restenosis and 100% and 98%, respectively, to detect significant (≥50%) 
peri-stent stenosis were observed for 64-slice MSCT. In particular, the technique may be useful for 
non-invasive exclusion of in-stent or peri-stent restenosis and avoid invasive imaging in a consider-
able number of patients.
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Abstract
Background
The aim was to validate a magnetic resonance high-resolution, phase-contrast sequence for 
quantifying flow in small and large vessels, and to demonstrate its feasibility to measure flow 
in coronary artery bypass grafts.   
Methods
A breathhold, echo planar imaging (EPI) sequence was developed and validated in a flow 
phantom using a fast field echo (FFE) sequence as reference. In 17 volunteers aortic flow was 
measured using both sequences. In 5 patients flow in the left internal mammary artery (LIMA) 
and aorta was measured at rest and during adenosine stress, and coronary flow reserve (CFR) 
was calculated; in 7 patients vein graft flow velocity was measured. 
Results
In the flow phantom measurements, the EPI sequence yielded an excellent correlation with 
the FFE sequence (r=0.99; p<0.001 for all parameters). In healthy volunteers, aortic volume 
flow correlated well (r=0.88; p<0.01), with a minor overestimation. It was feasible to measure 
flow velocity in the LIMA and vein grafts of the 12 patients.  
Conclusion
The high-resolution, breathhold MR velocity-encoded sequence correlated well with a free-
breathing, FFE sequence in a flow phantom and in the aortae of healthy volunteers. Using the 
EPI sequence, it is feasible to measure flow velocity in both LIMA and vein grafts, and in the 
aorta.  
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Introduction
Coronary artery bypass grafting (CABG) is one of the therapeutic options in obstructive coronary 
artery disease. Over time, atherosclerosis may progress in these bypass grafts and graft stenosis 
may develop, requiring invasive angiography to assess the severity of the lesions. However, the 
hemodynamic consequences of the stenotic lesions cannot be assessed from angiography 1;2. 
Measurement of flow velocity and flow reserve by phase-contrast velocity-encoded cardiovascular 
magnetic resonance (CMR) has recently been demonstrated for the evaluation of vein graft dis-
ease 3;4. Imaging of arterial grafts remains challenging because of the small luminal diameter of 
the internal mammary arteries, and metal clip artefacts. Earlier studies demonstrated the feasibility 
to measure flow in left internal mammary artery (LIMA) grafts by free-breathing and breathhold 
CMR sequences, but these sequences generated a limited spatial and temporal resolution 5-7. The 
aim of the present study was to validate a recently developed velocity-encoded CMR sequence to 
measure flow velocity in small and large vessels, and to demonstrate its feasibility to measure flow 
in coronary artery bypass grafts. 
Methods
In vitro validation
In order to validate the velocity-encoded CMR sequence in small vessels, a calibrated flow simulator 
(UHDC flow simulator, Shelley Medical Imaging Technologies, London, Ontario, Canada) was used to 
create biphasic flow velocity patterns, such as observed in nonstenotic bypass grafts and coronary 
arteries, in a MRI compatible phantom. The design of the pump and its value in application for MR 
flow studies were described before 8;9. The simulator provided an ECG-signal to allow triggering by 
the MR-system. The phantom consisted of a cylindrical container filled with water, with a 4-mm-di-
ameter glass tube running through the middle. The glass tube was connected to the flow simulator 
by two hoses, and filled with a blood-mimicking solution. The phantom was positioned in the bore of 
a 1.5 Tesla MRI scanner (Gyroscan ACS/NT, Philips Medical Systems, Best, the Netherlands) with Pow-
ertrak-6000 gradients (gradient strength 25mT/m, slow rate 100 T/m/s) and commercially available 
cardiac software (release 9, Philips Medical Systems, Best, the Netherlands). Scout scans of the glass 
tube were made, and a plane perpendicular to the tube was planned for the velocity measurements. 
A multishot echo planar imaging (EPI) velocity-encoded sequence yielded a field of view (FOV) of 
60×150 mm with an acquisition matrix of 55×144 voxels. Per acquisition 55 k-lines were scanned. 
Multi-shot gradient echo EPI was performed by acquisition of 5 EPI-readouts twice per frame (Figure 
1). For each time frame in the cardiac cycle a velocity-sensitive and a velocity-insensitive image was 
acquired, and for each image signals were averaged (NEx=2), resulting in an acquisition time of 22 
heartbeats. Number of phases to be acquired during the cardiac cycle was set to 30 by retrospective 
ECG-gating. The repetition time (TR), defined as the time to acquire 5 k-lines after one RF pulse, was 
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15 ms, rendering a temporal resolution of 30 ms (2×TR). Additional scan parameters were: echo time 
(TE) of 7 ms, in-plane resolution of 1.0×1.0 mm, interpolated to 0.29×0.29 mm by zero padding, slice 
thickness of 6 mm, flip angle of 40°, velocity encoding of 50-150 cm/s.    
Figure 1. Schematic presentation of the EPI sequence. Per heart beat 30 frames could be acquired, each consist-
ing of two shots, each representing one radiofrequency pulse and 5 EPI-readouts. The ECG-signal was recorded 
simultaneously for retrospective ECG-triggering. 
 
Stepwise increasing velocities in a biphasic pattern resembling bypass graft flow were implemented 
in the simulator and subsequently imaged. The series of velocity measurements was repeated using 
a free-breathing fast field echo (FFE) sequence, previously validated at our institution 10, using the 
following parameters: TR/TE 5.5/3.5, FOV of 370 mm, RFOV 60%, acquisition matrix 77×128 voxels, 
temporal resolution of 30 ms, pixel size of 3×3 mm, interpolated to 1.45×1.45 mm, slice thickness of 
6 mm, flip angle of 20°, retrospective ECG gating, scan duration of 256 heart beats. For determination 
of interstudy variability the velocity measurements were repeated using the EPI sequence.  
Image analysis
Velocity image acquisition consisted of paired modulus and phase images. For the velocity analysis 
a region of interest (ROI) of 1 pixel (2.1 mm²) was placed in the center of the glass tube in each phase 
image for the free-breathing sequence, using FLOW software (version 4.0.4, Medis, Leiden, the Neth-
erlands). Owing to the improved spatial resolution of the EPI sequence, 24 pixels (2.02 mm²) were 
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selected in the center of the tube in order to compare the two sequences. The peak velocity was 
defined as the mean velocity in the ROI for each time frame. The average peak velocity (APV; cm/s) 
was then defined as the average velocity measured in the ROIs over the cardiac cycle. Systolic peak 
velocity (SPV; cm/s) and diastolic peak velocity (DPV; cm/s) were defined as the maximal peak veloc-
ity during the first and second peak, respectively. 
In vivo validation
In 17 healthy volunteers aortic flow was measured using the EPI and FFE sequence. A scout scan in 
three planes of the thorax was made. Aortic flow was acquired in a transverse plane planned through 
the ascending aorta by both free-breathing FFE and EPI sequence. For this measurement FOV was 
increased to 370 mm in the EPI sequence, resulting in a voxel size of 2.6×2.6 mm, interpolated to 
0.7×0.7 mm. All breathholds were initiated at end-expiration in order to avoid aortic flow changes 
due to high intrathoracic pressures 11. 
Feasibility study
In 10 healthy volunteers LIMA and aortic flow were measured using the EPI sequence. Two surface 
coils were used, one placed at the proximal native LIMA and one placed at the center of the thorax 
to measure aortic flow. First, a scout scan in three planes of the thorax was made. A transversal bal-
anced turbo field echo (bTFE) survey scan of the proximal part of the LIMA was made to identify the 
arterial anatomy. The proximal portion of the LIMA was selected in order to avoid artefacts derived 
from metal clips in patients with LIMA grafts. The proximal part of the LIMA was scanned in plane in 
two perpendicular planes in order to plan a third plane orthogonally. The EPI sequence was applied 
to measure velocity in a single breathhold. The sequence validated in the phantom study was used. 
Then, aortic flow was acquired as described in the previous section.
In 5 randomly selected patients with LIMA grafts, who underwent coronary angiography because of 
recurrent chest pain, aortic and proximal LIMA graft flow was measured in the same manner. After 
acquiring the baseline aortic and LIMA flow, adenosine was administered intravenously in dosage of 
140 µg/kg/min in order to achieve maximal hyperemia 12. Aortic and LIMA flow velocity scans were 
repeated during adenosine stress. 
In 7 randomly selected patients with vein grafts, baseline flow velocity was measured. By means of 
the bTFE survey scan, vein grafts were visualized at the level of the ascending aorta. On two perpen-
dicular survey images showing the graft in plane, a plane was planned perpendicular to the graft 
and velocity was obtained using the EPI sequence. Beforehand, the nature of the study was fully 
explained to the patients, and all patients gave informed consent. The study was approved by the 
medical ethics committee of our institution. 
All patients underwent coronary angiography because of recurrent chest pain by a standard proce-
dure prior to the CMR examination. The MR operators were blinded to the results of invasive angi-
ography. Angiograms were evaluated by an experienced cardiologist for potential stenoses in the 
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examined bypass grafts and recipient vessels. If more than one stenosis was present in either bypass 
graft or recipient vessel, the most severe stenosis was taken into account. 
Image analysis
For the image analysis aortic and LIMA contours were traced by automatic contour detection, using 
FLOW 4.0.4 (Medis, Leiden, the Netherlands) 13;14. In the flow rate-versus-time curves the area-un-
der-the-curve was multiplied with the heart rate to obtain aortic and LIMA volume flow (ml/min). 
The maximal flow rate at systole and diastole were defined as the systolic peak flow (SPF; ml/s) and 
diastolic peak flow (DPF; ml/s), respectively. The diastolic-to-systolic flow ratio (DSFR) was defined 
as the ratio of DPF and SPF. The ratio of hyperemic to baseline volume flow was defined as coronary 
flow reserve (CFR). As values of LIMA flow are known to vary widely between individuals 5, LIMA flow 
was also expressed as a percentage of the aortic flow at rest and during stress. 
For vein grafts it has been demonstrated previously that the accuracy of volume flow analysis and 
peak velocity analysis is similar 15. Therefore, only peak velocity analysis was performed, in which 
4 pixels at the center of the vessel were selected and defined as the peak velocity for every phase 
in the cardiac cycle. APV, SPV, and DPV were derived from the velocity-versus-time curves, such as 
described for the flow simulator. 
Statistical analysis
Parameters were expressed as mean ± SD. The velocity parameters, measured by the flow phantom, 
and the flow parameters, measured in healthy volunteers, were compared using Pearson correlation 
and Bland-Altman analysis. Interstudy variability was expressed as correlation and calculated as the 
mean difference divided by the mean of the two measurements. Baseline and stress values in LIMA 
grafts were compared using a paired Student t-test. A p-value <0.05 was considered significant.
Results
In vitro validation
When comparing the FFE and EPI sequence with the flow simulator, an excellent correlation was 
demonstrated for APV (y=1.06x-2.6; r=0.99; p<0.001), as for SPV and DPV (y=1.05x-2.1; r=0.99 and 
y=1.05x-1.3; r=0.99; p<0.001). In the Bland-Altman analysis, the mean differences (95% limits of 
agreement) were for APV –1.26 cm/s (-2.89 to 0.36), for SPV –1.05 cm/s (-2.64 to 0.55), and for DPV 
0.19 cm/s (-2.84 to 3.23), indicating good agreement. A good reproducibility of the EPI sequence 
was demonstrated, expressed by the following correlations: y=x+0.2 for APV, y=x-0.5 for SPV and 
y=x+2.2 for DPV (r=0.99 and p<0.001 for all correlations). Interstudy variabilities were –0.2% for APV, 
-2.4% for SPV, and 5.5% for DPV.
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Figure 2. Correlation and Bland-Altman analysis of the comparison of the FFE and EPI sequence for aortic flow in 
healthy volunteers. Identity lines (y=x) are shown in the correlation plots in gray. In the Bland-Altman plots, solid 
lines represent the mean, and dotted lines represent the 95% limits of agreement. 
In vivo validation
In 17 healthy volunteers (mean age 30 years, range 20 to 60, male/female 7/10) aortic flow was mea-
sured by free-breathing FFE and breathhold EPI sequence. For 2 volunteers, image quality was insuf-
ficient due to inability to sustain the obligatory breathhold, and these individuals were excluded 
from further analysis. A good correlation was shown for the FFE and EPI sequences (Figure 2). The 
regression equation, y=1.2x-301, demonstrated a slight overestimation of volume flow, when the 
EPI sequence was used (r=0.88; p<0.01). The EPI sequence correlated well with the FFE sequence 
for SPF (y=1.04x-21; r=0.94; p<0.001). Bland-Altman analysis illustrated the overestimation of aortic 
flow with the EPI sequence with a mean difference of 560 ml/min (95% limits of agreement –872 to 
1992). For SPF mean difference was –4.5 ml/s (95% limits of agreement –75.0 to 66.0). 
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Feasibility study
In 10 volunteers native LIMA flow was adequately measured using the EPI sequence. Mean LIMA 
flow was 66.5 ± 22.3 ml/min (range 32.0 to 106.2), mean SPF was 5.2 ± 1.4 ml/s (range 3.1 to 7.3), and 
mean aortic flow was 5365 ± 1302 ml/min (range 3331 to 7493). When LIMA flow was expressed as 
percentage of aortic flow, the mean percentage was 1.2 ± 0.4% (range 0.6 to 2.0). 
Figure 3. Modulus (left) and phase (right) images of a sequential LIMA graft (arrowheads) to anterolateral and 
obtuse marginal branch in diastole, acquired using the EPI sequence. Top images represent baseline flow velocity 
and bottom images flow velocity during adenosine stress. 
In 5 male patients (mean age 56 years, range 43 to 73) with 5 LIMA grafts, proximal LIMA graft and aor-
tic flow were successfully measured at rest and during adenosine stress, see Figure 3. Grafts were anas-
tomosed to the left anterior descending (LAD) artery (n=1), first diagonal branch and LAD (n=2), an-
terolateral branch and obtuse marginal (OM) branch (n=1). In one patient the LIMA was anastomosed 
to the first diagonal branch and LAD, and a free right IMA was anastomosed from the LIMA to the OM 
Figure 4. Flow curve of the LIMA graft depicted in Figure 3. Black squares represent the flow rate  at baseline. 
Open squares characterize adenosine stress flow rate. LIMA volume flow was 58.3 mL/min at baseline and 159.5 
mL/min during adenosine stress, resulting in a CFR of 2.7. 
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and posterior descending branch. Mean interval between bypass surgery and CMR examination was 
48 months (range 8 to 104). A biphasic flow pattern was obtained in all grafts (Figure 4). The measured 
flow parameters are summarized in Table 1. All LIMA grafts were patent at coronary angiography. Ste-
noses in LIMA grafts or recipient vessels distal from the anastomosis were not observed.  In 7 male 
patients (mean age 67 years, range 57 to 75 years) flow velocity in 9 vein grafts at rest was obtained 
(mean time interval after CABG 9 years, range 5 to 15). Single vein grafts perfused the LAD (n=3), OM 
(n=2), or posterolateral branch (n=1). Sequential vein grafts were anastomosed to OM and posterior 
descending branch (n=3). The velocity parameters are presented in Figure 5. At coronary angiography 
7 grafts had no significant stenosis (≥50%), in 2 single grafts a diameter stenosis of 80% was observed. 
In concordance with previous studies 3;16, the velocity parameters of single vein grafts were lower than 
sequential vein graft values. Two grafts with significant stenosis showed low velocity values at rest. Us-
ing the EPI sequence it is feasible to measure flow velocity in both arterial and vein grafts.
Table 1. LIMA graft and aortic flow.
Baseline Stress
LIMA flow (mL/min)  37.1 ± 13.9 (22.3–58.3) 101.1 ± 45.6 (39.7–159.5)∗
SPF LIMA (mL/s) 1.28 ± 0.49 (0.70–2.03)  2.88 ± 0.72 (2.33–4.05)∗
DPF LIMA (mL/s) 1.03 ± 0.42 (0.54–1.64) 2.79 ± 1.55 (0.96–5.11)∗
DSFR 0.89 ± 0.44 (0.38–1.44) 1.03 ± 0.70 (0.31–2.19)
Aortic flow (mL/min) 5142 ± 901 (4116–6185) 6275 ± 1208 (4237–7116)
SPF aorta (mL/s) 406 ± 51 (334–473) 442 ± 59 (397–524)
LIMA/aortic flow (%) 0.71 ± 0.17 (0.52–0.94) 1.56 ± 0.52 (0.94–2.27)†
CFR  2.70 ± 0.88 (1.78–4.14)
Results are presented as mean ± SD (range). 
LIMA = left internal mammary artery, SPF = systolic peak flow, DPF = diastolic peak flow, DSFR = diastolic-to-systolic 
flow ratio, CFR = coronary flow reserve.
∗p < 0.05, †p < 0.01.
Figure 5. Diagram of the velocity parameters, measured in the vein grafts. 
APV = average peak velocity, SPV = systolic peak velocity, DPV = diastolic peak velocity.
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Discussion
In this study validation of a high-resolution, phase contrast CMR sequence was described. This se-
quence correlated well with a previously validated FFE sequence in a flow phantom and for aortic 
flow measured in healthy volunteers. In addition, the feasibility to measure LIMA and vein graft flow 
velocity using the proposed sequence was demonstrated.
In vitro and in vivo validation	
CMR phase contrast imaging has succesfully been used before to measure flow velocity in arterial 
and vein bypass grafts 3-7. In the current study an improved phase contrast EPI sequence was validat-
ed in vitro and in vivo against an established FFE sequence 10, and the feasibility to measure bypass 
graft flow velocity was demonstrated. The EPI sequence used segmented filling of k-space (factor 
5), and had an in-plane resolution of 1.0 × 1.0 mm, interpolated to 0.29 × 0.29 mm, with a temporal 
resolution of 30 ms. The measurements were obtained at breathholding, and with the use of retro-
spective ECG-gating, data could be collected during the full cardiac cycle. In comparison, spatial and 
temporal resolution of formerly established breathhold phase contrast sequences were 2.5×1.9 mm 
and 128 ms 6, 1.6×0.8 mm and 112 ms 7, 1.6 × 1.6 mm and 23 ms 3, and 0.9 ×1.5 mm and 125 ms 4, 
respectively. In LIMA grafts with a mean diameter of 2.42 ± 0.45 mm 17, an improvement of 0.5 mm in 
in-plane spatial resolution is of important benefit. A temporal resolution of 30 ms is adequate to ac-
curately measure the systolic and diastolic peak in peak flow velocity measurements 18. The formerly 
established breathhold sequences all used prospective ECG-triggering, with which the flow of late 
diastole may not be measured correctly. The presented sequence used retrospective gating, provid-
ing data collection throughout the whole cardiac cycle. Particularly in bypass grafts, where flow is 
maximal during diastole, this is an important improvement.      
For validation purposes, quantitative flow velocity measurements with FFE phase contrast imaging 
have been shown to be accurate 19-22. An excellent agreement between the EPI sequence and the 
conventional sequence was demonstrated in vitro, and the sequences correlated well in vivo.
In healthy volunteers aortic volume flow showed a minor overestimation using the EPI sequence, 
which may be explained in part by the fact that the EPI sequence had a better spatial resolution, 
causing partial volume effects to be less prominent 23. Also, phase offset errors or Maxwell con-
comitant terms may be more prominent using an EPI approach. These artefacts were not specifically 
investigated in this study. Moreover, at end-expiration left ventricle stroke volume was previously 
demonstrated to be higher than the average stroke volume in healthy volunteers 24. Thus, when aor-
tic volume flow is measured over 22 heart beats in an end-expiratory breathhold, measured volume 
flow may be higher than averaged over 256 heart beats in normal breathing, due to low intratho-
racic pressure.
The phase-contrast EPI sequence was initially developed for measuring flow velocity in bypass grafts. 
The results of the current study showed that this sequence may additionally be used in large arteries 
as part of an integrated CMR approach.
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CMR flow velocity in bypass grafts
Arterial grafts 
Absolute LIMA graft flow ranged considerably between patients without stenoses in the graft or 
recipient vessel of the graft. Standardized thresholds of the flow parameters are necessary to be 
able to detect flow-limiting stenoses. Ishida et al. studied volume flow by CMR in 24 LIMA grafts 
at rest and during dipyridamole stress in patients shortly after CABG, and the authors proposed 
threshold values for the detection of >70% stenosis of 35 ml/min for baseline LIMA volume flow, 
1.0 for diastolic-to-systolic velocity ratio, and 1.5 for CFR 7. These parameters however are known 
to change over time 17;25. Langerak et al. formulated a regression model to detect ≥50% and ≥70% 
stenoses in vein grafts by using CMR with velocity mapping 3. Arterial grafts (n=41) were addition-
ally investigated, but a sufficient number of stenoses to formulate a model for the identification of 
graft disease was lacking. Future studies are necessary to formulate a model to detect significant 
stenoses in arterial grafts noninvasively by velocity-encoded CMR. Such a study may be performed 
using the currently presented sequence.
Another application of LIMA flow measurements by CMR is assessment before and after surgical 
revascularization to evaluate patency of the graft. Stauder et al. demonstrated the feasibility of a 
combined CMR protocol, including contrast-enhanced MR angiography and phase contrast flow 
measurements, for assessment of patency in 42 LIMA grafts 26. The presented CMR flow velocity se-
quence may also be used for this purpose. 
Metal clips used in bypass graft surgery formed no obstacle in the present study, since proximal 
CMR measurements were performed. Metal clip artefacts did however prevent the acquisition of 
distal flow measurements. As CMR imaging gains acceptance as noninvasive follow-up after sur-
gery, MR compatible clips, e.g. titanium clips, may be used at CABG in a standard fashion.
Vein grafts
Vein graft flow velocity has been studied more extensively by CMR in previous studies 3;4;27;28. Two 
models were described to identify diseased vein grafts yielding a sensitivity and specificity of 94% 
and 63%, and 78% and 80%, respectively, using velocity-encoded CMR 3;4. Measurement of flow ve-
locity in vein grafts using this sequence was demonstrated to be feasible.  
Study limitations
In this study the results in patients are to show the feasibility of the EPI sequence to be used to measure 
flow velocity in bypass grafts. A future study validating this sequence to measure bypass grafts flow com-
pared with a prospectively-triggered, breathhold sequence with similar spatial resolution is needed.
Also, artefact sensitivity of EPI was not specifically investigated. Future studies may further focus on 
this issue. 
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Conclusion
In conclusion, the presented velocity-encoded CMR sequence allows accurate measurements of ve-
locity in small vessels with good reproducibility, demonstrated by means of a flow simulator. The 
presented sequence correlated well with a conventional sequence for measurement of aortic flow 
in healthy volunteers. In addition, the feasibility to quantify flow velocity in LIMA and vein grafts was 
demonstrated. 
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Abstract
 The role of non-invasive imaging techniques in the evaluation of patients with suspected or 
known coronary artery disease (CAD) has increased exponentially over the past decade. The 
traditionally available imaging modalities, including nuclear imaging, stress echocardiography 
and magnetic resonance imaging (MRI), relied on detection of CAD by visualization of its 
functional consequences (i.e. ischemia). However, at present, extensive research is invested 
in the development of non-invasive anatomical imaging using computed tomography (CT) or 
MRI to allow detection of (significant) atherosclerosis, eventually at a pre-clinical stage. 
 In addition to establishing the presence of or excluding CAD, identification of patients at high 
risk for cardiac events is of paramount importance to determine post-test management and 
for this purpose the majority of non-invasive imaging tests can also be used. The aim of the 
present chapter is to provide an overview of the available non-invasive imaging modalities 
and their merits for the diagnostic and prognostic work-up in patients with suspected or 
known CAD.
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Introduction
In the evaluation of patients with suspected or known coronary artery disease (CAD), the role of non-
invasive imaging techniques has increased exponentially over the past decade. The traditionally 
available imaging modalities relied on identification of the presence of significant coronary artery 
stenoses, by visualization of their functional consequences (i.e. ischemia), reflected by an induction 
of myocardial perfusion or systolic wall motion abnormalities following stress. For this purpose, 
nuclear imaging techniques, stress echocardiography and magnetic resonance imaging (MRI) are 
currently employed. Although these modalities permit reliable detection of ischemia, the presence 
of (significant) atherosclerosis in the absence of a flow-limiting stenosis is not detectable. At present, 
extensive research is invested in the development of non-invasive anatomical imaging, e.g. non-
invasive assessment of coronary artery calcium or even non-invasive coronary angiography using 
computed tomography (CT) or MRI. With these techniques, the presence of atherosclerosis rather 
than ischemia is being evaluated. 
Besides the detection or exclusion of CAD (diagnosis), identification of patients at high risk for 
adverse events (prognosis) is crucial to determine post-test management and to select those 
patients who may benefit from revascularization. Indeed, the non-invasive imaging tests provide not 
only diagnostic but also powerful prognostic information. The purpose of this review is to provide 
an overview of the available non-invasive imaging modalities and their merits in the diagnosis and 
prognosis in patients with suspected or known CAD.
Diagnosis of coronary artery disease
Detection of atherosclerosis 
Although detection of ischemia provides a reliable evaluation of patients with known or suspected 
CAD, the recent development of non-invasive imaging of coronary anatomy has increased the 
interest in detection of atherosclerosis in addition to ischemia. In particular, assessment of diffuse 
atherosclerosis without ischemia may target assessment of preclinical disease. For this purpose, 
evaluation of coronary artery calcium by CT techniques has attracted substantial attention, and 
more recent technological developments have resulted in the possibility to perform non-invasive 
coronary angiography.
Currently, non-invasive angiography is feasible with MRI, multi-slice CT (MSCT) and electron beam 
computed tomography (EBCT). Since the coronary arteries are small, tortuous and move substantially 
during the cardiac cycle, imaging remains technically challenging. As a result, all techniques still have 
shortcomings and limitations, but with the rapid technical advances, image quality and diagnostic 
accuracy are continuously improving. Besides non-invasive angiography, these techniques may in 
the future also allow assessment of plaque composition 1. 
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Coronary	artery	calcium	scoring
EBCT and MSCT allow non-invasive detection and quantification of coronary artery calcium. In 
Figure 1, examples of coronary calcium imaging with MSCT are shown. Both EBCT and MSCT provide 
similar measures of coronary artery calcium but the majority of data has been obtained with EBCT, 
which has a lower radiation dose and superior reproducibility. The Agatston score is the most 
widely applied technique for quantification of coronary artery calcium 2. Although the presence of 
coronary artery calcium is closely correlated with the total atherosclerotic burden, it is not predictive 
of significant coronary stenoses and it is not site-specific, meaning that calcified segments are not 
necessarily stenosed, and the reverse 3. 
Figure 1. Single-level MSCT calcium scans of patients with respectively no (Panel A), minor (Panel B) and extensive 
(Panel C) coronary calcifications. Coronary calcifications are identified as regions with high signal intensity, thus 
appearing as intensely white structures on the MSCT images.
Abbreviations: Ao: Aorta, LAD: left anterior descending coronary artery, RCA: right coronary artery.
Also, non-calcified plaques with a low X-ray density are not detected by coronary artery calcium 
imaging. However, an approximate of the total atherosclerotic plaque burden is provided and thus the 
likelihood of having focally obstructive CAD increases in parallel to the coronary artery calcium score 4. 
Non-invasive	coronary	angiography
Magnetic resonance imaging. With the first generation of MR coronary angiography techniques, 
only one 2D image was acquired per breath-hold, requiring a substantial number of consecutive 
breath-holds. Accordingly, the clinical applicability was limited 5. Superior image quality was 
achieved by 3D imaging, while real-time monitoring of diaphragm motion (respiratory navigator-
gating) has enabled data acquisition during free breathing. A pooled analysis of 28 studies (n=903 
patients) comparing MRI with invasive angiography as the standard demonstrated a weighted mean 
sensitivity of 72% with a specificity of 87% 6. However, the individual studies show a wide variation 
in diagnostic accuracy and only 1 multi-center study has been reported thus far 7. In addition, MRI 
techniques are still hampered by the relatively long acquisition times, and a substantial percentage 
of segments remains uninterpretable (Figure 2). Improvement of image quality and diagnostic 
accuracy is anticipated with the introduction of 3Tesla systems and newer acquisition protocols, 
including balanced steady-state-free-precession techniques and the improvement of blood pool 
contrast agents. 
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Figure 2. Diagnostic accuracies of the different non-invasive coronary angiography techniques, based on 
references 6;8.
Electron beam computed tomography. During EBCT, X-rays are created through an electron beam 
that is guided along a 210° tungsten target ring in the gantry. As a result, images are acquired with 
high temporal resolution (50-100 ms, depending on the scanner mode used). The acquisition of 
serial overlapping cross-sectional images with a 1.5 or 3.0 mm slice thickness is performed using 
prospective ECG triggering. To cover the whole heart, 40 to 50 slices are necessary, typically requiring 
a breath-hold of 30 to 40 seconds, depending on the heart rate.
A recently published pooled analysis of 10 studies with a total of 538 patients showed a weighted mean 
sensitivity and specificity of 87% and 91% to detect CAD with EBCT as compared to invasive angiography 
(Figure 2) 8. High percentages of uninterpretable segments were consistently observed, with exclusion 
of approximately 20% of segments from analysis. Another major limitation is the presence of extensive 
coronary calcifications that interfere with stenosis assessment and lead to overestimation of the degree 
of luminal narrowing. Motion artifacts also frequently occur, since prospective triggering is used, which 
does not allow reconstruction of data at other phases of the cardiac cycle. Consequently, EBCT is felt to 
be not yet robust enough to justify its implementation in clinical routine.
Multi-slice computed tomography. In the late 1990s, MSCT systems were introduced allowing 
the acquisition of multiple (4) slices instead of 1 slice in a single gantry rotation, thereby enabling 
CT systems to visualize the coronary arteries. Similar to EBCT, administration of iodinated contrast 
agent is needed. The initial results with the 4-slice systems were promising, although 20% of 
coronary segments had to be excluded from analysis due to non-diagnostic quality 6. Substantial 
improvement was achieved by the introduction of 16-slice scanners with submillimeter collimation 
as well as faster rotation times. At present, 11 studies (681 patients) have reported on the accuracy 
of 16-slice MSCT in comparison to conventional coronary angiography 6. On average, an increase in 
sensitivity from 80% (4-slice systems) to 88% (16-slice systems) was noted, with no loss in specificity. 
Furthermore, more complete coverage of the coronary tree was achieved, with an average of 96% 
of coronary segments showing sufficient image quality to allow interpretation. Overall diagnostic 
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accuracy and percentage interpretable segments with MSCT are depicted in Figure 2. In general, the 
specificity of MSCT is extremely high, suggesting that accurate exclusion of CAD can be achieved. 
However, no large studies have targeted low prevalence patient groups thus far. Further refinement 
of the technique may be achieved with the recently introduced 64-slice systems, of which an 
example is provided in Figure 3. Despite these encouraging results the technique has still several 
limitations. The radiation exposure during MSCT examination is in the range of 9-12 mSv, and 
refinements of imaging protocols are warranted to lower the radiation exposure. In addition, the 
reported results depend largely on patient selection, with a substantially lower accuracy in patients 
with higher heart rates or arrhythmias due to motion artifacts 9. To circumvent this problem, routine 
administration of beta-blocking medication is currently performed in many centers. Image quality 
may also be degraded in patients with severe CAD due to the presence of extensive calcifications 
which potentially limit precise assessment of the stenosis severity 10. 
Figure 3. Example of non-invasive coronary angiography with 64-slice MSCT. In Panel A, a curved multiplanar 
reconstruction of the right coronary artery with stent placement is shown. No significant stenoses are observed. 
In Panel B, a 3D volume-rendered reconstruction is depicted, showing the right coronary artery and its side-
branches. Findings were confirmed by invasive coronary angiography (Panel C).
However, whether elevated calcium scores should be used as an indication to defer MSCT coronary 
angiography remains debatable with recent research suggesting unaffected diagnostic accuracy 
even in the presence of high coronary calcification scores 11. Accordingly, further investigations 
are needed to determine which patient groups may ultimately benefit the most from non-invasive 
coronary angiography with MSCT 12.
Detection of ischemia
In the presence of a flow-limiting stenosis, resting myocardial blood flow is still preserved, whereas 
increased myocardial oxygen demand will result in a demand/supply mismatch, leading to inducible 
myocardial ischemia. As a result, a sequence of events is initiated, which is referred to as the ischemic 
cascade 13. Perfusion abnormalities are induced at an early stage, followed by diastolic and systolic 
left ventricular (LV) dysfunction. ECG changes and angina only occur at the end of the cascade. 
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Various imaging modalities are available to demonstrate these early changes during ischemia, 
including (gated) SPECT or PET, (contrast) stress echocardiography and MRI; local availability and 
expertise mainly determine which technique is used. Stress can be achieved using physical (bicycle 
or treadmill) exercise, or pharmacological stress (using dobutamine or vasodilators including 
dipyridamole and adenosine).
Nuclear	imaging	techniques
Single photon emission computed tomography. The most widely available nuclear technique to 
assess myocardial perfusion is SPECT using thallium-201, technetium-99m sestamibi or technetium-
99m tetrofosmin. Average sensitivity and specificity, based on a pooled analysis of 79 studies with 
8964 patients included, are 86% and 74%, respectively 14. Although the technique is very sensitive, as 
perfusion abnormalities occur early in the ischemic cascade, specificity is lower, as shown in Figure 
4. This may (in part) be related to post-test referral bias, meaning that patients with normal studies 
will only be referred for coronary angiography when the suspicion for CAD is high. Since the majority 
of true negative patients will not be referred, a relatively high false positive rate will be obtained, 
resulting in a lower specificity. To circumvent this problem, the normalcy rate is used, which indicates 
the frequency of normal test results in patients with a low to intermediate likelihood of CAD. In a 
pooled analysis of 10 SPECT studies (n=543 patients) the normalcy rate was 89% 14. 
Figure 4. Diagnostic accuracy of nuclear imaging techniques to detect significant CAD (Data based on 
references 14;15).
Another frequently encountered cause of reduced specificity is the occurrence of artefacts due to soft 
tissue attenuation that are mistaken for true perfusion defects. For this purpose, dedicated hardware 
and software have been developed that allow direct reconstruction of attenuation corrected images 
based on measurements of the attenuation distribution profile 16. In addition, the use of ECG gated 
imaging, which has allowed simultaneous assessment of LV function, has led to further improvement 
of the diagnostic accuracy of SPECT. By identifying normal wall motion in segments with artifacts 
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due to soft tissue attenuation, a substantial reduction in the number of false-positive test results 
can potentially be achieved 17. Indeed, Smanio et al demonstrated an increase in normalcy rate from 
74% to 93%, while the number of inconclusive tests decreased from 31% to 10% through addition of 
systolic function data to the original perfusion data 18.
Positron emission tomography. The main advantages of PET over SPECT are the systematic use 
of attenuation correction and the feasibility to perform absolute quantification of perfusion (ml/
min/g). Nitrogen-13 ammonia, rubidium-82 and Oxygen-15 labeled water are the most commonly 
used tracers. Pooled analysis of 7 studies (1 study using nitrogen-13 ammonia, 4 with rubidium-82 
and 2 using both) including 663 patients revealed a sensitivity and specificity of 89% and 86% to 
detect CAD (Figure 4) 15. In addition to the higher specificity as compared to SPECT, another potential 
advantage of PET is the high spatial resolution that allows distinction between epi- and endocardial 
perfusion in some cases 19. In addition, PET is the only technique that permits absolute quantification 
of resting and hyperemic blood flow, thereby allowing quantification of coronary flow reserve (CFR). 
This is of particular importance, since even in the absence of obstructive coronary artery disease, 
endothelial dysfunction that is associated with early atherosclerosis can be assessed by measuring 
CFR. Indeed, evidence is accumulating that in the presence of risk factors for CAD, including 
hypercholesterolemia, hypertension, diabetes mellitus and smoking, abnormal endothelial function 
is precedes clinically overt atherosclerotic changes in the epicardial coronary arteries 20-25. In addition, 
microvascular disease can be assessed by quantitative measurements of blood flow and CFR using 
PET. 
Thus, PET can be used to measure early atherosclerotic disease activity and resultant damage in 
patients with elevated risk profiles. Moreover, these measurements also permit monitoring response 
to different therapeutic strategies, including pharmacotherapy and life-style modification 26-28. 
Echocardiography
Stress echocardiography. The hallmark of myocardial ischemia during stress echocardiography 
is the induction of reduced systolic wall thickening. Pooled analysis of 43 available studies on the 
diagnostic accuracy of exercise echocardiography (15 studies, n=1849 patients) showed a weighted 
mean sensitivity of 84% and specificity of 82% and 80% and 84% for dobutamine echocardiography 
(28 studies, n=2246 patients) (Figure 5) 29. 
Contrast echocardiography. Limitations of stress echocardiography include suboptimal image 
quality (due to poor acoustic window or drop-out of the anterior and lateral wall) in 10-15% of 
patients, the operator dependency and reduced reproducibility. Second harmonic imaging as well as 
the use of intravenous contrast agents improve image quality. In addition, contrast echocardiography 
allows assessment of myocardial perfusion. The diagnostic value of stress echocardiography is 
enhanced by integration of perfusion and systolic wall motion abnormalities. Pooled analysis of the 
available studies (7 reports, n=245 patients) demonstrated a weighted mean sensitivity of 89% and a 
specificity of 63% (Figure 5) 30-36. Thus, specificity of contrast echocardiography is reduced, which may 
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(partially) be attributable to the still limited experience with image interpretation and optimization 
of data acquisition 31;32. Furthermore, a considerable variation exists among the available studies 
in both acquisition protocols and stressors. Consequently, no definite conclusions on the precise 
diagnostic accuracy of contrast echocardiography can currently be drawn.
Magnetic	resonance	imaging
Myocardial perfusion is evaluated by injecting a bolus of contrast agent followed by continuous data 
acquisition as the contrast passes through the cardiac chambers and into the myocardium. Relative 
perfusion deficits are recognized as regions of low signal intensity within the myocardium. Due to the 
high spatial resolution of MRI, the technique is, even better than PET imaging, capable of differentiation 
between subendocardial and transmural perfusion defects. At present, weighted mean sensitivity and 
specificity, derived from 17 reports with 502 patients are 84% and 85% (Figure 6) 29;37-39.
In addition to myocardial perfusion, global and regional systolic LV function can be assessed with 
high accuracy with MRI as well. Pooled analysis of 10 studies (n=654 patients) yielded a weighted 
mean sensitivity and specificity of 89% and 84% to detect CAD (Figure 6) 29;37. 
Figure 6. Diagnostic accuracy of perfusion and wall motion imaging MRI (Data are based on references 29;37-39).
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Figure 5. Diagnostic accuracy of stress-echocardiography (Data based on reference 29).
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Prognosis of coronary artery disease
Besides diagnosis of CAD, non-invasive imaging also provides prognostic information. For this 
purpose, patients are generally classified in 3 categories. Patients are considered at low risk when 
the cardiac mortality rate per year is less than 1%, whereas patients are considered at high risk when 
cardiac mortality exceeds 3% per year. Patients with an annual mortality rate between 1% and 3% 
are classified at intermediate risk. 
Patients with low to intermediate risk may benefit from aggressive risk factor modification, whereas 
invasive evaluation followed by intervention should be considered in patients with high risk.
Prognostic value of atherosclerosis
Extensive data are available on risk stratification by assessment of coronary artery calcium using EBCT. 
Since the presence of calcium in the coronary arteries is indicative for the presence of atherosclerosis, 
prognostic information can be derived from the total coronary calcium burden. However, much 
controversy still exists to the question whether coronary artery calcium scoring can provide prognostic 
information that is incremental to conventional cardiac risk assessment, as based on the Framingham 
model or the EuroSCORE. To address this issue, a meta-analysis of studies performing follow-up of 
asymptomatic individuals after EBCT calcium measurement was recently performed. Only studies that 
provided score-specific relative risks, adjusted for established risk factors, were included, resulting in 
analysis of 4 studies with a total of 3970 patients included 40. For calcium scores in the range of 1 to 100, 
a summary adjusted relative risk of 2.1% was observed. Higher relative risk estimates were obtained 
for higher calcium scores, ranging from 3.0 to 17.0 for calcium scores higher than 400, demonstrating 
that coronary artery calcium score indeed provides prognostic information incremental to risk factors. 
These findings were further confirmed by Shaw et al, who performed a 5-year follow-up study of a 
large cohort of 10.377 asymptomatic individuals after coronary artery calcium scoring with EBCT 41. 
Figure 7. Prognostic value of coronary artery calcium scoring with EBCT. Data have been obtained over a 5-year 
follow-up period in 10.377 asymptomatic individuals with risk factors for CAD (Data based on reference 41). 
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As depicted in Figure 7, patients with minimal or no calcium had an excellent survival with a 
mortality rate of 1%, whereas mortality increased to 12.3% for patients with a score >1000. In a risk-
adjusted model of mortality, it was demonstrated that the coronary artery calcium score was indeed 
a strong and independent predictor of all cause mortality. In fact, the authors showed that for 
various Framingham risk subsets, coronary artery calcium score could provide superior prediction 
of death, with 5-year mortality rates increasing from 1.1% for scores <10 to 9.0% for scores >1000 
in patients at an intermediate risk. Even in low-risk patients, coronary artery calcium score could 
provide refinement of risk stratification, with mortality rates increasing for 0.9% to 3.9% similar to 
above. Accordingly, coronary artery calcium screening may be used to identify those patients in 
whom aggressive risk reduction is needed, although the precise threshold of calcium value above 
which intervention is warranted is still unclear due to the wide inter-study variation. 
In addition to risk stratification, measurements of coronary calcium may also be used to monitor 
anti-atherosclerotic effect of medical therapy. Callister et al performed both baseline and follow-up 
assessment after a minimum of 12 months in 149 patients without previously known CAD, referred 
for screening with EBCT 42. In 105 patients lipid-lowering treatment was started at the discretion of the 
referring physician. In all patients, serial measurements of low-density lipoprotein (LDL) cholesterol 
were obtained in order to relate LDL levels to changes in calcium scores. In the untreated population, 
as well as in patients with LDL-levels still higher than 120 mg/dl despite medical treatment, increase 
in mean calcium-volume scores of respectively +52 ± 36% and +25 ± 22% (P<0.001) were observed. 
However, in patients that did respond to medical treatment, as reflected by LDL levels lower than 
120 mg/dl, a slight decrease in calcium volumes was observed (-7 ± 23%, P=0.01). These findings 
suggest that EBCT calcium assessment may also allow non-invasive monitoring of response to 
medical therapy. 
In contrast to EBCT calcium scanning, non-invasive angiography with either MRI or CT techniques is 
relatively new and the prognostic value of these techniques has not been established yet.
Prognostic value of ischemia
Numerous studies have ascertained the relation between the presence of stress-inducible ischemia 
and prognosis. Since both the induction of perfusion defects as well as wall motion abnormalities 
are indicative of ischemia, all techniques that assess these phenomena can theoretically be used for 
prognostification. Indeed, a large body of evidence has been obtained with particularly both nuclear 
techniques and echocardiography and risk stratification has become an integral part of these tests. 
Similarly, also MRI is likely to allow prognostification in addition to the diagnosis of CAD, although 
thus far, limited data are available. 
Nuclear	techniques
Single photon emission computed tomography. Of all studies dedicated to the assessment of 
prognosis in patients with suspected or known CAD, the vast majority have used SPECT. Recently, 
a meta-analysis of 31 papers comprising 69.655 patients on the prognostic value of SPECT was 
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published 43. A normal SPECT study was associated with an average hard event rate (cardiac death or 
myocardial infarction) of 0.85% per year, which is comparable to event rates in the general population 
without any evidence of CAD. In contrast, the hard event rate was 5.9% per year in patients with a 
moderately-severely abnormal SPECT study. In Figure 8, average annual event rates for normal and 
abnormal SPECT studies, obtained with either exercise or pharmacological stress are shown. From 
these data, it can be observed that studies using pharmacological stress show event rates that are 
slightly higher both in normal and abnormal studies, as compared to exercise testing. Accordingly, 
a difference in baseline characteristics and thus risk for cardiac events may exist between patients 
selected for pharmacological stress testing and those who can perform an exercise protocol. 
Moreover, exercise capacity itself has been shown to be a strong predictor of death 44 and is thus 
likely to influence event rates observed after stress testing. This observation was recently confirmed 
by Navare and colleagues 45 who performed a meta-analysis of 24 studies evaluating prognosis with 
either pharmacological or exercise stress SPECT comprising 14.918 patients. Although based on the 
similarity of the obtained odds ratios and ROC curves risk stratification was shown to be comparable 
between both techniques, high event rates were observed with pharmacological stress. Indeed, 
comparison of demographics revealed that patients selected for this type of stress were in general 
older, and had a higher prevalence of other factors of poor prognosis, including type 2 diabetes 
mellitus or previous myocardial infarction. 
Figure 8. Prognostic value of SPECT, obtained in 69655 patients. Numbers between parentheses are number of 
patients included (Data are based on reference 43).
Accordingly, these findings underline the relevance of the type of stress used as well as the individual 
patient’s characteristics when interpreting the prognostic significance of a functional imaging 
study.
It is well known that LV function (LV ejection fraction) and LV volumes also provide powerful 
prognostic information 46;47. With the introduction of gated SPECT, it became possible to integrate 
information on perfusion and function. Sharir et al were the first to demonstrate the strong 
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prognostic power of gated SPECT when perfusion and function data were integrated in 2.686 
patients with a mean follow-up of 21 ± 4.6 months 47. After adjustment for clinical information, the 
amount of perfusion defect reversibility was demonstrated to be the strongest predictor for non-
fatal myocardial infarction, whereas cardiac death was best predicted by post-stress left ventricular 
ejection fraction. This observation is of interest and supports the idea that ischemic events (e.g. 
infarction) are best predicted by the extent of reversible perfusion abnormalities, whereas the 
extent of scar tissue as reflected in the severity of reduction in LVEF is most predictive of cardiac 
death. Recent data suggest that further refinement of risk stratification can be achieved using end-
diastolic and end-systolic volume measures in addition to LVEF 48. Also, the observation of transient 
ischemic dilatation during stress has been shown to be associated with worse prognosis, even in the 
presence of normal myocardial perfusion 49. Particularly in such settings, when perfusion is normal 
or near-normal, these ancillary findings can have important implications for prognosis that would 
have been deemed to be excellent on the basis of the perfusion data only. 
Accordingly, functional imaging with SPECT has become an established modality in the identification 
of patients at elevated risk and who may benefit from more aggressive medical therapy or 
revascularization. 
Positron emission tomography. Currently, minimal data are available on the prognostic value of 
PET. Marwick et al evaluated the prognostic value of rubidium-82 PET in 685 patients with suspected or 
known CAD after a mean follow-up of 41 months 50. Mortality rate was significantly less in patients with 
a normal PET study (0.9%) as compared to patients with an abnormal study (4.3%). When all events, 
including also myocardial infarction, unstable angina and late (>3 months after the initial PET study) 
revascularization, were taken into account, a normal examination was associated with a 90% event-
free survival, whereas event-free survival in patients with small, moderate and extensive abnormalities 
were 87%, 75% and 76% respectively. Based on Cox proportional-hazards models, the PET results were 
demonstrated to be incremental to those of clinical and angiographic evaluation. Accordingly, PET may 
be a valuable alternative for prognostification, particularly in patients that are technically challenging 
to image with SPECT, such as obese patients or with extensive previous infarction. 
Echocardiography
Besides SPECT, stress echocardiography is often used for risk stratification in patients with suspected 
or known CAD. Similar to SPECT, it has been shown that a negative stress echocardiogram is associated 
with an excellent prognosis allowing identification of patients at low risk 51. Pooled analysis of 13 
stress echocardiography studies with 32.739 patients included, revealed an annual hard event rate 
(death or myocardial infarction) of 1.2% for a normal stress echocardiogram as compared to 7.0% for 
an abnormal study 52-64. In Figure 9, annual event rates for normal and abnormal studies are depicted 
for stress echocardiography according to the different stressors used. Although the emerging use of 
simultaneous assessment of myocardial perfusion by means of contrast administration is likely to 
enhance the prognostic value of stress echocardiography, no data are currently available to support 
this notion.
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Figure 9. Annual event rates (death or myocardial infarction) of normal and abnormal stress echocardiograms, 
obtained by pooled analysis of 13 studies with 32739 patients. Numbers between parentheses are number of 
patients included. For the individual analyses of either exercise or dobutamine stress only studies specifically 
stating the use of either exercise or dobutamine stress were included, while studies performing different stress 
protocols interchangeably during the study protocol were disregarded. However, these studies were included in 
the combined analysis of all available studies. (Data based on references 52-64).
Magnetic	resonance	imaging
Currently, only limited data on the value of MRI for prognosis in CAD are available. No prognostic 
data on MRI perfusion assessment are available, and only one study has evaluated the prognostic 
value of MRI wall motion assessment for prognostification. Hundley and colleagues performed 
stress-rest MRI and focused on systolic wall motion. The study comprised 279 patients who were 
referred for MRI because of poor LV endocardial border delineation on echocardiography 65. 
Patients were categorized according to the presence, extent, and location of inducible wall motion 
abnormalities during dobutamine/atropine administration and according to the LVEF being <40% 
or ≥40%. Over a mean follow-up period of 20 months, the annual hard event rate, defined as the 
occurrence of cardiac death or myocardial infarction, was 2% in the patients preserved LVEF (≥40%) 
without ischemia. Conversely, the annual hard event rate was 13% in the patients with depressed 
LVEF (<40%), regardless of the presence of ischemia. In patients with a LVEF ≥40% and evidence of 
inducible ischemia the annual hard event rate was 10.6%. These data illustrate the potential role of 
MRI for prognosis in patients with suspected or known CAD, but larger studies are needed.
Summary and Future Perspectives
With the increasing number of patients referred for evaluation of the presence and extent of CAD, 
non-invasive imaging techniques have become very important in the clinical patient management. 
Initially, the available techniques relied on visualization of ischemia using myocardial perfusion (with 
nuclear imaging techniques) or systolic wall motion (with echocardiography). With recent technical 
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developments, both nuclear imaging and echocardiography currently allow assessment of both 
perfusion and systolic function, thereby enhancing their diagnostic accuracy. Similarly, MRI can also 
provide integrated assessment of perfusion and systolic wall motion, with a comparable accuracy 
to SPECT and echocardiography. In addition to the diagnosis of CAD, SPECT and echocardiography 
have been used extensively for risk stratification.
Besides the evaluation of ischemia with the established non-invasive imaging techniques, the 
assessment of coronary artery calcium with CT techniques, and even non-invasive angiography 
with MSCT and MRI is shifting the emphasis from ischemia detection to assessment of preclinical 
atherosclerosis and coronary anatomy. Although these techniques appear very accurate for 
exclusion of atherosclerosis, it is currently unclear what the clinical value is when these examinations 
demonstrate atherosclerosis. The following case report is presented to illustrate this dilemma.
A 54-year old man presented to the outpatient clinic with atypical chest pain, smoking and 
hypercholesterolemia. The patient was referred for further evaluation using gated SPECT and non-
invasive angiography using MSCT. The SPECT study was performed using bicycle exercise; blood 
pressure and heart rate response were normal, exercise capacity was adequate, the exercise ECG 
Figure 10.  Non-invasive imaging in a 54-year old man with suspected CAD.  SPECT perfusion imaging demon-
strated normal myocardial perfusion in all territories (Panel A). MSCT coronary angiography was also performed 
(Panel B). From the left to the right, curved multiplanar reconstructions are shown of the right coronary artery 
(RCA), left circumflex (LCx) and left anterior descending coronary artery (LAD). Only minor wall irregularities were 
observed in the RCA and LCx. In the LAD however, a proximal extensive calcified lesion (arrow head) and various 
non-calcified plaques (arrows) were observed. 
Abbreviations: LAD: left anterior descending coronary artery, LCx: left circumflex coronary artery, RCA: right coronary 
artery, SA: short-axis, VLA: vertical long-axis.
stressSA, 
stress
SA,
rest
VLA, 
stress
VLA, 
rest
A
B
RCA LCx LAD
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did not show ischemia and angina was not reported. The LVEF on the gated images was 63%, LV 
volumes were normal. No perfusion abnormalities were observed during SPECT imaging, as shown 
in Figure 10A. In Figure 10B, the results of the MSCT study are shown. Only minor wall irregularities 
were observed in the right and left circumflex coronary artery. The left anterior descending coronary 
artery however, showed a significant calcified lesion and various non-calcified plaques in the 
proximal and mid part of the vessel.
Patient with Atypical Angina + Risk Factors 
Calcium/MSCT - CA 
Normal Atherosclerosis 
Functional Imaging 
Safe Discharge 
Invasive coronary  
angiography  and  
revascularization if  
required 
Ischemia No  Ischemia 
Medical Therapy  and  
Aggressive Risk Factor  
Modification 
Figure 11. Flow-chart for patients presenting with an intermediate likelihood of CAD in which MSCT (calcium 
scoring and coronary angiography) is used as a first-line evaluation tool. Patients with normal coronary arteries 
can be discharged safely. If atherosclerosis is observed however, patients are referred for functional imaging to 
determine the presence of ischemia. Consequently, patients with inducible ischemia are then referred for inva-
sive coronary angiography, potentially followed by revascularization. If no ischemia is demonstrated, patients 
can be managed with medical therapy and aggressive life-style and risk factor modification. 
209Diagnostic and Prognostic Value of Non-Invasive Imaging in Known or Suspected Coronary Artery Disease
These findings now raise the question how this patient should be further treated. Should coronary 
angiography be performed (with potential intervention) based on the lesions visualized on MSCT or 
should aggressive medical therapy and risk factor modification be proposed based on the absence 
of ischemia on the SPECT study? 
Accordingly, algorithms are needed on when to use which of the 2 main categories of non-invasive 
imaging: ischemia detection and atherosclerosis imaging. A potential algorithm is proposed in Figure 11.
First, imaging should mainly be applied to patients with an intermediate likelihood of CAD. In 
these patients, who present with either atypical angina or who are even asymptomatic but have 
an elevated risk profile due to the presence of coronary risk factors (e.g. type 2 diabetes mellitus), 
a first step could be to assess coronary artery calcium or non-invasive angiography. In the absence 
of coronary atherosclerosis, further imaging may not be needed and the patient can be reassured. 
In the presence of atherosclerosis, assessment of ischemia is needed. When ischemia is absent, risk 
factor modification and aggressive medical therapy is indicated. When ischemia is present, invasive 
evaluation (and potential intervention) should follow. The required information can be gathered by 
sequential testing using CT technology (to assess atherosclerosis/anatomy) and a technique that 
allows assessment of ischemia (i.e. SPECT, PET, echo or MRI), or integrated imaging, which is possible 
with PET-CT (or maybe in the near future with SPECT-CT). 
Indeed, hybrid or dual-modality imaging offers the promising prospect of co-registration of 
anatomic landmarks with physiological data. Since the CT images can be used for attenuation 
correction, both efficiency and image quality of PET data acquisition is likely to improve, thereby 
enhancing its diagnostic accuracy while reducing data acquisition time substantially. On the other 
hand, incremental information will be added to the MSCT examination, since PET will provide data 
on the pathophysiological impact of the detected lesions, which is needed to determine treatment 
strategy. Accordingly, the simultaneous assessment of coronary lesions and their pathophysiological 
impact is likely to enhance diagnostic certainty and optimize clinical decision-making, as recently 
demonstrated by Namdar et al 66. From a practical point of view however, incorporation of CT with 
SPECT systems may be preferable in daily clinical routine, and fusion of these two modalities is 
currently under development.  
In conclusion, non-invasive imaging is a powerful tool in the diagnostic and prognostic work-up of 
patients with suspected or known CAD. Integration and fusion of imaging technologies will be the 
future in management of patients, with a focus on integration of information on atherosclerosis and 
ischemia.   
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Abstract
Background
Multi-slice computed tomography (MSCT) detects atherosclerosis, whereas myocardial per-
fusion imaging (MPI) detects ischemia; how these 2 techniques compare in patients with an 
intermediate likelihood of CAD is unknown. Aim of the study was to perform a head-to-head 
comparison between MSCT and MPI in patients with an intermediate likelihood of coronary 
artery disease (CAD), and to compare non-invasive findings to invasive coronary angiography.
Methods 
114 patients, mainly with intermediate likelihood of CAD, underwent both MSCT and MPI. 
MSCT studies were classified as having no CAD, non-obstructive (<50% luminal narrowing) 
CAD or obstructive CAD. MPI examinations were classified as showing normal or abnormal 
(reversible and/or fixed defects). In a subset of 58 patients, invasive coronary angiography was 
performed. 
Results
Based on the MSCT data, 41 (36%) patients were classified as having no CAD, of which 90% 
had normal MPI. A total of 33 (29%) patients showed non-obstructive CAD, whereas at least 
1 significant (≥50% luminal narrowing) lesion was observed in the remaining 40 (35%) pa-
tients. Only 45% of patients with an abnormal MSCT had abnormal MPI; even in patients with 
obstructive CAD on MSCT, 50% still had a normal MPI. In the subset of patients undergoing 
invasive angiography, the agreement with MSCT was excellent (90%).
Conclusions 
MPI and MSCT provide different and complementary information on CAD, namely detection 
of atherosclerosis versus detection of ischemia. As compared to invasive angiography, MSCT 
has a high accuracy for detecting CAD in patients with an intermediate likelihood of CAD.
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Introduction
In the evaluation of patients with suspected coronary artery disease (CAD), the role of non-invasive 
imaging has increased exponentially over the past decades. Particularly in patients with an interme-
diate pre-test likelihood of CAD, non-invasive imaging plays an important role in risk stratification 
and selection of further treatment strategies. Traditionally, the detection of CAD by non-invasive im-
aging was based on assessment of the hemodynamic significance of the stenoses through visualiza-
tion of inducible ischemia. For this purpose, myocardial perfusion imaging (MPI) with gated single 
photon emission computed tomography (SPECT) has been used extensively 1. 
More recently, multi-slice computed tomography (MSCT) has been proposed as an alternative imag-
ing modality for evaluation of patients with suspected CAD. With the recently introduced 64-slice 
MSCT, high sensitivity and specificity for the detection of significant (≥50% luminal narrowing) ste-
noses have been reported 2-7. However, since MSCT visualizes coronary artery stenoses directly rather 
than the hemodynamic significance of the lesions, it is important to recognize that, unlike MPI, the 
technique identifies atherosclerosis rather than ischemia. 
Thus far, data regarding the diagnostic accuracy of MSCT have been obtained in populations under-
going invasive coronary angiography because of a high likelihood of CAD. In contrast, its value in pa-
tients with a lower likelihood of CAD remains to be established, despite the fact that this population 
represents the target population for non-invasive diagnostic imaging. Moreover, the relative merits 
MPI and MSCT in patients with an intermediate likelihood of CAD remain to be established. Accord-
ingly, the aim of the present study was to perform a head-to-head comparison between MSCT and 
MPI in patients with mainly an intermediate likelihood of CAD, including women. In addition, the 
non-invasive findings were compared to invasive coronary angiography in a subset of patients. 
Methods 
Patients and Study protocol
The study group consisted of 114 consecutive patients who presented to the outpatient clinic (Leiden, 
the Netherlands and Aalst, Belgium) for the evaluation of chest pain without history of CAD in whom non-
invasive imaging with gated SPECT was clinically indicated. In addition to MPI, patients underwent non-
invasive coronary angiography with MSCT within one month. Exclusion criteria were  1) known allergy 
to iodinated contrast agent, 2) renal insufficiency (serum creatinine >120 mmol/L), 3) atrial fibrillation, 4) 
pregnancy, and 5) known CAD, defined as history of myocardial infarction or coronary revascularization 
and/or presence of one or more angiographically documented coronary stenosis ≥50% luminal diameter 
8;9. For each patient, the baseline clinical characteristics (type of symptoms and risk factors) were recorded 
10. Pre-test likelihood of CAD was determined according to the Diamond and Forrester method using per-
cent cut-offs of <13.4%, >87.2% and in-between for respectively low, high and intermediate pre-test like-
lihood 11. The study protocol was approved by the ethics committee and informed consent was obtained. 
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MSCT coronary angiography
In the first 28 patients, data acquisition was performed using a 16-slice MSCT scanner (Aquilion 16, 
Toshiba Medical Systems, Japan) with a collimation of 16 x 0.5 as previously described 9. In the re-
maining 86 patients, imaging was performed using a 64-slice MSCT scanner (Aquilion 64, Toshiba 
Medical Systems, Japan or Sensation 64, Siemens, Germany). Accordingly, data were acquired with 
a collimation of either 64 x 0.5 mm or 32 x 2 x 0.6 mm and a tube rotation time of 400 or 330 ms, 
respectively. For the Aquilion 64, the tube current was 300 mA at 120 kV for patients with normal 
posture. In case of patients with higher body mass indexes, tube current was increased to 350 or 400 
mA at 135 kV. For the Siemens 64, tube currents up to 550 ms at 120 kV were available. During 16-
slice MSCT, non-ionic contrast material was administered in the antecubital vein with an amount of 
130 to 140 ml, depending on the total scan time, and a flow rate of 4 ml/sec (Xenetix 300 ®) followed 
by a saline flush. Similarly, for 64-slice MSCT, 80 to 110 ml, again depending on the total scan time, 
was administered with a flow rate of 5 ml/sec (Iomeron 400 ®) resulting in comparable contrast doses 
for 16- and 64-slice MSCT. Subsequently, data sets were reconstructed and transferred to a remote 
workstation as previously described 9. Briefly, images were initially reconstructed at 75% of the car-
diac cycle. In case of motion artefacts, a representative single slice was reconstructed throughout 
the cardiac cycle in steps of 20 ms to determine the most optimal additional reconstruction phases. 
MSCT examinations were evaluated on a patient level and vessel level by an experienced operator 
blinded to the gated MPI data for the presence of significant (≥50% luminal narrowing) stenoses. For 
this purpose, both the original axial dataset as well as curved multiplanar reconstructions were used. 
The MSCT studies, or coronary arteries, without significant or obstructive stenoses were further clas-
sified as completely normal or as having non-obstructive CAD, when atherosclerotic lesions <50% of 
luminal diameter were present.
 
Stress-rest gated myocardial perfusion imaging
In all patients, stress-rest MPI (using either technetium-99m tetrofosmin or technetium-99m sestamibi) 
was performed with symptom-limited bicycle exercise or pharmacological (dipyridamole, adenosine 
or dobutamine) stress 12. Data were acquired with either a dual-head SPECT camera (Vertex Epic ADAC 
Pegasus, n=27) or a triple-head SPECT camera (GCA 9300/HG, Toshiba Corp., Tokyo, Japan, n=87) fol-
lowed by reconstruction into long- and short-axis projections perpendicular to the heart-axis; data 
were presented in polar map format (normalized to 100%), and a 17-segment model was used in which 
myocardial segments were allocated to the territories of the different coronary arteries as previously 
described 13;14. Perfusion defects were identified on the stress images (segmental tracer activity less than 
75% of maximum) and divided into ischemia (reversible defects, with ≥10% increase in tracer uptake 
on the resting images) or scar tissue (irreversible defects). Accordingly, examinations were classified as 
being either normal or abnormal, the latter being further divided in those demonstrating reversible 
defects and those demonstrating irreversible defects. The gated images were used to assess regional 
wall motion to improve differentiation between perfusion abnormalities and attenuation artifacts 15.
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Conventional coronary angiography
A total of 58 patients were referred for conventional coronary angiography based on clinical presen-
tation and/or imaging findings at the discretion of the referring cardiologist. Conventional coronary 
angiography was performed according to standard clinical protocols. Coronary angiograms were 
evaluated by two experienced observers blinded to the MSCT data using the same classification as 
used for the MSCT studies (normal, significant stenoses defined as ≥50% luminal narrowing or non-
obstructive atherosclerosis). 
Statistical analysis
Continuous variables were described by mean ± SD. Comparisons between patient groups were 
performed using 1-way ANOVA for continuous variables and the Chi-Square test with Yates’ correc-
tion for categorical variables. A P-value <0.05 was considered statistically significant.
Results
Patient characteristics
In total 114 patients (64 male, 50 female, average age 60 ± 11 years) were enrolled and underwent 
both MSCT and stress-rest gated SPECT within 1 month of each other. Patient characteristics are 
Table 1. Clinical characteristics of the study population (n=114).
n (%)
Gender (M/F) 64/50
Age (years) 60 ± 11
Risk factors for CAD       
        Diabetes Mellitus 24 (21%)
        Hypertension 53 (46%)
        Hypercholesterolemia 53 (46%)
        Positive family history 36 (32%)        
        Current smoking 33 (29%)
        Obese (BMI ≥ 30 kg/m2) 16 (14%)
Symptoms
       Asymptomatic 10 (9%)
       Dyspnoea 1 (1%) 
       Non-anginal chest pain 5 (4%)
       Atypical angina pectoris 88 (77%)
       Typical angina pectoris 10 (9%)
Pre-test likelihood of CAD
     Low   7 (6%)
     Intermediate   97 (85%)
    High               10 (9%)
Abbreviations: BMI: body mass index, CAD: coronary artery disease.
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described in detail in Table 1. Pre-test likelihood of CAD according to Diamond and Forrester was 
low, intermediate and high in respectively 7 (6%), 97 (85%) and 10 (9%) patients. For men, these per-
centages were respectively 3%, 84%, and 13%. In women, pre-test likelihood was low in 10%, inter-
mediate in 86% and high in 4% of women. Based on clinical presentation and/or imaging results, 58 
patients (38 men, 20 women, average age 63 ± 10 years) were referred for invasive coronary angiog-
raphy. Clinical parameters of these patients are provided in Table 2. In this subset, pre-test likelihood 
of CAD was low, intermediate or high in 1 (2%), 48 (83%) and 9 (15%) of patients, respectively. 
Table 2. Clinical characteristics of patients referred for invasive angiography (n=58). 
n (%)
Gender (M/F) 38/20
Age (years) 63 ± 10
Risk factors for CAD
        Diabetes Mellitus 17 (29%)
        Hypertension 36 (62%)
        Hypercholesterolemia 34 (59%)
        Positive family history 18 (31%)
        Current smoking 23 (40%)
        Obese (BMI ≥ 30 kg/m2) 10 (17%)
Symptoms
       Asymptomatic 3 (5%)
       Dyspnea   1 (2%)
       Non-anginal chest pain 1 (2%)
       Atypical angina pectoris 44 (76%)
       Typical angina pectoris 9 (15%)
Pre-test likelihood of CAD
     Low                    1 (2%)
     Intermediate  48 (83%)
     High                  9 (15%)
Abbreviations: BMI: body mass index, CAD: coronary artery disease.
MSCT coronary angiography
Average heart rate during MSCT data acquisition was 66 ± 15 beats per minute. Based on the MSCT 
images, 41 (36%) patients were classified as having no CAD. A total of 33 (29%) patients showed non-
obstructive CAD, whereas at least one significant ≥50% luminal narrowing was observed in the re-
maining 40 (35%) patients. Analysis on a vessel basis resulted in 342 coronary arteries, of which 157 
(%) were normal. CAD was identified in the remaining 185 coronary arteries with at least 1 significant 
lesion in 62 (18%) coronary arteries.
Stress-rest gated myocardial perfusion imaging
In the majority of patients, stress was performed with symptom-limited bicycle exercise (n=72; 63%). 
In those patients, at least 85% of maximum age-predicted heart rate was achieved if no stress-in-
duced symptoms or changes in ECG or blood pressure occurred. In the remaining patients, pharma-
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cological stress was applied using adenosine (n=30; 26%), dobutamine (n=7; 7%) or dipyridamole 
(n=5; 3%). Normal myocardial perfusion in both stress and rest images was observed in 77 (68%) pa-
tients. In the remaining 37 patients, reversible and fixed defects were observed in 28 and 12 patients, 
respectively; 3 patients showed both fixed and reversible defects. On a vascular territory basis, 284 
(83%) territories showed normal myocardial perfusion, whereas reversible and fixed defects were 
observed in 38 (11%) and 20 (6%) vascular territories, respectively.
Conventional coronary angiography
Out of 58 patients undergoing invasive coronary angiography, no abnormalities were seen in 9 
(16%) patients, whereas 22 (38%) patients showed non-obstructive CAD. In the remaining 27 (47%) 
patients, at least 1 significant narrowing was detected.  
Relation between findings on MSCT angiography and myocardial perfusion 
imaging
Patient	based	analysis	
As demonstrated in Figure 1, the majority of patients with a normal MSCT study showed normal perfu-
sion on MPI (n=37, 90%). In patients with an abnormal MSCT study (with either obstructive or non-ob-
structive CAD), 40 (55%) patients had a normal MPI, whereas 33 (45%) had an abnormal MPI. 
In Figure 2, the distribution of MPI results among patients with either obstructive or non-obstructive 
CAD on MSCT is depicted. In patients with obstructive CAD on MSCT, abnormal perfusion was observed 
in 20 (50%) patients. Of these patients, respectively 7 and 15 patients showed fixed or reversible defects. 
The majority of patients (n=20, 61%) with non-obstructive CAD on MSCT had normal perfusion on MPI. 
In the remaining 13 (39%) patients, reversible defects were observed in 11 with only 2 patients showing 
fixed defects. An example of a patient with abnormal MSCT but normal MPI is provided in Figure 3.
Figure 1. Pie-charts depicting the relation between MSCT and MPI results. Of note, the MSCT abnormal popula-
tion includes both patients with non-obstructive and obstructive CAD. 
MSCT Abnormal
40, 55%
33, 45%
MPI Normal
MPI Abnormal
MSCT Normal
37, 90%
4, 10%
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Figure 2. Pie-charts depicting the relation between MSCT and MPI results. 
In a separate analysis depicted in Table 3, results were compared between data obtained with 16-
slice and 64-slice MSCT, indicating no significant differences in distribution of normal and abnormal 
MPI examinations for the different MSCT categories.
Vessel	based	analysis	
In total, 342 coronary arteries and related perfusion territories were evaluated. The majority of the 
157 normal coronary arteries on MSCT showed normal MPI as well, (n=142, 90%). Also, in 143 of 185 
(77%) vascular territories corresponding to coronary arteries with abnormal MSCT, normal perfusion 
was demonstrated. In coronary arteries showing non-obstructive CAD on MSCT, normal MPI was ob-
tained in 104 of 123 (85%) corresponding vascular territories. Finally, 24 of 62 (39%) coronary arteries 
with obstructive CAD on MSCT showed abnormal myocardial perfusion. 
Comparison of MSCT and MPI to conventional coronary angiography in 58 
patients
MSCT Obstructively diseased
20; 50%20; 50%
MPI Normal
MPI Abnormal
MSCT Non-obstructively diseased
20; 61%
13; 39%
Table 3. Comparison of 16-slice versus 64-slice MSCT.
16-slice MSCT 64-slice MSCT P-value*
MPI Abnormal/MPI Normal
MSCT Normal 2/8 2/29 NS
MSCT Non-obstructively diseased 5/3 8/17 NS
MSCT Obstructively diseased 7/3 13/17 NS
*Chi-square analysis with Yates’ correction.
The relation between findings on MSCT, MPI and conventional coronary angiography is illustrated 
in the flowcharts in Figure 4. All patients with normal MSCT (n=9) had normal coronary arteries on 
conventional coronary angiography; the majority of these patients (n=7, 78%) also had a normal 
MPI; all patients with normal MSCT, normal invasive angiography but abnormal MPI had a mild fixed 
defect suggestive of attenuation artefacts. 
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An abnormal MSCT was noted in 49 patients (with 16 non-obstructive and 33 obstructive CAD) and 
invasive coronary angiography confirmed CAD in all patients. Interestingly, only 29 (59%) patients 
had an abnormal MPI. 
Non-obstructive CAD on MSCT was observed in 16 (28%) patients, and all had non-obstructive CAD on 
invasive angiography; of note, 6 (38%) patients had a normal MPI and 10 (62%) had an abnormal MPI. 
Obstructive CAD (at least one significant stenosis) on MSCT was noted in 33 (57%) patients, with 27 
(82%) having obstructive CAD on invasive coronary angiography. An abnormal MPI was present in 16 
(59%) patients, whereas 11 (41%) patients had a normal MPI. Of interest, 2 of these patients had 3-vessel 
disease. In a separate analysis, data obtained with 16-slice MSCT were compared to 64-slice data. 
With 16-slice MSCT, 19 of 21 (90%) patients were correctly diagnosed as compared to invasive coro-
nary angiography, whereas correct diagnosis was obtained in 33 of 37 (89%) patients studied with 
64-slice MSCT (P=NS). 
Figure 3. Discrepancy between MSCT and MPI: Example of a 69-year-old male patient with an abnormal MSCT 
but no perfusion abnormalities on MPI. In Panels A, C, and D, curved multiplanar MSCT reconstructions of 
respectively the left anterior descending coronary artery, the left circumflex coronary artery and the right coro-
nary artery are provided. Panel B is an enlargement of the proximal part of the left anterior descending coro-
nary artery perpendicular to Panel A, whereas a 3D volume rendered reconstruction is provided in Panel E. In 
all 3 coronary arteries, the presence of diffuse atherosclerosis can be observed. In Panel F, however, short-axis 
(upper two rows), vertical long-axis (middle two rows) and horizontal long-axis (lower two rows) MPI images 
during exercise (first, third and fifth rows) and rest (second, fourth and sixth rows) demonstrate homogeneous 
myocardial perfusion without perfusion defects.
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Figure 4. Flow charts describing the relation between findings on MSCT, MPI and invasive coronary angiography. 
MSCT normal
n=9
MPI abnormal
n=3
MPI normal
n=6
Angio normal
n=9
MSCT non-obstructive
n=16
MPI abnormal
n=10
MPI normal
n=6
Angio non-obstructive
n=16
MSCT obstructive
n=33
MPI abnormal
n=19
MPI normal
n=14
Angio non-
obstructive
n=3
Angio
obstructive
n=11
Angio non-
obstructive
n=3
Angio
obstructive
n=16
A
B
C
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Discussion
This head-to-head comparison between non-invasive coronary angiography with MSCT and func-
tional imaging by MPI in a large population with an intermediate likelihood of CAD, reveals several 
findings. Firstly, 55% of patients with an abnormal MSCT had normal MPI, indicating that only half of 
the observed lesions on MSCT may be of hemodynamic significance. Even in patients with obstruc-
tive CAD on MSCT, 50% had a normal MPI. 
Conversely, patients with a normal MPI frequently (52%) exhibited an abnormal MSCT, indicating 
that a normal MPI does not exclude the presence of coronary atherosclerosis. In the subgroup of 
patients undergoing coronary angiography, similar results were obtained. These findings highlight 
the discrepancy between the 2 tests, namely that atherosclerosis is not synonymous to ischemia, but 
also emphasize the complementary information that both tests provide. 
Finally, this is a first attempt to apply MSCT in patients with an intermediate likelihood of CAD, in-
cluding 44% of women. The MSCT findings correlated well with invasive coronary angiography, sug-
gesting that the high accuracy of MSCT demonstrated previously in patients with a high likelihood 
of CAD also applies to patients with an intermediate likelihood of CAD. 
Obstructive CAD versus hemodynamic significance
In the current study, a normal MPI was obtained in 55% of patients with an abnormal MSCT. More-
over, 50% of patients with obstructive CAD on MSCT had a normal MPI. The findings are in line with 
preliminary results by Hacker et al 16 who compared MSCT and MPI in 25 patients with known or 
suspected CAD. These authors showed that only 8 of 17 (47%) significant stenoses on MSCT were 
associated with abnormal perfusion on MPI. 
These observations confirm that the severity of focal stenosis severity in itself is not sufficient to 
predict the hemodynamic significance of the coronary plaque burden. In our study, vessel based 
analysis shows indeed that only 39% of obstructed vessels have abnormal MPI while 15% of non 
obstructive vessels show perfusion abnormalities. In the latter situation, the additive effect of mul-
tiple mild stenoses in series eventually causes the perfusion defect 17. Similarly discrepant results 
have been reported when comparing invasive angiography with non-invasive imaging or invasive 
fractional flow reserve measurements. Salm et al 18 showed that MPI was normal in 50% of angio-
graphically significant lesions. In particular lesions with an intermediate stenosis severity (defined 
as a percent diameter stenosis between 40% and 70%) vary in hemodynamic significance 18-20. To 
some extent, these discrepancies may be attributable to imperfect allocation of perfusion defects 
to corresponding coronary arteries due to individual variations in coronary anatomy. Still, analysis 
on a vessel basis further emphasizes that only a moderate proportion of anatomically significant 
stenoses are of hemodynamic significance and result in abnormal perfusion in the corresponding 
vascular territory.
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Atherosclerosis versus MPI findings
Alternatively, CAD was completely absent in only 48% of patients with normal MPI of which 52% had 
atherosclerosis on MSCT and 26% already exhibited obstructive CAD on MSCT. Thus, a normal MPI 
does not exclude CAD and non-invasive coronary angiography with MSCT allows detection of CAD 
at a much earlier stage than MPI. The relation between atherosclerosis detected by coronary calcifi-
cations and MPI was explored recently by Berman et al 21 in 1195 patients without known CAD who 
underwent electron beam computed tomography. The authors showed a poor relation between the 
presence of atherosclerosis on electron beam computed tomography and MPI results. Similar to the 
current results, a large proportion of patients with a normal MPI had atherosclerosis according to 
coronary artery calcium scoring, indicating again that a normal MPI does not exclude the presence 
of CAD.
Clinical implications
The current observations have important clinical implications. With the introduction of MSCT and 
comparison to MPI, a paradigm-shift occurs in the definition of CAD, displacing the emphasis from 
inducible ischemia to atherosclerosis. Based on the discrepancy between MSCT and MPI, one can 
argue that MSCT could be used as the first-line test. A normal MSCT excludes CAD and the patient 
can be reassured. Alternatively, in the presence of atherosclerosis on MSCT, additional information is 
needed to define the hemodynamic significance of the observed lesions. This additional information 
could be provided by sequential MSCT and nuclear myocardial perfusion imaging using either PET 
or SPECT. Patients with an abnormal MSCT but normal MPI have CAD. In those, aggressive medical 
therapy and risk factor modification should be considered (targeted primary prevention), whereas 
patients with an abnormal MSCT and an abnormal MPI should be referred for invasive angiography 
with potential revascularization.
MSCT in patients with an intermediate likelihood of CAD
As emphasized in a recent meta-analysis 22, the available MSCT studies have been performed in pa-
tients with known CAD or a high likelihood of CAD; in particular, pooling of 24 MSCT studies revealed 
a prevalence of significant stenoses on MSCT and invasive angiography of 65%. Pooled data from six 
64-slice MSCT studies (including 363 patients) showed a sensitivity of 96% and a specificity of 92% 
to detect or exclude significant CAD 2-7. The current study was performed in patients with predomi-
nantly intermediate likelihood of CAD, yet the agreement between MSCT and invasive angiography 
remains excellent. All patients with normal MSCT had normal coronary arteries on invasive angiog-
raphy, and all patients with (obstructive or non-obstructive) CAD on MSCT had CAD on invasive an-
giography. Only 6 of 33 (18%) patients with a significant stenosis on MSCT did not have a significant 
stenosis on invasive coronary angiography by visual estimation. 
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These observations suggest that MSCT may be as accurate in patients with an intermediate like-
lihood as in patients with a high likelihood of CAD, although larger studies are clearly needed to 
confirm this finding. 
 
Limitations
In the present study, MSCT and MPI protocols were not uniform in all patients. For MSCT, scanners 
from 2 generations as well as manufacturers were used, while for MPI different tracers and stressors 
were applied. This however, reflects the daily clinical routine and confers generalized applicability to 
our observations. Also, comparison of results obtained with either 16-slice or 64-slice MSCT did not 
show any significant differences.
Conventional coronary angiography was performed in approximately half of the patients included 
in the study and stenotic segments were not analyzed by quantitative angiography. However, the 
angiography was performed as considered clinically indicated and according to standard practice. 
Finally, despite the introduction of 64-slice MSCT, the technique still suffers from several important 
limitations, including limited diagnostic accuracy in case of extensive calcifications or elevated heart 
rates. Also, combination of MSCT with MPI and (potentially) conventional coronary angiography will 
result in a considerable radiation exposure.
Conclusions
MSCT and MPI provide different information on CAD, namely atherosclerosis versus ischemia. How 
both techniques should be integrated in the clinical setting is not entirely clear yet, but the discrep-
ant results provided by the 2 techniques underscore that MSCT and MPI provide complementary 
information.
Also, our study demonstrates that MSCT may be as accurate in men and women with an intermedi-
ate likelihood of CAD as was previously reported in patients with a high likelihood of CAD. 
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Traditionally, imaging is used for the non-invasive detection of coronary artery disease (CAD) 
in patients with an intermediate likelihood of disease  1. Various imaging modalities are currently 
available for this purpose, including nuclear imaging with PET and SPECT, echocardiography and 
magnetic resonance imaging 1. These tests rely on the demonstration of stress-inducible ischemia, 
evidenced by the induction of perfusion abnormalities or systolic dysfunction, as a surrogate marker 
for CAD. Based on the location, extent and severity of ischemia, patients may be referred for invasive 
coronary angiography followed by interventional therapy 2.
Recently, this algorithm has been challenged by the introduction of non-invasive anatomical 
imaging (i.e. non-invasive coronary angiography), using multi-slice computed tomography (MSCT). 
Thus far MSCT has only been validated against the anatomical gold standard for CAD, being invasive 
coronary angiography,  and in selected patient populations the technique has been demonstrated to 
provide reliable detection of significant coronary artery stenoses 3-5. The most important contribution 
of MSCT however, is the exclusion of CAD, since the likelihood of CAD is virtually nihil in the presence 
of a normal MSCT examination. 
Substantial data on the performance of MSCT in relation to other imaging techniques (e.g. SPECT) 
however, are currently not available. In this issue of the Journal, Hacker and colleagues report their 
results of a direct comparison between 64-slice MSCT and gated SPECT imaging in 38 (74% male) 
patients presenting with stable angina 6. CAD was suspected in 26 (68%), whereas 12 patients 
presented with a previous history of CAD (7 previous coronary artery bypass surgery, 8 previous 
percutaneous coronary intervention). Coronary arteries on MSCT were evaluated for the presence of 
significant (≥ 50% luminal diameter narrowing) stenoses and results were compared to myocardial 
perfusion assessed with SPECT. In total, 152 coronary arteries were evaluated, with 43 (28%) showing 
at least 1 significant stenosis.
Only 7 of 109 coronary arteries without significant stenoses on MSCT were associated with abnormal 
myocardial perfusion on SPECT, resulting in a negative predictive value of 94%. Thus, in the absence 
of significant lesions on MSCT, perfusion will be normal. These findings indicate that MSCT may allow 
accurate exclusion of flow-limiting coronary stenoses.
Conversely, abnormal perfusion on SPECT (including both fixed and reversible defects) was noted 
in only 23 of 43 (53%) of coronary arteries with significant lesions on MSCT. Moreover, only 12 of 
38 coronary arteries with significant CAD revealed ischemia (reversible perfusion abnormalities) 
on SPECT. As a consequence, the corresponding positive predictive value of MSCT to detect 
hemodynamically relevant stenoses was only 32%.  
Similar observations have been reported by the same authors when 16-slice MSCT was compared 
to SPECT imaging 7. Data obtained in 99 coronary arteries of 25 patients with known (n=14) or 
suspected CAD (n=11) revealed that all 82 coronary arteries without significant (≥ 50% diameter 
narrowing) lesions were associated with normal perfusion on SPECT, yielding a negative predictive 
value of 100%. On the other hand, a positive MSCT was not consistently associated with abnormal 
perfusion and only 8 of 17 (47%) stenotic coronary arteries on MSCT were associated with abnormal 
perfusion on SPECT. 
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Thus, only half of the significant lesions on MSCT appear to have hemodynamical consequences, 
indicating that the presence of coronary atherosclerosis with luminal obstruction does not invariably 
imply the presence of ischemia. Accordingly, a non-invasive angiographic imaging technique such 
as MSCT cannot be used to predict the hemodynamical importance of observed lesions. 
This discrepancy between anatomical and functional imaging was noted already in direct 
comparisons between invasive angiography and myocardial perfusion imaging. Particularly, lesions 
with an intermediate stenosis severity (40% to 70% luminal narrowing) have been demonstrated 
to show a wide variation in hemodynamic relevance 8. For example, Heller et al 8 demonstrated 
that only 48% of 67 intermediate lesions on invasive angiography (with on average 59±12% 
luminal narrowing) were associated with ischemia on myocardial perfusion imaging. An even 
lower percentage was reported by Chamuleau et al, who performed SPECT and invasive coronary 
angiography in 191 patients with at least 1 severe (>70% diameter narrowing) and 1 intermediate 
(defined as between 40% to 70% diameter narrowing) lesion on invasive angiography 9. In particular, 
153 (80%) patients showed ischemia on SPECT in the vascular territory corresponding to the severe 
lesion, but only 30 (16%) patients exhibited ischemia in the territory of the intermediate lesion. 
These observations underscore that anatomical imaging does not provide information on the 
hemodynamic consequences of the lesions, and functional testing remains required to provide this 
information. 
Consequently, the question that emerges is: “What are the implications of these observations for the 
clinical use of MSCT in addition to SPECT?” 
In fact, the combined use of anatomic and functional imaging may actually be preferred since 
this combination may allow better characterization of patients. In subjects with a normal SPECT, 
MSCT coronary angiography allows further differentiation into patients with atherosclerosis (but 
non-obstructive lesions, not resulting in ischemia), and patients with completely normal coronary 
arteries. This differentiation permits to identify CAD at an earlier stage, i.e. atherosclerosis present, 
but no ischemia yet. Accordingly, the availability of non-invasive visualization of the coronary 
arteries has resulted in a paradigm shift: the hallmark of CAD on non-invasive imaging is shifting 
from demonstration of ischemia to assessment of atherosclerosis.
In this respect, sequential use of MSCT and SPECT may provide a useful approach to patients 
presenting with an intermediate likelihood of CAD. As depicted in Figure 1, anatomic imaging with 
MSCT could be the initial test. 
If the coronary arteries reveal no abnormalities on MSCT, the patient may be safely discharged 
without the need for further testing. The reliable exclusion of significant CAD by MSCT is supported 
by the extensive literature validating the technique against invasive coronary angiography 10 
consistently showing that if the MSCT examination is normal, the likelihood of finding significant 
CAD on invasive coronary angiography is negligible. 
Next, in the presence of atherosclerosis without significant lesions (<50% diameter narrowing), the 
likelihood of ischemia is low as demonstrated in the current study 6. These patients need aggressive 
risk factor modification and medical therapy. 
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Finally, if obstructive lesions are demonstrated on MSCT, subsequent functional testing is needed 
to determine the presence and extent of ischemia, on which the decision for referral to invasive 
coronary angiography and possible revascularization is based.
Thus, rather than competing, MSCT and SPECT appear to be complementary techniques which each 
its valuable position in the diagnostic work-up of patients with suspected CAD. Still, before adopting 
these algorithms in clinical practice, more studies are needed, particularly focusing on long-term 
prognosis.
Patient with suspected CAD 
Non - invasive anatomical imaging 
Normal 
Functional imaging 
Safe discharge 
Invasive coronary 
angiography +  
revascularization if 
needed 
Ischemia No  ischemia 
Medical therapy and  
aggressive risk factor  
modification 
Obstructive 
Atherosclerosis 
Non - obstructive 
Atherosclerosis 
Figure 1. Potential algorithm for diagnostic imaging in patients with suspected CAD. 
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Abstract 
Background 
For the non-invasive evaluation of coronary artery disease (CAD), both multi-slice computed 
tomography (MSCT) and gated single photon emission computed tomography (SPECT) are 
available. How these 2 modalities relate however is yet unclear. The purpose of the study was 
to perform a head-to-head comparison between MSCT and gated SPECT results on a regional 
basis (per vessel distribution territory) in patients with known or suspected CAD. 
Methods
140 patients underwent both MSCT for coronary calcium scoring and coronary angiography 
and gated SPECT for myocardial perfusion imaging. Coronary calcium score was determined 
for each coronary artery. Coronary arteries on MSCT angiography were classified as having 
no CAD, non-significant stenosis (<50% luminal narrowing), significant stenosis, or total or 
subtotal occlusion (≥90% luminal narrowing). Gated SPECT examinations were classified as 
normal or abnormal (reversible and/or fixed defects) and allocated to one of the territories of 
the different coronary arteries. 
Results 
In coronary arteries with a calcium score ≤10, corresponding myocardial perfusion was normal 
in 87% (n=194 of 224). In coronary arteries with extensive calcifications (>400), percentage 
vascular territories with normal myocardial perfusion was lower, 54%, (n=13 of 24). Similarly, in 
the majority of the normal coronary arteries on MSCT angiography, corresponding myocardial 
perfusion on SPECT was normal (156 of 175, 89%). In contrast, percentage normal SPECT was 
significantly lower in coronary arteries with obstructive lesions (59%) and total or subtotal 
occlusions (8%) (P<0.01). Nonetheless, only 48% of vascular territories with normal perfusion 
corresponded to normal coronary arteries on MSCT angiography, whereas non-significant 
and significant stenoses were present in respectively 40% and 12% of corresponding coronary 
arteries. 
Conclusion 
Although a relation exists between the severity of CAD on MSCT and myocardial perfusion 
abnormalities on SPECT, analysis on a regional basis showed only moderate agreement 
between observed atherosclerosis and abnormal perfusion. Accordingly, MSCT and gated 
SPECT provide complementary rather than overlapping information and further studies 
should address how these 2 modalities can be integrated to optimize patient management. 
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Introduction
Choice of treatment strategy in patients with suspected or known coronary artery disease (CAD) 
stems from the integration of both the extent and severity of anatomical disease and the functional 
significance of the coronary lesions, i.e. signs of ischemia. Coronary anatomy used to be accessible 
only through invasive coronary angiography while several imaging techniques can detect inducible 
ischemia, among which myocardial perfusion imaging using single photon emission computed 
tomography (SPECT). Because of its invasive nature, coronary angiography comes second and 
the presence/absence of ischemia is the gatekeeper that determines access to the anatomical 
information.
This paradigm is challenged with the emergence of non-invasive coronary angiography using multi-
slice computed tomography (MSCT). Because coronary anatomy can now be obtained non-invasively, 
MSCT coronary angiography is increasingly often performed at earlier stages of the disease, in the 
absence of functional evaluation 1. Preliminary data comparing MSCT with SPECT show that in fact a 
large discrepancy exists between the anatomic extent of CAD and ischemia, and that a considerable 
number of stenoses do not result in abnormal perfusion 1;2. Thus, it remains undetermined in which 
sequence tests should be performed and ultimately, who will benefit from the performance of non-
invasive coronary angiography. In order to design proper evaluation strategies, it will be necessary 
to understand how anatomical and functional findings relate to each other on a regional basis, per 
vessel distribution territory. 
Therefore, we have further explored in an unselected patient population, the relation between 
the severity of anatomical CAD based on coronary calcium and MSCT angiography and perfusion 
abnormalities assessed by SPECT.
Methods 
Patients and study protocol
The study group consisted of 140 consecutive patients (84 male, average age 59 ± 11 years) who were 
referred for both gated SPECT and MSCT due to clinical suspicion of CAD and who underwent these 
investigations within 1 month of each other. CAD was known in 32 (23%) patients, and suspected 
in the remaining 108 patients. Characteristics of the study population are summarized in Table 1. 
Average left ventricular ejection fraction during resting gated SPECT was 60% ± 13%.
Exclusion criteria were contra-indications to MSCT 3, and the occurrence of unstable angina, 
myocardial infarction or revascularization between both procedures. The study protocol was 
approved by the local ethics committee and informed consent was obtained in all patients.
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MSCT coronary angiography
First, a prospective coronary calcium scan was performed prior to MSCT angiography with a collimation 
4 x 3.0 mm, gantry rotation time 500 ms, the tube voltage 120 kV and tube current 200 mA. The 
temporal window was set at 75% after the R-wave for electrocardiographically triggered prospective 
reconstruction. Coronary calcium score was derived using dedicated software (Vitrea2, Vital Images, 
Plymouth, Minn. USA). Coronary calcium was identified as a dense area in the coronary artery exceeding 
the threshold of 130 HU. The global Agatston score as well as per coronary artery was recorded for each 
patient. Coronary calcium scores were classified into 4 categories: ≤10, 11-100, 101-400, and >400.   
For the contrast enhanced helical scan, data were acquired with a collimation of either 16 x 0.5 mm 
or 64 x 0.5 mm and a tube rotation time of 400 ms, 450 ms or 500 ms (depending on the heart rate), 
respectively. The tube current was 300 mA, at 120 kV. In 31 patients 16-slice MSCT (Aquilion 16, Toshiba 
Medical Systems, Japan) was used 3 and in 109 patients, 64-slice MSCT (Aquilion 64, Toshiba Medical 
Systems, Japan) was used. Non-ionic contrast material was administered in the antecubital vein with 
an amount of 120 to 140 ml for 16-slice MSCT and 80 to 110 ml for 64-slice MSCT, depending on the 
total scan time, and a flow rate of 5 ml/sec (Iomeron 400 ®), followed by a saline flush. Subsequently, 
data sets were reconstructed and transferred to a remote workstation as previously described 3.
Table 1. Clinical characteristics of the study population (n=140). 
n (%)
Gender (M/F) 84/56
Age (years) 59 ± 11
Heart rate (bpm)  57 ± 8
Suspected CAD 108 (77%)
Known CAD 32 (23%)
Previous myocardial infarction 30 (21%)
Previous PCI 28 (20%)     
Previous stent placement 24 (17%)
        Stent in RCA 10 (7%)
        Stent in LAD 18 (13%)
        Stent in LCx 4 (3%)
Previous CABG    2 (1%)
       Graft to RCA 1 (1%)
       Graft to LAD 2 (1%)
       Graft to LCx 1 (1%)
Type of stress (SPECT)
       Exercise 90 (64%)
      Adenosine 41 (29%)
      Dobutamine 9 (6%)
LVEF during rest (SPECT) 60% ± 13% 
Average coronary calcium score (Agatston) 310 ± 775
Abbreviations: bpm: beats per minute, CABG: coronary artery bypass grafting, CAD: coronary artery disease, LAD: 
left anterior descending coronary artery, LCx: left circumflex coronary artery, LVEF: left ventricular ejection fraction, 
PCI: percutaneous coronary intervention, RCA: right coronary artery, SPECT: single photon emission computed 
tomography.
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MSCT angiographic examinations were evaluated by an interventional cardiologist blinded to the 
SPECT data for the presence of 1) no atherosclerosis, 2) atherosclerosis without significant (≥50% 
luminal narrowing) stenoses, 3) significant (≥50% luminal narrowing) stenoses or 4) (sub)total (≥90% 
luminal narrowing) occlusion. In the analysis, the left main coronary artery was considered part of 
the left anterior descending coronary artery. In patients with previous coronary bypass grafting, the 
graft as well as its distal run-off was evaluated. In case of an occluded or stenosed graft, also the 
native coronary artery proximal of the anastomosis was included in the analysis. 
Stress-rest Gated SPECT
In all patients, stress-rest gated SPECT (2x 500 MBq technetium-99m tetrofosmin) was performed 
using symptom-limited exercise or pharmacological (adenosine or dobutamine) stress as previously 
described 4. Data were acquired with a triple-head SPECT camera (GCA 9300/HG, Toshiba Corp., Tokyo, 
Japan) followed by reconstruction in long- and short-axis projections perpendicular to the heart-axis. 
The short-axis data were displayed in polar map format; the polar maps were divided in 17 segments 5 
and normalized to peak myocardial activity (100%). The 17 segments were allocated to the territories 
of the different coronary arteries as previously described 5. Perfusion defects were identified on the 
stress images (tracer activity <75% of maximum) and divided into ischemia (reversible defects, with 
≥10% increase in tracer uptake on the resting images) or scar tissue (fixed defects, no ≥10% increase in 
tracer uptake on the resting images). Accordingly, examinations were classified as being either normal 
or abnormal, the latter being further divided in reversible or irreversible defects. The gated images 
were used to assess regional wall motion to improve differentiation between perfusion abnormalities 
and attenuation artifacts. For irreversible defects, it was recorded whether the defects were located in 
a region with documented previous myocardial infarction. The left ventricular ejection fraction was 
derived from the gated SPECT data using previously validated and automated software (quantitative 
gated SPECT [QGS]; Cedars-Sinai Medical Center, Los Angeles, CA); gating was only performed at rest. 
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Figure 1. Distribution of the different coronary calcium score categories (per coronary artery).
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Statistical analysis
Continuous variables were described by mean ± SD. Comparisons between patient groups were 
performed using 1-way ANOVA for continuous variables and the χ2 test with Yates’ correction for 
categorical variables. A P-value <0.05 was considered statistically significant.
Results
Analysis on a vessel basis
MSCT	and	SPECT	findings		
Coronary calcium score was available in 134 (96%) patients and accordingly in 402 coronary 
arteries. Average coronary calcium score per coronary artery was 102.6 ± 311.2 (range 0 - 3739). The 
distribution of the different coronary calcium scores per coronary artery is provided in Figure 1. In 
Figure 2A, average coronary calcium scores for the 3 coronary arteries are depicted, demonstrating 
more calcium in the left anterior descending coronary artery as compared to the right and left 
circumflex coronary artery (P<0.001, Kruskall-Wallis). 
With MSCT angiography, a total of 420 vessels were evaluated. All coronary arteries were included. 
No abnormalities were observed on MSCT angiography in 175 (42%) vessels, whereas 245 vessels 
revealed either atherosclerosis without significant stenosis (n=165, 39%) or at least 1 significant 
stenosis (n=80, 19%). In the latter, total or subtotal occlusions were present in 13 vessels. Results per 
coronary artery are displayed in Figure 2B.
On SPECT, 420 vascular territories were available, of which 327 (78%) showed normal myocardial 
perfusion. Abnormal perfusion was observed in the remaining 93 (22%) territories. In 20 territories 
fixed defects corresponding to territories with known previous myocardial infarction were observed. 
In the remaining 73 vascular territories, 41 territories revealed ischemia, 27 showed fixed defects, 
while 5 territories showed both. Figure 2C shows the distribution of perfusion findings among the 
territories of the different coronary arteries. 
Stenoses	on	MSCT	angiography	versus	coronary	artery	calcium	score
Average coronary artery calcium score was 1.4 ± 6.0 for normal coronary arteries and increased to 
111.6 ± 212.9 and 313.3 ± 600.4 for coronary arteries with non-significant and significant stenoses, 
respectively (P<0.001 Kruskall-Wallis). Considering only (sub-)total lesions, the extent of coronary 
calcifications was even higher, 656.5 ± 280.9 (P<0.001).  In the majority (n=284, 90%) of coronary 
arteries with a coronary calcium score below 100, no significant stenoses were demonstrated. In 33 
of 60 coronary arteries with a calcium score between 100 and 400, significant stenoses was present 
in 45%. This percentage further increased to 60% in 25 coronary arteries with a calcium score above 
400. 
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Perfusion	on	SPECT	versus	coronary	artery	calcium	score
The average calcium score in coronary arteries with normal myocardial perfusion on SPECT was 69 ± 
167, whereas a significantly higher calcium score of 272 ± 646 was noted for coronary arteries with 
abnormal SPECT (P<0.001, Mann-Whitney).
Figure 3 shows the distribution of normal and abnormal myocardial perfusion (with exclusion of 19 
vascular territories with previous myocardial infarction) according to the different calcium scores. 
In the majority (n=194, 87%) of coronary arteries with no or minimal calcium (≤10), a normal SPECT 
was obtained. Percentage normal perfusion was only slightly lower (85%) in coronary arteries with 
a calcium score between 11 and 100 (P=NS). In coronary arteries with more extensive calcifications, 
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Figure 3. Distribution of normal (n=316) and abnormal (n=67) myocardial perfusion (vessel based) on SPECT 
between the different coronary calcium score categories. 
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percentage normal myocardial perfusion on SPECT was significantly lower: 75% and 54% for 
coronary arteries with calcium scores between 100 and 400 and >400, respectively (P=0.008).
Thus, the likelihood of normal perfusion on SPECT decreased in parallel to an increasing calcium 
score on MSCT. The predictive value of absence of calcium (score ≤10) for normal perfusion was 87% 
(Fig. 4A), but the value of significant calcium (score >400) for prediction of abnormal perfusion was 
only 46% (Fig. 4B). 
Perfusion	versus	stenoses	on	MSCT	angiography	
In the majority of normal coronary arteries on MSCT angiography, myocardial perfusion on SPECT in the 
corresponding territories was normal (156 of 175, 89%). In coronary arteries with stenoses (regardless of 
severity, n=225) on MSCT (with exclusion of 20 vascular territories with previous myocardial infarction), 
myocardial perfusion on SPECT was still normal in 171 (76%) corresponding territories. However, the 
likelihood of normal perfusion in coronary arteries with a significant stenosis or (sub-)total occlusion 
decreased significantly (Fig. 5). Of the 78 coronary arteries with significant stenoses on MSCT, abnormal 
perfusion on SPECT was present in 38 (49%) of the corresponding territories, and perfusion on SPECT 
was abnormal in almost all coronary arteries with (sub-)total occlusion (11 of 12, 92%). 
Thus, a normal MSCT had a high predictive value for normal myocardial perfusion (89%, Fig. 6A); 
however, normal perfusion on SPECT did not exclude abnormalities on MSCT and the value of 
normal perfusion to predict a normal MSCT was only 48% (Fig. 6B). 
In Figure 7 the relation between MSCT and SPECT is depicted per coronary artery/vascular territory. 
No significant differences were observed between the different coronary arteries. However, 
significant stenoses located in the right coronary artery tended to result more frequently in abnormal 
myocardial perfusion on SPECT as compared to the left anterior descending and left circumflex 
coronary artery, although no statistical significance was reached (P=0.056). 
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Figure 6. Relation between MSCT and SPECT.
(A) Prediction of normal and abnormal perfusion.
(B) Prediction of normal and (non-) significantly stenosed coronary arteries.
Disagreement between MSCT angiography and SPECT 
A normal MSCT angiogram but abnormal SPECT:
In 19 (5%) vascular territories, abnormal myocardial perfusion was observed whereas MSCT showed 
no atherosclerosis in the corresponding coronary artery. In the majority of these vascular territories 
with abnormal SPECT, the observed abnormality was predominantly a small fixed defect (n=12, 63%, 
Fig. 7) with inferior or septal location in respectively 6 and 4 patients.
A normal SPECT but CAD on MSCT angiography: 
Only 48% of vascular territories with normal SPECT corresponded to normal coronary arteries. In 
the majority of abnormal coronary arteries with normal perfusion (131, 77%), lesions were non-
significant and did not result in ischemia. In 40 (10%) vascular territories, myocardial perfusion 
was completely normal despite significant lesions in the corresponding coronary artery on MSCT. 
In these cases, coronary lesions may not have been hemodynamically relevant. Importantly, in 2 
patients with a discrepancy between MSCT and SPECT on a vessel basis, stenosis of both the right 
coronary artery and left main coronary artery was present; only the lesion in the right coronary artery 
was detected by abnormal perfusion. Finally, in 2 patients with a completely normal SPECT, 3-vessel 
disease was demonstrated on MSCT. 
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Analysis on a patient basis
MSCT	and	SPECT	findings
Average coronary calcium per patient was 310 ± 775 (range 0 to 6264). MSCT coronary angiography 
was normal in 43 (31%) patients, whereas non-obstructive and obstructive CAD was noted in 
respectively 51 (36%) and 46 (33%) patients. A normal SPECT study was obtained in 77 (55%) patients, 
whereas abnormal perfusion was noted in 63 (45%) patients, corresponding to previous myocardial 
infarction in 15 (11%) patients.
Stenoses	on	MSCT	angiography	versus	coronary	artery	calcium	score
Average coronary artery calcium score was 3.8 ± 11 for patients with normal coronary arteries and 
increased to 207 ± 271 and 726 ± 1239 in patients with non-significant and significant stenoses, 
respectively (P<0.001 Kruskall-Wallis). In the majority (n=45, 88%) of patients with a coronary calcium 
score ≤ 10, no significant stenoses were demonstrated. In 20 of 57 patients with a calcium score 
between 11 and 400, significant stenoses were present in 35%. This percentage further increased to 
65% in patients with a calcium score above 400. 
Perfusion	on	SPECT	versus	coronary	artery	calcium	score
The average calcium score in patients with normal myocardial perfusion on SPECT was 162 ± 332, 
whereas a significantly higher calcium score of 580 ± 1232 was noted for patients with abnormal 
SPECT (P<0.05, Mann-Whitney).
In the majority (n=49, 78%) of patients without extensive calcium (≤100), a normal SPECT was 
obtained. Percentage normal perfusion was slightly lower (60%) in patients with a calcium score 
between 101 and 400 (P=NS). In coronary arteries with calcium scores >400, percentage normal 
myocardial perfusion on SPECT was even lower (41%, P=NS).
Figure 7. Relation between MSCT and SPECT per coronary artery/vascular territory.
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Perfusion	versus	stenoses	on	MSCT	angiography	
In the majority of patients with normal MSCT angiography, the corresponding SPECT study was 
normal as well (37 of 43, 86%). In patients with non-significant stenoses on MSCT angiography 
(n=38, with exclusion of 13 patients with abnormal perfusion corresponding to previous myocardial 
infarction), myocardial perfusion on SPECT was normal in 24 (63%) patients. The percentage normal 
perfusion studies further decreased to 36% in patients with at least 1 significant stenosis (P<0.05). 
Thus, a normal MSCT angiogram had a high predictive value for normal myocardial perfusion 
(86%). However, similar to the vessel-based analysis, normal perfusion on SPECT did not exclude 
abnormalities on MSCT angiography as a normal MSCT angiogram was obtained in only 37 (48%) of 
77 patients with normal perfusion. 
Discussion
In the present study, atherosclerosis imaging with MSCT was compared to myocardial perfusion 
imaging with gated SPECT on a coronary artery and corresponding vascular territory basis. Normal 
coronary arteries on MSCT were associated with normal perfusion in the majority (89%) of vascular 
territories. Moreover, the likelihood of an abnormal SPECT study increased gradually in relation 
to increasing abnormalities on MSCT, with 92% of SPECT studies being abnormal in (sub-)total 
occlusions on MSCT. Still, 76% of the coronary arteries with atherosclerosis on MSCT did not exhibit 
perfusion abnormalities on SPECT, indicating that atherosclerosis does frequently not result in 
ischemia. Normal perfusion on SPECT was associated with normal MSCT in only 48% of vascular 
territories; 52% of territories with normal SPECT had atherosclerosis on MSCT, with 40% having non-
obstructive and 12% having obstructive CAD. 
These observations highlight that normal perfusion on SPECT does not exclude atherosclerosis. 
Accordingly, MSCT and gated SPECT provide complementary rather than redundant information, 
since the techniques reflect distinct functional and anatomical patho-physiological processes.
An abnormal MSCT does not necessarily imply ischemia
The vast majority (76%) of lesions on MSCT did not result in perfusion abnormalities or ischemia 
on SPECT imaging. In particular, 89% of non-obstructive lesions on MSCT were not associated with 
perfusion abnormalities on SPECT. This observation underscores that MSCT permits detection 
of CAD at an earlier stage than SPECT imaging: the detection of atherosclerosis while perfusion is 
not yet compromised. Similar results were reported recently by Hacker et al, using 16-slice MSCT, 
and demonstrated in 25 patients that only 8 (47%) of 17 significant stenoses on MSCT resulted 
in abnormal perfusion on SPECT 2. Yet, in the present study, a stepwise increase in the incidence 
of SPECT perfusion abnormalities was observed in relation to an increasing severity of MSCT 
abnormalities (Fig. 5). In particular, (sub-) total occlusions were in 92% of cases associated with 
abnormal myocardial perfusion on SPECT. Also, less severe but still significant lesions resulted in 
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abnormal perfusion in 41% of vascular territories. These findings illustrate the relation between the 
stenosis severity on MSCT and hemodynamic consequences as assessed by SPECT, but the results 
simultaneously highlight the discrepancy between atherosclerosic plaque burden and ischemia. As 
a result of variations in stenosis length and composition, angle and location, as well as the presence 
or absence of collateral vessels, an apparently identical stenosis may be incapable of producing 
symptoms in one patient while causing severe ischemia in another. Indeed, several studies comparing 
invasive coronary angiography findings to functional testing revealed at best a fair agreement with 
approximately half of significant lesions showing abnormal myocardial perfusion 2;6. This can also 
result from the fact that SPECT, by virtue of its relative nature, merely detects severe reductions in 
coronary flow reserve while modest reductions in flow reserve may not result in detectable defects 
7. Thus, an abnormal MSCT does not necessarily result in abnormal perfusion, but more frequently 
represents non-obstructive atherosclerosis, and functional testing is mandatory in patients with 
abnormal MSCT to determine the hemodynamic consequences of the MSCT abnormalities.
A normal SPECT does not exclude CAD
In the present study, atherosclerosis was present in 52% of coronary arteries with normal SPECT 
results. Moreover, advanced CAD with at least 1 significant, obstructive lesion was noted in 12% 
of territories with normal perfusion, underlining that a normal SPECT does not invariably exclude 
the presence of CAD. Indeed, studies correlating atherosclerosis assessment (based on coronary 
artery calcium scoring) to SPECT revealed similar observations, namely that (extensive) coronary 
calcifications are frequently observed in patients with normal SPECT studies 8;9. These observations 
may initially appear in conflict with the extremely low annual event rate that is associated with a 
normal SPECT study, which is approximately 0.6% for patients without known CAD 10. Nonetheless, 
among those patients with normal SPECT studies, certain subgroups, including those patients 
referred for pharmacological testing or with substantial comorbidity, have been identified that 
may actually be at elevated risk (1.2% to 2.0%) 11. In addition, patients with subclinical CAD, as 
demonstrated by MSCT, may constitute another category of patients that may have an elevated 
long-term risk of developing coronary events despite a normal SPECT; this hypothesis needs to be 
addressed by further outcome-based studies. However, knowledge concerning the presence and 
extent of subclinical CAD is still relevant and will help to identify patients with a normal SPECT who 
yet have atherosclerosis in whom optimized medical therapy and aggressive life-style modification 
is indicated, in contrast to individuals with a normal SPECT without atherosclerosis, who may be re-
assured without the need for further routine visits to the outpatient clinics.
Regional analysis
Concerning the different coronary arteries and corresponding vascular territories, a relatively 
larger plaque burden, as reflected by a higher coronary calcium score, was observed in the left 
anterior descending coronary artery as compared to the right and left circumflex coronary artery. 
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Also slightly more abnormalities were encountered in this coronary artery and corresponding 
vascular territory during coronary angiography and perfusion imaging, respectively. Nonetheless, 
in the present study significant stenoses located in the right coronary artery tended to result most 
frequently in abnormal myocardial perfusion on SPECT, which may be attributable to the higher 
frequency of severe, (sub)total occlusions in this coronary artery as compared to the left anterior and 
left circumflex coronary arteries. 
Limitations
Some limitations need to be defined. First, myocardial perfusion on SPECT was related to 
atherosclerosis in coronary arteries and perfect alignment between these methods is difficult, 
since precise definition of vascular territories is hampered by variations in coronary anatomy. Also, 
a threshold of 50% luminal narrowing on MSCT was applied, while a threshold of 70% might have 
resulted in increased agreement between the 2 techniques. Second, the study population consisted 
of patients with various clinical presentations with both suspected and known CAD. Studies 
performed in more homogenous study populations may provide more uniform results, yet may not 
be generalizable to a “real life” population referred for evaluation of CAD, such as the one included 
in the present study. Similarly, applied stress protocols for gated SPECT were not identical, as these 
were performed as part of standard clinical routine. 
Other limitations include the lack of attenuation correction for SPECT, which may (partially) explain 
the abnormal SPECT findings in the presence of a completely normal MSCT, albeit a relatively 
unfrequent finding. Also, no comparison to conventional coronary angiography was available. In 
addition, data were acquired with 2 different generations of MSCT scanners, while ideally all patients 
would have been evaluated with 64-slice MSCT. Finally, several limitations of MSCT in general need 
to be acknowledged. The technique involves radiation, and further technical developments are 
needed to lower the radiation burden. Also, motion artifacts as well as severe coronary calcifications 
have been demonstrated to reduce diagnostic accuracy 12;13. 
Conclusions
The current analysis on a regional basis underscores that although a relation exists between the 
2 modalities, MSCT and SPECT provide complementary information, namely the presence of 
(subclinical) atherosclerosis versus the presence of ischemia. Further studies should address how 
these 2 modalities may be integrated to optimize patient management. 
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Abstract
Background 
Preliminary comparisons suggest a large discrepancy between an abnormal Multi-Slice 
Computed Tomography (MSCT) study and myocardial perfusion imaging (MPI) results. How 
these contradictory findings should be interpreted remains presently unclear. The purpose of 
the present study was to perform, in addition to MSCT and MPI, invasive imaging, not only of 
the coronary lumen (using quantitative coronary angiography, QCA) but also of the vessel wall 
(using intravascular ultrasound, IVUS).
Methods
A total of 62 patients underwent both MSCT and MPI followed by conventional coronary 
angiography and IVUS imaging (in 45 patients). QCA and IVUS measurements were performed 
of the severest lesion, while MSCT studies were classified as normal (no stenosis exceeding 
30% luminal narrowing), or abnormal with further classification into borderline (30% to 70% 
luminal narrowing) or severe stenosis (≥70% luminal narrowing). Stress-rest gated MPI was 
performed to evaluate myocardial perfusion. 
Results 
A good agreement between modalities was observed in patients with abnormal MPI. However, 
a normal MPI study was in most patients associated with an abnormal MSCT study (82%) 
despite only minimal luminal stenosis on QCA (26.0%). Further evaluation by IVUS revealed the 
presence of considerable plaque burden (57.9%), yet without luminal compromise (average 
minimal luminal area 5.9 mm2).
Conclusion 
Observations between MPI, MSCT and QCA may appear initially contradictory as an abnormal 
MSCT is frequently obtained in patients with normal perfusion and conventional angiograms. 
In these patients, the detected atherosclerosis may be located mainly in the vessel wall, rather 
than extending into the coronary lumen.
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Introduction
Traditionally, the evaluation and management of patients with suspected coronary artery disease 
(CAD) has been based on the non-invasive detection of ischemia followed by invasive coronary angi-
ography to confirm the presence of luminal stenosis. However, this paradigm has recently been chal-
lenged by the introduction of multi-slice computed tomography (MSCT). With this new technique, the 
presence of CAD is detected through direct visualization of the coronary artery stenoses rather than 
through their hemodynamical consequences. Preliminary comparisons between MPI and MSCT sug-
gest a large discrepancy between imaging results and abnormal MSCT studies appear to be frequently 
associated with normal MPI studies 1;2. How these diverging findings should be interpreted remains at 
present unclear. It is conceivable that the vast majority of patients with abnormal MSCT but normal 
MPI have non-obstructive CAD, located mainly in the vessel wall, rather than encroaching on the coro-
nary artery lumen. To test this hypothesis, additional studies are needed involving invasive imaging, 
not only of the coronary artery lumen (using invasive coronary angiography) but also of the vessel wall 
(using intravascular ultrasound, IVUS).
Methods 
Patients and study protocol
The study group consisted of 62 symptomatic patients who underwent MSCT and MPI but also 
invasive coronary angiography in combination with IVUS.
Exclusion criteria were contra-indications to MSCT 3, and the occurrence of unstable angina, 
myocardial infarction or revascularization during the study period. The study protocol was approved 
by the local ethics committee and informed consent was obtained in all patients.
Multi-slice computed tomography coronary angiography
MSCT coronary angiography was performed using either an Aquilion 64 (Toshiba Medical Systems, Japan) 
or a Sensation 64 (Siemens, Germany). Collimation was either 64 x 0.5 mm or 64 x 0.6 mm, respectively. 
The tube current was 300 mA, at 120 kV. Non-ionic contrast material was administered in the antecubital 
vein with an amount of 80 to 110 ml for 64-slice MSCT, depending on the total scan time, and a flow rate 
of 5 ml/sec (Iomeron 400 ®), followed by a saline flush. Subsequently, data sets were reconstructed and 
transferred to a remote workstation as previously described 3.
MSCT angiographic examinations were evaluated on a vessel and patient basis by 2 experienced readers 
including an interventional cardiologist blinded to the SPECT data for the presence of atherosclerosis ex-
ceeding 30% luminal narrowing. Abnormal studies were further classified as borderline stenosis, showing 
30% to 70% luminal narrowing, or severe stenosis, showing ≥70% luminal narrowing. In the vessel-based 
analysis, the left main coronary artery was considered part of the left anterior descending coronary artery. 
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Myocardial perfusion imaging
In all patients, stress-rest MPI (using either technetium-99m tetrofosmin or technetium-99m 
sestamibi) was performed with symptom-limited bicycle exercise or pharmacological (dipyridamole, 
adenosine or dobutamine) stress 4. Data were acquired with either a dual-head SPECT camera 
(Vertex Epic ADAC Pegasus) or a triple-head SPECT camera (GCA 9300/HG, Toshiba Corp., Tokyo, 
Japan) followed by reconstruction into long- and short-axis projections perpendicular to the heart-
axis; data were presented in polar map format (normalized to 100%), and a 17-segment model 
was used in which myocardial segments were allocated to the territories of the different coronary 
arteries as previously described 5;6. Perfusion defects were identified on the stress images (segmental 
tracer activity less than 75% of maximum) and divided into ischemia (reversible defects, with ≥10% 
increase in tracer uptake on the resting images) or scar tissue (irreversible defects)2. Accordingly, 
examinations were classified as being either normal or abnormal, the latter being further divided 
in those demonstrating reversible defects and those demonstrating irreversible defects. The gated 
images were used to assess regional wall motion to improve differentiation between perfusion 
abnormalities and attenuation artifacts 7. The left ventricular ejection fraction was derived from the 
gated SPECT data using previously validated and automated software (quantitative gated SPECT 
[QGS]; Cedars-Sinai Medical Center, Los Angeles, CA); gating was only performed at rest. 
Conventional coronary angiography
Conventional coronary angiography was performed according to standard clinical protocols. 
Quantitative coronary angiography (QCA) was performed using QCA-CMS 6.0 (Medis, Leiden, the 
Netherlands). For each coronary artery, the most severe stenosis was identified. The tip of the catheter 
was used for calibration and after automated vessel contour detection with manual correction if 
needed, percentage diameter stenosis was calculated. 
Intravascular ultrasound
IVUS imaging was performed with 2.9Fr 20-MHz catheters (Eagle Eye, Volcano, Brussels, Belgium). 
After intracoronary administration of nitrates, the IVUS catheter was advanced to the distal portion 
of coronary artery under fluoroscopic guidance. Using automated pullback device, the transducer 
was withdrawn at a continuous speed of 0.5 mm/s up to the coronary ostium. Cine runs before and 
during contrast injection were performed to confirm the position of the IVUS transducer before 
IVUS evaluation was started. All data were stored digitally and were analysed off-line with the 
use of QCU-CMS 4.0 (Medis, Leiden, The Netherlands). After motion correction had been applied, 
coronary arteries were divided into segments according to the modified American Heart Association 
classification 8 using coronary ostia and side branches as landmarks. In each coronary segment, the 
frame with the most severe cross-sectional area of narrowing was selected for analysis. In addition, 
proximal and distal reference sites that had the largest lumen area by IVUS in the proximal and distal 
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portion of the vessel segment in the 10 mm adjacent (but before any side-branch) to the lesion site 
were selected. Subsequently, lumen and external elastic membrane (EEM) contours were manually 
traced to determine lumen area and EEM area at the lesion site and proximal and distal reference 
site. EEM area was defined as the area that was circumscribed by the border between the hypoechoic 
media zone and the surrounding echocardiographically bright adventitia. Plaque plus media area 
was calculated as the difference between the EEM and the lumen area. Based on these parameters, 
minimal lumen area (MLA), plaque area, plaque burden, lumen area stenosis, lumen diameter 
stenosis and corrected lumen area stenosis were calculated per coronary segment as previously 
described 9;10. 
In addition, vascular remodelling was determined in 2 ways, as previously described 11;12. First, the 
impact of excess plaque accumulation (at the lesion compared with the reference section) on lumen 
compromise was calculated using the following formula: (reference lumen area- MLA)/ (plaque 
area at the lesion – plaque area at the reference section) 11. Accordingly, with increasing index 
values, the impact of plaque accumulation on lumen compromise will be more severe. In contrast, 
an index of 0 will be obtained if all the additional plaque accumulation is accommodated for by 
arterial remodelling, resulting in no decrease in lumen area. Secondly, the number of lesions with 
positive remodelling was determined by calculating the remodelling index (RI) by dividing the 
lesion EEM area by the average of the proximal and distal reference EEM area. Subsequently, positive 
remodelling was defined as a RI ≥ 1.0, whereas RI < 1.0 was classified as negative remodelling 12.  
Statistical analysis
Data were analysed on a per-patient and per-vessel basis and for the corresponding calculations, 
the coronary artery and coronary segment showing the most severe stenosis on either QCA or IVUS 
were used respectively. Continuous variables were described by mean ± SD. Comparisons between 
patient groups were performed using the independent samples T test for continuous variables and 
the χ2 test with Yates’ correction was used for comparison of categorical variables. A P-value <0.05 was 
considered statistically significant. All statistical analyses were performed using SPSS (SPSS Institute, 
Chicago, Illinois, USA).
Results
Patient characteristics
Characteristics of the study population are summarized in Table 1. Briefly, 62 patients were included, 
of which 41 (66%) were male with an average age of 62 ± 11 years. CAD was known in 5 (8%) patients, 
and suspected in the remaining 57 (92%) patients. Previous coronary artery bypass grafting was 
previously performed in one patient. A total of 2 vascular territories were excluded from the analysis, 
since these territories were supplied by coronary artery bypass grafts. In all patients MPI, MSCT and 
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conventional coronary angiography (with QCA) were performed. In 45 patients, additional vascular 
imaging with IVUS was performed in a total of 94 coronary arteries.
MPI versus MSCT and invasive angiography
Patient	basis 
The results of the analysis on a patient basis (n=62) are presented in Table 2 and Figure 1. Abnormal 
perfusion on SPECT was noted in 23 (37%) patients. This abnormal perfusion was associated an 
abnormal MSCT in all patients, with borderline stenosis in 9 (39%) patients and at least 1 severe 
lesion in 14 (61%). Considering the most severe stenosis per patient on conventional angiography, 
QCA showed an average percentage stenosis of 78.3% ± 16.5%. 
The remaining 39 (63%) patients had normal perfusion on SPECT. In these patients, MSCT was 
abnormal in 32 (82%) patients with all patients classified as having borderline stenosis. However, 
average percentage stenosis of the most severe lesion was only 26.0% ± 16.8% on QCA (P<0.001 
versus patients with abnormal SPECT).
Table 1. Clinical characteristics of the study population (n=62).
n (%)
Gender (M/F)  41/21 
Age (years) 62 ± 11
Risk factors for CAD       
        Diabetes Mellitus18  (32%)
        Hypertension41  (72%)
        Hypercholesterolemia  31 (54%)
        Positive family history  22 (39%)        
        Current smoking  22 (39%)
        Obese (BMI ≥ 30 kg/m2)  12 (25%)
Agatston calcium score (range)  374 ± 764 (0,4828)
LVEF on gated SPECT  58%  ± 14%
Nr of significantly stenosed vessels on angiography
       0  31 (50%)
       1  12 (19%)
       2  11 (18%)
       3  8 (13%)
Abbreviations: BMI: body mass index, CAD: coronary artery disease, IVUS: intravascular ultrasound, LVEF: left ventricu-
lar ejection fraction, SPECT: single photon emission computed tomography.
Table 2. Angiographic characteristics (MSCT and QCA) for patients with respectively abnormal and normal perfusion.
MPI abnormal (n=23) MPI normal (n=39)  P -value
MSCT
  Normal 0 7 (18%)
 Abnormal 23 (100%) 32 (82%) P=NS
     Borderline stenosis 9 (39%) 32 (100%)
     Severe stenosis 14 (61%) 0 (0%) P<0.01
QCA 78.3% ± 16.5% 26.0% ± 16.8% P<0.01
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Vessel	basis	
On a vessel basis, abnormal myocardial perfusion was noted in 34 (17%) of 184 vascular territories 
with ischemia in 29 and fixed perfusion defects in 3 vascular territories (Table 3). In all of the 
corresponding coronary arteries, MSCT was abnormal as well.  At least 1 severe lesion was observed 
in 16 (47%) coronary arteries, while lesions were classified as borderline in 18 (53%) vessels. Average 
percentage stenosis on QCA was 70.6% ± 24.5%. 
In 150 (82%) vascular territories with normal perfusion on SPECT, atherosclerosis was detected on 
MSCT in 109 (73%) of the corresponding coronary arteries, of which the majority (105, 96%) were 
classified as showing borderline stenosis. A total of 41 (27%) coronary arteries were normal on 
MSCT. According to QCA, average percentage stenosis in coronary arteries associated with normal 
perfusion was 22.1% ± 18.7% (P<0.001 as compared to abnormal SPECT). 
62 patients
39 (63%) normal23 (37%) abnormal
23 (100%) abnormal
(14, 61%, severe lesion)                
(9, 39%, borderline lesion)
0 (0%) normal
78.3 ± 16.5%
MPI
MSCT
QCA
32 (82%) abnormal
(0, 0% severe lesion)                         
(32, 100%, borderline lesion)
7 (18%) normal
26.0 ± 16.8% P<0.01
P=NS
Figure 1.   Flow chart describing the MSCT and QCA findings in 62 patients with respectively abnormal and normal 
MPI results. Note the discrepancy between the imaging modalities in patients with normal MPI. In the majority of 
these patients MSCT was abnormal, despite normal perfusion and only minimal luminal narrowing on QCA. 
Abbreviations: MPI: myocardial perfusion imaging, MSCT: multi-slice computed tomography, QCA: quantitative coro-
nary angiography.
Table 3. Angiographic characteristics (MSCT and QCA) for vascular territories with respectively abnormal and 
normal perfusion. 
MPI abnormal (n=34) MPI normal (n=150) P –value
MSCT
  Normal 0 41 (27%)
 Abnormal 34 (100%) 109 (73%) P=NS
    Borderline stenosis 18 (53%) 105 (96%)
    Severe stenosis 16 (47%) 4 (4%) P<0.01
QCA 70.6% ± 24.5% 22.1% ± 18.7% P<0.01
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Correlation of MPI with MSCT, invasive angiography and IVUS (Figure 2)
In 45 of 62 (73%) of patients, additional vascular imaging with IVUS was performed in a total of 94 
coronary arteries. In the remaining 17 patients, IVUS imaging was not possible due to the presence 
of left main stenosis, severe stenosis or occlusion (n=10) and technical problems or time constraints 
during conventional coronary angiography (n=7). 
Patient	basis	
In total, MPI was abnormal in 14 of 45 (31%) of patients in whom IVUS imaging was obtained. In all 
patients, MSCT was abnormal as well with severe stenosis in 3 (21%). Average percentage of luminal 
narrowing as determined by QCA was relatively low in these patients (58.6 ± 24.3%), possibly due 
to the exclusion of patients with severe stenosis in whom IVUS imaging could not be performed. 
Nonetheless, average MLA was 3.5 ± 1.3 mm2 with an average plaque area and plaque burden of 
respectively 9.9 ±5.2 mm2 and 71.7% ± 10.6%, confirming the presence of potentially flow-limiting 
stenoses. At these lesions, the impact of plaque accumulation on lumen compromise was on average 
1.7 ± 2.3. Moreover, 12 (86%) lesions were associated with constrictive remodelling. 
Normal perfusion was observed in the remaining 31 (69%) of the 45 patients that underwent 
additional IVUS imaging. In these patients, MSCT revealed atherosclerosis in 27 (87%), all classified as 
having borderline stenosis. 
Figure 2. Flowchart describing the observations in 45 patients in whom additional IVUS imaging was performed. 
In almost all patients with normal MPI, the presence of atherosclerosis was observed on MSCT with negligible 
luminal narrowing identified on QCA. IVUS imaging confirmed the presence of substantial atherosclerosis 
(plaque burden 57.9%), yet without luminal compromise (MLA 5.9 mm2). 
Abbreviations: IVUS: intravascular ultrasound, MLA: minimal lumen area, MPI: myocardial perfusion imaging, MSCT: 
multi-slice computed tomography, QCA: quantitative coronary angiography.
31 (69%) normal
27 (87%) abnormal
(0, 0% severe lesion)                                  
(27, 100% borderline lesion)
25.2 ± 14.3% 
MPI
MSCT
QCA
Luminal measurements
MLA  5.9 ± 3.4 mm2
Vessel wall measurements
Plaque area 8.3 ± 3.5 mm2 
Plaque burden 57.9 ± 18.2%
Remodeling
Positive remodeling 48%
IVUS
14 (31%) abnormal
14 (100%) abnormal
(3, 21% severe lesion)                                 
(11, 79%, borderline lesion)
58.6 ± 24.3% 
Luminal measurements
MLA  3.5 ± 1.3 mm2
Vessel wall measurements
Plaque area 9.9 ± 5.2 mm2 
Plaque burden 71.7 ± 10.6%
Remodeling
Positive remodeling 14%
45 patients
P<0.05
P<0.05
P<0.05
P=NS
P=NS
P=NS
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Considering only the most severe percentage stenosis per patient, an average of only 25.2% ± 14.3% 
luminal narrowing was observed on QCA, indicating minimal stenosis on angiography. In line with 
these observations, preservation of the lumen was observed on IVUS with an average MLA of 5.9 ± 
3.4 mm2, significantly higher as compared to patients with abnormal MPI (P<0.01). Nonetheless, 
considerable atherosclerosis was identified on IVUS with an average plaque area of 8.3 ± 3.5 mm2, not 
significantly different as compared to patients with perfusion abnormalities (P=0.29). Also substantial 
plaque burden was observed, with an average of 57.9% ± 18.2% (P<0.05 as compared to abnormal 
MPI). The impact of plaque accumulation on lumen compromise was considerably less as compared to 
patients with abnormal MPI ( -0.21  ± 5.8 versus 1.7 ±  2.3, P=0.24). In line with this observation, positive 
remodeling was identified in approximately half (15, 48%) of patients with normal MPI, as compared to 
14% in patients with abnormal MPI (P=0.03). Details are specified in Table 4. 
In Figure 3, an example of a patient with discrepant MPI and MSCT observations is provided.  
Vessel	basis	
In total, 14 (15%) of 94 coronary arteries were associated with abnormal perfusion in the 
corresponding vascular territory during MPI. In all coronary arteries with abnormal perfusion, 
atherosclerosis was identified on MSCT, with severe stenosis on MSCT in 3 (21%) coronary arteries 
and an average degree of stenosis of 57.1% ± 26.1% on QCA. In the remaining 80 (85%) coronary 
arteries without perfusion abnormalities, atherosclerosis was absent on MSCT in 15 (19%). The 
average degree of stenosis on QCA was 21.4% ± 13.8%. Further details of the IVUS measurements on 
a vessel basis are provided in Table 5. 
Finally, as shown in Figure 4, significant differences in IVUS measurements were observed when 
comparing patients with and without atherosclerosis on MSCT.  
Table 4.  IVUS characteristics of the most severe lesion in patients with respectively abnormal and normal perfusion 
on MPI.
Abnormal perfusion 
(n=14)
Normal perfusion 
(n=32)
P-value
Reference section
 EEM area (mm2) 15.0 ± 6.1 15.6 ± 4.0 0.21
 Lumen area (mm2) 8.9 ± 3.6 10.2 ±3.2 0.24
Lesion section
  EEM area (mm2) 13.4 ± 5.8 14.2 ± 4.4 0.62
  MLA (mm2) 3.5 ± 1.3 5.9 ± 3.4 <0.01
  Plaque area (mm2) 9.9 ± 5.2 8.3 ±3.5 0.29
  Lesion plaque burden (%) 71.7 ± 10.6 57.9 ± 18.2 <0.01
  Lumen area stenosis (%) 60.4 ± 17.6 42.6 ± 22.9 0.01
  Lumen diameter stenosis (%) 39.0 ± 16.3 25.8 ± 15.5 0.01
  Corrected lumen area stenosis (%) 74.8 ± 10.3 60.9 ±20.9 <0.01
Remodeling
    Impact plaque on lumen index 1.7 ± 2.3 -0.2 ± 5.8 0.24
    Positive remodeling (n, %) 2 (14%) 15 (48%) 0.03
Abbreviations: EEM: external elastic membrane, MLA: minimal lumen area. 
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Discussion
The main observations of the present study can be summarized as follows. 
Comparison of MSCT to SPECT showed that abnormal perfusion was in all cases associated with 
an abnormal MSCT. In these patients, significant CAD was also observed during invasive imaging, 
as reflected by an average percentage stenosis of 78% on conventional angiography as well as an 
average MLA of less than 4.0 mm2 on IVUS.
However, in many patients with normal perfusion on SPECT, discrepant findings were obtained. 
Frequently, MSCT showed extensive atherosclerosis, whereas only minor stenosis (average 26.0%) 
was observed on conventional coronary angiography/QCA. Nonetheless, IVUS revealed considerable 
plaque burden (57.9%). Importantly, the observed atherosclerosis involved the arterial wall rather 
than leading to luminal compromise, as reflected by a preserved MLA of 5.9 mm2 on average.
 
Figure 3. A 60-year old male presented to the outpatient clinic with dyspnea and an elevated risk profile for 
coronary artery disease, including hypertension, hypercholesterolemia and smoking. Contrast enhanced MSCT 
coronary angiography revealed considerable atherosclerosis in the left anterior descending coronary artery 
(Panel A). Panels B and C are cross-sectional images of the areas indicated by the arrows in Panel A. In contrast, 
myocardial perfusion imaging (Panel D), which was performed during exercise stress (first and third panel) and 
rest (second and fourth panel), showed normal perfusion. However, also during intravascular ultrasound imag-
ing (Panels E and F), considerable plaque burden was demonstrated, yet with preservation the coronary lumen.
Hemodynamically relevant stenoses
Abnormal perfusion on SPECT was in all cases associated with an abnormal MSCT. In line with 
these observations, lesions that were flow-limiting as determined by MPI were also associated with 
significant focal luminal narrowing on invasive imaging. On QCA, an average percentage diameter 
stenosis of 78% was obtained. Also, in the subset of patients undergoing IVUS imaging, an average 
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MLA of 3.5 mm2 was identified, in line with previous investigations. Nishioka and colleagues 
compared IVUS measurements in 70 coronary lesions to gated SPECT 9 and observed an average 
MLA of 3.3 mm2 in lesions with a positive SPECT study. Similar findings have been obtained in other 
studies employing fractional flow reserve 12;13 indicating a clear convergence of findings between the 
different imaging modalities in the presence of hemodynamically relevant stenoses.
Atherosclerosis in the presence of normal perfusion
In 39 patients, a normal MPI study was obtained. In these patients, only mild luminal narrowing (26.0%) 
was observed during conventional coronary angiography. Contradictory findings were obtained with 
MSCT, since only 7 (18%) patients were classified as having normal coronary arteries. Similarly, on a vessel 
basis only 41 of 150 (27%) of coronary arteries were normal on MSCT. In line with the observations of 
conventional coronary angiography/QCA, average lumen diameter stenosis on IVUS was only 25.8% and 
19.5% on a patient and vessel basis respectively. However, considerable plaque burden was detected with 
an average of 58% in patients with abnormal MSCT. Importantly, this observed atherosclerosis involved 
the arterial wall rather than leading to luminal compromise, as reflected by an average MLA of 5.9 mm2. 
A discrepancy in imaging findings has been described previously in studies comparing MPI to 
coronary calcium scoring. In a large cohort of 1195 patients without history of CAD, extensive 
atherosclerosis as reflected by a calcium score >400 was observed in 31% of patients with normal 
MPI studies 14. Moreover, the presence of substantial disease has been described in angiographically 
normal segments previously; Mintz et al showed in a large consecutive series of patients that 
atherosclerosis is commonly present in angiographic reference segments and only 6.8% of studied 
segments were classified as entirely normal by both QCA and IVUS imaging 15. 
Table 5. IVUS characteristics in coronary arteries with respectively abnormal and normal perfusion in the 
corresponding vascular territory.
Abnormal perfusion 
(n=14)
Normal perfusion 
(n=80)
P-value
Reference section
 EEM area (mm2) 15.9 ± 6.1 15.1 ± 5.2 0.62
 Lumen area (mm2) 9.0 ± 3.9 9.9 ± 3.7 0.39
Lesion section
  EEM area (mm2) 14.3 ± 5.8 14.2 ± 5.2 0.93
  MLA (mm2) 3.6 ± 1.6 6.7 ± 3.7 <0.01
  Plaque area (mm2) 10.7 ± 5.0 7.5 ± 3.7 <0.01
  Lesion plaque burden (%) 73.2 ± 9.3 51.9 ± 17.3 <0.01
  Lumen area stenosis (%) 59.1 ± 20.1 33.3 ± 21.2 <0.01
  Lumen diameter stenosis (%) 38.3 ± 17.6 19.5 ± 13.7 <0.01
 Corrected lumen area stenosis (%) 75.6 ± 10.2 54.5 ± 19.0 <0.01
Remodeling
    Impact plaque on lumen index 1.5 ± 2.3 0.34 ± 5.7 0.20
    Positive remodeling 4 (29%) 34 (43%) 0.36
Abbreviations: EEM: external elastic membrane, MLA: minimal lumen area.  
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Accordingly, the noted discrepancies in fact reflect that the techniques provide information 
on different aspects of CAD. Conventional coronary angiography and MPI detect anatomically 
significant and hemodynamically relevant stenoses respectively. In contrast, the techniques remain 
limited in depicting the distribution and extent of diffuse, non-obstructive atherosclerosis, a process 
which primarily involves the arterial wall. 
Figure 4. Differences in IVUS measurements between coronary arteries with CAD and without CAD as deter-
mined on MSCT. 
Panel A: MLA (mm2) and corrected lumen area stenosis (%). Panel B: plaque area (mm2) and plaque burden (%). 
All measurements were significantly different between coronary arteries with and without CAD identified on 
MSCT.
Abbreviations: CAD: coronary artery disease, IVUS: intravascular ultrasound, MLA: minimal lumen area, MSCT: multi-
slice computed tomography. 
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Clinical implications 
Traditionally, non-invasive detection of CAD is based on demonstration of ischemia 16. However, with 
the introduction of new non-invasive imaging techniques such as MSCT, clinicians started to appre-
ciate better the different stages of CAD, ranging from early coronary atherosclerosis to obstructive 
stenoses. Indeed in the current study, we identified patients with perfusion defects on MPI, indicat-
ing hemodynamically obstructive stenoses, representing advanced CAD; these patients revealed sig-
nificant stenoses on invasive angiography with QCA, and IVUS further strengthened these findings by 
demonstration of obstructive CAD. 
On the other end of the spectrum, patients with (pre-clinical) atherosclerosis were identified. These 
patients presented with normal perfusion on MPI, with (nearly) normal invasive angiography/QCA. 
Many of these patients however had extensive atherosclerosis on MSCT; this was further supported by 
the IVUS findings indicating absence of obstructive stenoses, but confirming extensive atherosclerosis, 
mainly located in the vessel wall.
The main clinical implication of the current study is thus that integrated use of the non-invasive im-
aging techniques (MPI and MSCT) may permit optimal characterization of atherosclerotic lesions and 
differentiate early atherosclerosis without hemodynamic consequences from atherosclerotic lesions 
that result in ischemia. Whether this advanced characterization of atherosclerotic lesions will result in 
superior prognostification of patients, remains to de determined.
Study limitations
In the present study, MSCT examinations were visually assessed, as no validated quantification 
algorithms are currently available for MSCT. Also, IVUS imaging was not performed in all vessels in 
every patient. In addition, MSCT has several disadvantages in general including the high radiation 
burden and the need for a low and stable heart rate during data acquisition. 
Conclusion
The current findings demonstrate a good agreement between non-invasive imaging techniques (MPI, 
MSCT) and invasive techniques (angiography, QCA and IVUS) in patients with advanced CAD. These pa-
tients exhibited abnormal perfusion on MPI, atherosclerosis on MSCT, and obstructive stenoses on angi-
ography/QCA and IVUS.
In patients with early atherosclerosis, discrepant findings were noted. Perfusion on MPI was normal, but 
MSCT demonstrated atherosclerosis. Although invasive angiography/QCA did not reveal significant coro-
nary lesions, IVUS demonstrated considerable atherosclerosis, which was however mainly located in the 
vessel wall and associated with positive remodeling, rather than resulting in luminal obstruction.
The current observations further support the integrated use of MPI and MSCT to better characterize 
atherosclerotic lesions.
Accordingly, the current findings underline the complementary nature of MSCT and MPI. 
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Abstract
Background 
Plaque composition rather than degree of luminal narrowing may be predictive of acute 
coronary syndromes (ACS). The purpose of the study was to compare plaque composition 
and distribution with multi-slice computed tomography (MSCT) between patients presenting 
with either stable coronary artery disease (CAD) or ACS. 
Methods 
MSCT was performed in 22 and 24 patients presenting with ACS or stable CAD, respectively. 
Coronary lesions were classified as calcified, non-calcified or mixed while signal intensity (SI) 
was measured. 
Results 
In patients with stable CAD, the majority of lesions were calcified (89%). In patients with ACS, 
less calcifications were observed with a greater proportion of non-calcified (18%) or mixed 
(36%) lesions (P<0.001). Accordingly, mean SI of plaques was significantly less in ACS (320 
± 201 HU versus 620 ± 256 HU in stable CAD, P<0.001). Dividing lesions in the ACS group 
according to culprit versus non-culprit vessel location resulted in no significant difference in 
average SI between these 2 groups while still lower as compared to stable CAD (P<0.001). 
Conclusions
In patients with ACS, significantly less calcifications were present as compared to stable 
CAD. Moreover, even in non-culprit vessels, multiple non-calcified plaques were detected, 
indicating diffuse rather than focal atherosclerosis in ACS.
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Introduction
Non-ST-elevation acute coronary syndromes (ACS) are recognized as among the most frequent and 
important manifestations of coronary artery disease (CAD) and contribute to a considerable per-
centage of both morbidity and mortality. In addition, the occurrence of an ACS is associated with an 
elevated risk of further coronary incidents within the subsequent year 1.  
It is widely acknowledged that local thrombus formation due to plaque rupture or erosion plays a 
pivotal role in the pathogenesis of ACS. Consequently, plaque composition rather than the degree 
of luminal narrowing may be predictive of the patient’s risk for further coronary events. Extensively 
calcified lesions most likely represent atherosclerosis at later stages of remodeling and may reflect 
more stable lesions 2. On the other hand, earlier stages of atherosclerosis that lack the presence of 
calcium deposits may be more prone to rupture with subsequent occurrence of acute events. Recent 
studies indicate a higher degree of inflammation in patients presenting with unstable clinical con-
ditions, resulting in diffuse destabilization of atherosclerotic plaques in the entire coronary tree 3;4. 
Indeed, multiple sites of rupture-vulnerable plaque may be present rather than one site of complex 
plaque or thrombus, explaining the increased incidence of recurrent ACS, repeat intervention and 
coronary bypass grafting in the subsequent year 5.
During the past few years, MSCT has emerged as a new modality to evaluate the presence of signifi-
cant CAD through direct visualization of the coronary arteries. Besides the assessment of coronary 
artery stenoses, the technique allows visualization of atherosclerotic plaques. As a result, the tech-
nique may potentially be used to assess plaque composition. Indeed, few recent studies have dem-
onstrated the feasibility of differentiation between calcified, non-calcified or mixed plaques based 
on differences in signal intensity (SI) 6. Since the availability of non-invasive coronary angiography 
with MSCT is continuously expanding, the technique will increasingly be used to identify patients 
at either low- or high- risk for developing coronary events. Accordingly, its potential to differentiate 
between various patterns of atherosclerotic lesions needs to be explored. Eventually, this may prove 
to provide additional information useful for refinement of risk stratification and may allow early insti-
tution of appropriate therapy to prevent further events. 
The purpose of the present study was to compare plaque composition and distribution between 
patients presenting with either stable CAD or non-ST-elevation ACS. 
Methods
Study populations
The study group consisted of 22 patients presenting with ACS and 24 age- and gender matched pa-
tients with known, stable CAD; all underwent MSCT and invasive coronary angiography. Referral for 
coronary angiography was based on the presence of symptoms, abnormal or inconclusive previous 
exercise ECG and/or nuclear testing. Only patients in sinus rhythm without contraindications to MSCT 
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were included. Exclusion criteria were: (supra-) ventricular arrhythmia, renal insufficiency (serum cre-
atinine >120 mmol/L), known allergy to iodine contrast media, severe claustrophobia and pregnancy. 
All patients gave written informed consent to the study protocol, which was approved by the local 
ethics committees.
MSCT data acquisition
Data acquisition was performed at 2 centers (the Eberhard-Karls-University, Tübingen, Germany and 
the Leiden University Medical Center, Leiden, the Netherlands). 16-slice MSCT was performed using 
either a Sensation Siemens (Siemens, Germany) or Toshiba Aquilion (Toshiba Medical Systems, Japan) 
scanner. In all patients, imaging was performed during electrocardiographic gating and the adminis-
tration of a bolus of non-ionic contrast agent with a flow rate of 4 ml/s, as previously described 7-9.
Data evaluation
Data were evaluated on a remote workstation using dedicated software (Vitrea, Vital Images, USA). 
For each patient, the entire coronary arterial tree was inspected for the presence of coronary plaques 
(regardless of their severity). For this purpose, knowledge from invasive coronary angiography was 
used in order to ensure most optimal lesion detection. Lesions identified on the MSCT were recorded 
and classified as being interpretable or not. Interpretable lesions were subsequently visually classified 
as calcified, non-calcified or mixed plaques. Examples of each type of lesion are provided in Figure 1. 
Figure 1. Example of the different lesion types as visually assigned on the MSCT images. Panel A: non-calcified 
lesion; Panel B: mixed plaque; Panel C: dense calcified lesion.  
In each plaque, SI was measured in 3 regions of interest of each 2-3 mm2, placed in subsequent axial 
slices. Subsequently, the average SI was calculated. The location of each lesion was documented 
according to the American Heart Association-American College of Cardiology segmentation 10. 
Lesions observed in segments 1, 2, 5, 6 and 11 (proximal and mid right coronary artery, left main, 
proximal left anterior descending coronary artery and proximal left circumflex coronary artery) were 
considered to be located proximally in the coronary arteries. In patients presenting with ACS, further 
distinction was made between lesions located in the culprit coronary artery versus elsewhere. 
Culprit vessels were identified using electrocardiographic findings, left ventricular wall motion 
abnormalities, angiographic lesion morphology, as previously described 11;12.
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Statistical analysis  
Continuous variables were described by their means and standard deviations. Comparisons between 
patient groups were performed using 1-way ANOVA for continuous variables and the 2 test with 
Yates’ correction for categorical variables. Nonparametric Mann-Whitney and Kruskall-Wallis tests 
were used to compare the means of the plaque SI between the different groups. All statistical 
analyses were performed using SPSS software (version 12.0, SPSS Inc, Chicago, Il, USA). A P-value 
<0.05 was considered to indicate statistical significance. 
Results
Patient characteristics
The baseline characteristics of the patients are summarized in Table 1. No significant differences 
in risk factors were present between the 2 groups. By invasive angiography, the average number 
of coronary arteries with a ≥50% stenosis was 1.5 ± 1.4 and 2.1 ± 1.0 in patients with respectively 
stable CAD and ACS, and was not significantly different between the 2 groups. By MSCT, the average 
number of vessels with any evidence of atherosclerotic lesions (including coronary arteries with 
both ≥50% as well as coronary arteries with only lesions <50% diameter narrowing) however, was 
Table 1. Baseline characteristics of the study population.
Stable CAD ACS
Nr. patients 24 22
Gender (M/F) 22/2 21/1
Age (yrs) 62 ± 11 61 ± 12
Risk factors for CAD
    Average Body Mass Index (kg/m2) 29 ± 4 26 ± 3
    Diabetes mellitus type 2 11 (46%) 10 (46%)
    Hypertension 20 (83%) 15 (68%)
    Hypercholesterolemia 20 (83%) 19 (86%)
    Family history of CAD 7 (29%) 12 (56%)
    Current smoking 12 (50%) 13 (59%)
History
    Previous PCI/CABG 6/2 6/6
    Previous MI 6 13
Significant CAD as observed on CAG
    No significant CAD 9 (38%) 2 (9%)
    Single vessel CAD 3 (13%) 5 (23%)
    Multiple vessel CAD 12 (50%) 12 (55%)
Average nr. of coronary arteries with significant stenoses 1.5 ± 1.4 2.1 ± 1.0
Average nr. of coronary arteries with any atherosclerotic plaques 2.0 ± 1.0 2.6 ± 0.7
Abbreviations: ACS: acute coronary syndrome; CABG: coronary artery bypass grafting; CAD: coronary artery disease; 
CAG: conventional coronary angiography; PCI: percutaneous intervention; MI: myocardial infarction.
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significantly higher in the ACS patients (2.6 ± 0.7 as compared to 2.0 ± 1.1, P<0.05). In patients with 
ACS, 57 diseased coronary arteries were identified, with a total of 106 diseased segments. In patients 
with stable CAD, atherosclerotic lesions were present in 101 segments (in 48 coronary arteries). 
Spatial distribution of calcified, mixed or non-calcified lesions
In total, 207 segments with a total 258 coronary lesions were identified, of which 228 (88%) lesions 
(in 175 evaluable segments) were of sufficient image quality to assign plaque type and measure 
average SI. 
In patients with ACS, 73 (58%) of 125 lesions were located proximally as compared to a slightly lower 
percentage (72 of 133 lesions, 54%) in patients with stable CAD (P=NS). The majority of non-calcified 
and mixed lesions (81% and 62%, respectively) tended to be located in the proximal part of the 
coronary arteries. Calcified lesions were more equally distributed between the proximal and more 
distal parts of the coronary arteries with 56% of calcifications located proximally (P<0.05). 
Distribution of plaque types between ACS and stable CAD patients 
In patients presenting with stable CAD, 128 of 133 (96%) identified lesions were interpretable. The 
majority of observed lesions, 114 (88%), were calcified, whereas only 3 (2%) and 11 (9%) lesions 
were either completely non-calcified or mixed, respectively. On the contrary, a larger part of 
demonstrated lesions were non-calcified or mixed in patients with ACS. A total of 100 (80%) lesions 
were interpretable, of which 18 (18%) and 36 (36%) were respectively non-calcified or mixed. Forty-
six percent of plaques were calcified (P<0.001). Results are summarized in Table 2 and Figure 2.
As a result of the relatively lower number of calcifications, mean SI of the observed plaques was 
significantly lower in the ACS patients as compared to the stable CAD patients (320 ± 201 HU versus 
620 ± 256 HU, P<0.001). 
Culprit vessels versus non-culprit vessels 
In the patients with ACS, we compared culprit with non-culprit vessels. In the 22 culprit vessels, a total 
of 50 plaques were present, of which 42 could be identified and evaluated with MSCT. The relative 
distribution of non-calcified, mixed and calcified lesions, as shown in Table 3, were respectively 9 
Table 2.  Distribution of plaque types, as visually assessed using MSCT, between patients with stable and 
unstable angina pectoris. 
Plaque type Stable CAD ACS patients
Non-calcified 3 (2%) 18 (18%)
Mixed 11 (9%) 36 (36%)
Calcified 114 (89%) 46 (46%)
Total 128 100
Abbreviations: ACS: acute coronary syndrome; CAD: coronary artery disease.
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(21%), 19 (45%) and 14 (33%). In the 35 remaining, non-culprit vessels with atherosclerotic lesions, 
75 plaques were present, of which 58 could be evaluated with MSCT. In these vessels, relatively more 
calcified lesions were observed, 32 (55%, P=NS). In the remaining lesions, calcium was absent in 9 
(16%), whereas a mixture was observed in 17 (29%) plaques. 
 Although mean signal intensity was higher in plaques located in non-culprit vessels (346 ±196 HU) 
as compared the average value observed in culprit vessels (284 ± 205 HU), no statistical difference 
was reached (P=NS). Still, as depicted in Figure 3, SI of both culprit and non-culprit vessels in the ACS 
patients were significantly lower as compared to the SI of plaques in coronary vessels of the patients 
with stable CAD.
Figure 3. Box plot of average signal intensities of lesions in culprit vessels, non-culprit vessels of acute coro-
nary syndrome (ACS) patients and signal intensities of lesions in stable coronary artery disease (CAD) patients. 
The box extends from the 25th percentile to the 75th percentile, with a line at the median (the 50th percentile). 
The whiskers extend above and below the box to show the highest and lowest values. No significant differ-
ence was observed between the average lesion signal intensity in culprit and non-culprit vessel of ACS patients 
whereas a significantly higher average signal intensity was observed in patients with stable CAD. 
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Figure 2. Bar graph demonstrating the relative distribution of the different lesion types in patients with ACS and 
stable CAD (P<0.001). 
Abbreviations: ACS: acute coronary syndrome; CAD: coronary artery disease.
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Discussion
Comparison of contrast-enhanced MSCT coronary angiograms of patients with stable CAD and 
ACS revealed the following findings. Firstly, non-calcified plaques tended to cluster in the proximal 
portion of the coronary arteries, whereas calcified lesions were more equally distributed. The second 
observation was that in patients presenting with ACS, a significantly lower percentage of observed 
lesions were completely calcified as compared to lesions in the patients with stable CAD. Accordingly, 
average plaque SI was significantly lower in the ACS patients as compared the patients with stable 
CAD. Finally, even in non-culprit vessels, multiple non-calcified lesions were noted. Accordingly, 
average lesion SI was lower in both culprit and non-culprit vessels in ACS patients as compared to 
lesions in stable CAD patients.
The spatial distribution of non-calcificied lesions 
In the present study, the majority of non-calcified lesions were located in the proximal regions of the 
coronary arteries. Although this finding may have been influenced by the possibility that smaller non-
calcified plaques located more distally are more difficult to detect, previous studies underline the 
current observation. Wang et al recently studied the spatial distribution of acute myocardial infarction 
occlusions in 208 patients and observed that the majority of acute coronary occlusions, caused by 
unstable plaque erosions or ruptures, were located in the proximal third of the coronary artery tree 13. 
The incidence of calcified lesions 
A relative lack of calcified lesions in patients with ACS has been reported previously with most 
observations based on angiographic or intravascular ultrasound (IVUS) findings 14-17. In a recent 
study by Beckman et al. the extent of coronary calcifications was measured by the angle of its arc in 
43 and 18 patients with respectively unstable angina and myocardial infarction, while 17 patients 
with stable CAD served as a control group 15. The authors observed a significant decrease in the 
average calcium arc from 32 ±7° in the stable CAD patients to an average of 15±4° in the patients 
with unstable angina.In other angiographic studies, similar results have been reported 14;16;17. 
Although the presence and extent of coronary calcifications can be evaluated with MSCT, data 
obtained with MSCT are currently still scarce. In a recent study, plaque morphology and composition 
Table 3. Distribution of plaque types between culprit and non-culprit lesions of ACS patients as compared to 
plaques in stable CAD patients.
Plaque type Culprit vessels Non-culprit vessels Vessels in stable CAD 
Non-calcified 9 (21%) 9 (16%) 3 (2%)
Mixed 19 (45%) 17 (29%) 11 (9%)
Calcified 14  (33%) 32 (55%) 114 (89%)
Total 42 58 128
Abbreviations: ACS: acute coronary syndrome; CAD: coronary artery disease.
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was evaluated using MSCT in 37 patients presenting with either ACS or stable CAD. In line without our 
observations, the authors found relatively more non-calcified plaques in culprit lesions in patients 
with ACS as compared to patients with stable CAD (100% versus 77%) 18. In contrast, the prevalence 
of calcified plaques in culprit lesions in ACS patients was considerably lower (71% versus 85%). 
These findings underline the notion that the presence of coronary calcium more likely represents 
a feature of advanced obstructive CAD rather than the typical substrate for acute coronary events. 
Accordingly, identification of patients at risk based on merely coronary calcium scoring, as has been 
proposed, may be insufficient in the setting of ACS. 
The incidence of non-calcified lesions in culprit and non-culprit vessels
Another finding of the current study was that the non-calcified and mixed plaques were equally 
distributed among culprit and non-culprit vessels of ACS patients, resulting in an average SI of 
lesions located in non-culprit vessels that was still significantly lower than that of lesions in stable 
CAD patients. Although the number of significantly stenosed vessels was comparable between 
populations, lesions tended to be more diffuse in patients with ACS, reflected by a significantly 
higher average number of diseased coronary arteries per patient.
A surge of coronary events has been observed in ACS patients in the months following their initial 
presentation 5. Even within a year, a large portion of patients will present with recurrent ACS or 
infarction and may require intervention 5. Not only worsening of the originally treated culprit lesions 
may be the cause of recurrent complaints in these patients but also worsening of lesions that were 
initially deemed insignificant. Indeed, evidence is accumulating that multiple sites of rupture-
vulnerable plaque are present in patients presenting with ACS rather than one site of complex plaque 
or thrombus 5. Plaque instability may result from generalized inflammation that affects the entire 
coronary tree rather than a single site, a finding that is underlined by the elevated inflammation 
markers circulating in patients presenting with unstable symptoms. Thus, although one single lesion 
may be clinically active at the time of ACS, multiple, potentially unstable, lesions may be present 
throughout the entire coronary tree.
 
(Non-invasive) imaging
Accordingly, conventional coronary angiography may be suboptimal in patients presenting with 
ACS, particularly with regard to prognosis. Invasive angiography may identify only the most severe 
lesions rather than assessing the presence of widespread but non-significant lesions and as a 
consequence overall plaque burden may be underestimated. Although the additional use of IVUS 
during coronary angiography may be extremely useful for depicting the coronary artery wall, it is 
an invasive technique with inherent limitations. MSCT on the other hand, has the advantage that it 
permits direct and non-invasive visualization of coronary artery lumen with corresponding plaques. 
Accordingly, MSCT may allow identification of patients at risk for ACS, but larger studies are needed 
to confirm this hypothesis.
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Limitations
The current study has several limitations. First, only conventional coronary angiography was 
performed and no comparison between MSCT and IVUS was available. Accordingly, observed 
plaques were classified as calcified, mixed or non-calcified whereas identification of fibrotic or lipid-
rich material was not possible. Also, data were acquired using 2 different MSCT scanners, which may 
hamper the reproducibility of our results. Second, whether lesions with low SI on MSCT actually 
reflect potentially unstable lesions has not been established yet and prospective studies are needed 
to determine whether these plaques are indeed associated with an increased incidence of coronary 
events. 
Finally, several limitations need to be acknowledged that are inherent to MSCT. The radiation burden 
of MSCT is still high and the technique remains limited to patients with low heart rate, making 
administration of beta-blocking agents necessary prior to MSCT 19. 
Conclusion
MSCT revealed that significantly less calcified lesions were present in ACS patients as compared 
to patients with stable CAD. Moreover, even in non-culprit vessels, multiple non-calcified plaques, 
which may represent high-risk lesions, were detected, indicating diffuse disease rather than focal 
atherosclerosis in ACS. Future studies are warranted to determine whether assessment of plaque 
type and distribution with MSCT may indeed allow identification of patients at increased risk for 
coronary events.
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Abstract
Background
Cardiovascular events are high in patients with type 2 diabetes while their risk stratification 
is more difficult. The higher risk may be related to differences in coronary plaque burden and 
composition. The purpose of the study was to evaluate whether differences in the extent and 
composition of coronary plaques in patients with and without diabetes can be observed using 
MSCT. 
Methods
MSCT was performed in 215 patients (86, 40% with type 2 diabetes). The number of diseased 
coronary segments was determined per patient; each diseased segment was classified as 
showing obstructive (≥50% luminal narrowing) disease or not. In addition, plaque type (non-
calcified, mixed and calcified) was determined. Plaque characteristics were compared in 
patients with and without diabetes. Regression analysis was performed to assess correlation 
between plaque characteristics and diabetes.
Results
Patients with diabetes showed significantly more diseased coronary segments compared 
to non-diabetic patients (4.9±3.5 vs. 3.9±3.2, p=0.03) with more non-obstructive (3.7±3.0 
vs. 2.7±2.4, p=0.008) plaques. Relatively more non-calcified (28% vs. 19%), calcified (49% vs. 
43%) and less mixed (23% vs. 38%) plaques were observed in diabetes (p<0.0001). Diabetes 
correlated with the number of diseased segments, non-obstructive, non-calcified and calcified 
plaques.
Conclusions
Differences in coronary plaque characteristics on MSCT were observed between patients 
with and without diabetes. Diabetes was associated with higher coronary plaque burden. 
More non-calcified and calcified plaques while less mixed plaques were observed in diabetic 
patients. Thus, MSCT may be used to identify differences in coronary plaque burden, which 
may be useful for risk stratification.
285Non-Invasive Assessment of Plaque Characteristics in  Diabetes
Introduction
At present, 200 million people have diabetes mellitus worldwide while its prevalence is expected 
to continue increasing exponentially 1. A close relationship between type 2 diabetes and the 
development of coronary artery disease (CAD) exists and cardiovascular disease is the main cause of 
death in this patient population 2.
Non-invasive testing, including myocardial perfusion scintigraphy and dobutamine stress-
echocardiography, has been used to detect CAD in diabetic patients 3;4 and a clear association 
between abnormal test results and worse outcome has been demonstrated similar to the general 
population 6. Nonetheless, after normal findings, still elevated event rates are observed in diabetic 
patients as compared to non-diabetic individuals 6;7, indicating a need for further refinement of 
prognostification in this population. The higher event rates in patients with diabetes as compared 
to patients without diabetes could be related to differences in coronary plaque burden and 
composition. Therefore, direct visualization of coronary plaque burden could be a useful tool for risk 
stratification. Indeed, using invasive techniques, a considerably higher extent of CAD and plaque 
burden has been demonstrated in the presence of diabetes 8;9.
To date, atherosclerosis has been non-invasively assessed in patients with type 2 diabetes using 
coronary calcium scoring revealing extensive atherosclerosis 5;6. Still, coronary calcium scoring may 
seriously underestimate coronary plaque burden as non-calcified lesions are not recognized 7. More 
recently, contrast-enhanced multi-slice computed tomography (MSCT) coronary angiography 
has become available which allows, in contrast to calcium scoring, detection of both calcified and 
non-calcified coronary lesions 8-11. As a result, the technique potentially allows a more precise non-
invasive evaluation of coronary atherosclerosis, which in turn could be valuable for improving risk 
stratification. Accordingly, the purpose of the present study was to evaluate whether differences in 
the extent and composition of coronary plaques in patients with diabetes as compared to patients 
without diabetes can be observed with MSCT.
Methods
The study population consisted of 86 (40%) patients with known type 2 diabetes mellitus and 
129 (60%) patients without diabetes mellitus who underwent examination with MSCT coronary 
angiography for recurrent chest pain complaints. Fifty-one (24%) patients were examined with 
16-slice MSCT scanner, while the majority (164, 76%) underwent examination with 64-slice MSCT. 
Diabetes was diagnosed according to the criteria set by American Diabetes Association 12: 1) 
symptoms of diabetes and casual plasma glucose level of ≥11.1 mmol/l or 2) fasting plasma glucose 
level of ≥7.0 mmol/l. Only patients in sinus rhythm, without contraindications to MSCT were included 
13. All patients gave written informed consent to the study protocol, which was approved by local 
ethics committee.
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MSCT data acquisition
All examinations were performed using Toshiba Multi-slice Aquilion systems (Toshiba Medical 
Systems, Tokyo, Japan). First, a prospective coronary calcium scan without contrast enhancement 
was performed, followed by 16- or 64-slice MSCT coronary angiography performed according to the 
protocols described elsewhere 14;15. If the heart rate was ≥65 beats/min additional oral β-blockers 
(metoprolol, 50 or 100 mg, single dose, 1 hour prior to the examination) were provided if tolerated.
MSCT data analysis
Coronary	artery	calcium	score
Coronary artery calcium was identified as a dense area in the coronary artery exceeding the threshold 
of 130 HU. Total Agatston score was recorded for each patient.
Coronary	plaque	assessment
MSCT angiograms were evaluated by two experienced observers who were unaware of the clinical his-
tory of the patients. Coronary arteries were divided into 17 segments according to the modified American 
Heart Association classification 16. The presence of coronary plaques was visually evaluated using axial im-
ages and curved multiplanar reconstructions. One coronary plaque was assigned per coronary segment. 
Plaques were classified as obstructive and non-obstructive using a 50% threshold of luminal narrowing. 
As shown in Figure 1, three types of plaques were identified: 1. non-calcified plaques=plaques having 
lower density compared with the contrast-enhanced vessel lumen, 2. calcified plaques=plaques with 
high density and 3. mixed plaques=plaques with non-calcified and calcified elements within a single 
plaque. The presence of coronary plaques on MSCT, the presence of obstructive CAD in general and 
if located in left main (LM)/left anterior descending (LAD) coronary artery as well as the presence of 
obstructive CAD in one vessel (single vessel disease) or two or three vessels (multi-vessel disease) 
were evaluated. For each patient, the number of diseased coronary segments (segments containing 
plaques or previously implanted stents), the number of coronary segments with non-obstructive as 
well as obstructive plaques were determined. Also, the number of segments with respectively non-
calcified, mixed and calcified plaques was determined.
Statistical analysis
Categorical variables were expressed as numbers (percentages) and compared between groups with 
Chi-square test. Continuous variables were expressed as mean (standard deviation) and compared 
with the two-tailed t-test for independent samples. When not normally distributed, continuous 
variables were expressed as medians (interquartile range) and compared using nonparametric 
Mann-Whitney test.
To determine the relationship between plaque characteristics and the presence of diabetes linear 
regression analysis was performed when dependent variable was continuous and logistic regression 
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analysis was performed when dependent variable was categorical. First univariate analysis was 
performed, followed by multivariate analysis with correction for the following variables: age, gender, 
risk factors for CAD, clinical presentation (typical angina pectoris or atypical chest pain together with 
the presence of multiple CAD risk factors) and use of statins.
P-values <0.05 were considered as statistically significant. Statistical analyses were performed using 
SPSS software (version 12.0, SPSS Inc, Chicago, Il, USA) and SAS software (The SAS system, release 
6.12, Cary, NC, USA: SAS Institute Inc.).
Results
Baseline characteristics of patients with diabetes and without diabetes are provided in Table 1. In 
total, 215 patients (136, 63% men, mean age 58±11 years) were included of which 86 (40%) were 
patients with known type 2 diabetes mellitus. Ninety-six (45%) patients used statins (41 (48%) 
Figure 1. An example of diffuse atherosclerosis demonstrated on MSCT coronary angiography in a patient with 
type 2 diabetes. Three-dimensional volume rendered reconstruction depicts severe narrowing of the proximal 
and mid- left anterior descending coronary artery (LAD) and occluded left circumflex coronary artery (LCx) (A). 
The findings were confirmed by conventional coronary angiography (B). Curved multiplanar reconstruction and 
the corresponding transversal sections of the LAD show multiple obstructive mixed plaques in the whole course 
of the artery (C, D). A non-obstructive plaque followed by vessel occlusion was demonstrated in the LCx coronary 
artery (E). Diffuse non-obstructive calcified plaque and an obstructive non-calcified plaque were seen in the 
right coronary artery (RCA) (F), which was confirmed by conventional coronary angiography (G).
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patients with diabetes, 55 (43%) without diabetes, p=0.47), 91 (42%) aspirin, 78 (36%) β-blockers and 
69 (32%) angiotensin converting enzyme inhibitors. Patients with diabetes mellitus were significantly 
younger as compared to patients without diabetes, had a higher mean body mass index and lower 
prevalence of previous CAD.
MSCT plaque characteristics
Total	patient	population
Coronary plaque characteristics on MSCT in the entire population and in patients presenting 
with or without diabetes mellitus are presented in Table 2 and Figure 2. After exclusion of 64 (2%) 
segments with non-diagnostic quality (n=11 small caliber, n=45 motion artefacts due to elevated 
heart rate, n=8 increased signal-to-noise ratio), a total of 2941 coronary segments were included in 
the analysis. CAD was completely absent on MSCT in 41 (19%) patients. In the remaining 174 (81%) 
patients 917 (31%) segments with plaques (n=871, 29%) or previously implanted stents (n=46, 2%) 
were observed. Of segments containing plaques, 675 (77%) showed non-obstructive and 196 (23%) 
showed obstructive CAD. In general, non-calcified plaques were observed in 204 (23%) segments, 
mixed in 271 (31%) and calcified in 396 (46%).
Diabetic	patients	versus	non-diabetic	patients
As can be derived from Table 2, the average number of diseased segments was higher in patients with 
diabetes (4.9±3.5) as compared to non-diabetic patients (3.9±3.2), p=0.03. Particularly non-obstructive 
coronary plaques were more frequently observed on MSCT in the former population (Figure 2 A). In 
addition, CAD tended to be more severe in diabetic patients as both LM/LAD disease and multi-vessel 
Table 1. Characteristics of patients with diabetes and without diabetes.
All patients
(n=215)
Patients with 
diabetes
(n=86)
Patients without 
diabetes
(n=129)
Age (yrs)* 58±11 56±11 59±12
Male gender 136 (63%) 56 (65%) 80 (62%)
Hypercholesterolemia 114 (53%) 53 (62%) 61 (47%)
Arterial hypertension 107 (50%) 48 (56%) 59 (46%)
Smoking 80 (37%) 33 (38%) 47 (36%)
Family history of CAD 82 (38%) 30 (35%) 52 (40%)
Body mass index (kg/m2)* 27±4 28±5 26±4
Obesity 37 (17%) 20 (24%) 17 (14%)
Cardiac history
Previous MI*
Previous PCI*
41 (19%)
42 (20%)
8 (9%)
9 (11%)
33 (26%)
33 (26%)
* p<0.05 between patients with and without diabetes.
Data are mean±SD or n (%).
CAD, coronary artery disease; MI, myocardial infarction; PCI, percutaneous coronary intervention.
289Non-Invasive Assessment of Plaque Characteristics in  Diabetes
disease were more frequently diagnosed, although the difference did not reach statistical significance. 
Concerning plaque types however, significant differences were observed in between diabetic and 
non-diabetic patients since patients with diabetes presented with significantly more segments 
containing non-calcified plaques (1.3±2.0 versus 0.7±1.2, p=0.005) as well as calcified plaques 
(2.3±2.8 versus 1.5±2.1, p=0.02). Accordingly, also the relative distribution of plaque types, which is 
illustrated in Figure 2 B, differed since plaques in patients with diabetes were more frequently either 
non-calcified (114/406, 28% versus 90/465, 19%) or calcified (198/406, 49% versus 198/465, 43%). In 
contrast, plaques in patients with diabetes were less frequently mixed (94/406, 23% versus 177/465, 
38%), p <0.0001.
Correlation of MSCT plaque characteristics and diabetes
The results of uni- and multivariate analyses of the correlation between MSCT plaque characteristics 
and the presence of diabetes are depicted in Table 3. After correction for baseline characteristics, the 
correlation of the number of diseased coronary segments as well as the number of segments with 
non-obstructive plaques and the presence of diabetes remained statistically significant. Concerning 
plaque type, both the number of coronary segments with non-calcified and calcified plaques 
remained significantly correlated with diabetes.
Table 2.  MSCT plaque characteristics in the whole study population and comparison
between patients with diabetes and without diabetes.
All 
patients
(n=215)
Patients with 
diabetes
(n=86)
Patients 
without 
diabetes
(n=129)
Patients 
Coronary plaques on MSCT 174 (81%) 73 (85%) 101 (78%)
Obstructive CAD 80 (37%) 34 (40%) 46 (36%)
Single vessel disease 43 (20%) 16 (19%) 27 (21%)
Multi-vessel disease 37 (17%) 18 (21%) 19 (15%)
Obstructive CAD in LM/LAD 61 (28%) 29 (34%) 32 (25%)
Total Agatston calcium score 73 (0-387) 72 (0-372) 74 (0-391)
Segments 
Nr of diseased segments* 4.3±3.4 4.9±3.5 3.9±3.2
Nr of segments with obstructive plaques 0.9±1.7 1.0±1.8 0.9±1.6
Nr of segments with non-obstructive plaques* 3.1±2.7 3.7±3.0 2.7±2.4
Nr of segments with non-calcified plaques* 1.0±1.6 1.3±2.0 0.7±1.2
Nr of segments with mixed plaques 1.3±1.8 1.1±1.5 1.4±2.0
Nr of segments with calcified plaques* 1.8±2.4 2.3±2.8 1.5±2.1
* p<0.05 between patients with and without diabetes.
Data are mean±SD, median (interquartile range) or n (%). 
CAD, coronary artery disease; LAD, left anterior descending coronary artery; LM, left main coronary artery; MSCT, 
multi-slice computed tomography.
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Figure 2. A. Clustered columns demonstrating the distribution of diseased coronary segments, segments with 
non-obstructive and obstructive plaques in diabetic and non-diabetic patients. B. Bar graph demonstrating the 
relative distribution of coronary segments with different plaque types in patients with diabetes mellitus and 
without diabetes (p<0.0001).
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Table 3. Estimates of correlation of MSCT plaque characteristics with the presence of diabetes.
Univariate Multivariate
MSCT characteristics Parameter 
estimate
p-value Parameter 
estimate
p-value
Patients
Total Agatston calcium score 127.91 0.11 139 0.08
Coronary plaques on MSCT 1.56 (0.76-3.21) 0.23 1.35 (0.56-3.26) 0.50
Non-obstructive CAD 1.53 (0.70-3.32) 0.28 1.11 (0.42-2.94) 0.83
Obstructive CAD 1.59 (0.72-3.52) 0.25 2.09 (0.68-6.49) 0.20
Obstructive CAD in LM/LAD 1.70 (0.77-3.74) 0.19 2.89 (0.90-9.31) 0.08
Single vessel disease 1.11 (0.46-2.67) 0.82 1.35 (0.43-4.29) 0.61
Multi-vessel disease 1.77 (0.72-4.35) 0.21 4.78 (0.66-
34.37)
0.12
Segments
Nr of diseased segments 1.01 0.03 1.51 0.0004
Nr of segments with obstructive plaques 0.13 0.58 0.33 0.17
Nr of segments with non-obstructive plaques 0.99 0.008 1.27 0.0005
Nr of segments with non-calcified plaques 0.63 0.006 0.69 0.004
Nr of segments with mixed plaques -0.28 0.28 0.03 0.91
Nr of segments with calcified plaques 0.77 0.02 0.88 0.008
Data are odds ratios (CI) or estimates of correlation. 
CAD, coronary artery disease; LAD, left anterior descending coronary artery; LM, left main coronary artery; MSCT, 
multi-slice computed tomography.
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Discussion
In the present study, differences in coronary plaque characteristics between patients with and 
without diabetes mellitus were observed using MSCT coronary angiography. A significant, positive 
correlation between the presence of diabetes and coronary plaque extent was demonstrated. In 
particular, diabetes was associated with an increased number of non-obstructive plaques, indicating 
more diffuse CAD as compared to patients without diabetes. Also, differences in the distribution 
of coronary plaque types were observed, with diabetic patients showing more non-calcified and 
calcified plaques and less mixed plaques.
Plaque burden
In the present study, a larger plaque burden was observed in patients with diabetes. Similar obser-
vations  have been reported in previous invasive as well as postmortem studies 5;17;18. Nicholls et al 
recently reported observations in 654 subjects (including 128 with diabetes) using intravascular ul-
trasound; the authors demonstrated that diabetes was a strong, independent predictor of percent 
plaque volume and total atheroma volume, indicating that diabetes appears to be associated with a 
substantial increase in (diffuse) plaque burden 18.
In addition, diabetes was associated with more non-obstructive plaques in current study. This has also 
been observed in studies using invasive coronary angiography 8;9. The increased total plaque burden 
may be related with the increased event rate, as observed in diabetic patients. Moreover, it has been sug-
gested that plaque rupture may occur often in non-obstructive lesions, referred to as vulnerable plaques 
24-27. Many of these non-obstructive lesions will not be associated with stress-inducible ischemia, result-
ing in normal results on functional imaging tests, such as nuclear imaging or stress echocardiography 
28;29. Whether the larger total plaque burden and the increased prevalence of non-obstructive lesions in 
diabetic patients translate into a higher event rate remains to be determined in future studies.
Plaque composition
Another important finding of the present study is the difference in distribution of different coronary 
plaque types between patients with and without diabetes. Relatively more non-calcified and calcified 
plaques were observed in patients with diabetes. At the same time, the proportion of mixed plaques 
(possibly regarded as an intermediate phase of coronary plaque development) was significantly lower 
in patients with diabetes. Accordingly, these observations could suggest a more rapid development 
of atherosclerosis in the presence of diabetes, with faster progression from non-calcified lesions to 
completely calcified lesions. A faster progression of atherosclerosis in patients with diabetes has been 
suggested previously based on event rates in patients undergoing nuclear perfusion imaging 19;20. In 
the general population, a normal perfusion scan is associated with a low (<1%) hard event rate which 
is sustained over long-term follow-up. In patients with diabetes, the hard event rate is equally low 
in the first 2 years in patients with a normal perfusion scan, but an increased event rate (despite the 
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initial normal myocardial perfusion scan) is observed after 2 years follow-up. This observation has been 
considered to be related to a faster progression of CAD in diabetic patients.
The increased prevalence of both non-calcified and calcified plaques may also have implications 
for calcium scoring. In a recent study by Raggi et al, 10,377 asymptomatic individuals (including 
903 patients with diabetes) were followed for a period of 5±3.5 years after coronary calcium scoring 
with electron beam computed tomography 31. Higher mortality was observed in diabetic patients 
as compared to non-diabetic patients despite similar coronary calcium scores, a finding which was 
observed for every level of coronary calcification. The authors hypothesized that the difference in 
prognosis in diabetic and non-diabetic patients despite similar calcium load could be attributed 
to the presence of extensive diffuse non-calcified atherosclerosis, which could not be detected by 
calcium scoring. In line with these suggestions, the current study indeed demonstrated the presence 
of diffuse atherosclerosis with a significantly higher amount of non-calcified coronary plaques in the 
diabetic patients. Accordingly, calcium scores may underestimate total coronary plaque burden to 
higher extent in patients with diabetes, and thus, MSCT coronary angiography may have substantial 
incremental value over coronary calcium scoring, although this concept needs further study.
Limitations
This study is a comparative study, describing coronary atherosclerosis in patients with and without 
diabetes. Examinations were performed at a single time point and were not repeated over time. Also, 
MSCT angiograms were evaluated visually since no reliable quantitative algorithms are currently 
available. Two scanner generations (16- and 64-slice MSCT) were used during the study, which could 
have affected the accuracy of detection of different plaque types. Follow-up data are not yet available 
and these data are needed to determine whether the observations on MSCT may provide prognostic 
information and may potentially be used to identify diabetic patients at increased risk. Finally, patients 
in the present study were referred for non-invasive cardiac evaluation of chest pain with known or 
suspected CAD. Accordingly, the findings may not be applicable to asymptomatic diabetic patients.
In addition, several limitations of MSCT in general should be mentioned. MSCT is still associated with 
an elevated radiation dose, while also the administration of contrast media is required. Finally, the 
presence of ischemia cannot be determined on MSCT and abnormal MSCT findings should ideally 
be combined with functional data.
Conclusions
Differences in coronary plaque characteristics on MSCT were observed between patients with 
diabetes and without diabetes. Diabetes may be associated with a higher coronary plaque burden as 
determined on MSCT. Also, more non-calcified and calcified plaques in combination with less mixed 
plaques were observed in patients with diabetes, possibly reflecting faster progression of CAD in the 
presence of diabetes. MSCT may be used to identify differences in coronary plaque burden, which 
may eventually be useful for risk stratification of patients with diabetes.
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Abstract
Background 
It is expected that multi-slice computed tomography (MSCT) will be increasingly used as 
an alternative imaging modality in the diagnosis of patients with suspected CAD. Data on 
prognostic value of MSCT however are currently not available. The purpose of the study was 
to determine the prognostic value of MSCT coronary angiography in patients with known or 
suspected coronary artery disease (CAD).
Methods 
A total of 100 patients (73 men, age 59±12 years), who were referred for further cardiac 
evaluation due to suspicion of significant CAD, underwent additional MSCT coronary 
angiography to evaluate the presence and severity of CAD. Patients were followed for the 
occurrence of: 1. cardiac death, 2. non-fatal myocardial infarction, 3. unstable angina requiring 
hospitalization, 4. revascularization.
Results 
Coronary plaques were detected in 80 (80%) patients. During a mean follow-up of 16 months, 
33 events occurred in 26 patients. In patients with normal coronary arteries on MSCT, first year 
event rate was 0% versus 30% in patients with any evidence of CAD on MSCT. Observed event 
rate was highest in the presence of obstructive lesions (63%) and when obstructive lesions 
were located in the left main (LM) /left anterior descending (LAD) coronary arteries (77%). 
Nonetheless elevated event rate was also observed in patients with non-obstructive CAD 
(8%). In multivariate analysis, significant predictors of events included the presence of CAD, 
obstructive CAD, obstructive CAD in LM/LAD, number of segments with plaques, and number 
of segments with obstructive plaques. 
Conclusions 
MSCT coronary angiography provides independent prognostic information over baseline 
clinical risk factors in patients with known and suspected CAD. Excellent prognosis was noted 
in patients with a normal MSCT.
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Introduction
In patients presenting with suspected or known coronary artery disease (CAD), assessment of 
prognosis is essential in selecting appropriate patient management. Currently, extensive data are 
available on the prognostic value of myocardial perfusion imaging with single photon emission 
computed tomography (SPECT). A normal SPECT study has been shown to indicate a good clinical 
outcome with an annual death or infarct rate of < 1% per year, whereas the likelihood to develop 
cardiac events is significantly increased when perfusion abnormalities are detected 1;2. Similarly, 
coronary artery calcium score assessed by electron beam computed tomography (EBCT) or, less 
frequently, by multi-slice computed tomography (MSCT) has been used for risk stratification in 
patients with known or suspected CAD, and a calcium score < 100 has been associated with excellent 
outcome, with an increase in event rate paralleling the increase in calcium score 3;4. 
More recently non-invasive coronary angiography techniques (magnetic resonance imaging, EBCT 
and MSCT) have been introduced which allow direct visualization of coronary artery lesions. At 
present, MSCT appears to be to most robust technique for this purpose and it is expected that this 
technique will be increasingly used as an alternative first-line imaging modality in the diagnosis of 
patients presenting with chest pain suspect for CAD. MSCT allows detection of both obstructive 
as well as non-obstructive lesions, while also non-calcified lesions are visualized. Although the 
diagnostic accuracy of MSCT has been demonstrated, data on the prognostic value of MSCT are 
not available. Accordingly, the aim of the study was to determine the prognostic value of MSCT in 
patients with known or suspected CAD.
Methods
Patients and study protocol
The study population consisted of consecutive patients who presented to the outpatient clinic and 
were referred for further evaluation (using exercise-ECG, perfusion imaging or invasive coronary 
angiography) of suspected CAD (chest pain complaints, elevated risk profile or abnormal test results). 
In all patients, MSCT coronary angiography was performed in addition to the standard clinical work-
up. Subsequent clinical management was based on the latter; MSCT findings were not included in 
the diagnostic/therapeutic work-up.
Only patients without previous coronary bypass grafting who were in sinus rhythm and without 
contraindications to iodinated contrast media were included. As a result of these inclusion criteria, 
5 potentially eligible patients were not enrolled in the study due to potential contrast allergy (n=3) 
and atrial fibrillation (n=2), respectively. All patients gave written informed consent to the study 
protocol, which was approved by the local ethics committee.
A structured interview and clinical history were acquired and the following cardiac risk factors were 
assessed before the MSCT examination. 
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1. Diabetes mellitus (defined as a fasting glucose level of ≥ 7 mmol/L or the need for insulin or oral 
hypoglycaemic agents) 5. 2. Hypercholesterolemia (defined as a total cholesterol level ≥ 5 mmol/L 
or treatment with lipid lowering drugs) 6. 3. Hypertension (defined as blood pressure was ≥ 140/90 
mmHg or by the use of antihypertensive medication) 7. 4. Obesity (body mass index ≥30kg/m²) 8. 5. 
Positive family history of CAD (defined as the presence of CAD in first degree relatives younger than 
55 (males) or 65 (females) years of age) 9 and 6. Smoking (defined as previous or current smoking). 
MSCT data acquisition
All examinations were performed using Toshiba Multi-slice Aquilion systems (Toshiba Medical 
Systems, Tokyo, Japan). If the heart rate was ≥65 beats/min additional oral beta-blockers (metoprolol, 
50 mg, single dose, 1 hour prior to scan) were provided if tolerated. First, a prospectively triggered 
coronary calcium scan was performed prior to MSCT angiography with identical parameters for 16- 
and 64-slice MSCT systems: collimation 4 x 3.0 mm, gantry rotation time 500 ms, the tube voltage 
and tube current 120 kV and 200 mA, respectively. The temporal window was set at 75% after the 
R-wave for electrocardiographically triggered prospective reconstruction.
Sixteen-slice MSCT coronary angiography was performed according to the protocol described 
elsewhere 10. The following parameters were applied for 64-slice MSCT CA: collimation of 64 x 0.5 
mm, tube rotation time of 400, 450 or 500 ms, depending on the heart rate, tube current 300 mA at 
120 kV. Non-ionic contrast material was administered in the antecubital vein with an amount of 80 
to 105 ml, depending on the total scan time, and a flow rate of 5 ml/sec (Iomeron 400 ®, Bracco Altana 
Pharma, Konstanz, Germany). Automated detection of peak enhancement in the aortic root was used 
for timing of the scan. All images were acquired during an inspiratory breath hold of approximately 
10 s, with simultaneous registration of the patient’s electrocardiogram. With the aid of a segmental 
reconstruction algorithm, data of one, two or three consecutive heartbeats were used to generate a 
single image.
To evaluate the presence of coronary artery plaques, reconstructions in diastole (typically 75% of the 
cardiac cycle) were generated with a slice thickness of 0.5 mm at an increment of 0.3 mm. If motion 
artefacts were present, additional reconstructions were made in different time points of the R-R 
interval. Axial data sets were transferred to a remote workstation (Vitrea2, Vital Images, Plymouth, 
Minn. USA) for post-processing and subsequent evaluation.
MSCT data analysis
Coronary	artery	calcium	score
The coronary artery calcium score was assessed with the application of dedicated software (Vitrea2, 
Vital Images, Plymouth, Minn. USA). Coronary artery calcium was identified as a dense area in the 
coronary artery exceeding the threshold of 130 HU. An overall Agatston score was recorded for each 
patient.  
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Coronary	plaque	assessment
For the current study, all MSCT angiograms were evaluated within a time-frame of 2 weeks by 
2 experienced observers unaware of the clinical history of the patients, using a standard analysis 
(see below). In case of disagreement, a joint reading was performed and a consensus decision was 
reached. Coronary arteries were divided into 17 segments according to the modified American 
Heart Association classification 11. Only segments with a diameter >1.5 mm (as measured on the 
MSCT coronary angiogram) were included. First, each segment was classified as interpretable or not. 
Predefined, patients were excluded from the analysis in case of 1. an uninterpretable proximal or mid 
segment or 2. more than 3 uninterpretable segments in general. 
Then, the interpretable segments were evaluated for the presence of any atherosclerotic plaque using 
axial images and curved multiplanar reconstructions. Coronary plaques were defined as structures >1 
mm2 within and/or adjacent to the coronary artery lumen, which could be clearly distinguished from the 
vessel lumen and the surrounding pericardial tissue, as previously described 12. Subsequently, the type of 
plaque was determined per segment using the following classification:  1. non-calcified = plaque having 
lower density compared with the contrast-enhanced vessel lumen present without any calcification 
discernible, 2. calcified plaque = only plaque with high density present and 3. mixed plaque = plaque 
with non-calcified and calcified elements present. Finally, it was determined for each segment whether 
obstructive luminal narrowing, using a threshold of 50% luminal narrowing, was present or not. For 
each patient, the number of diseased coronary segments, number of segments with obstructive lesions 
as well as number of each type of plaques was calculated. Patients without coronary artery calcium or 
coronary plaques on MSCT were considered normal; an abnormal MSCT was defined in the presence of 
≥1 coronary plaque. Abnormal patients were further classified as having obstructive coronary plaques 
(≥50% luminal narrowing) in one ore more coronary arteries, as well as having obstructive coronary 
lesions in the left main (LM) and/or left anterior descending (LAD) coronary arteries. 
Follow-up
Follow-up information was obtained by either clinical visits or telephone interviews. Hospital 
records of all patients were screened for the occurrence of clinical events to confirm the obtained 
information. Clinical endpoints were the occurrence of 1. cardiac death, 2. non-fatal infarction, 3. 
unstable angina requiring hospitalization, 4. revascularization. Cardiac death was defined as death 
caused by acute myocardial infarction, ventricular arrhythmias, or refractory heart failure. Nonfatal 
myocardial infarction was defined based on criteria of typical chest pain, elevated cardiac enzyme 
levels, and typical changes on the ECG 13. 
Statistical analysis 
Categorical baseline characteristics are expressed as numbers and percentages, and compared 
between 2 groups with the Chi-square test. Continuous variables are expressed as mean (standard 
deviation) and compared with the two-tailed t-test for independent samples. When not normally 
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distributed, continuous variables are expressed as medians (25th - 75th percentile range) and 
compared using non-parametric Mann-Whitney test. 
To identify the association between MSCT variables and outcomes, Cox regression analysis was used. A 
composite endpoint of cardiac death, non-fatal infarction, unstable angina requiring hospitalization, 
and revascularization was used. First, univariate analysis of baseline clinical characteristics and MSCT 
variables was performed to identify potential predictors. Hazard ratios were calculated with 95% 
confidence intervals as an estimate of the risk associated with a particular variable. To determine 
independent predictors of the composite endpoint, multivariate analysis of MSCT variables with p ≤ 
0.05 in the univariate analysis was performed, which was corrected for scanner type, age, EuroSCORE 
and baseline characteristics with p ≤ 0.5 in the univariate analysis.
Cumulative event rates as a function over time were obtained by the Kaplan-Meier method. Event 
curves of the composite endpoint (cardiac death, non-fatal infarction, unstable angina requiring 
hospitalization, revascularization) and hard cardiac events (cardiac death, non-fatal infarction and 
unstable angina requiring hospitalization) were compared using the log-rank test. 
Statistical analyses were performed using SPSS software (version 12.0, SPSS Inc, Chicago, Il, USA) and 
SAS software (The SAS system, release 6.12, Cary, NC, USA: SAS Institute Inc.). P-values < 0.05 were 
considered as statistically significant.
Results
Patient characteristics
In total, 104 consecutive patients were enrolled in the present study and underwent MSCT coronary 
angiography. In 4 patients, an elevated and/or irregular heart rate during MSCT data acquisition 
rendered the MSCT data set uninterpretable, and these patients were excluded from the analysis. As 
a result, 100 patients (73 men, mean age 59±12 years) were included in the analysis (15 patients were 
included in a previous study on the diagnostic accuracy of MSCT in direct comparison with invasive 
angiography 10). Baseline characteristics are provided in Table 1. Briefly, 65 patients (65%) presented 
with suspected CAD at the time of MSCT, whereas CAD was known in the remaining 35 patients (35%) 
(33 patients had previous myocardial infarction, 31 patients had previous percutaneous coronary 
intervention). In total, 55 patients underwent 16-slice MSCT and 45 underwent 64-slice MSCT.
Multi-Slice Computed Tomography
MSCT characteristics are provided in Table 2. Only coronary segments with sufficient lumen diameter 
for evaluation of presence of plaques were included in the analysis. After exclusion of 33 (2%) coronary 
segments with stents and 19 (1%) non-evaluable segments due to motion artefacts, plaque burden was 
evaluated in 1298 segments. CAD was completely absent in 20 patients. In the remaining 80 patients, 345 
coronary segments with plaques were observed, of which 47 (14%) contained non-calcified plaques, 109 
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(31%) mixed plaques and 189 (55%) calcified plaques. In 71 (21%) segments of 32 (32%) patients, plaques 
were regarded as obstructive (≥ 50% luminal narrowing). Thirty-two (9%) segments with obstructive le-
sions in 23 (23%) patients were located in the LM and/or LAD coronary artery. In Figure 1, examples of 
different MSCT observations, including normal coronary arteries, non-obstructive CAD and obstructive 
CAD in the LM, are illustrated. 
Follow-up results
During a mean follow-up of 16 ± 8 months (median 12 months, range 5 – 39 months), 33 events 
occurred in 26 patients (with 7 events occurring repeatedly). One patient (1%) died of acute myocardial 
infarction. Non-fatal myocardial infarction occurred in 3 patients (3%), unstable angina requiring 
hospitalization occurred in 4 patients (4%, with 1 also undergoing revascularization). A total of 24 
patients (24%) underwent coronary revascularization; percutaneous coronary intervention was 
performed in 17 patients, whereas the remaining 7 patients underwent coronary artery bypass 
grafting. The decision for revascularization was based on worsening angina and/or the presence of 
ischemia on non-invasive testing.
Table 1. Characteristics of the study population and comparison between patients with and without events 
(data are expressed as number (%)).
All patients
(n=100)
Patients
with events
(n=26)
Patients without 
events
(n=74)
Clinical characteristics
Age (yrs)*
(mean ± SD)
59±12 63±10 58±12 
Male gender 73 (73%) 20 (77%) 53 (72%)
Obesity 20 (20%) 4 (18%) 16 (22%)
Diabetes 21 (21%) 5 (19%) 16 (22%)
Hypercholesterolemia 50 (50%) 15 (58%) 35 (47%)
Hypertension 44 (44%) 9 (35%) 35 (47%)
Family history of CAD 42 (42%) 12 (46%) 30 (41%)
Smoking 39 (39%) 13 (50%) 26 (35%)
EuroSCORE value* (mean ± SD) 2.4±2.2 3.4±2.5 2.1±2 
Cardiac history
Suspected CAD
Previous MI
Previous revascularization
65 (65%)
33 (33%)
31 (31%)
14 (54%)
11 (42%)
10 (39%)
51 (65%)
22 (30%)
21 (28%)?
Medical therapy
ACE inhibitors 37 (37%) 7 (27%) 30 (41%)
Nitrates 14 (14%) 4 (15%) 10 (14%)
Beta-blockers 56 (56%) 16 (62%) 40 (54%)
Aspirin 54 (54%) 17 (65%) 37 (50%)
Statins 50 (50%) 12 (46%) 38 (51%)
* p < 0.05 between patients with and without events.
ACE: angiotensin converting enzyme; CAD: coronary artery disease; MI: myocardial infarction. 
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Figure 1.  Examples of different MSCT observations. In Panels A, B, and C, curved multi-planar reconstructions of 
respectively the LAD, LCx and RCA of a patient with normal coronary arteries are provided. In Panel D, a curved 
multi-planar reconstruction of the RCA is provided revealing diffuse CAD without obstructive lesions. In Panel E, 
stenosis of the LM as well as proximal LAD can be observed.
Table 2. MSCT Characteristics of the study population and comparison between patients with and without 
events
All patients
(n=100)
Patients
with events
(n=26)
Patients without 
events
(n=74)
Total Agatston score*
(median, 25th-75th percentile)
147 (0-383) 311 (122-552) 62 (0-309)
Coronary plaques on MSCT* (number (%)) 80 (80%) 26 (100%) 54 (73%)
Obstructive CAD* (number (%)) 32 (32%) 20 (77%) 12 (16%)
Obstructive CAD in LM/LAD* (number (%)) 23 (23%) 18 (69%) 5 (7%)
Nr of segments with plaques*
(median, 25th-75th percentile) 
3 (1-5) 5 (4-7) 2 (0-5)
Nr of segments with obstructive plaques*
(median, 25th-75th percentile)
0 (0-1) 1.5 (0.8-3) 0
Nr of segments with non-calcified plaques
(median, 25th-75th percentile)
0 (0-1) 0 (0-1) 0 (0-1)
Nr of segments with mixed plaques*
(median, 25th-75th percentile)
0 (0-2) 2 (0.8-3.3) 0 (0-2)
Nr of segments with calcified plaques*
(median, 25th-75th percentile)
1 (0-3) 2.5 (1-4) 1 (0-3)
* p < 0.05 between patients with and without events.
CAD: coronary artery disease; LAD: left anterior descending coronary artery; LM: left main coronary artery; MSCT: 
multi-slice computed tomography.
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Predictors of events
Baseline and clinical characteristics of patients with and without events are described in Table 1. Patients 
presenting with events during follow-up were significantly older (p = 0.03) and had worse clinical condi-
tion, as indicated by an elevated EuroSCORE value (p = 0.01). No significant differences in risk factors for 
CAD and use of medication were observed.  
Differences in MSCT characteristics of patients with and without events are summarized in Table 2. Pa-
tients with events had more extensive atherosclerosis on MSCT as reflected by a higher coronary calcium 
score, and a higher number of segments showing (obstructive) plaques. Also, relatively more mixed and 
calcified plaques were observed as compared to patients without events.  
In Table 3, the univariate analysis of both clinical and MSCT characteristics to predict events is sum-
marized. In the multivariate analysis (Table 4), MSCT characteristics that were significant during 
Table 3. Univariate predictors of events
HR (95% CI) p-value
Clinical characteristics
Age (yrs) 1.0 (0.99 -1.0) 0.12
Male gender 0.86 (0.34-2.2) 0.75
Obesity 0.71 (0.24-2.0) 0.52
Diabetes 0.85 (0.32-2.3) 0.74
Hypercholesterolemia 1.4 (0.62-3.0) 0.45
Hypertension 0.62 (0.28-1.3) 0.24
Family history of CAD 1.3 (0.61-2.9) 0.47
Smoking 1.7 (0.77-3.6) 0.19
Previous revascularization 1.4 (0.62-3.1) 0.63
Previous infarction 1.5 (0.67-3.2) 0.92
EuroSCORE value 1.1 (0.99-1.3) 0.08
Medical therapy
ACE inhibitors 0.65 (0.28-1.6) 0.34
Nitrates 1.0 (0.36-3.0) 0.94
Beta-blockers 1.4 (0.61-3.0) 0.46
Aspirin 1.8 (0.80-4.0) 0.15
Statins 0.86 (0.40-1.9) 0.70
MSCT characteristics
Total Agatston score 1.1 (1.0-1.1) 0.06
Presence of coronary plaques on MSCT 8.0 (1.1-59) 0.04
Abnormal coronary arteries, non-obstructive CAD (as compared to no CAD) 2.7 (0.32-22) 0.36
Abnormal coronary arteries, obstructive CAD (as compared to no CAD) 22 (2.9-166) 0.003
Abnormal coronary arteries, non-obstructive CAD in LM/LAD        3.1 (0.39-25) 0.29
Abnormal coronary arteries, obstructive CAD in LM/LAD 36 (4.7-276) 0.0006
Nr of segments with plaques* 1.3 (1.1-1.4) 0.0005
Nr of segments with obstructive plaques* 1.8 (1.5-2.1) <0.0001
Nr of segments with non-calcified plaques* 1.1 (0.78-1.6) 0.43
Nr of segments with mixed plaques* 1.5 (1.3-1.9) 0.0002
Nr of segments with calcified plaques* 1.1 (0.98-1.3) 0.1
* Ratio per segment
ACE: angiotensin converting enzyme; CAD: coronary artery disease; CI: confidence interval; HR: hazard ratio; LAD: 
left anterior descending coronary artery; LM: left main coronary artery; MI: myocardial infarction; MSCT: multi-slice 
computed tomography.
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univariate analysis were corrected for age and EuroSCORE as well baseline characteristics with p ≤ 
0.5 during univariate analysis to ensure absence of potential confounders. Also, the type of scanner 
(16- versus 64-slice MSCT) used was included in the multivariate analysis. As indicated in Table 4, 
the remaining significant independent predictors of cardiac events in the multivariate analysis were 
the presence of coronary plaques, obstructive CAD, LM/LAD disease, number of coronary segments 
with plaques, number of coronary segments with obstructive plaques and number of coronary seg-
ments with mixed plaques.
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Table 4. Multivariate predictors of events, corrected for baseline variables
MSCT characteristics Multivariate p-value
Presence of coronary plaques on MSCT 8.8 (1.1-70) 0.04
Obstructive CAD 28 (3.3-239) 0.002
Obstructive CAD in LM/LAD 35 (4.3-288) 0.0009
Nr of segments with plaques* 1.3 (1.1-1.6) 0.0009
Nr of segments with obstructive plaques* 1.8 (1.5-2.2) <0.0001
Nr of segments with mixed plaques* 1.6 (1.2-2.0) 0.0003
* Ratio per segment
Data are Cox’s proportional hazard ratios (95% confidence intervals).
MSCT: multi-slice computed tomography.
Figure 2. Kaplan-Meier curves for all events (cardiac death, non-fatal infarction, unstable angina requiring hospi-
talization, revascularization) in patients with normal and abnormal coronary arteries on MSCT. 
Abbreviations: MSCT: multi-slice computed tomography.
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Survival analysis
Kaplan-Meier survival curves are provided in Figures 2 to 5. As can be derived from Figure 2, no 
events occurred in patients with normal coronary arteries on MSCT, whereas a first year event rate 
(including all events) of 30% was observed in patients with any CAD on MSCT (log-rank p-value = 
0.005). Excluding revascularizations resulted in a first year hard cardiac event rate of 5% in patients 
with CAD on MSCT, as compared to 0% in patients with completely absent CAD on MSCT (log-rank 
p-value = 0.19) (Figure 3). 
In Figure 4, the relation between the severity of CAD and the occurrence of events was further 
explored, showing an increased event rate in patients with obstructive CAD (63%) as compared to 
patients without CAD (0%) or non-obstructive CAD (8%) (log-rank p-value < 0.001). Finally, LM/LAD 
disease was found to be associated with the highest event rate (77%) as shown in Figure 5 (log-rank 
p-value < 0.001).  
Discussion 
In the present study MSCT coronary angiography provided independent prognostic information for 
predicting cardiac events. Patients with completely absent CAD on MSCT coronary angiography had 
excellent prognosis (0% event rate), whereas an increased event rate (30%) was observed in patients 
with CAD on MSCT. Furthermore, the risk of cardiac events increased with the extent of CAD as 
observed on MSCT, and patients with obstructive lesions (particularly in the LM and LAD) were shown 
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Figure 3. Kaplan-Meier curves for hard cardiac events (cardiac death, non-fatal infarction and unstable angina 
requiring hospitalization) in patients with normal and abnormal coronary arteries on MSCT. 
MSCT: multi-slice computed tomography.
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to be at the greatest risk for cardiac events. Even after correction for baseline clinical variables such as 
age and risk factors, MSCT variables reflecting coronary plaque burden, including the severity, extent 
and location of atherosclerosis, remained independent predictors of cardiac events. 
The prognostication and subsequent management of patients with known or suspected CAD in current 
practice relies on initial clinical evaluation, with the low-risk patients being reassured and the high-
risk patients being referred for invasive angiography 14. However, the majority of these patients are in 
the intermediate risk group, in whom prognosis and subsequent management is less well-defined. 
Accordingly, these patients need additional testing with one or more of the established non-invasive 
modalities, which include exercise electrocardiography, stress SPECT imaging or stress echocardiography 
14. All these techniques aim at detecting ischemia. Exercise electrocardiography is not an ideal modality 
due to the suboptimal accuracy, and imaging of stress-induced perfusion abnormalities or systolic wall 
motion abnormalities may be preferred; indeed average sensitivity and specificity of 87% and 73% 
to detect CAD have been reported for SPECT versus 82% and 84% for stress echocardiography 15;16. In 
addition, these tests proved to be predictive of future cardiac events when abnormalities were found 
and were associated with a low risk for events when the test results were normal 17-19.
MSCT coronary angiography is a highly accurate, non-invasive imaging technique for the diagnosis 
of CAD; in particular, the negative predictive value of MSCT approaches 100%, allowing rule out of 
CAD 20;21.
The current study explored the prognostic value of MSCT in a symptomatic patient population 
with known or suspected CAD and a high prevalence of conventional risk factors.  Consequently, 
the pre-test likelihood of CAD was high in this population, and even in patients without known 
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Figure 4. Kaplan-Meier curves for all events (cardiac death, non-fatal infarction, unstable angina requiring hos-
pitalization, revascularization) in patients with normal coronary arteries, non-obstructive CAD and obstructive 
CAD on MSCT. 
CAD: coronary artery disease; MSCT: multi-slice computed tomography.
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disease, CAD was present on MSCT in 69%. Not surprisingly therefore, high cardiac event rates were 
observed. Most importantly however, a 100% event free survival was noted in patients without 
any abnormalities on MSCT, highlighting an excellent negative predictive value of a normal MSCT. 
This finding is of major clinical relevance, since these patients may indeed be safely reassured 
without need for further testing. Patients with coronary atherosclerosis identified on MSCT were 
shown to have worse prognosis. More detailed analysis revealed that although the risk of events 
was considerably higher in patients with obstructive CAD, patients with non-obstructive CAD still 
were at elevated risk as compared to patients without CAD. Indeed, previous studies support the 
notion that plaque composition (in addition to stenosis severity) is predictive of events. Moreover, 
Mann et al demonstrated in a post-mortem study that lipid core size and minimal cap thickness, 
2 major determinants of plaque vulnerability, were not related to absolute plaque size or degree 
of stenosis 22. Accordingly, vulnerable plaques may occur across the full spectrum of severity of 
stenosis, underlining that also non-obstructive lesions may contribute to coronary events 23;24. Since 
less-obstructive plaques are more frequent than severely obstructive plaques, coronary occlusion 
and myocardial infarction may in fact most frequently arise from mild to moderate stenoses 23;25-28. 
Pooling of these angiographical studies showed that 68% of myocardial infarctions were attributable 
to so-called “angiographically silent” lesions (luminal narrowing < 50%), whereas the culprit in 
only 14% could be assigned to a severe stenotic lesion (> 70%) 29. In line with these observations, 
multivariate analysis of the possible predictors of cardiac events in the present study demonstrated 
that non-obstructive CAD was indeed an independent predictor of future cardiac events. Of interest, 
the presence of mixed plaques, which may represent less advanced and possibly less stabilized 
Figure 5. Kaplan-Meier curves for all events (cardiac death, non-fatal infarction, unstable angina requiring hos-
pitalization, revascularization) in patients with normal coronary arteries, patients without obstructive CAD in 
LM/LAD and patients with obstructive CAD in LM and/or LAD on MSCT. 
CAD: coronary artery disease; LAD: left anterior descending coronary artery; LM: left main coronary artery; MSCT: 
multi-slice computed tomography.
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atherosclerosis as compared to dense calcified lesions 30, was shown to be an independent predictor 
as well. However, further investigations are clearly needed to support these observations.
Nonetheless, considering individual lesions, the likelihood of progression to coronary occlusion 
(and subsequent myocardial infarction) remains highest for severe obstructive lesions 23;25;26. Indeed, 
prospective evaluation of non-bypassed coronary segments, as was performed in the Coronary 
Artery Surgery Study (CASS), showed that during a 5 year follow-up only 0.7% and 2.3% of segments 
with narrowing of respectively <5% and 5% to 49% resulted in coronary occlusion 25. In contrast, 
occlusion occurred in 10.1% and even 23.6% of lesions with narrowing 50% to 80% and 81% to 95%, 
respectively. In agreement, high event rates were observed for patients with obstructive CAD in 
the present study. More detailed analysis showed that hazard ratios were highest for patients with 
obstructive CAD in either the LM or LAD coronary arteries. Indeed previous studies demonstrated 
that patients with severe proximal LAD disease are at high risk 31-33; for example Califf et al reported 
a 59% event free survival at 5 years in patients with 3-vessel disease and proximal LAD disease 34. 
Accordingly, early identification of these patients with MSCT will be crucial to optimize therapy. 
Study limitations
The prognostic value of MSCT in the present study was evaluated in patients presenting with a 
wide spectrum of different conditions, including patients with no previous history of CAD as well 
as patients with previous myocardial infarction and revascularization. Accordingly, treatment 
strategies may have differed substantially within the studied population and future studies will 
need to address the prognostic role of MSCT coronary angiography in more homogeneous patient 
populations. Also, the study population was small and some clinically relevant predictors may not 
have reached statistical significance. Studies in larger cohorts (with longer follow-up) are clearly 
warranted to confirm these initial results. 
Conclusion
This is the first study to demonstrate the independent prognostic value of MSCT coronary 
angiography over baseline clinical risk factors in patients presenting with chest pain. An excellent 
prognosis (0% event rate) was noted in patients with a normal MSCT. The presence of CAD (either 
non-obstructive or obstructive atherosclerotic lesions) was associated with an event rate of 30%. 
The event rate was highest in the presence of obstructive lesions and when lesions were located in 
the LM/LAD coronary arteries. Future studies are needed to further define the prognostic value of 
MSCT.
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Abstract
Background 
Contrast-enhanced Magnetic Resonance Imaging (ce-MRI) allows precise delineation of 
infarct transmurality. An issue of debate is whether data analysis should be performed visually 
or quantitatively. Accordingly, a head-to-head comparison was performed between visual and 
quantitative analysis of infarct transmurality on ce-MRI. In addition, infarct transmurality was 
related to the severity of resting wall motion abnormalities. 
Methods 
In 27 patients with chronic ischemic left ventricular (LV) dysfunction (LV ejection fraction 
33 ± 8%) and previous infarction, cine MRI (to assess regional wall motion) and ce-MRI were 
performed. Using a 17-segment model, each segment was assigned a wall motion score (from 
normokinesia to dyskinesia) and segmental infarct transmurality was visually assessed on a 
5-point scale (0=no infarction, 1=transmurality ≤25% of LV wall thickness, 2=transmurality 26-
50%, 3=transmurality 51-75%, and 4=transmurality 76-100%). Quantification of transmurality 
was performed using threshold analysis; myocardium showing signal intensity above the 
threshold was considered scar tissue and the percentage of transmurality qwas calculated 
automatically. 
Results 
Wall motion was abnormal in 56% of the 459 segments and 55% of segments revealed 
hyperenhancement (indicating scar tissue). The agreement between visual and quantitative 
analysis was excellent: 90% (kappa 0.86) of segments were categorized similarly by visual and 
quantitative analysis. Infarct transmurality paralleled the severity of contractile dysfunction; 
96% of normal or mildly hypokinetic segments had infarct transmurality ≤25%, whereas 93% 
of a- and dyskinetic segments had transmurality >50% on visual analysis. 
Conclusion 
Visual analysis of ce-MRI studies may be sufficient for assessment of transmurality of 
infarction. 
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Introduction
Assessment of viability and scar tissue is important to guide treatment of patients with ischemic 
cardiomyopathy 1-3. Recently, contrast-enhanced magnetic resonance imaging (ce-MRI) has 
emerged as a non-invasive technique that allows imaging of scar tissue with a high spatial resolution. 
A close correlation has been shown between irreversible myocardial injury and hyperenhancement 
following administration of a gadolinium-based contrast agent 4;5. Furthermore, ce-MRI allows 
precise delineation of the transmurality of infarction. A current issue of debate is whether the analysis 
of the ce-MRI studies should be performed visually or quantitatively. Quantitative analysis may be 
time-consuming while on the other hand visual assessment of transmurality may be less accurate. 
Accordingly, the purpose of this study was 2-fold: (1) to demonstrate the feasibility of quantitative 
assessment of transmurality, and (2) to perform a head-to-head comparison between visual and 
quantitative analysis. In addition, the results of both techniques were related to the severity of 
resting wall motion abnormalities. 
Methods
Patients and study protocol 
The study group consisted of 27 consecutive patients with chronic coronary artery disease and 
a previous infarction (>1 month before the study). The inclusion criteria were: 1) sinus rhythm, 2) 
angiographically proven coronary artery disease, 3) myocardial infarction >1 month before the study.
Exclusion criteria included: 1) recent myocardial infarction (≤1 month) or episode of unstable angina 
and/or heart failure requiring hospitalization (≤1 month), 2) cardiac pacemakers or intracranial 
aneurysm clips, 3) (supra-)ventricular arrhythmias.
The study protocol included a resting cine MRI-study to analyze regional and global LV function, 
followed by ce-MRI to determine infarct size. All patients gave written informed consent to the study 
protocol, which was approved by the local ethics committee.
Data acquisition 
Patients were positioned supine in a clinical 1.5-T scanner (Gyroscan NT Intera, Philips Medical Systems, 
Best, The Netherlands). All images were acquired using a five elements synergy coil during breath-
holds and were gated to the electrocardiogram. To determine the final short-axis imaging plane, 
transverse, oblique sagittal, and double-oblique left ventricular long-axis scout images were obtained 
as previously described 6. Depending on the heart size, the heart was imaged from apex to base with 
10 to 12 imaging levels in the short-axis orientation using a sensitivity encoding imaging technique 
balanced fast field echo sequence. Typical parameters were field of view 400 x 400 mm2, matrix size 
256 x 256, slice thickness 10.00 mm, slice gap 0.00 mm, flip angle 50°, time to echo 1.82 ms and time 
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to repeat 3.65 ms. The number of cardiac phases depended on the heart rate. Prior to the acquisition 
of the delayed enhancement images, optimization of inversion time was performed for each patient 
individually starting at 15 minutes after a bolus injection of Gd-DTPA (Magnevist; Schering/Berlex, 
Berlin, Germany, 0.15 mmol/kg). In order to achieve maximum contrast between viable and non-
viable myocardial tissue, a series of real-time planscan images with decreasing inversion time, starting 
at approximately 300 ms were obtained. Real-time planscanning allows immediate adjustment of 
inversion time by instant acquisition of short-axis test slices, without the need for breath holding. 
In 50-70 seconds a series of images with different inversion times in steps of 5 ms can be acquired 
to obtain the optimum inversion time with nulled (black) myocardium and high signal intensity of 
infarcted tissue. The following parameters were applied: field of view 400 x 400 mm2, matrix size 256 x 
256, slice thickness 6.00 mm, flip angle 15°, time to echo 1.44 ms and time to repeat 4.3 ms. 
Contrast-enhanced images were acquired at 17-19 minutes after contrast administration, with an 
inversion-recovery gradient echo sequence, in the same views as those used for cine MR. Depending 
on the patient’s heart rate and heart size, 20 to 24 slices were obtained in two breath-hold acquisitions 
of approximately 15 seconds. Typical parameters were the following: field of view 400 x 400 mm2, 
matrix size 256 x 256, slice thickness 5.00 mm, slice gap – 5 mm, flip angle 15°, time to echo 1.36 ms 
and time to repeat 4.53 ms. 
Data analysis
Regional	and	global	function 
For the assessment of regional wall motion, cine MR images were visually interpreted by two 
experienced observers (blinded to other MR and clinical data) using a previously described 
17-segment model 7. Each segment was assigned a wall motion score using a 5-point scale: 0: 
normokinesia, 1: mild hypokinesia, 2: severe hypokinesia, 3: akinesia, and 4: dyskinesia.
To determine global function, endocardial borders were outlined manually on the short-axis cine 
images using previously validated software (MR Analytical Software System [MASS], version 5.0, 
Leiden, The Netherlands). Papillary muscles were regarded as being part of the ventricular cavity. 
LV end-systolic and LV end-diastolic volumes were calculated. Subsequently the related LV ejection 
fraction was derived by subtracting the end-systolic volume from the volume at end-diastole and 
dividing the result by the end-diastolic volume.
Scar	tissue;	Visual	analysis 
Delayed enhancement images were scored visually by two experienced observers (blinded to other 
MR and clinical data) using the same 17-segment model as used for function analysis (see Figure 21.1). 
Each segment was graded on a 5-point scale: 0: absence of hyperenhancement, 1: hyperenhancement 
1-25% of LV wall thickness, 2: hyperenhancement extending to 26-50%, 3: hyperenhancement 
extending to 51-75%, and 4: hyperenhancement extending to 76-100% of LV wall thickness 8. To 
assess intra- and interobserver agreements, 10 patients were re-analyzed. The resulting intra- and 
interobserver agreement were 97% and 94%, respectively.
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Scar	tissue;	Quantitative	analysis 
The transmural extent of infarction was also determined using threshold analysis (see Figure 1). 
In one representative slice of each delayed enhancement set, 2 regions of interest were manually 
drawn; one in a region showing the highest signal intensity (center of infarction) and another equally 
sized region of interest in normal myocardium (with normal wall motion). A threshold value was 
calculated by dividing the sum of the signal intensities in both regions of interest by 2. Myocardial 
tissue showing a signal intensity ≥ the threshold value was considered scar tissue.  
The extent of transmurality was subsequently determined by the use of the modified centerline 
method 9. Using 10 points along each centerline chord, percentage of LV wall thickness with 
increased signal intensity was determined and expressed as an average per segment to allow 
comparison with the visual analysis. Signal intensity of the 10 equidistant points was determined 
by bipolar interpolation. No zoom was used. To assess inter- and intraobserver variability of 
quantitative analysis (to assess extent of infarcted tissue), 10 patients were re-analyzed. The inter- 
and intraobserver variability were 4.2 ± 6.6% and 3.0 ± 5.1%, respectively. 
Statistical analysis
Continuous data were expressed as mean ± SD and compared using the 2-tailed Student’s t test 
for paired and unpaired data when appropriate. Simultaneous comparison of >2 mean values was 
performed using 1-way analysis of variance (ANOVA). Relations were determined by linear regression 
analysis. The agreement for segmental wall motion and scar score, and visual and quantitative 
Figure 1. Subsequent steps of quantitative analysis of transmurality of infarction.
A1: Representative contrast enhanced, short-axis slice. A2: Two manually drawn regions of intereset; 1 in the 
center of infarction (black arrow) and another in normal myocardium (white arrow). A3: Contrast-enhanced slice 
after application of the threshold value. B1: Application of the modified centerline method, resulting in 100 
equidistant chords along the LV wall. B2: Enlargement of the dashed box in Panel B1. 
B3: A signal intensity curve of one of these centerline chords, showing the signal intensity in 10 points along this 
particular centerline chord, revealing infarction of 50% of LV wall thickness.
320 Chapter 21
analysis of scar tissue, was assessed from 5 x 5 tables using weighted kappa statistics. Kappa values of 
<0.4, between 0.4 and 0.75 and >0.75 were considered to represent poor, fair to good and excellent 
agreement, respectively, based on Fleiss’ classification 10. The kappa values are reported with their 
standard errors (SE). A P-value <0.05 was considered statistically significant.
Results
Patients
The patient characteristics are summarized in Table 1. The study group consisted of 27 males, with 
a mean age of 65 ± 7 years. All patients had a history of previous myocardial infarction (>3 months 
before the study) and showed Q waves on the electrocardiogram (11 inferior, 16 anterior). The 
patients had on average 2.7 ± 0.6 stenosed coronary arteries. Cardiac medication was continued 
during the study period and consisted of β-blockers (n = 12), angiotensin-converting enzyme-
inhibitors (n =16), diuretics (n = 16), statins (n = 15), calcium antagonists (n = 10), nitrates (n = 9) and 
oral anti-coagulation or aspirin (n = 27).   
Regional function, Global function  
Systolic wall thickening was normal in 200 (44%) of 459 segments. End-diastolic volumes measured 
from the short-axis cine images ranged from 187 to 407 ml (mean 269 ± 70 ml). End-systolic volumes 
ranged from 99 tot 313 ml (mean 184 ± 68 ml). Accordingly, LV ejection fraction ranged from 21% 
to 52% (mean 33 ± 8%). Since assessment of viability is most important in patients with severely 
depressed LV ejection fraction, separate analysis was performed in 15 patients with a LV ejection 
fraction ≤35%. In these patients end-diastolic and end-systolic volumes ranged from 218 to 407 ml 
(mean 311 ± 66 ml) and 155 to 313 ml (mean 229 ± 58 ml), respectively. Mean LV ejection fraction 
Table 1. Clinical characteristics of the study population (n=27).
n (%)
Age (years)  65 ± 7
Previous infarction 27 (100%)
Q wave on electrocardiogram 27 (100%)
Multi-vessel disease 24 (89%)
Angina Pectoris
    CCS class 1/2 23 (85%)
    CCS class 3/4 4 (15%)
Heart Failure (NYHA class)
                 1/2 15 (56%)
                 3/4 12 (44%)
CCS: Canadian Cardiovascular Society; 
NYHA: New York Heart Association.
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was 27 ± 4% (range 21 to 35%). Linear regression revealed good correlations (y = -0.37 x + 22.0, r = 
0.79, P <0.01 and y = -0.37 x + 17.8, r = 0.79, P <0.01) between LV ejection fraction and the number of 
dysfunctional segments and between LV ejection fraction and the number of severe dysfunctional 
segments, respectively.
Figure 2. Percentag segments with different scores of transmurality of delayed enhancement in relation to re-
gional wall motion score. The extent of hyperenhancement paralleled the severity of contractile dysfunction.
ak = akinesia, dysk = dyskinesia, mhk = mild hypokinesia, and shk = severe hypokinesia.
Visual analysis of scar tissue 
Of the 459 segments evaluated, 253 (55%) segments revealed hyperenhancement. The extent of 
hyperenhancement paralleled the severity of contractile dysfunction (Figure 2) and the likelihood of 
hyperenhancement >50% of LV wall thickness, was significantly higher in a- or dyskinetic segments 
than in mildly hypokinetic or normal segments (93% vs. 2% vs. 0%, P <0.05). Precise data are shown in 
Table 2. Percentages of visual scar scores in relation to the segmental wall motion score are depicted 
in Figure 2.
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Table 2. Relation between visual hyperenhancement score and severity of contractile  dysfunction (expressed 
as wall motion score) (65%, kappa 0.51).
Wall motion 
score
      Hyperenhancement score (visual analysis) 
0 1 2 3 4 Total 
0 172 28 0 0 0 200
1 31 70 9 2 0 112
2 3 28 25 23 0 79
3 0 2 3 21 28 54
4 0 0 0 3 11 14
Total 206 128 37 49 39 459
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Quantitative analysis of scar tissue 
The quantitative percentage of transmurality on delayed enhancement images also paralleled 
the severity of resting wall motion abnormalities and increased from an average of 14% in mild 
hypokinetic segments to an average of 85% in dyskinetic segments (P <0.05). Average percentages 
of transmurality for each wall motion score are shown in Figure 3. An excellent agreement was found 
between the visual and quantitative analysis: 90% of 459 segments were scored identically (with a 
kappa statistics of 0.86, SE 0.02). Quantitative assessment of scar tissue yielded a different result in 45 
(10%) segments, and shifted 13 (29%) of these discrepant segments to a lower transmurality score 
and 32 (71%) to a higher transmurality score (Table 3). Average quantitative scores for the different 
visual scores are presented in Figure 4.
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Figure 3. Relation between the severity of contractile dysfunction (expressed as wall motion score) and the 
average quantitative percentage of hyperenhancement through the left ventricular wall. Average quantitative 
percentage of hyperenhancement increased from 14% in mild hypokinetic segments to an average of 85% in 
dyskinetic segments (P <0.05).
ak = akinesia, dysk = dyskinesia, mhk = mild hypokinesia, norm = normokinesia, and 
shk = severe hypokinesia.
Table 3. Agreement between quantitative and visual scoring of scar tissue (90%, kappa 0.86).
Visual 
analysis
      Quantitative analysis 
0 1-25% 26-50% 51-75% 76-100% Total
0 188 18 0 0 0 206
1 5 117 4 2 0 128
2 0 3 33 1 0 37
3 0 0 0 42 7 49
4 0 0 0 5 34 39
Total 193 138 37 50 41 459
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Discussion
Recently, gadolinium-based contrast agents have been used extensively in combination with MRI to 
identify infarcted myocardium 8;11. The accuracy of ce-MRI in the assessment of infarcted myocardium 
has been evaluated by Kim and colleagues 11. The authors demonstrated in animal-model of 
occlusion and reperfusion, an excellent agreement between the transmural and circumferential 
extent of infarction assessed by ce-MRI as compared to histology. In addition, in patients after acute 
myocardial infarction, the extent of scar tissue on ce-MRI correlated well with the enzymatically 
assessed damage 8.
In patients with chronic ischemic cardiomyopathy, direct comparisons with positron emission 
tomography and F18-fluorodeoxyglucose demonstrated a good agreement between the 2 
techniques for assessing viability 12. Moreover, Kim and colleagues demonstrated that the extent 
of scar tissue on ce-MRI was predictive of improvement of function after revascularization 13: 
patients with small subendocardial necrosis had a high likelihood of functional recovery post-
revascularization, as compared to a low likelihood of recovery in patients with transmural infarction.
The major advantage of MRI over other imaging techniques is the extremely high resolution, 
allowing assessment of minimal infarction. Recently, Wagner et al 14 performed a head-to-head 
comparison between ce-MRI and SPECT imaging, and demonstrated that 47% of segments with 
small subendocardial infarctions on ce-MRI were not detected by SPECT.
Currently, the ce-MRI studies are analyzed visually, and the transmurality of infarction is divided into 
quintiles based on visual inspection 8;13. However, the high resolution of MRI makes the technique 
extremely suited for quantitative analysis. At present, various MRI-derived parameters have been 
evaluated quantitatively, including LV volumes, LV ejection fraction, segmental systolic thickening 
and end-systolic wall thickness 15-17, providing extreme precision to assess these parameters. 
Similarly, quantitative evaluation of transmurality of infarcted tissue on ce-MRI would allow a higher 
precision to define the exact percentage infarcted tissue of the LV wall. All previous studies however 
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Figure 4. Average percentage hyperenhancement (quantitative) in relation to segmental visual scar score.
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have relied on visual analysis; in the current study, the feasibility of a more objective, quantitative 
approach was demonstrated. Using threshold analysis for signal intensity, precise delineation of the 
transmural extent of infarcted tissue was possible (although animal experiments are still needed 
to validate the technique). However, when the quantitative approach was compared directly to 
visual analysis, an excellent agreement with 90% of segments classified in the same quintiles of 
transmurality (Table 3), and only 10% of segments was shifted to a lower or higher quintile when 
quantitative analysis was compared to visual analysis. Based on these findings, one may conclude 
that visual analysis may be sufficient for clinical assessment of the extent and transmurality on ce-
MRI. Eventually, a head-to-head comparison between visual and quantitative analysis is needed in 
patients undergoing revascularization, in order to determine whether precise quantification results 
in superior prediction of improvement of function after revascularization. 
Besides the comparison between visual and quantitative analysis, the transmurality on ce-MRI was 
compared to the severity of contractile dysfunction. Comparable to the findings by Mahrholdt et al 
18, the extent of transmurality paralleled the severity of wall motion abnormalities: segments with 
normal function had no or minimal infarction, whereas segments with a- or dyskinesia had extensive 
scar tissue.
In conclusion, excellent agreement between visual and quantitative analysis of ce-MRI for assessment 
of scar tissue was demonstrated, suggesting that visual analysis is sufficient in the assessment of 
transmurality of infarction on ce-MRI.
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Abstract
Background 
In patients with previous infarction comprehensive assessment is needed for optimal risk 
stratification, including assessment of coronary artery stenoses, left ventricular (LV) function 
and perfusion. Currently, different imaging modalities are needed to provide the information, 
but multi-slice computed tomography (MSCT) may be able to provide all information from 
a single data set. The purpose of the study was to evaluate a comprehensive MSCT protocol 
in patients with previous infarction, including assessment of coronary artery stenoses, LV 
function and perfusion.
Methods
16-slice MSCT was performed in 21 patients with previous infarction; from the MSCT data, 
coronary artery stenoses, (regional and global) LV function and perfusion were assessed. 
Invasive coronary angiography and gated single photon emission computed tomography 
(SPECT) served as the gold standard for coronary artery stenoses and LV function/perfusion 
respectively.
Results 
In total, 236 of 241 (98%) coronary artery segments were interpretable on MSCT. The 
sensitivity and specificity for detection of stenoses were 91% and 97%. Pearson’s correlation 
showed excellent agreement for assessment of LV ejection fraction between MSCT and 
SPECT, respectively 49±13% vs 53±12%, r=0.85. Agreement for assessment of regional wall 
motion was excellent (92%, κ statistic 0.77). Finally, in 68 of 73 (93%) segments, MSCT correctly 
identified a perfusion defect as compared to SPECT, whereas the absence of perfusion defects 
was correctly detected in 277 of 284 (98%) segments. 
Conclusions 
MSCT permits accurate, non-invasive assessment of coronary artery stenoses, LV function and 
perfusion in patients with previous infarction. All parameters can be assessed from a single 
data set. 
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Introduction
The evaluation of patients with previous myocardial infarction is extensive but mandatory to allow 
optimal risk stratification. Coronary angiography is needed for precise assessment of the location 
and severity of obstructive coronary artery lesions. Information on systolic function (left ventricular 
ejection fraction, LVEF) needs to be evaluated, since this is an important prognostic factor. LVEF 
can be assessed by 2D echocardiography, nuclear imaging with gated SPECT, or invasively by left 
ventricular (LV) angiography. Finally, assessment of perfusion in the infarct region is of importance; 
this can be performed by gated single photon emission computed tomography (SPECT). An 
imaging modality that could provide all this information during one acquisition would be preferred. 
Over the past few years, multi-slice computed tomography (MSCT) has emerged as a non-invasive 
imaging modality that allows the acquisition of high resolution 3D images of the entire heart 
within 25 seconds. The technique allows non-invasive coronary angiography, with sensitivities 
and specificities for the detection of significant stenoses ranging from 70% to  98%1-5. Since MSCT 
data acquisition is gated to the electrocardiogram (ECG), LV function can be derived from the same 
dataset1;6. In particular, both global LV function (LVEF) and regional LV function (wall motion) can 
be assessed. Moreover, due to the acquisition of images during the first pass of a contrast agent, 
hypoenhanced areas can be identified, indicating reduced perfusion. Accordingly, a single MSCT 
examination could potentially provide all this information, but currently no data are available on 
the value of MSCT on this topic. The purpose of the present study was to evaluate the feasibility of 
MSCT to assess all these parameters during a single acquisition. Conventional modalities were used 
as gold standard to compare these different parameters, including invasive coronary angiography 
to assess coronary stenoses and nuclear perfusion imaging with SPECT to assess resting perfusion. 
Moreover, since the SPECT studies were assessed in gated mode, global (LVEF) and regional LV 
function (wall motion) could also be derived from SPECT. 
Methods
Patients and study protocol
Twenty-one patients with a history of myocardial infarction (>3 months before the study) underwent 
MSCT and resting gated SPECT using technetium-99m. In 20 patients also invasive coronary 
angiography was performed. Patients with atrial fibrillation were excluded, as well as patients with 
renal insufficiency (serum creatinine >120 mmol/L), known allergy to iodine contrast media, severe 
claustrophobia, and pregnant patients. All patients provided informed consent to the study protocol, 
which was approved by the local ethics committee.
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MSCT, data acquisition
MSCT examinations were performed with a 16-slice Toshiba Multi-slice Aquilion 16 system (Toshiba 
Medical Systems, Otawara, Japan). Collimation was 16 x 0.5 mm (if arterial grafts were present, a 
collimation was 16 x 1.0 mm was used to decrease scan time), and rotation time was 400, 500 or 600 ms, 
depending on heart rate. Tube current and tube voltage were 250 mA and 120 kV, respectively. Total 
contrast dose for the scan varied from 120 to 150 ml, depending on total scan time, with an injection 
rate of 4 ml/s through the antecubital vein (Xenetix 300, Guerbet, Aulnay S. Bois, France), followed by 
a saline flush of 40 ml. To time the scan, automated detection of peak enhancement in the aortic root 
was used. All images were acquired during an inspiratory breath hold, while the ECG was registrated 
simultaneously for retrospective gating of the data. With the aid of a segmental reconstruction 
algorithm, data of 2 or 3 consecutive heartbeats were used to generate a single image. Estimated 
radiation dose was 8 mSv for men and 10 mSv for women.
Evaluation	of	coronary	artery	stenoses
For evaluation of coronary artery stenoses, images with a slice thickness of 0.5 mm were reconstructed 
at typically 75% of the cardiac cycle. In case of motion artifacts, reconstructions at 40% to 50% were 
explored. Subsequently, images were transferred to a remote workstation (Vitrea2, Vital Images, 
Plymouth, Mn, USA) for post- processing.
Evaluation	of	LV	function	and	resting	perfusion
For evaluation of LV function and resting perfusion, 2.0-mm slices were reconstructed in the short-
axis orientation at 20 time points, starting at early systole (0% of cardiac cycle) to end-diastole (95% 
of cardiac cycle) in steps of 5%. Images were transferred to a remote workstation with dedicated 
cardiac function analysis software (MR Analytical Software System, Medis, Leiden, The Netherlands).
 
MSCT, data analysis 
Assessment	of	significant	coronary	artery	stenoses
For the assessment of significant coronary artery stenoses, the MSCT angiograms were evaluated 
by 2 experienced observers, blinded to the results of conventional coronary angiography. Coronary 
arteries were divided in 17 segments according to the guidelines of the American Heart Association/
American College of Cardiology 7. Only segments with a diameter ≥2.0 mm were included. First, 
segments were classified as evaluable or not. Thereafter, the interpretable segments were evaluated 
for the presence of significant narrowing (≥50% decrease in luminal diameter). In case of previous 
bypass surgery and patent bypass grafts, only segments distal to the anastomosis were evaluated.
LV	function
To determine LV function, an independent observer outlined endocardial borders manually on the 
short-axis cine images. The papillary muscles were regarded as being part of the LV cavity. The LV 
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end-systolic and end-diastolic volumes were calculated and the LVEF was derived. Regional wall 
motion was assessed visually using the short-axis slices in cine-loop mode, by one observer blinded 
to all other data using a 17- segment model 8. A three-point scale was used to assign to each segment 
a wall motion score (1 = normokinesia, 2 = hypokinesia, 3 = a- or dyskinesia) 9.
Myocardial	perfusion
To assess myocardial perfusion, the transmural extent of the LV wall showing reduced perfusion was 
evaluated in terms of transmurality of decreased signal intensity. A five-point scoring system was 
used with 0 = no perfusion defect, 1 = a perfusion defect involving 1% - 25% of the LV wall, 2 = a 
defect involving 26% - 50% of the LV wall, 3 = a defect involving 51% - 75% of the LV wall, and 4 
= a defect involving >75% of the LV wall, using the same 17-segment model as described for the 
assessment of regional wall motion 10.  
Resting gated SPECT
Myocardial perfusion SPECT imaging with technetium-99m tetrofosmin (500 MBq, injected at rest) was 
performed using a triple head SPECT camera system (GCA 9300/HG, Toshiba Corp.) equipped with low 
Figure 1. Example of MSCT coronary angiography.
Panel (A) Conventional angiography showing the LCX (white arrow) and the LAD (white arrow head). 
Panel B-E: Corresponding MSCT images. (B) MSCT 3D volume-rendered reconstruction depicting the LAD (white 
arrows) and the D1 (white arrowhead). (C) MPR of the LCX (white arrows). (D) MPR of the LAD (white arrow heads) 
with soft plaque (white arrow). (E) Transaxial image of the LAD (white arrows) demonstrating small calcifications.  
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energy high-resolution collimators. Around the 140-KeV energy peak of technetium-99m tetrofosmin, 
a 20% window was used. A total of 90 projections (step and shoot mode, 35 seconds per projection, 
imaging time 23 minutes) were obtained over a 360-degree circular orbit. Data were stored in a 64 x 64, 
16-bit matrix. Resting perfusion was assessed using segmental tracer activity (0 = ≥75% of maximum 
tracer activity, 1 = 50% - 75% of maximum tracer activity, 2 = 25% - 50% of maximum tracer activity, 3 = 
≤25% of maximum tracer activity), using a similar 17-segment model as described above11.
LV volumes were calculated from the gated short-axis images using previously validated and commercially 
available automated software (quantitative gated SPECT, QGS, Cedars-Sinai Medical Center, Los Angeles, 
California)12. After segmentation of the LV, endo- and epicardial surfaces are estimated and displayed, 
the LV end-systolic and end-diastolic volumes are calculated and the LVEF can be derived. Regional wall 
motion was evaluated using the same 17-segment model and three-point scale as described for MSCT. 
Invasive coronary angiography 
Conventional coronary angiography was performed according to the standard techniques. To obtain 
vascular access the femoral approach with the Seldinger technique was used. An experienced observer 
blinded to the MSCT data performed visual evaluation of the coronary angiograms. Coronary arteries 
were divided in 17 segments according to the guidelines of the American Heart Association/American 
College of Cardiology 7. Consequently, the segments with a diameter ≥2.0 mm were evaluated for the 
presence of significant narrowing (defined as ≥50% decrease in luminal diameter). In case of previous 
bypass surgery and patent bypass grafts, only segments distal to the anastomosis were evaluated.
Statistical analysis
Sensitivity, specificity, positive and negative predictive values were calculated to detect significant 
coronary artery stenoses (≥50% decrease in luminal diameter) on MSCT using invasive angiography 
as the gold standard. Pearson’s correlation coefficient r was calculated for the linear regression 
analysis of the LVEFs (MSCT versus gated SPECT). Bland-Altman analysis was performed for each pair 
of values of LVEF to calculate the limits of agreement and systematic error between the 2 modalities 
(MSCT versus gated SPECT) 13. A P value <0.05 was considered statistically significant. 
A 3 x 3 table using weighted κ statistics was applied to express the agreement for regional wall 
motion between MSCT and gated SPECT. A κ value of < 0.4 represents poor agreement, a κ value 
between 0.4 and 0.75 fair to good agreement and a κ >0.75 states excellent agreement 14. 
Results
MSCT was performed successfully in all 21 patients. The study population consisted of 20 men and 1 wom-
an, with a mean age of 61 ± 13 years. A total of 17 (81%) patients used beta-blocking agents, no additional 
beta-blockade was administered prior to MSCT imaging. The mean heart rate was 64 ± 9 bpm, range 51 to 
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78 bpm, duration of breath hold was approximately 20 seconds, and success rate of obtaining adequate 
breath hold was 100%. Clinical characteristics of the study population are summarized in Table 1. 
Non-invasive coronary angiography by MSCT
Conventional, invasive coronary angiography was performed in 20 patients. In these patients, a 
total of 241 segments were available for evaluation. Of these segments, 236 (98%) were of sufficient 
image quality on MSCT to assess the presence/absence of significant stenoses. During conventional 
coronary angiography, significant stenoses were observed in 46 segments, with 42 (91%) correctly 
identified on MSCT. In 185 of 190 (97%) segments, MSCT correctly ruled out the presence of 
significant stenoses. Accordingly, the sensitivity and specificity were 91% and 97% respectively. 
In Table 2, the diagnostic accuracy of MSCT is summarized (for segments, vessels and patients). 
An example of MSCT coronary angiography and the corresponding conventional angiography is 
provided in Figure 1.
Table 1. Clinical characteristics of the study population (n=21).
n (%)
Age (yrs)
Men
Previous infarction
Location
    Anterior
    Inferior
    Both
Q wave on electrocardiogram
Previous CABG
Multi-vessel CAD
Angina pectoris
   CCS class I/II
   CCS class III/IV
Heart failure
   NYHA class I/II
   NYHA class III/IV
       61 ± 13
   20 (95%)
21 (100%)
   10 (48%)
   10 (48%)
        1 (4%)
   13 (62%)
      8 (38%)
   13 (62%)
   10 (48%)
  11 (52%)
   17 (81%)
     4 (19%)
CAD: coronary artery disease; CCS: Canadian Cardiovascular Society; 
NYHA: New York Heart Association.
Table 2. Diagnostic accuracy of MSCT for the detection of significant (≥50% luminal narrowing) stenoses. 
Segment-based Vessel-based Patient-based
Evaluable (%) 98 (236/241) 99 (76/77)* 100 (20/20)
Sensitivity (%) 91 (42/46) 92 (23/25) 92 (12/13)
Specificity (%) 97 (185/190) 96 (49/51) 86 (6/7)
PPV (%) 89 (42/47) 92 (23/25) 92 (12/13)
NPV (%) 98 (185/189) 96 (49/51) 86 (6/7)
Data are percentages (segments).
* in 1 patient the LCx was uninterpretable due to its small size, whereas in 3 patients both the LAD and LCx were 
supplied by patent grafts. In these patients, the LM was not evaluated. 
NPV: negative predictive value; PPV: positive predictive value.
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LV function: MSCT versus gated SPECT
The average LVEF was 53 ± 12% (range 27% to 72%) on gated SPECT, as compared to 49 ± 13% (range 
24% to 72%) on MSCT. An excellent correlation was demonstrated using linear regression analysis (r 
= 0.85, P<0.0001) (Figure 2A). Bland-Altman analysis (Figure 2B) showed a mean difference of 3.3 ± 
13.6%, which was not statistically different from zero.  
On resting gated SPECT, regional wall motion abnormalities were detected in 75 (21%) of 357 segments, 
with 40 (53%) showing hypokinesia and 35 (47%) a- or dyskinesia. In 69 (92%) of the dysfunctional 
segments, decreased systolic wall motion was also observed on the MSCT images (Table 3). An 
excellent agreement was shown between the 2 techniques, with 92% of segments scored identically 
on both modalities (κ statistics 0.77). Agreements for the individual gradings (1 to 3) were 96%, 75%, 
and 74%, respectively. An example of decreased wall motion on MSCT is provided in Figure 3.
y = 0.88x + 3.27
R = 0.85, P<0.0001
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Figure 2. (A) Linear regression plot shows correlation between left ventricular ejection fraction (LVEF) as mea-
sured by SPECT and MSCT (CT). (B) Bland-Altman plot of LVEF shows the difference between each pair plotted 
against the average value of the same pair, i.e. mean value of differences (solid line) and mean value of differ-
ences ± 2 SDs (dotted lines).
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Resting perfusion: MSCT versus SPECT 
On the resting SPECT images, reduced tracer uptake was observed in 73 (20%) of 357 segments. Of 
these 73 segments, perfusion defects were detected on MSCT in 68 (93%) segments. In 277 of 284 
(98%) segments with normal perfusion on SPECT, no perfusion defects were observed on MSCT as 
well. The degree of transmurality of the perfusion defects on MSCT paralleled the relative reduction 
in tracer activity on SPECT. An example of a large perfusion defect on MSCT is provided in Figure 4.
Discussion
The evaluation of patients with previous infarction is extensive and different imaging modalities are 
needed to provide the necessary information. For efficient patient management, a comprehensive 
non-invasive cardiac examination would be ideal. The current study was designed to evaluate the 
possibility to derive additional information on LV function and perfusion from cardiac MSCT, apart 
from the information on coronary arteries.
Conventional coronary angiography is considered the diagnostic standard for determining the 
presence of coronary artery stenoses and MSCT has recently been demonstrated to assess coronary 
artery stenoses with high accuracy 1-5. The current findings demonstrate that non-invasive coronary 
angiography with MSCT also in patients with previous myocardial infarction has a high sensitivity 
and specificity (91% and 97% respectively) for the detection of coronary artery stenoses, in line 
with previous observations in patients with known or suspected coronary artery disease 1-5. Other 
parameters can also be obtained using the same data set as used for evaluation of the coronary 
arteries, including LV function and perfusion. In particular LVEF is an important prognostic parameter 
after myocardial infarction 15. The current results demonstrated an excellent agreement between 
MSCT and gated SPECT for the assessment of LVEF. Previous studies have shown similar results with 
other imaging modalities, including magnetic resonance imaging (MRI) and 2D echo, although these 
studies were not specifically evaluating a selected study population after myocardial infarction, and 
mainly focusing on patients with relatively preserved LVEF 1;16-18. 
Table 3. Agreement between assessment of regional wall motion on MSCT as compared to resting gated SPECT 
(agreement 92%, kappa 0.77).
MSCT
SPECT 1 2 3 Total
1 271 10 1 282
2 6 30 4 40
3 0 9 26 35
Total 277 49 31 357
1= normokinesia, 2=hypokinesia, 3= akinesia or dyskinesia.
336 Chapter 22
Besides assessment of global LV function, MSCT can also be used to evaluate regional wall motion. 
A good agreement between MSCT and gated SPECT (κ statistics 0.77) was observed in the present 
study. No direct comparisons between gated SPECT and MSCT for assessment of regional wall motion 
have been reported, but Mahnken et al. reported a good agreement for assessment of regional wall 
motion between 16-slice MSCT and MRI (κ statistics 0.79) 16.  
Finally, MSCT was used in the present study to assess resting perfusion. The results demonstrated 
that MSCT detected perfusion defects correctly in 93% of the segments with a perfusion defect on 
SPECT imaging. On the other hand, MSCT did not detect any perfusion abnormalities in 98% of the 
segments with normal perfusion on SPECT. In addition, the extent of transmurality of the perfusion 
defects on MSCT corresponded to the relative reduction in tracer activity as assessed on SPECT. Most 
segments with ≥75% tracer activity had no or minimal perfusion abnormalities on MSCT, whereas 
segments with ≤25% tracer activity had predominantly extensive, transmural perfusion defects 
on MSCT. Minimal information on assessment of perfusion with MSCT is currently available. Two 
recent studies have focused on assessment of perfusion defects (indicating scar tissue) with MSCT in 
comparison to MRI. Nikolaou et al. compared 16-slice MSCT with MRI for assessment of myocardial 
infarction, and reported a sensitivity and specificity of 91% and 79% respectively 19. In the second 
study, both early-phase MSCT as well as late-enhancement MSCT were performed and compared to 
MRI for the evaluation of perfusion defects and infarct size in 28 patients with reperfused myocardial 
infarction 20. A good agreement between MRI and MSCT for the detection of scar tissue was 
demonstrated. MRI is currently regarded as gold standard for the assessment of LV function, while 
scar tissue due to myocardial infarction can be evaluated by delayed enhancement on MRI as well. A 
major advantage of this technique is the lack of radiation exposure.
Several limitations of the present study need attention. The study population was relatively small, 
and larger studies are needed to confirm the current observations. A drawback of MSCT remains the 
Figure 3. Example of wall motion analysis with MSCT of a patient with an inferior myocardial infarction. Short-axis 
images in end-diastole (A) and end-systole (B) show reduced wall thickening (black arrow) in the inferior wall.
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radiation dose (8 to 10 mSv in this study, which is higher as compared to a conventional diagnostic 
angiography) and future developments are needed to reduce radiation. Furthermore, most MSCT 
parameters were evaluated qualitatively, and software allowing quantitative analysis needs to be 
developed. In addition, MSCT at present only provides information on resting perfusion. Additional 
imaging during stress conditions would allow assessment of stress perfusion and the combination 
of the stress and rest images would potentially allow detection of ischemia and scar tissue. However, 
in view of the radiation burden, such a protocol may currently not be feasible for routine clinical 
practice.
In conclusion, the findings in the present study demonstrate the feasibility of integrated assessment 
of coronary anatomy, regional and global LV function and perfusion with MSCT in patients with 
previous infarction. Agreement with invasive coronary angiography and gated SPECT (for assessment 
of function and perfusion) was excellent. In patients with previous infarction, non-invasive evaluation 
of the coronary arteries can be performed for the detection or exclusion of possible new significant 
stenoses. In patients with previous bypass surgery, non-invasive evaluation with MSCT can provide 
information of the patency of the grafts. The additional data on LV function as well as extent of 
(possibly) infarcted myocardium can be taken into account in the risk stratification in these patients; 
this concept needs further testing in future studies.
 
Figure 4. Example of a large perfusion defect on SPECT and MSCT of the patient depicted in Figure 3.
(A) SPECT short-axis image showing a perfusion defect in the inferior wall (white arrow) at rest, (B) corresponding 
MSCT short-axis image in end-diastole, revealing a hypoenhanced area (black arrow) in the inferior wall, indicat-
ing a perfusion defect.
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Abstract
Background  
In recent years, Multi-Slice Computed Tomography (MSCT) has emerged as a rapidly expanding 
modality for non-invasive assessment of coronary artery disease. Simultaneously, left 
ventricular (LV) function can be evaluated although this is not yet a routine component of an 
MSCT examination. Accordingly, the purpose of the present study was to validate assessment 
of LV function with MSCT using 2D-echocardiography in a large cohort of patients.
Methods 
In 70 patients (57 male, 13 female), 16-slice MSCT was performed (Toshiba Aquilion 16, 
Japan) followed by retrospective analysis of global LV function. For these measurements 2D-
echocardiography served as the standard of reference.
Results 
For LV volumes, excellent correlations for both end-diastolic volume (EDV) (r=0.97) and end-
systolic volume (ESV) (r=0.98) were obtained by linear regression analysis. At Bland-Altman 
analysis, mean differences (± standard deviations) of -1.4 ml ± 11.3 ml and -3.0 ml ± 7.7 ml were 
observed between MSCT and 2D-echocardiography for LV EDV and LV ESV respectively. As a 
result, LV EF was slightly overestimated with MSCT (1.7% ± 4.9%, P<0.05). Correlation between 
the two techniques was excellent (r= 0.91). 
Conclusion 
In a large cohort of patients, an excellent correlation was observed between 16-slice MSCT 
and 2D-echocardiography in the evaluation of LV volumes and EF. The addition of LV function 
analysis to the anatomical MSCT data may potentially enhance the diagnostic value of the 
technique.
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Introduction
Recently, MSCT has emerged as a rapidly progressing and expanding modality for non-invasive 
assessment of coronary anatomy. Pooled analysis of recent studies, using 16-slice technology, has 
shown an average sensitivity and specificity of 88% and 96% in the detection of significant coronary 
artery stenoses 1. Accordingly, the expectation is that the technique will become increasingly used 
as an alternative modality to evaluate the presence of coronary artery disease in patients presenting 
with chest pain and having risk factors for coronary artery disease. In these patient populations, 
additional assessment of cardiac function is often desired for prognostic purposes 2. Generally, this 
implies an additional examination with Magnetic Resonance Imaging (MRI), or more frequently, 
echocardiography. MRI is currently the gold standard in the assessment of left ventricular (LV) 
volumes and ejection fractions (EF), but is a relatively costly and time-consuming technique. As a 
result, the technique is not widely available for application in larger patient populations. Thus, in 
daily clinical practice, 2D-echocardiography is routinely performed to assess function as it is more 
widely available and associated with lower costs. 
Functional parameters, however, can also be retrospectively obtained from a MSCT coronary 
angiography examination since the data are acquired in a helical mode during ECG gating. As a 
result, a high-resolution 3D volume set is obtained that allows retrospective reconstruction of short-
axis images during the entire cardiac cycle.  Indeed, the feasibility of additional LV function analysis 
during MSCT coronary angiography has been demonstrated in previous studies, comparing data 
to other imaging modalities, including MRI or 2D-echocardiography 3-6. Thus far, these data have 
been obtained in relatively small patient populations while using older 4-slice MSCT systems in the 
majority of studies. Accordingly, the purpose of the present study was to compare 16-slice MSCT to 
2D-echocardiography in a relatively large patient population. 
Methods
Patients and protocol
The study group consisted of 70 patients presenting to our outpatient clinic for the evaluation of 
novel or recurrent chest pain. All patients underwent an MSCT examination as part of ongoing 
protocols at our institution concerning the evaluation of coronary artery disease with MSCT. For 
comparison, 2D-echocardiography was performed in all patients. Exclusion criteria were: 1. atrial 
fibrillation (2 patients excluded), 2. renal insufficiency (serum creatinine >120 mmol/L), 3. known 
allergy to iodine contrast media (1 patient excluded), 4. severe claustrophobia, and 5. pregnancy. 
All patients gave written informed consent to the study protocol, which was approved by the local 
ethics committee. 
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MSCT; Data acquisition
MSCT was performed using a Toshiba Multi-Slice Aquilion 16 system (Toshiba Medical Systems, Tokyo, 
Japan) with a collimation of 16 x 0.5 mm. Rotation time was 0.4s or 0.5s, depending on the heart rate, 
while the tube current was 250 mA, at 120 kV. Non-ionic contrast material was administered in the 
antecubital vein with an amount of 120-150 ml, depending on the total scan time and a flow rate of 
4.0 ml/sec (Xenetix 300®, Guerbet, Aulnay S. Bois, France). Automated peak enhancement detection 
in the aortic root was used for timing of the scan. In all patients, the heart was imaged from the aortic 
root to the cardiac apex during inspiratory breath hold preceded by mild hyperventilation. During 
the examination, the ECG was recorded simultaneously for retrospective gating of the data. 
MSCT; Data analysis
For the evaluation of LV function, data sets were reconstructed in the short-axis orientation at 
20 different time points and subsequently transferred to a dedicated cardiac analysis program 
Figure 1. Example of 16-slice MSCT short-axis reconstructions in end-diastole and end-systole to assess global 
LV function. 
In Figure 1A, an example is provided of a patient with a normal LV EF of 67%. In all LV wall segments, normal 
contractility can be observed. 
In Figure 1B, a patient with a decreased LV EF of 26% is shown. In both the anterior region (arrowhead) as well as 
inferolateral (arrow) reduced wall motion and thickening is present.
Abbreviations: ED: end-diastole, ES: end-systole
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(MR Analytical Software System [MASS], Medis, Leiden, the Netherlands) running on a remote 
workstation. On the short-axis cine images, endocardial contours were outlined from the base to 
the apex manually by an independent observer in both end-diastole and end-systole. Papillary 
muscles were regarded as being part of the ventricular cavity. LV end-systolic (ESV) and end-diastolic 
volumes (EDV) were calculated using commercially available software (CT-MASS, Medis, Leiden, The 
Netherlands) by summation of the product (area x slice distance) of all included slices. Finally, the 
related LV EF was derived by subtracting the end-systolic volume from the volume at end-diastole 
and dividing the result by the end-diastolic volume. 
2D-echocardiography
2D-echocardiography was performed in the left lateral decubitus position using a Vingmed System 
FiVe/Vivid-7 (General Electric-Vingmed, Milwaukee, WI, USA). Images were acquired using a 3.5 MHz 
transducer at a depth of 16 cm in the parasternal and apical 2-, 4- and 5-chamber views. LV volumes 
and EFs were calculated by an independent observer without knowledge of the MSCT data from 
the 2- and 4-chamber images using the biplane Simpson’s rule and commercially available software 
(Echopac 6.1, General Electric-Vingmed) 7-9. 
Statistical analysis
Continuous data are expressed as mean ± standard deviations (SD). Agreement for global LV function 
(EDV, ESV, EF) was determined by Pearson’s correlation coefficient for linear regression and Bland-
Altman analysis 10. The 95% limits of agreement were defined as the range of values ± 2SD from the 
mean difference. The statistical significance of the mean difference between the different modalities 
was tested by Student’s t test for paired samples. A p-value <0.05 was considered to be significant.
Results
Patient characteristics
A total of 70 patients (57 male, 13 female) with an average age of 66 ± 11 years was included in the 
study and underwent MSCT as well as 2D-echocardiography without complications. Average heart 
rate during the MSCT studies was 66 ± 11 beats per minute, ranging between 41 beats per minute 
to 98 beats per minute. No additional beta-blocking medication was administered prior to MSCT 
imaging. Previous percutaneous transluminal coronary angioplasty was performed in 32 (46%) 
patients, whereas 24 (34%) patients had undergone previous coronary bypass grafting. Previous 
myocardial infarction was present in 31 (44%) patients (anterior wall infarction; n=15, inferior wall 
infarction; n=16). Examples of short-axis reconstructions of patients with respectively normal and 
decreased LV EF are provided in Figure 1. 
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LV Volumes and EF
Time to reconstruct the required phases and to calculate LV volumes and EF was approximately 
10 to 15 minutes. Mean values of all variables are provided in Table 1. Excellent correlations were 
demonstrated by linear regression analysis for both LV EDV and ESV, respectively r=0.97 and r=0.98 
(Figures 2A and 3A). At Bland-Altman analysis (Figures 2B and 3B) both parameters were shown to be 
slightly underestimated with MSCT with mean differences (and limits of agreement) of respectively 
-1.4 ml (-24 ml to 21 ml, P>0.05) and -3.0 ml (-18.5 ml to 12.4 ml, P<0.05). For LV EF a slightly lower 
correlation of 0.91 was observed between the two modalities (Figure 4A) with a small but significant 
overestimation of LV EF by MSCT (1.7% and -8.0% to 11.5%, P<0.05) (Figure 4B). 
In addition, intra- and interobserver variability were evaluated and resulted in a mean difference of 
-0.13% ± 2.4% and 1.1% ± 1.9% for LV EF, respectively. Intraobserver variabilities for LV EDV and LV 
ESV were respectively 0.82 ml ± 7.7 ml and -0.53 ml ± 7.6 ml, whereas mean interobserver differences 
for LV EDV and LV ESV were -1.23 ml ± 6.0 ml and -1.77 ml ± 4.9 ml, respectively.
Discussion
In patients with coronary artery disease, LV chamber volumes and EF are independent and 
important predictors of morbidity and mortality 2;11. Accordingly, information of LV function is 
frequently required in these populations to determine further clinical management. In recent 
years, MSCT has emerged as a rapidly expanding imaging modality that allows the acquisition of 
high-resolution, 3D imaging of the entire heart and coronary arteries within a single breath hold 12. 
Simultaneously, the technique can also be used to assess cardiac chamber anatomy and function 3-
6.Thus, in a single examination of approximately 15 minutes, information of coronary anatomy and 
LV function is obtained. However, data thus far have been obtained in limited patient populations 
and validations in larger populations have not been performed yet. 
In the present study, global LV function analysis was performed using 16-slice MSCT in 70 patients 
Table 1. Comparison of MSCT to 2D-echocardiography in 70 patients.
Parameter Mean MSCT Mean 2D echo Mean Difference
Pearson 
(r)
t Test 
(P-value)
EDV (ml)
151.5 ± 40.1
(70.6, 251.3)
152.9 ± 42.9
(64, 251.0)
1.4 ± 11.3 0.97 >0.05
ESV (ml)
74.8 ± 35.2
(22.9, 172.0)
77.9 ± 35.6
(21.0,183.0)
3.0 ± 7.7 0.98 <0.05
EF (%)
52.2 ± 11.7 
(20.5, 73.5)
50.5 ±12.0
(19.7, 79.6)
-1.7 ± 4.9 0.91 <0.05
Data are mean values ± standard deviation (minimum value, maximum value).
Abbreviations: EDV: end-diastolic volume, EF: ejection fraction, ESV: end-systolic volume, MSCT: multi-slice computed 
tomography.
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Figure 2. Linear regression (a) and Bland-Altman (b) plots in the comparison of MSCT and 2D-echocardiography 
in the assessment of LV EDV. In the Bland-Altman plot, the difference between each pair is plotted against the aver-
age value of the same pair (solid line, mean value of differences; dotted lines, mean value of differences ±2 SD).
Abbreviations: EDV: end-diastolic volume, LV: left ventricular, MSCT: multi-slice computed tomography.
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Figure 3. Linear regression (a) and Bland-Altman (b) plots in the comparison of MSCT and 2D-echocardiography in 
the assessment of LV ESV. In the Bland-Altman plot, the difference between each pair is plotted against the average 
value of the same pair (solid line, mean value of differences; dotted lines, mean value of differences ±2 SD).
Abbreviations: ESV: end-systolic volume, LV: left ventricular, MSCT: multi-slice computed tomography.
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Figure 4. Linear regression (a) and Bland-Altman (b) plots in the comparison of MSCT and 2D-echocardiography in 
the assessment of LV EF. In the Bland-Altman plot, the difference between each pair is plotted against the average 
value of the same pair (solid line, mean value of differences; dotted lines, mean value of differences ±2 SD).
Abbreviations: EF: ejection fraction, LV: left ventricular, MSCT: multi-slice computed tomography.
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and compared to 2D-echocardiography. Excellent correlations, r=0.97 and r=0.98 respectively, were 
observed between MSCT and 2D-echocardiography in the assessment of LV EDV and ESV. For both 
variables a small underestimation (<5 ml) with MSCT as compared to 2D-echocardiography was 
observed, which was significant for LV ESV. As a result, LV EF was slightly overestimated by MSCT 
with an average of 1.7 ± 4.9%. Correlation between the two modalities in the assessment of LV EF 
was still excellent with an r-value of 0.91.
These findings are in line with previous observations obtained in smaller patient populations 3;13. 
An initial comparison of LV EF derived from 4-slice MSCT and 2D-echocardiography in 15 patients 
presenting with unstable angina was described by Dirksen et al, who observed an excellent 
correlation between both modalities of 0.93 although MSCT underestimated LV EF with an 
average of –1.3 ± 4.5% 3. More recently, results of LV functional analysis with 16-slice MSCT and 2D-
echocardiography in 19 patients has been published, demonstrating excellent correlations between 
the two techniques 13. In line with our study, a small overestimation of LV EF of 2.9% on average was 
observed. Thus far, two studies have reported on comparisons of LV function parameters between 
multiple modalities including MSCT (8- and 16-slice) 5;14. In both studies, performed in 41 and 24 
patients respectively, a closer agreement was observed between MSCT and MRI than between 
2D-echocardiography and MSCT, suggesting that MSCT may actually be more accurate than 2D-
echocardiography. Indeed, particularly in patients with coronary artery disease, the 3D approach 
of MSCT is likely to provide superior measurements as compared to echocardiography, since the 
geometrical assumptions that are needed with the latter may frequently result in significant errors in 
volumetric calculations. On the other hand, the accuracy of MRI is not likely to be surpassed by MSCT 
in the near future, as temporal resolution of the former remains at present superior.  
In addition, reproducibility of the LV measurements was evaluated in the present study, and 
excellent agreement was observed, with a mean difference of -0.13% ± 2.4% and 1.1% ± 1.9% for LV 
EF (intra- and interobserver variability respectively). Accordingly, LV measurements obtained with 
MSCT appear to be highly reproducible. 
Limitations
Several limitations need to be acknowledged. A disadvantage of MSCT in general is the radiation 
exposure of 9 to 15 mSv during a single examination. Preferably, functional testing should be 
repeated during stress conditions to detect early ischemia and thus further enhance risk stratification. 
However, as such a protocol with MSCT would imply a second radiation dose and contrast material 
delivery, repeated imaging remains at least at present undesirable. Moreover, with regard to the 
radiation dose, use of the technique solely for the purpose of functional analysis cannot be not 
justified. Post-processing time, including the drawing of endocardial contours, is still relatively time-
consuming for LV function analysis. Future improvements in image quality, as expected with the 
recently introduced 64-slice systems, would allow considerable reduction in post-processing time 
by enabling more accurate and rapid automated endocardial border detection. Another limitation 
of the present study is the fact that functional parameters were compared to 2D-echocardiography 
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rather than the current gold standard for volumetric measurement, MRI. In daily clinical practice 
however, LV function is most commonly assessed by means of 2D-echocardiography as it a widely 
available technique associated with relatively low costs. Finally, as the indications for performing 
MSCT, and thus the precise patient populations that may potentially benefit from this technique, are 
still under definition, the precise incremental value additional LV EF calculation would provide is also 
at present unclear. 
Conclusion
The present study confirms that reliable assessment of LV volumes and EF is possible with MSCT. As 
recent years have witnessed a rapid and continuous advancement of the technique, it is anticipated 
that MSCT will increasingly be used for routine evaluation of CAD in certain subsets of patients 
prior to more invasive investigations. The addition of LV functional parameters to the angiographic 
information would entail the addition of a frequently needed prognostic marker to the examination, 
thereby potentially enhancing the diagnostic value of an MSCT investigation.
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Abstract
Background
Cardiac resynchronization therapy (CRT) is an attractive treatment for selected heart failure 
patients. Knowledge on venous anatomy may help identifying candidates for successful left 
ventricular lead implantation. The purpose of the study was to evaluate the value of 64-slice 
computed tomography (CT) to visualize the cardiac veins and evaluate the relation between 
variations in venous anatomy and history of infarction.
Methods
The 64-slice CT of 100 individuals (age 61±11 years, 68% men) was studied. Subjects were di-
vided in 3 groups: 28 controls, 38 patients with significant coronary artery disease (CAD), 34 
patients with a history of infarction. Presence of the following coronary sinus (CS) tributaries 
was evaluated: posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV) 
and left marginal vein (LMV). Vessel diameters were also measured.
Results
CS and PIV were identified in all individuals. PVLV was observed in 96% of controls, 84% of 
CAD and 82% of infarction patients. In patients with a history of infarction, a LMV was sig-
nificantly less observed as compared to controls and CAD patients (27% versus 71% and 61% 
respectively, p<0.001). None of the patients with lateral infarction and only 22% of patients 
with anterior infarction had a LMV. Regarding quantitative data no significant differences were 
observed between the groups.
Conclusion
Non-invasive evaluation of cardiac veins with 64-slice CT is feasible. There is considerable 
variation in venous anatomy. Patients with a history of infarction were less likely to have a LMV 
which may hamper optimal left ventricular lead positioning in CRT implantation.
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Introduction
Cardiac resynchronization therapy (CRT) has become an attractive treatment option for highly 
symptomatic heart failure patients with a broad QRS complex on the surface ECG and poor left 
ventricular (LV) systolic function 1-3. In selected patients CRT reduces symptoms and improves ex-
ercise capacity. The CARE-HF trial also reported a significant reduction of morbidity and mortal-
ity, compared to optimized medical treatment 4. However, in large randomized trials, up to 30% 
of the patients undergoing CRT do not respond favourably to this invasive treatment 5. In order to 
improve the success rate, several issues including echocardiographic evaluation of mechanical dys-
synchrony and the evaluation of viability in the target region for the LV pacing lead, should be ad-
dressed during the selection of potential candidates 6. Another important pre-implantation issue is 
knowledge on the cardiac venous anatomy of the candidate. Even if viable tissue is identified in the 
region with the latest mechanical activation, endocardial CRT implantation will only be success-
ful if the LV lead can be positioned in a vein draining this region. Ideally, venous anatomy should 
be assessed before implantation, non-invasively in the outpatient clinic, to determine whether a 
transvenous approach is feasible. The feasibility of multi-slice computed tomography (MSCT) to 
visualize the venous anatomy was recently demonstrated in a study with 16-detector row CT 7. The 
authors described a marked variability in venous anatomy, confirming previous invasive studies 8. 
The absence of coronary sinus tributaries may be related to scar formation secondary to previous 
myocardial infarction in the region drained by these specific veins. In the present study, the car-
diac venous anatomy of 100 subjects undergoing non-invasive coronary angiography with 64-slice 
MSCT was retrospectively evaluated. The study aims were 1) to evaluate the feasibility of 64-slice 
MSCT to depict the cardiac venous system and 2) to evaluate the relationship between variations in 
cardiac venous anatomy and previous myocardial infarction.
Methods
Study population
The anatomy of the cardiac venous system was retrospectively studied in 100 consecutive subjects 
(68 men, age 61 ± 11 years) in whom MSCT was performed for non-invasive evaluation of the coro-
nary arteries. The population was divided in three groups. Twenty-eight subjects had normal coro-
nary arteries (controls). Thirty-eight patients had significant coronary artery disease (CAD) without 
a history of previous infarction. Thirty-four patients had CAD and a history of myocardial infarc-
tion; mean time between occurrence of the myocardial infarction and CT acquisition was 49 ± 7 
months.
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Multi-slice computed tomography
Imaging was performed with a 64-detector row Toshiba Multislice Aquilion 64 system (Toshiba 
Medical Systems, Otawara, Japan). Between 80 and 110 ml of contrast material (Iomeron 400, Bracco 
Altana Pharma GmbH, Konstanz, Germany) at an injection rate of 5 ml/minute was used. Scanning 
was performed using simultaneous acquisition of 64 sections with a collimated slice thickness of 0.5 
mm. Rotation time ranged from 400 to 500 ms depending on heart-rate and tube voltage was 120 
kV at 300 mA. A segmental reconstruction algorithm allowed inclusion of patients with a range of 
heart rates without the need for pre-oxygenation or beta-blocking agents. Retrospective ECG gating 
was performed to eliminate cardiac motion artefacts. Data reconstruction was performed on a Vitrea 
post-processing workstation (Vital Images, Plymouth, Minnesota). During analysis, the observers 
were blinded to the group assignments of the participants.
Anatomic observations
The tributaries of the cardiac venous system (Figure 1) were identified on volume-rendered recon-
structions. Thereafter, the course of the veins was evaluated in three orthogonal planes using mul-
tiplanar reformatting. The presence of the following cardiac veins was evaluated: CS, anterior inter-
ventricular vein, posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV) and 
left marginal vein (LMV). The number of side branches of these tributaries was also evaluated. 
Figure 1. Volume-rendered re-
construction of the heart, postero-
lateral view. The first tributary of 
the coronary sinus (CS) is the pos-
terior interventricular vein (PIV), 
running in the posterior interven-
tricular groove. The second tribu-
tary of the CS is the posterior vein 
of the left ventricle (PVLV) with 
several side branches (asterix). The 
next tributary is the left marginal 
vein (LMV). The great cardiac vein 
(GCV) will then continue as ante-
rior cardiac vein in the anterior 
interventricular groove. Also note 
the circumflex coronary artery (CX) 
and right coronary artery (RCA).
Quantitative data
The ostium of the CS was defined as the site where the CS makes an angle with the right atrium in 
the crux cordis area. Multiplanar reformatting was used to determine the size of the ostium in two 
directions (Figure 2). The diameters of the proximal parts of the PIV, PVLV and LMV were measured. 
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The proximal diameter of the Great Cardiac Vein (GCV) and the distal diameter of the GCV before 
continuing its course in the anterior interventricular groove as Anterior Cardiac Vein were also evalu-
ated. Finally, the distance between the origins of the various venous tributaries was measured on 
volume-rendered reconstructions (Figure 3).
Statistical analysis
A statistical software program SPSS 12.0 (SPSS Inc, Chicago,Il, USA) was used for statistical analy-
sis. Continuous variables are presented as mean ± standard deviation. Categorical variables are 
presented as absolute number (percentage). Analysis of variance (ANOVA) was used to study 
differences between the groups regarding continuous variables; Chi-square testing was used 
to study differences regarding categorical data. A p-value <0.05 was considered statistically 
significant.
Figure 2. Measurement of the diameter of the Coronary Sinus (CS). The ostium of the CS was defined as the site 
where the CS makes an angle with the right atrium in the crux cordis area. This is best seen on the transverse 
plane. The diameter is first measured in the antero-posterior position (Panel A).  Multiplanar reformatting was 
then used to determine the size of the ostium in the supero-inferior direction on the coronal plane (Panel B). 
RA: right atrium, LA: left atrium, RV: right ventricle. 
Results
Baseline characteristics
In Table 1, baseline characteristics of the individuals are summarized. Compared to controls, patients 
with significant CAD or a history of infarction were older and were more frequently male. They also 
had a higher frequency of cardiac risk factors including hypercholesterolemia and smoking. 
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Table 1. Baseline characteristics of the study population.
Controls
n = 28
CAD
n = 38
Infarction
n = 34
p-value
Age (yrs) 56 ± 11 64 ± 10 62 ± 11 0.02
Male gender 14 (50%) 26 (68%) 28 (82%) 0.03
LV ejection fraction 64 ± 9 % 58 ± 14 % 50 ± 13 % 0.0001
Cardiac risk factors
Hypertension 10 (40%) 17 (50%) 11(37%) NS
Hypercholesterolemia 11 (44%) 24 (71%) 22 (73%) 0.047
Smoking 4 (16%) 10 (29%) 14 (47%) 0.048
Diabetes mellitus 9 (35%) 14 (40%) 3 (10%) 0.02
Familial history CAD 7 (28%) 7 (21%) 12 (39%) NS
CAD: coronary artery disease; LV: left ventricular.
Left ventricular ejection fraction was significantly lower in patients with a history of infarction. 
Regarding the coronary artery lesions: none of the controls had significant coronary stenosis (by 
definition). In the CAD group, 10 patients had lesions occluding ± 50% of the coronary lumen, 
25 patients had lesions occluding ≥75% of the lumen. A significant stenosis was present in the 
left anterior descending coronary artery in 78%, in the left circumflex coronary artery in 38% and 
in the right coronary artery in 30%. For patients with a history of infarction, these percentages 
were 88%, 46% and 42% respectively. Regarding the location of the infarction, 23 patients (68%) 
had a previous anterior infarction, 4 (12%) a lateral infarction and 7 (21%) an inferior infarction. 
Twelve of the 34 infarction (35%) patients had a non-Q wave infarction, 22 (65%) had a Q wave 
infarction.
Anatomic observations
No patients had to be excluded because of suboptimal study quality. The CS, Anterior Interventricu-
lar Vein and PIV were observed in nearly all patients (100%, 100% and 99% respectively). The PVLV 
was observed in 96% of the controls, in 84% of the CAD patients and in 82% of the patients with pre-
vious infarction (p=NS). LMV was significantly less often identified in patients with a previous infarc-
tion as compared to CAD patients and controls (27% vs 61% vs 71%, p<0.001, Figure 4). An example 
of a patient with a previous infarction and absence of the LMV is presented in Figure 5. None of the 
patients with a history of a lateral infarction had a LMV, only 22% of the patients with a history of an 
anterior infarction had a LMV whereas 43% of the patients with a previous inferior infarction had a 
LMV. In the 12 non-Q wave infarction patients the PVLV was present in 11 patients (92%) and the 
LMV was present in 5 patients (42%). In the 24 Q-wave infarction patients the PVLV was only present 
in 17 patients (77%) and the LMV in 4 (18%) patients.
In patients with a previous infarction, the presence of both a PVLV and LMV was significantly less of-
ten observed as compared to CAD patients and normals (26.5% vs 60.5% vs 71.4%, p<0.01, Figure 6). 
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Patients with a PIV exhibited one side branch in 7%, two side branches in 28% and three side branch-
es in 2% of patients; 63% of these patients had no side branches. In the patients in whom a PVLV was 
identified, one side branch was observed in 2%, 2 side branches in 16% and 3 side branches in 1% of 
patients; 81% had no side branches. In patients with a LMV, one side branch was present in 4% and 
two side branches in 23% of patients, 73% of these patients had no side branches. No significant 
differences were observed between controls, patients with CAD with or without previous infarction 
regarding the number of side branches. 
Figure 4. Presence of the coronary sinus (CS) and its main tributaries: posterior interventricular vein (PIV), Pos-
terior vein of the left ventricle (PVLV) and left marginal vein (LMV) in the three subsets (controls, patients with 
coronary artery disease (CAD) and patients with CAD and history of myocardial infarction). 
Figure 3. Example of measurement of the distance between the origins of the tributaries of the coronary sinus. 
(PIV: posterior interventricular vein, PVLV: posterior vein of the left ventricle, LMV: left marginal vein).
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Quantitative measurements from MSCT
The quantitative measurements are presented in Table 2. Inter- and intra-observer agreement were 
assessed in 10 patients; percentage agreements were 94% and 97%. For all patients, the diameter of 
the CS in the supero-inferior direction was significantly larger as compared to the antero-posterior 
direction: 12.2 ± 3.3 mm versus 11.3 ± 3 mm (p = 0.002). The more distant tributaries of the CS had 
smaller diameters. Within the three groups (controls, CAD patients or patients with previous infarc-
tion) no significant differences were noted. The distances between the origins of the different vessels 
were also comparable between the three groups.
Discussion
The main findings in the current study are two-fold. First, non-invasive evaluation of the cardiac ve-
nous system in CAD patients is feasible using 64-slice MSCT. Second, variation of the cardiac venous 
anatomy in CAD patients appears related to a history of previous myocardial infarction; patients with 
previous infarction have significantly less left marginal veins. These observations may have impor-
tant implications for selection of potential CRT candidates with a history of myocardial infarction.
Figure 5. Example of absence of the posterior and left marginal vein in a patient with a history of an anterolateral 
infarction. Panel A: posterior view, Panel B: left lateral view. The only tributary of the coronary sinus (CS) and great 
cardiac vein (GCV) is the posterior interventricular vein (PIV). Also note the obtuse marginal (MO) branch of the 
circumflex coronary artery and the right coronary artery (RCA).
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Non-invasive evaluation of the cardiac venous system
Until recently, the cardiac venous system could only be evaluated invasively using retrograde ve-
nography, either by direct manual contrast injection or after occlusion of the coronary sinus 8,9. In 
2000, few studies reported on the use of non-invasive imaging with electron beam CT to depict the 
cardiac venous system 10,11. Recently, Mao et al analyzed the electron beam CT of 231 patients and 
demonstrated that this technique provides 3-D visualization of most components of the coronary 
venous system 12. In 2003, Tada et al reported the feasibility of MSCT to obtain high quality three-
 dimensional images of the cardiac venous system in one patient 13. Recently, preliminary studies 
were published on the value of 16-slice MSCT to evaluate the cardiac veins 7,14,15. Since then, 16-
slice MSCT is gradually being replaced by 64-slice MSCT, offering a higher spatial resolution with a 
decreased acquisition time. Abbara et al suggested that due to the shorter scanning time, venous 
opacification might be insufficient using scanning protocols tailored for imaging the coronary artery 
system 14. However, the feasibility of depicting the cardiac venous system with 64-slice MSCT was 
clearly demonstrated in the present study. Despite a shorter scanning time, the CS and its tributaries 
could be evaluated in all individuals. Prominent side branches - suitable for insertion of pacemaker 
leads - were adequately visualized but the distal parts of side branches with a smaller diameter could 
not be detected in all patients.
Table 2. Quantitative measurements in venous anatomy from MSCT.
Controls
n = 28
CAD
n = 38
Infarction
n = 34
p-value
Diameters 
CS antero-posterior (mm) 11.5 ± 2.4 11.2 ± 3.7 11.2 ± 2.9 NS
CS supero-inferior (mm) 12.6 ± 3.2 11.7 ± 3.3 12.5 ± 3.3 NS
GCV proximal (mm) 7.2 ± 1.4 7.0 ± 1.8 7.4 ± 1.4 NS
GCV distal (mm) 4.9 ± 1.1 5.0 ± 1.0 5.1 ± 1.3 NS
PIV (mm) 5.0 ± 0.7 5.2 ± 1.3 5.2 ± 1.3 NS
PVLV (mm) 3.8 ± 0.7 3.9 ± 1.0 4.1 ± 1.1 NS
LMV (mm) 3.1 ± 0.8 3.6 ± 1.5 5.3 ± 5.8 NS
Distance between origin of 
PIV and PVLV (mm) 32 ± 17 27 ± 14 36 ± 22 NS
PVLV and LMV (mm) 41 ± 13 39 ± 15 38 ± 17 NS
PVLV and AIV (mm) 51 ± 16 55 ± 17 57 ± 10 NS
LMV and AIV (mm) 45 ±   9 44 ± 14 46 ± 13 NS
AIV: anterior interventricular vein; CS: coronary sinus; GCV: great cardiac vein; LMV: left marginal vein; PIV: posterior 
interventricular vein; PVLV: posterior vein.
Variations in cardiac venous anatomy
In the current report the accepted terminology for the CS and its tributaries of the Nomina Ana-
tomica (English version) as described by von Lüdinghausen was used to permit comparison with 
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previous studies 16. Of note, in various studies the PVLV is often described as the Middle Cardiac Vein. 
Both in anatomical series and imaging series, either invasive venography or non-invasive evaluation 
with CT, a substantial variation in anatomy was reported. 
First, the CS was analyzed. The CS is the most constant component of the cardiac venous system and 
was detected in all patients. The diameter of the CS was larger in the supero-inferior direction as 
compared to the antero-posterior direction, indicating an oval shape of the ostium, confirming the 
16-slice MSCT observations of Jongbloed et al 7. and MRI observations by Wittkamp et al 17.
Secondly, the tributaries of the CS were evaluated. The PIV was observed in (nearly) all patients. The 
highest variability was observed in the number of tributaries between the PIV and the Anterior In-
terventricular Vein. In anatomical series the PVLV existed as a single large vessel in 63% of the cases 
(diameter ranging from 1.0 – 5.5 mm) and the prevalence of the LMV was between 73% and 88% of 
cases (diameter varying from 1.0 – 3.0 mm) 15. Meisel et al studied 129 patients referred for cardio-
verter-defibrillator implantation with invasive venography and noted a PVLV in 55% and a LMV in 
83% 8. In studies using  noninvasive modality (Electron Beam CT or 16 slice MSCT), the prevalence of 
the PVLV varied between 13% and 80 % and the prevalence of the LMV between 38% and 93% 11-14. 
The number of patients with CAD was not  specified in every study and data on the prevalence and 
site of infarction were frequently lacking. Mao and co-workers, analyzed 231 patients and found the 
CS in 100%, the PIV in 100%, the Posterior Vein in 78% and the Marginal Vein in 81% 12.  Abbara et al 
14 included 54 patients with suspected CAD, referred for 16-slice MSCT. In 4 patients (7.4%) no LMV 
could be identified and in 11 (20.4%) patients no Posterior Vein could be found; however none of 
Figure 6. Prevalence of both the posterior vein of the left ventricle (PVLV) and the left marginal vein (LMV), only 
the PVLV and neither PVLV and LMV according to subject category: controls, coronary artery disease (CAD) and 
myocardial infarction patients. Overall p = 0.003.
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the patients had a definite diagnosis of acute myocardial infarction 14. Jongbloed et al studied 38 pa-
tients including 18 CAD patients 7. The CS and PIV were observed in all patients, the PVLV was found 
in 95% and the LMV in 60% of patients.
A novelty of the current study is the demonstration of an association between these anatomic 
variations and the history of a previous myocardial infarction. None of the patients with a previous 
lateral infarction had a LMV and patients with anterolateral myocardial infarctions and especially 
Q-wave infarctions were lacking the LMV. Post-mortem studies on cardiac veins in ischemic heart 
disease are scarce. Hansen studied several series of patients who died from ischemic heart disease 
and detected thrombosis of the epicardial veins in large transmural infarctions 18. In all cases the 
thrombosed veins were those draining the infarcted myocardium 19. Indirect evidence supporting 
the association between previous infarction and absent cardiac veins is provided by Komamura et 
al who used thermodilution meaurements of great cardiac vein flow after reperfusion and dem-
onstrated that salvaged myocardium after successful thrombolysis was not observed in patients 
demonstrating a progressive decrease in great cardiac vein flow 20. 
Clinical implications
The observation that patients with previous infarction are frequently lacking the LMV has impor-
tant implications for the selection of potential candidates for CRT. Positioning the LV lead is the 
most challenging part of CRT implantation. Before referring the patient with previous infarction 
for CRT implantation, a triad of questions (Figure 7) has to be answered. First: where is the area of 
latest activation located? As shown by Ansalone et al, the best clinical response occurs in patients 
who had their LV lead placed in or near the site of latest activation 21.  Echocardiography with 
tissue Doppler imaging is an adequate non-invasive imaging modality to answer this question 
22,23. Second: does the area of latest mechanical activation not contain transmural scar tissue? Re-
cently, Bleeker et al observed that patients with transmural posterolateral scar tissue on contrast-
enhanced MRI failed to respond to CRT 24. This observation underscored that assessment of LV 
dyssynchrony in patients with ischemic cardiomyopathy should be combined with assessment of 
scar tissue, to verify whether the region that will be targeted for LV pacing does not contain trans-
mural scar tissue. After having identified the region of latest activation without scar tissue a final 
and third question has to be answered: are their cardiac veins, draining this target region, suitable 
for LV lead placement? MSCT can provide an answer to this question that appears important in 
patients with a history of myocardial infarction. If suitable cardiac veins are absent, a surgical ap-
proach is preferred over transvenous LV lead positioning. MSCT is a reliable technique to depict 
the cardiac venous system and the 3D reconstruction will also allow segmental classification to 
map the cardiac veins and tributaries in relation to the left ventricular wall in a manner compara-
ble to that of echocardiography. (25) MSCT is able to detect anatomic and quantitative differences 
that may occur in CS and venous anatomy of heart failure patients who are candidates for CRT. 
MSCT will not only confirm the presence of a specific CS tributary but will also provide information 
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on the course of the vessel, side-branches, the diameter, the distance from the CS and the relation 
with adjacent structures. Depending on the experience of the implanting cardiologist, no invasive 
venography at all or only selected venography of the target cardiac vein may be sufficient to im-
plant the lead successfully, based on the MSCT data. In addition, information on cardiac venous 
anatomy acquired with MSCT could possibly also be used during CRT implantation for 3-D naviga-
tion into the heart cavities and veins 26.
Figure 7. Non-invasive approach for left ventricular (LV) lead positioning.  
Limitations
The 64-slice MSCT scans were tailored for optimal visualization of the coronary arteries. This could 
have caused suboptimal enhancement of the coronary veins, particularly of second and third de-
gree side branches with a small diameter. Since atrial fibrillation is considered a contraindication for 
MSCT of the coronary arteries only patients in sinus rhythm were included. Prospective confirmation 
of the current findings is needed in patients referred for CRT.
Conclusion
Non-invasive evaluation of the cardiac venous anatomy with 64-slice MSCT is feasible. There is con-
siderable variation in cardiac venous anatomy. Patients with a history of myocardial infarction were 
less likely to have a LMV possibly limiting optimal LV lead positioning for CRT.
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Summary and Conclusion
The general introduction (Chapter 1) of this thesis provides an overview of the different modalities 
that are available for diagnosis of coronary artery disease (CAD). The individual strengths and 
limitations as well as the current accuracies - based on pooled analyses of the literature when 
available - of each imaging modality are described, followed by the outline of the thesis.
Part I 
The first part of the thesis focuses on the recently introduced technique Multi-Slice Computed 
Tomography (MSCT). MSCT is a rapidly developing technique that allows direct noninvasive 
visualization of the coronary arteries. In Chapter 2, the technical background of performing 
noninvasive coronary angiography with this novel technique is described. Data acquisition and 
post-processing protocols for optimal image quality and data evaluation are discussed. In addition, 
the potential applications of MSCT coronary angiography are outlined. 
Subsequently, the diagnostic accuracy of this novel technique in the detection of significant CAD 
(defined as 50% luminal narrowing or more) as compared to conventional coronary angiography is 
explored in Chapters 3-5. In Chapter 3, the diagnostic accuracy of 16-slice MSCT to detect significant 
stenosis was evaluated in 45 patients presenting with suspected or known CAD. A total of 94% of 
native coronary artery segments could be evaluated with MSCT, whereas 85% of grafts and 79% of 
coronary stents were interpretable. For all segments, overall sensitivity, specificity, and positive and 
negative predictive values were 85%, 89%, 71%, and 95%, respectively. In addition to evaluation of 
the coronary arteries, left ventricular ejection fraction (LVEF) was evaluated and compared to 2D-
echocardiography, which revealed a close correlation between these modalities. With regard to 
the high specificity and negative predictive value observed, it was concluded that 16-slice MSCT 
may be useful as a noninvasive modality to rule out significant stenosis. In addition, LVEF, being an 
important prognostic marker, may be evaluated with high accuracy. More recently, 64-slice MSCT 
has become available with the simultaneous acquisition of 64 rather than 16-slices per rotation 
as well as with improved rotation times. Chapter 4 describes the initial results obtained with this 
scanner. A sensitivity and specificity of 94% and 97%, respectively, were obtained on a patient basis. 
In conclusion, the study confirmed - in line with previous investigations - that 64-slice MSCT enables 
accurate noninvasive evaluation of significant coronary artery stenoses. Finally, a meta-analysis of 
the available literature on noninvasive coronary imaging with either MSCT or Magnetic Resonance 
Imaging (MRI) was performed. In Chapter 5 the results from this meta-analysis are described. 
Comparison of sensitivities and specificities revealed significantly higher values for MSCT (weighted 
average 85% and 95%) as compared with MRI (weighted average 72%, and 87%). In addition, a 
significantly higher odds ratio (16.9-fold) for the presence of significant stenosis was observed for 
MSCT as compared with MRI (6.4-fold) (P < 0.0001). Accordingly, the results of this meta-analysis 
of the available literature on noninvasive coronary angiography with MRI and MSCT indicated that 
MSCT has currently a significantly higher accuracy to detect or exclude significant CAD. 
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Part II
In the second part of the thesis, the potential use of MSCT and MRI is explored in subpopulations 
in order to identify those patient populations that may or may not benefit from these techniques. 
For example, patients with certain risk factors for CAD may benefit from early identification of CAD 
followed by targeted atherosclerotic treatment. However, it is important to establish beforehand 
whether the presence of these risk factors do not have any negative influence on the diagnostic 
performance of MSCT. In Part II A, therefore, the diagnostic performance of 4-and 16-slice MSCT 
was explored in the setting of different risk factors. In Chapter 6, the potential of MSCT coronary 
angiography was evaluated in patients with type 2 diabetes. A total of 86% of segments was 
interpretable with MSCT. In these segments, sensitivity and specificity for detection of coronary 
stenoses were 95%. Including the uninterpretable segments, sensitivity and specificity were 81% and 
82%, respectively. In addition, no significant difference was observed between LVEF values obtained 
by MSCT and 2D-echocardiography, while agreement in the assessment of regional contractile 
function was also excellent (91%). Accordingly, no major effect of type 2 diabetes on the diagnostic 
performance of MSCT was revealed, indicating that this technique may allow optimal identification of 
high-risk patients in this population. In Chapter 7, MSCT was applied in patients with hypertension. 
A total of 88% coronary artery segments could be evaluated with MSCT. Sensitivity and specificity for 
the detection of significant stenoses were 93% and 96%. On a per-patient basis, MSCT was accurate 
in 90% of patients. The results suggest that in patients with hypertension, MSCT may be applied for 
noninvasive triage of patients.  Finally in Chapter 8, the effect of gender and various risk factors for 
CAD (including type 2 diabetes, hypertension, obesity, smoking and hypercholesterolemia) on the 
diagnostic accuracy of 16-slice was explored in 197 patients. Patients were enrolled in the Erasmus 
Medical Center Rotterdam and the Leiden University Medical Center. Overall, a sensitivity and 
specificity of 99% and 86%, respectively, on a patient level were demonstrated. Among the various 
subsets of patients, similar values were observed, with no statistical differences, indicating a high 
diagnostic accuracy of MSCT coronary angiography, regardless of gender and risk factors. 
In part II B, patients with a history of revascularisation were studied. In this population, noninvasive 
imaging may be more challenging as compared to patients with suspected CAD due to the presence 
of stents and surgical clips, resulting in metal artefacts. In addition, the presence of extensive 
atherosclerosis may also pose substantial difficulties. In Chapter 9, the feasibility of 16-slice MSCT 
to evaluate patency of intracoronary stents was investigated in patients referred for conventional 
coronary angiography. For each stent, assessability was determined and related to stent type and 
diameter. Subsequently, the presence of significant restenosis was determined in the evaluable 
stents as well as peri-stent lumina. Of 65 stents, 50 (77%) were considered assessable. Uninterpretable 
stents tended to have a thicker strut thickness (≥ 140 μm) and/or a smaller diameter (≤ 3.0 mm). 
In the evaluable stents, a sensitivity and specificity of 78% and 100%, respectively, were obtained. 
Sensitivity and specificity for the detection of peri-stent stenosis were 75% and 96%, respectively. 
In conclusion, in stents with a larger diameter and relatively thin struts, MSCT may be useful in 
the assessment of stent patency and may function as a gatekeeper prior to invasive diagnostic 
procedures.
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The expectation of improved assessability of coronary stents with 64-slice MSCT was tested in 
Chapter 10. State-of-the-art imaging and evaluation protocols were applied in 182 patients 
presenting with a total of 192 stents. MSCT images obtained by 64-slice MSCT (either using a 
Siemens Sensation or Toshiba Aquilion) were evaluated by experienced observers at each center 
for the presence of significant in-stent restenosis. Only stents with a diameter ≥ 2.5 mm were 
included. Ninety-three percent of stents were of good diagnostic quality. In interpretable stents, 
high sensitivity and specificity to identify in-stent restenosis were observed. Accordingly, in stents 
with a larger diameter, in-stent restenosis can be evaluated with 64-slice MSCT with good diagnostic 
accuracy. In particular, a high negative predictive value of 99% was observed indicating that 64-slice 
MSCT may be most valuable as a noninvasive method of excluding in-stent restenosis.
In Chapter 11, the performance of 64-slice MSCT in the assessment of in-stent restenosis was 
evaluated in more detail. In 50 patients, 64-slice MSCT was performed in addition to conventional 
coronary angiography with quantitative coronary angiography (QCA). For each stent, assessability 
was determined and related to stent characteristics and heart rate. In the interpretable stents, the 
presence of significant (≥50%) restenosis was determined. Since restenosis may frequently occur at 
the stent borders, also peri-stent lumina (5.00 mm proximal and distal to the stent) were evaluated. 
Of 76 stents, 86% were determined assessable. Increased heart rate and overlapping positioning 
were found to be associated with increased stent uninterpretability, whereas stent location and 
strut thickness were not. In the interpretable stents, the presence or absence of significant (≥50%) 
in-stent restenoses was correctly detected in all stents. Sensitivity and specificity for the detection 
of significant (≥50%) peri-stent stenosis were 100% and 98%, respectively. In selected patients with 
previous stent implantation, 64-slice MSCT may allow accurate evaluation of in-stent and peri-stent 
stenosis. 
Although percutaneous coronary intervention is increasingly performed in the treatment of 
obstructive CAD, a considerable portion of patients still receives coronary bypass surgery. In 
Chapter 12, a high-resolution, phase contrast MRI sequence for quantifying flow in small and large 
vessels was validated. In addition, its feasibility to measure flow in coronary artery bypass grafts was 
demonstrated. For this purpose, a breath-hold, echo planar imaging (EPI) sequence was developed 
and validated in a flow phantom using a fast field echo (FFE) sequence as reference. In 17 volunteers 
aortic flow was measured using both sequences. In 5 patients flow in the left internal mammary 
artery (LIMA) and aorta was measured at rest and during adenosine stress, and coronary flow reserve 
(CFR) was calculated; in 7 patients, vein graft flow velocity was measured. In the flow phantom 
measurements, the EPI sequence yielded an excellent correlation with the FFE sequence, while also 
aortic volume flow in healthy volunteers correlated well with only a minor overestimation. It was 
feasible to measure flow velocity in the LIMA and vein grafts of the 12 patients. 
Part III  
Based on the consistently high negative predictive value of MSCT coronary angiography, the 
technique has been proposed as a suitable alternative for first-line evaluation in patients presenting 
with suspected CAD. However, functional imaging modalities have traditionally been used for this 
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purpose. As a result, the presence and extent of ischemia, i.e. the hemodynamical consequences of a 
lesion, have served as the gatekeeper for referral to conventional coronary angiography. In contrast, 
MSCT coronary angiography provides direct information on coronary anatomy. Accordingly, in 
order to fully appreciate both the potential and limitations of this new technique as well as to allow 
optimal integration, its performance needs to be evaluated not only against conventional coronary 
angiography but also against functional imaging.
In Chapter 13, an update of the various noninvasive modalities, including both anatomical as well 
as functional modalities, is provided. Their values in both the diagnosis of obstructive CAD and 
prognostification are discussed. In addition, a potential algorithm for integration of anatomical 
imaging with MSCT and functional imaging is proposed. 
In order to design and support such algorithms, the relationship between noninvasive coronary 
angiography with MSCT and myocardial perfusion imaging (MPI) needs to be determined. 
Therefore, in Chapter 14, a total of 114 patients, presenting with an intermediate pre-test likelihood 
of CAD, underwent both MSCT coronary angiography and myocardial perfusion imaging (MPI) 
using gated SPECT. An excellent agreement was observed between normal coronary arteries on 
MSCT and the presence of normal myocardial perfusion on gated SPECT (90%). In contrast, only 
50% of patients with a significant stenosis on MSCT displayed abnormal perfusion during gated 
SPECT. Accordingly, an abnormal MSCT does not imply the presence of a hemodynamically relevant 
stenosis. As knowledge of ischemia is needed to determine further management and decide 
between aggressive intervention or conventional therapy, functional testing appears necessary 
following an abnormal MSCT scan. On the other hand, CAD could be ruled out by MSCT in only 46% 
of patients with a normal perfusion study, indicating that a normal MPI cannot rule out extensive 
atherosclerosis. Combination of both techniques, either by integrated or sequential imaging, may 
therefore be preferred and allow more precise cardiac assessment. This current change in paradigm 
- namely the shift from detection of ischemia to detection of (sub)clinical atherosclerosis - is further 
discussed in Chapter 15.  
In Chapter 16, the relation between anatomical imaging, using both MSCT calcium scoring and 
noninvasive coronary angiography, and MPI was assessed in an unselected population, including 
patients with known CAD. Analysis of data on a regional basis revealed that in coronary arteries with 
a calcium score of 10 or less, the corresponding myocardial perfusion was normal in 87%. In coronary 
arteries with extensive calcifications (calcium score > 400), the percentage of vascular territories 
with normal myocardial perfusion was substantially lower, 54%. Similarly, coronary arteries without 
detectable atherosclerosis as well as coronary arteries with non-obstructive atherosclerosis were 
generally found to be associated with normal myocardial perfusion in the corresponding vascular 
territory (89%). 
In contrast, the percentage of normal SPECT findings was significantly lower in coronary arteries 
with obstructive lesions (59%) or with total or subtotal occlusions (8%). Nonetheless, only 48% of 
vascular territories with normal perfusion corresponded to normal coronary arteries on MSCT 
angiography, whereas insignificant and significant stenoses were present in, respectively, 40% and 
12% of corresponding coronary arteries.
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These discrepant findings were further investigated in Chapter 17. In a subset of patients, the 
discrepancy between MPI and MSCT was compared to invasive imaging, not only of the coronary 
artery lumen (using invasive coronary angiography) but also of the vessel wall (using intravascular 
ultrasound, IVUS). A good agreement between modalities was observed in patients with abnormal 
MPI. However, a normal MPI study was in most patients associated with an abnormal MSCT study. 
In these patients only minimal luminal stenosis was observed on QCA (26.5%) as well. Considerable 
plaque burden (58%), however, was revealed by IVUS imaging, yet without luminal compromise 
(average minimal luminal area 5.7 mm2). From the chapter was concluded that in patients with 
discrepant MSCT and MPI findings, the detected atherosclerosis may be located mainly in the vessel 
wall, rather than extending into the coronary lumen.
Part IV 
A particular feature of MSCT is that it allows visualization of not only luminal narrowing but also of 
the coronary vessel wall. While this may lead to discrepant results with other imaging modalities 
as described in Part III, knowledge of the presence and extent of atherosclerosis may eventually 
become an advantage of MSCT. 
In Chapter 18 the hypothesis that MSCT may detect differences in plaque composition and 
distribution between patients with stable CAD versus patients presenting with acute coronary 
syndromes (ACS) was tested. In patients with stable CAD, the majority of lesions were calcified (89%), 
whereas in patients with ACS, a greater proportion of noncalcified (18%) or mixed (36%) lesions 
was noted. Moreover, even in non-culprit vessels, multiple noncalcified plaques were detected, 
indicating the presence of diffuse rather than focal atherosclerosis in ACS. 
In Chapter 19, the influence of type 2 diabetes on MSCT plaque characteristics, including plaque 
extent and composition was evaluated in 215 patients, of whom 40% with type 2 diabetes. Significant 
differences in plaque characteristics were observed and the presence of diabetes was demonstrated 
to correlate with the number of diseased segments and the number of nonobstructive, noncalcified, 
and calcified plaques. Diabetes was associated with increased coronary plaque burden as well as 
more noncalcified and calcified plaques and less mixed plaques. Since MSCT may provide an estimate 
of coronary plaque burden as well as distinction in atherosclerotic patterns between various clinical 
presentations, this information obtained with MSCT may be useful for risk stratification. Chapter 
20 describes the observations in 100 patients who were followed for coronary events (including 
cardiac death, nonfatal myocardial infarction, unstable angina requiring hospitalisation, and 
revascularisation) after a baseline MSCT examination. During a mean follow-up of 16 months, 33 
events occurred in 26 patients. In patients with normal coronary arteries on MSCT, the first-year 
event rate was 0% versus 30% in patients with any evidence of CAD on MSCT. The observed event 
rate was highest in the presence of obstructive lesions (63%) and when obstructive lesions were 
located in the left main (LM)/left anterior descending (LAD) coronary arteries (77%). Nonetheless, 
an elevated event rate was also observed in patients with nonobstructive CAD (8%). In multivariate 
analysis, significant predictors of events were the presence of CAD, obstructive CAD, obstructive CAD 
in LM/LAD, number of segments with plaques, number of segments with obstructive plaques, and 
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number of segments with mixed plaques. From this chapter it was concluded that MSCT coronary 
angiography provides independent prognostic information over baseline clinical risk factors in 
patients with known and suspected CAD. Of particular importance, an excellent prognosis was 
noted in patients with a normal MSCT, supporting safe rule-out of CAD with this technique.
Part V 
In the final part of the thesis, non-coronary applications of MSCT and MRI are described. Delayed 
enhancement MRI allows precise delineation of infarcted myocardium including assessment of 
transmural extent. In Chapter 21, a head-to-head comparison was performed between visual and 
quantitative analyses of infarct transmurality in 27 patients with long-term ischemic LV dysfunction 
and previous infarction. In addition, infarct transmurality was related to the severity of wall motion 
abnormalities at rest. Both cine MR imaging (to assess regional wall motion) and contrast enhanced 
(ce) - MR imaging were performed and visually analysed using a 17-segment model for wall motion 
and segmental infarct transmurality. Quantification of transmurality was performed with threshold 
analysis. The agreement between visual and quantitative analyses was excellent: 90% of segments 
(kappa 0.86) were categorised similarly by visual and quantitative analyses. Infarct transmurality 
paralleled the severity of contractile dysfunction; 96% of normal or mildly hypokinetic segments 
had infarct transmurality ≤25%, whereas 93% of akinetic and dyskinetic segments had transmurality 
>50% on visual analysis. In conclusion, visual analysis of ce-MR imaging studies may be sufficient for 
assessment of transmurality of infarction.
Information on myocardial infarct tissue may also be derived from MSCT. As a 3D data set is acquired 
during ECG gating, images can be reconstructed in the short-axis orientation throughout the cardiac 
cycle. In addition, imaging is performed during a bolus administration of contrast agent, resulting 
in images during first-pass. As a result, areas of reduced myocardial perfusion can be identified as 
hypodense areas on the MSCT images. The purpose of Chapter 22 was to evaluate the potential of 
MSCT to provide a comprehensive cardiac assessment, with evaluation of LV function and perfusion in 
addition to coronary anatomy. In 21 patients with previous infarction, MSCT was performed in addition 
to conventional coronary angiography (coronary anatomy) and gated SPECT imaging (perfusion and 
function). In this population, observed sensitivity and specificity for detection of stenoses were 91% 
and 97% with 98% of segments being interpretable on MSCT.  Excellent agreement was observed for 
assessment of LVEF and regional wall motion between MSCT and SPECT. With regard to perfusion, 
MSCT correctly identified a resting perfusion defect in 93%, whereas the absence of perfusion defects 
was correctly detected in 98% of segments. LV function measurements were further validated in 
Chapter 23. Measurements of LV volumes and LVEF were compared to 2D-echocardiography. 
Linear regression analysis showed excellent correlations between the 2 techniques, although LVEF 
was slightly overestimated with MSCT. Finally, in Chapter 24, a novel application of MSCT coronary 
angiography, namely the visualization of the cardiac venous system, was evaluated. For successful LV 
lead implantation in cardiac resynchronization therapy (CRT), knowledge of venous anatomy may be 
useful. The presence of the coronary sinus tributaries was evaluated in a total of 100 patients of whom 
28 control patients, 38 patients with significant CAD, and 34 patients with a history of myocardial 
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infarction. While the coronary sinus and posterior interventricular vein were identified in all patients, 
a left marginal vein (LMV) was significantly less frequently observed in patients with a history of 
infarction as compared with control patients and CAD patients (27% vs. 71% and 61%, respectively). 
None of the patients with lateral wall infarction and only 22% of patients with anterior wall infarction 
showed a LMV on MSCT in. Accordingly, there appears to be a considerable variation in venous 
anatomy. Patients with a history of myocardial infarction showed less frequently a LMV, which may 
hamper optimal LV lead positioning in CRT implantation.  
Conclusion
 
Various modalities are available in the diagnostic and prognostic evaluation of patients presenting 
with known or suspected CAD. A particularly rapidly expanding technique is noninvasive coronary 
angiography with MSCT. During the past few years, noninvasive coronary angiography with 
this technique has witnessed an enormous development. In comparison to invasive coronary 
angiography, the technique has been demonstrated to allow accurate detection of significant 
coronary stenoses and currently outperforms noninvasive coronary angiography with MRI. Due to 
the high negative predictive value, the most important contribution of the technique will lie in the 
noninvasive exclusion of CAD in patients presenting with suspected CAD and intermediate pre-test 
likelihood. Although imaging in populations such as patients with previous stent placement appears 
to be more challenging, promising results have been obtained in these populations as well. 
However, it remains important to realize that only half of the significant lesions on MSCT appear 
to have hemodynamical consequences. These observations indicate that the presence of coronary 
atherosclerosis with luminal obstruction does not invariably imply the presence of ischemia. 
Accordingly, a noninvasive angiographic imaging technique such as MSCT cannot be used to 
predict the hemodynamical importance of observed lesions. In patients with borderline stenosis or 
limited image quality on MSCT, therefore, functional testing will remain necessary to determine the 
presence of ischemia. This can be performed by nuclear imaging, stress echocardiography or MRI. 
Moreover, the latter may allow measurements of coronary flow in coronary bypass grafts.
One of the advantages of MSCT on the other hand, is the fact that the technique allows detection of 
CAD at a far earlier stage than functional imaging. Initial investigations even suggest that MSCT may 
distinguish different plaque characteristics between various presentations. Potentially, this information 
could be useful for risk stratification. Finally, in addition to information on the coronary arteries, also 
other non-coronary information can be derived from the MSCT examination. LV function can be 
evaluated with high accuracy while also information on the cardiac venous system can be obtained. 
With regard to daily clinical management in patients presenting with (suspected) CAD, integration 
of MSCT coronary angiography with functional imaging techniques may potentially be most 
beneficial. This will allow accurate exclusion as well as earlier detection of CAD in combination with 
knowledge of ischemia. However, it is important to realize that available data are currently scarce 
and investigations supporting improved outcome as well as cost-effectiveness of algorithms 
incorporating both MSCT coronary angiography and functional testing are eagerly awaited. 
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Samenvatting en Conclusie
In de algemene inleiding (Hoofdstuk 1) wordt een overzicht gegeven van de verschillende 
technieken die beschikbaar zijn voor de diagnostiek van coronairlijden. Van elke techniek worden 
de voor- en nadelen beschreven, evenals de huidige diagnostische nauwkeurigheid - gewogen op 
basis van de beschikbare literatuur- , gevolgd door een overzicht van het proefschrift. 
Deel I 
Het eerste gedeelte van het proefschrift beschrijft de onlangs geïntroduceerde techniek multi-slice 
computed tomography (MSCT). MSCT is een techniek die zich enorm snel heeft ontwikkeld en die 
directe weergave van de kransslagaderen toelaat. Hoofdstuk 2 beschrijft de technische achtergrond 
van niet-invasieve coronairangiografie met deze techniek. Protocollen voor 1. data-acquisitie en 2. 
beeldbewerking om optimale beeldkwaliteit te bereiken worden beschreven. Daarnaast wordt een 
overzicht gegeven van de mogelijke toepassingen van MSCT. 
Hoofdstukken 3-5 verkennen de diagnostische nauwkeurigheid van MSCT in het opsporen van 
significante vernauwingen (gedefinieerd als minimaal 50% vernauwing van het lumen van het vat) 
in vergelijking met de traditionele invasieve coronairangiografie. 
In Hoofdstuk 3 is de nauwkeurigheid van 16-slice MSCT onderzocht om significante vernauwingen 
te herkennen in een populatie van 45 patiënten. In totaal kon 94% van de natieve kransslagaderen 
beoordeeld worden, terwijl 85% van de coronaire omleidingen en 79% van de coronaire stents 
beoordeelbaar waren. Op segmentniveau werd een sensitiviteit van 85% en een specificiteit 
van 89% aangetoond. De bereikte positief en negatief voorspellende waarden waren 71% en 
95%. Naast beoordeling van coronairvernauwingen zijn de MSCT beelden ook gebruikt om de 
linkerventrikelejectiefractie (LVEF) bij alle patiënten te bepalen. Deze metingen werden vergeleken 
met 2D-echocardiografie, waarbij een goede correlatie tussen de metingen werd gevonden. 
Op basis van deze resultaten werd geconcludeerd dat, gelet op de hoge specificiteit en negatief 
voorspellende waarde, MSCT van nut kan zijn om op niet-invasieve wijze de aanwezigheid van 
significante vernauwingen uit te sluiten. Eveneens kan de LVEF, - als belangrijke prognostische marker 
-, nauwkeurig bepaald worden waarbij gebruik wordt gemaakt van dezelfde gegevens als die voor 
de coronairangiografie. Sindsdien is 64-slice MSCT beschikbaar gekomen. Met deze generatie van 
MSCT scanners worden 64 in plaats van 16 coupes per omwenteling van de röntgenbuis verkregen 
bij een snellere omwentelingstijd. Hoofstuk 4 beschrijft de eerste resultaten met deze nieuwe 
scanner bij patiënten die verwezen waren voor traditionele coronairangiografie. Op patiëntniveau 
bedroegen de verkregen sensitiviteit en specificiteit 94% en 97%. De conclusie is dat nauwkeurige 
en niet-invasieve beoordeling van significante coronairvernauwingen mogelijk is met 64-slice MSCT, 
in lijn met eerder behaalde resultaten. 
Tot slot werd een meta-analyse van de beschikbare literatuur op het gebied van niet-invasieve 
coronairangiografie met MSCT en kernspin resonantie tomografie (MRI) uitgevoerd. De resultaten 
van deze meta-analyse worden beschreven in Hoofdstuk 5. Vergelijking van sensitiviteit en 
specificiteit waarden onthulde significant hogere waarden voor MSCT (gewogen sensitiviteit en 
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specificiteit 85% en 95% voor MSCT versus 72% en 87% voor MRI). Tevens werd een significant 
hogere odds ratio (16.9-voud) voor de aanwezigheid van een significante vernauwing gevonden 
voor MSCT in vergelijking tot MRI (6.4-voud). Op basis van deze meta-analyse is geconcludeerd dat 
MSCT momenteel een significant betere nauwkeurigheid heeft dan MRI voor het aantonen dan wel 
uitsluiten voor significant coronairlijden. 
Deel II 
In Deel II is het mogelijke gebruik van MSCT en MRI in bepaalde subpopulaties onderzocht om de 
patiëntenpopulaties te identificeren die al dan niet baat kunnen hebben bij toepassing van deze 
technieken. Patiënten met bepaalde risicofactoren voor coronairlijden zouden bijvoorbeeld een 
gezondheidsvoordeel kunnen hebben bij vroegtijdige opsporing van de ziekte, gevolgd door 
gerichte anti-atherosclerotische behandeling. Daarentegen is het, voordat de techniek tot dit doel 
gebruikt kan worden, van groot belang om te bepalen of de aanwezigheid van deze risicofactoren 
geen negatieve invloed op de diagnostische nauwkeurigheid van MSCT kan hebben.
In Deel II A is daarom de diagnostische nauwkeurigheid van 4-slice en 16-slice MSCT onderzocht 
in de aanwezigheid van risicofactoren voor coronairlijden. Hoofdstuk 6 beschrijft de resultaten bij 
patiënten met type 2 diabetes. In totaal was 86% van de coronairsegmenten beoordeelbaar met 
MSCT. In deze beoordeelbare segmenten werden een sensitiviteit en een specificiteit van 95% 
gevonden. Inclusie van de onbeoordeelbare coronairsegmenten resulteerde in een sensitiviteit van 
81% en een specificiteit van 82%. Bovendien werd in de vergelijking van de LVEF bepalingen met 
MSCT en 2D-echocardiografie slechts een klein niet-significant verschil gezien. Tevens werd een 
zeer goede overeenkomst gevonden in de beoordeling van regionale wandbewegingsstoornissen 
(91%). Van de aanwezigheid van type 2 diabetes op de nauwkeurigheid van MSCT is geen aanzienlijk 
effect waargenomen, hetgeen suggereert dat MSCT een geschikte techniek zou kunnen zijn om 
in patiënten met type 2 diabetes coronairlijden vroegtijdig op te sporen. In Hoofdstuk 7 is MSCT 
toegepast bij patiënten met hypertensie. In 88% van de beoordeelbare coronairsegmenten, werd 
een sensitiviteit en een specificiteit van 93% en 96% gevonden. Op patiëntniveau werd met MSCT 
de juiste diagnose gesteld bij 90% van patiënten. De gevonden resultaten wijzen er op dat MSCT 
toegepast kan worden voor niet-invasieve triage van patiënten met hypertensie. Tot slot is in 
Hoofdstuk 8 de invloed onderzocht van geslacht en verschillende risicofactoren voor coronairlijden 
in een grote populatie van 197 patiënten (geïncludeerd in het Erasmus Medisch Centrum en 
Leids Universitair Medisch Centrum). Er werden geen verschillen gevonden in de verschillende 
subpopulaties, hetgeen de eerdere bevindingen bevestigt. 
In Deel II B zijn patiënten met een revascularisatieprocedure in hun voorgeschiedenis bestudeerd. 
In deze populatie is niet-invasieve beeldvorming mogelijk uitdagender door de aanwezigheid 
van metaalartefacten als gevolg van stents en chirurgische clips. Bovendien kan de aanwezigheid 
van vaak uitgebreide atherosclerose bij deze patiënten nog meer moeilijkheden opleveren. In 
Hoofdstuk 9 is de haalbaarheid van 16-slice MSCT om coronaire stents te beoordelen op restenose 
onderzocht in patiënten die reeds verwezen waren voor invasieve coronairangiografie. Voor elke 
stent werd bepaald of deze beoordeelbaar was. Vervolgens werd de beoordeelbaarheid van stents 
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gerelateerd aan de grootte en het type van de stent. In de beoordeelbare stents en peri-stent lumina 
werd de aanwezigheid van significante in-stent restenose vastgesteld. Van de 65 stents waren 50 
(77%) beoordeelbaar. In onbeoordeelbare stents werd vaker een grotere strutdikte (≥ 140 μm) 
en/of een kleiner diameter (≤ 3.0 mm) gevonden in vergelijking met beoordeelbare stents. In de 
beoordeelbare stents werd een sensitiviteit en specificiteit van 78% en 100% verkregen. Sensitiviteit 
en specificiteit voor de beoordeling van peri-stent lumina waren 75% en 96%. Op basis van deze 
resultaten is geconcludeerd dat in stents met een grotere diameter en relatief kleinere strutdikte, 
16-slice MSCT gebruikt kan worden voor het uitsluiten van in-stent of peri-stent restenose.
De verwachting dat met 64-slice MSCT coronaire stents beter beoordeelbaar zouden kunnen zijn, is 
onderzocht in Hoofdstuk 10. Recent ontwikkelde beeldvorming- en beoordelingsprotocollen zijn 
toegepast bij 182 patiënten met een totaal van 192 stents. De MSCT beelden - verkregen met een 64-
slice Siemens Sensation en een 64-slice Toshiba Aquilion - werden beoordeeld op de aanwezigheid 
van significante in-stent restenose met als goudstandaard kwantitatieve coronairangiografie. Slechts 
stents met een diameter ≥ 2.5 mm werden geïncludeerd. In totaal kon 93% van de beschikbare stents 
beoordeeld worden, met een sensitiviteit en een specificiteit van 95% en 93% in de beoordeelbare 
stents. Geconcludeerd is dat in stents met voldoende diameter in-stent restenose betrouwbaar kan 
worden beoordeeld. Met name de negatief voorspellende waarde is hoog, hetgeen er op wijst dat 
MSCT het waardevolst is voor het niet-invasief uitsluiten van in-stent restenose. 
In Hoofdstuk 11 is de waarde van 64-slice MSCT om stents te beoordelen in meer detail geëvalueerd. 
In totaal ondergingen 50 patiënten een onderzoek met 64-slice MSCT in aanvulling op traditionele 
coronairangiografie in combinatie met kwantitatieve coronairangiografie, of QCA. Voor elke stent 
werd de beeldkwaliteit bepaald en vervolgens gerelateerd aan stentkarakteristieken en het hartritme. 
In de beoordeelbare stents werd de aanwezigheid van significante (≥50%) in-stent restenosis bepaald. 
Aangezien restenose ook frequent optreedt op de stentranden, werden ook de peri-stent lumina (5 
mm proximaal en distaal) geëvalueerd. Van de 76 stents waren 65 (86%) beoordeelbaar. Een verhoogd 
hartritme en overlappende plaatsing van meerdere stents bleken verband te houden met verminderde 
beoordeelbaarheid. In de beoordeelbare stents werden een hoge sensitiviteit en specificiteit bereikt, 
net als voor het identificeren van peri-stent restenose. 
Alhoewel percutane interventies in toenemende mate toegepast worden bij de behandeling van 
patiënten met coronairlijden, ondergaat nog steeds een aanzienlijk gedeelte van de patiënten 
coronaire bypasschirurgie. In Hoofdstuk 12 wordt een nieuwe MRI sequentie geïntroduceerd om de 
doorstroming in arteriële en veneuze omleidingen te meten. Hiervoor werd een “echo planar imaging” 
(EPI) sequentie ontwikkeld en door middel van een fantoom gevalideerd tegen een “fast field echo” 
(FFE) sequentie. Bij 17 gezonde vrijwilligers werd de doorstroming van de aorta gemeten door middel 
van beide sequenties. In 5 patiënten werd de doorstroming in de linker arteriële omleidingen en aorta 
gemeten in rust en tijdens adenosinestress. Op basis hiervan werd de doorstromingsreserve bepaald; bij 
7 patiënten werd de doorstromingssnelheid gemeten in de veneuze omleiding. De fantoommetingen 
brachten een uitstekende correlatie tussen de beide sequenties naar voren. Ook de doorstroming in 
gezonde vrijwilligers toonde een goede correlatie. Tevens kon in patiënten met behulp van de nieuwe 
sequentie de doorstroming gemeten worden in arteriële en veneuze omleidingen.
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Deel III 
Op basis van de consistent hoge negatief voorspellende waarde van MSCT coronairangiografie wordt de 
techniek beschouwd als een geschikt alternatief voor vroege diagnostiek in patiënten met verdenking 
op coronairlijden. Van oudsher zijn echter de functionele beeldvormingtechnieken voor dit doeleinde 
toegepast. Als gevolg hiervan wordt verwijzing naar traditionele coronairangiografie al tijden lang 
bepaald op basis van de aanwezigheid en uitgebreidheid van ischemie (het hemodynamische gevolg 
van een vernauwing). Daarentegen verschaft MSCT coronairangiografie directe informatie over de 
coronairanatomie. Om de mogelijkheden evenals de beperkingen van deze nieuwe techniek beter op 
waarde te schatten, en tevens een zo optimaal mogelijke integratie in de kliniek toe te staan, moeten 
de prestaties van de techniek niet alleen vergeleken worden met traditionele coronairangiografie maar 
ook met de veelvuldig gebruikte functionele beeldvormende technieken. 
In Hoofdstuk 13 wordt een bijgewerkt overzicht gegeven van de verschillende niet-invasieve 
beeldvormende technieken (zowel anatomische als functionele). Hun waarden en prestaties in 
de diagnostiek en prognose van obstructief coronairlijden worden besproken. Tot slot wordt een 
mogelijk algoritme voor de integratie van anatomische beeldvorming met MSCT en functionele 
beeldvorming voorgesteld. 
Om tot zulke algoritmes te komen, dient de relatie tussen niet-invasieve coronairangiografie met 
MSCT en myocardiale perfusie scintigrafie (MPS) nader te worden bepaald. In Hoofdstuk 14 is dan 
ook in een totaal of 114 patiënten die zich op de polikliniek presenteerden met een gemiddelde 
voorafkans op coronairlijden, zowel MSCT als MPS (met behulp van gated SPECT) uitgevoerd. Tussen 
normale kransslagaderen op het MSCT beeld en normale doorbloeding op het gated SPECT beeld 
werd een goede overeenkomst (90%) gevonden. Daarentegen werd slechts bij 50% van de patiënten 
met een significante vernauwing op de MSCT scan afwijkende perfusie gevonden. Het lijkt er dus op 
dat een abnormaal MSCT onderzoek niet direct de aanwezigheid van een hemodynamisch relevante 
vernauwing impliceert. Daar informatie over de aanwezigheid van ischemie noodzakelijk is om het 
vervolgbeleid - de keuze tussen revascularisatie of meer terughoudende medicamenteuze therapie 
- te bepalen, lijkt vervolgonderzoek met behulp van functionele beeldvorming noodzakelijk in 
het geval van een afwijkend MSCT onderzoek. Anderzijds werd coronairlijden slechts in 46% van 
de patiënten met een normaal MPS onderzoek volledig uitgesloten door MSCT. Deze bevinding 
wijst erop dat normale doorbloeding van de hartspier niet per definitie betekent dat coronairlijden 
afwezig is. Het combineren van beide technieken, hetzij door geïntegreerde, hetzij door sequentiële 
beeldvorming, verdient wellicht de voorkeur en staat mogelijk preciezere cardiale beoordeling toe. 
De verschuiving van het onderzoeksdoel die momenteel gaande is in de diagnostiek van 
coronairlijden, namelijk de verschuiving van het uitsluitend opsporen van ischemie naar de 
opsporing van (sub)klinische atherosclerose, wordt in Hoofdstuk 15 gedetailleerder besproken. 
Hoofdstuk 16 beschrijft de relatie tussen de bepaling van de kalkscore, MSCT coronairangiografie 
en MPS in een ongeselecteerde populatie bestaand uit patiënten zowel bekend met als verdacht 
van coronairlijden. Analyse van de resultaten op regionaal niveau (kransslagader versus het 
bijbehorende stroomgebied van de hartspier), liet normale doorbloeding zien in 87% van de 
kransslagaderen met een calcium score <10. Daarentegen was dit percentage significant lager (54%) 
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in kransslagaderen met uitgebreide verkalkingen (calcium score >400). Ook in kransslagaderen 
zonder zichtbare atherosclerose of met atherosclerose zonder vernauwingen werd in het 
merendeel normale doorbloeding gevonden (89%). Het percentage normale MPS onderzoeken 
was daarentegen significant lager in kransslagaderen met significante vernauwingen (59%) of met 
totale of subtotale occlusies (8%). Desalniettemin toonde slechts 48% van de stroomgebieden met 
normale doorbloeding ook afwezigheid van atherosclerose op de MSCT onderzoeken, terwijl niet-
significante en significante vernauwingen aanwezig waren in respectievelijk 40% en 12% van de 
bijbehorende kransslagaderen. 
Deze verschillen zijn verder onderzocht in Hoofdstuk 17. In een gedeelte van de patiënten is het 
verschil tussen MPS en MSCT vergeleken met invasieve beeldvorming. Niet alleen het lumen van de 
coronair, door middel van invasieve coronairangiografie, maar ook de coronairwand, door middel 
van intravasculaire ultrasound of IVUS, werd onderzocht. Een goede overeenkomst werd gezien in 
het geval van een afwijkend MPS onderzoek. Echter, een normaal MPS onderzoek ging in de meeste 
patiënten gepaard met een afwijkend MSCT onderzoek. Ook waren bij de patiënten slechts geringe 
afwijkingen op de traditionele coronairangiografie (gemiddelde stenose graad 26.5%) zichtbaar. 
Beeldvorming van de coronairwand met IVUS liet in deze patiënten aanzienlijke plaque-opbouw 
zien (gemiddelde plaque belasting 58%) zonder vermindering van het lumen oppervlak (gemiddeld 
5.7 mm2). In patiënten met tegenstrijdige MSCT en MPS bevindingen lijkt deze discrepantie 
verklaard te kunnen worden door de aanwezigheid van de atherosclerose die voornamelijk in de 
wand gelokaliseerd is in plaats van zich uitbreidend naar het lumen.
Deel IV 
Een specifieke eigenschap van MSCT is dat de techniek niet alleen het lumen laat zien maar ook 
de opbouw van atherosclerotische plaques in de coronairwand. Terwijl dit tot discrepanties met 
resultaten van andere technieken kan leiden, zoals beschreven in Deel IV, kan kennis van de 
aanwezigheid en uitgebreidheid van atherosclerose ook voordelen bieden. Het is dan ook goed 
mogelijk dat beoordeling van aanwezigheid en uitgebreidheid van coronairplaques een belangrijke 
component van het MSCT onderzoek zal worden. 
In Hoofdstuk 18 is de hypothese onderzocht dat MSCT verschillende patronen in atherosclerotische 
plaques kan herkennen. MSCT werd uitgevoerd bij 22 patiënten met verdenking op een acuut 
coronair syndroom (ACS) en vergeleken met 24 patiënten met stabiel coronairlijden. In patiënten 
met stabiel coronairlijden werden voornamelijk gecalcificeerde plaques geïdentificeerd (89% van het 
totaal). Daarentegen was een significant groter gedeelte van de gevonden plaques in patiënten met 
ACS danwel niet-gecalcificeerd (18%) of een combinatie van gecalcificeerd en niet-gecalcificeerd 
weefsel (36%). Vergelijking van de culprit vaten met de niet-culprit vaten in de patiënten met ACS liet 
bovendien zien dat ook in de niet-culprit vaten verscheidene niet-gecalcificeerde plaques aanwezig 
waren, hetgeen wijst op de aanwezigheid van uitgebreide en diffuse in plaats van plaatselijk 
beperkte atherosclerose in deze patiënten groep. Vervolgonderzoek dient uit te wijzen of deze 
gevonden verschillen ook prospectief kunnen worden gebruikt om patiënten met een verhoogd 
risico op ACS op niet-invasieve wijze te identificeren. 
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In Hoofdstuk 19 is de invloed onderzocht van type 2 diabetes op MSCT plaquekarakteristieken 
zoals de uitgebreidheid en het type. In een populatie van 215 patiënten, waarvan 40% met type 
2 diabetes werd MSCT uitgevoerd. Significante verschillen werden gevonden tussen patiënten 
met en zonder type 2 diabetes. De aanwezigheid van diabetes hield verband met het totaal aantal 
atherosclerotisch aangetaste en het aantal niet-obstructieve vernauwde coronairsegmenten. De 
hoeveelheid van zowel niet-gecalcificeerde als gecalcificeerde plaque was positief gecorreleerd met 
de aanwezigheid van type 2 diabetes. Geen verschillen werden gevonden in de totale hoeveelheid 
significante vernauwingen. Op basis van deze niet-invasieve MSCT bevindingen is geconcludeerd 
dat type 2 diabetes gepaard gaat met een toegenomen hoeveelheid plaques die voornamelijk 
niet-obstructief zijn. Gemengde plaques zijn beduidend minder aanwezig bij patiënten met type 2 
diabetes. 
Daar men met behulp van MSCT een schatting kan geven van de hoeveelheid atherosclerose in de 
kransslagaderen en een onderscheid kan maken tussen verschillende atherosclerotische patronen, 
is het aannemelijk dat de informatie die MSCT verschaft gebruikt kan worden voor risicostratificatie. 
Hoofdstuk 20 beschrijft de bevindingen bij 100 patiënten die gedurende een periode van gemiddeld 
16 maanden gevolgd zijn voor het optreden van coronaire gebeurtenissen nadat zij een MSCT scan 
hadden ondergaan. Tijdens de follow-up traden 33 gebeurtenissen op bij 26 patiënten. In patiënten 
met volledig normale kransslagaderen op MSCT werd in het eerste jaar een complicatiefrequentie 
van 0% gezien in vergelijking tot 30% bij patiënten met aanwijzingen voor coronairlijden op MSCT. 
Multivariate analyse, waarbij gecorrigeerd werd voor patiëntenkarakteristieken, toonde aan dat 
de aanwezigheid van coronairlijden, significant coronairlijden, significant coronairlijden in de 
hoofdstam, het aantal segmenten met plaques, het aantal segmenten met obstructieve plaques, en 
het aantal segmenten met mixed plaques significante voorspellers zijn van coronaire gebeurtenissen. 
Op basis van dit hoofdstuk is geconcludeerd dat MSCT coronairangiografie onafhankelijk van 
patiëntenkarakteristieken belangrijke prognostische informatie kan verschaffen. In het bijzonder is 
van belang dat een de uitstekende prognose van patiënten met een normaal MSCT onderzoek is 
gevonden, hetgeen laat zien dat MSCT veilig uitsluiten van coronairlijden toestaat. 
Deel V
In het laatste gedeelte van de thesis worden niet-coronaire toepassingen van MSCT en MRI 
beschreven. 
Contrast MRI staat precieze afgrenzing van infarctweefsel toe. Hierbij kan ook de mate van 
transmuraliteit worden bepaald. In Hoofdstuk 21 werd visuele beoordeling van de infarct 
transmuraliteit vergeleken met kwantitatieve bepaling. Hiernaast werd infarct transmuraliteit 
gerelateerd aan de ernst van bewegingsstoornissen in rust.  Beeldvorming met MRI werd uitgevoerd 
bij 27 patiënten met langdurig ischemische LV disfunctie op basis van een eerder doorgemaakt 
infarct. Zowel cine MRI (om de regionale wandbeweging te beoordelen) als contrast MRI (om het 
infarctweefsel te detecteren) werden uitgevoerd in rust en visueel geanalyseerd. Hiervoor werd 
een 17 segments model gebruikt. De mate van transmuraliteit werd tevens gekwantificeerd op 
basis van drempelanalyse. Een goede overeenkomst tussen visuele en kwantitatieve analyses werd 
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gevonden en 90% van de myocardsegmenten werden vergelijkbaar geclassificeerd. De mate van 
transmuraliteit hield verband met de ernst van wandbewegingsstoornissen; 96% van de segmenten 
met normale of slechts geringe afwijkende wandbeweging lieten infarcering van ≤25% van de 
wand zien. Daarentegen was in 93% van segmenten met akinesie of dyskinesie  >50% van de wand 
betrokken. Geconcludeerd is dat, in vergelijking tot kwantitatieve analyse, visuele analyse van 
contrast MRI studies voldoende is voor de beoordeling van de mate van infarct transmuraliteit. 
Informatie aangaande infarctweefsel kan ook verkregen worden met MSCT. Aangezien een 
3D dataset wordt verkregen tijdens registratie van het ECG, kunnen beelden gereconstrueerd 
worden in de korte-as oriëntatie op elk tijdstip van de hartcyclus. Bovendien worden de beelden 
verkregen tijdens de toediening van een contrast bolus, resulterend in beelden tijdens de eerste 
passage van contrast. Als gevolg hiervan kunnen gebieden met verminderde doorbloeding worden 
herkend als hypodense gebieden. Het doel van Hoofdstuk 22 was om met MSCT de haalbaarheid 
te onderzoeken van een compleet cardiaal onderzoek, inclusief beoordeling van LV functie en 
doorbloeding in combinatie met de coronairanatomie. Bij 21 patiënten met een doorgemaakt 
infarct werd MSCT in aanvulling op traditionele coronairangiografie (beoordeling coronairanatomie) 
en gated SPECT (beoordeling doorbloeding en functie) uitgevoerd. In vergelijking met traditionele 
coronairangiografie bereikte MSCT een sensitiviteit en specificiteit van 91% en 97%. Een uitstekende 
overeenstemming werd gezien in de bepaling van LVEF en regionale wandbeweging tussen 
MSCT en gated SPECT. Met betrekking tot de beoordeling van doorbloeding in rust identificeerde 
MSCT 93% van gebieden met hypoperfusie correct, terwijl tevens de afwezigheid van een 
doorbloedingsstoornis correct beschreven werd in 98%. 
Hoofdstuk 23 beschrijft de resultaten van onze validatie van functie metingen met MSCT in een 
groot patiëntencohort. Globale functie (LV volumina en EF) werd bepaald met 16-slice MSCT en 
vergeleken met 2D-echocardiografie. Lineaire regressie liet uitstekende correlaties zien alhoewel 
een geringe overschatting van LVEF met MSCT werd gezien. 
Tot slot is in Hoofdstuk 24 een zeer nieuwe toepassing van MSCT coronairangiografie, namelijk 
de weergave van het cardiale veneuze systeem, onderzocht. Voor succesvolle implantatie van 
de LV draad bij cardiale resynchronisatie behandeling kan kennis van het veneuze systeem 
zeer bruikbaar zijn. In deze studie werd dan ook de aanwezigheid van de verschillende venen 
onderzocht bij 100 patiënten (38 patiënten met significant coronairlijden, 34 met een doorgemaakt 
infarct en 28 patiënten als controle groep). De sinus coronarius en diens eerste zijtak, de posterior 
interventriculaire vene, werden geïdentificeerd in alle patiënten. Daarentegen bleek bij patiënten 
met een doorgemaakt infarct de linker marginale vene frequent te ontbreken, hetgeen succesvolle 
implantatie van de LV draad bij cardiale resynchronisatie behandeling zou kunnen verhinderen.  
Conclusie
Verscheidene modaliteiten zijn beschikbaar in de diagnostiek en risicostratificatie van patiënten 
die zich presenteren met bekend of verdenking op coronairlijden. Een in het bijzonder snel 
ontwikkelende techniek is niet-invasieve coronairangiografie met MSCT. In vergelijking met invasieve 
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coronairangiografie is aangetoond dat de techniek zeer nauwkeurig significante vernauwingen kan 
opsporen en momenteel een geschiktere techniek is voor niet-invasieve coronairangiografie dan MRI. 
Gelet op de hoge negatief voorspellende waarde ligt de voornaamste bijdrage van de techniek in het 
uitsluiten van coronairlijden op niet-invasieve wijze in patiënten met verdenking op coronairlijden 
en gemiddelde voorafkans hierop. Hoewel beeldvorming in patiënten met bekend coronairlijden, 
zoals patiënten met eerdere stent implantatie, lastiger lijkt, zijn ook in deze patiëntenpopulaties 
veelbelovende resultaten verkregen. 
Ondanks deze veelbelovende observaties dient men zich te realiseren dat slechts de helft van de 
vernauwingen die op MSCT gezien worden hemodynamische gevolgen lijkt te hebben. Deze 
bevindingen wijzen erop dat de aanwezigheid van coronairatherosclerose, zelfs wanneer deze leidt 
tot vernauwing, niet altijd de aanwezigheid van ischemie impliceert. Zodoende blijft in het geval 
van twijfelachtige stenosering of beperkte beeldkwaliteit op MSCT functionele beeldvorming 
noodzakelijk om de aanwezigheid van ischemie te bepalen. Voor dit doel kunnen nucleaire 
beeldvorming, stress echocardiografie of MRI worden toegepast. Met de laatste techniek kan zelfs 
de bloeddoorstroming gemeten worden in coronaire omleidingen. Wellicht zullen metingen in de 
natieve kransslagaderen in de toekomst ook worden uitgevoerd.
Een van de grote voordelen van MSCT is de zeer vroegtijdige detectie van coronairlijden. Onderzoek 
heeft laten zien dat MSCT verschillende plaque-karakteristieken kan onderscheiden tussen 
verschillende klinische presentaties zoals bij patiënten met ACS. Het is zeer goed mogelijk dat deze 
informatie nuttig kan zijn voor verfijning van risicostratificatie. Tot slot, in aanvulling op informatie 
over de coronairanatomie, kan ook andere, niet-coronair gerelateerde, informatie verkregen 
worden met deze techniek. De LV functie kan betrouwbaar worden bepaald terwijl bijvoorbeeld ook 
informatie over de doorbloeding in rust of het cardiale veneuze systeem kan worden verkregen. 
Terugkerend naar de behandeling van coronairlijden lijkt integratie van MSCT coronairangiografie 
met functionele beeldvorming de geschiktste strategie. Op deze wijze kan coronairlijden met 
hoge zekerheid worden uitgesloten of juist vroegtijdig worden gedetecteerd. In het laatste geval 
kan de behandeling vervolgens worden bepaald aan de hand van de aanwezigheid van ischemie. 
Men dient zich evenwel te realiseren dat de beschikbare data op dit gebied nog spaarzaam zijn. 
Vervolgstudies moeten aantonen of toepassing van zulke strategieën tot een patiëntenbeleid zal 
leiden dat resulteert in zowel een verbeterde uitkomst als besparing van kosten.
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